Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

    
          Number of people
          
104 763 (51.32% female)
          
          People with ≥2 records
          52.40%

          Median duration from first to last measurement
          2.25 years

Coding

Definition

OMOP Concept ID: 3029187— open in OHDSI Athena.
Part of collection: Natriuretic peptide.B prohormone N-Terminal with 1 other OMOP concept — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029187	p-probnp	ng/l (ng/l)	86654	251889	0.22%
3029187	p-probnp	— (—)	28113	49832	100.00%	Distribution not available
3029187	s-probnp	ng/l (ng/l)	1295	1508	0.00%
3029187	b-probnp	ng/l (ng/l)	591	1338	0.00%
3029187	p-pbnp-lb	ng/l (ng/l)	582	1239	0.00%
3029187	b-ntprobnp	ng/l (ng/l)	453	910	0.00%
3029187	p-ntprobnp	ng/l (ng/l)	400	1396	0.00%
3029187	p-probnp(ksks)	ng/l (ng/l)	283	541	0.00%
3029187	b-ntprobnp	— (—)	263	441	100.00%	Distribution not available
3029187	p-pro-bnp	ng/l (ng/l)	243	634	0.00%
3029187	s-probnp	— (—)	186	189	100.00%	Distribution not available
3029187	p-pbnp-o	ng/l (ng/l)	165	223	0.00%
3029187	p-probnp(k	ng/l (ng/l)	145	199	0.00%
3029187	b-probnp	— (—)	143	175	100.00%	Distribution not available
3029187	p-pbnp-lb	— (—)	141	174	100.00%	Distribution not available
3029187	p-ntprobnp	— (—)	98	196	100.00%	Distribution not available
3029187	b-probnp-o	ng/l (ng/l)	82	115	0.00%
3029187	p-probnpvt	ng/l (ng/l)	75	161	0.00%
3029187	p-prbnpvt	ng/l (ng/l)	72	82	0.00%
3029187	p-probnp(ksks)	— (—)	62	67	100.00%	Distribution not available
3029187	p-probnp(pika)	ng/l (ng/l)	61	103	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-termin.prop	ng/l (ng/l)	54	66	0.00%
3029187	p-vprobnp	ng/l (ng/l)	46	109	0.00%
3029187	b-probnp-o	— (—)	40	57	100.00%	Distribution not available
3029187	b-probnpo	ng/l (ng/l)	38	44	9.09%
3029187	p-pbnp-o	— (—)	33	36	100.00%	Distribution not available
3029187	p-prbnpvt	— (—)	31	45	100.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypin(32-)	ng/l (ng/l)	25	29	0.00%
3029187	p-pro-bnp	— (—)	22	23	100.00%	Distribution not available
3029187	p-probnpvt	— (—)	19	24	100.00%	Distribution not available
3029187	p-probnp(	ng/l (ng/l)	19	22	0.00%
3029187	p-probnp-pika	ng/l (ng/l)	19	22	0.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropepti(ko)	ng/l (ng/l)	15	15	0.00%
3029187	-bnp	ng/l (ng/l)	15	43	0.00%
3029187	-probnppoc	ng/l (ng/l)	14	17	0.00%	Distribution not available
3029187	p-prbnp-vt	ng/l (ng/l)	14	15	0.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypin(32-)(pi)	ng/l (ng/l)	14	14	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropeptidi	ng/l (ng/l)	12	12	0.00%
3029187	nt-probnp	ng/l (ng/l)	11	14	0.00%
3029187	p-probnp(pika)	— (—)	11	14	100.00%	Distribution not available
3029187	p-probnp(pi)	ng/l (ng/l)	11	11	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-termin.prop	— (—)	10	11	100.00%	Distribution not available
3029187	s-natriureettinenpeptidi,b-tyypinn-terminaalinenpropeptidi	ng/l (ng/l)	10	10	0.00%
3029187	p-probnpv	ng/l (ng/l)	9	13	0.00%	Distribution not available
3029187	probnp	ng/l (ng/l)	9	25	0.00%
3029187	p-probnp-pika	— (—)	9	12	100.00%	Distribution not available
3029187	p-probnpviitasaari	ng/l (ng/l)	9	10	0.00%	Distribution not available
3029187	b-pbnp-pt	ng/l (ng/l)	9	9	0.00%	Distribution not available
3029187	natriureettinenpeptidi(p-probnp)	— (—)	8	8	100.00%	Distribution not available
3029187	p-probnp(k	— (—)	8	8	100.00%	Distribution not available
3029187	p-probnp-o	ng/l (ng/l)	7	8	0.00%	Distribution not available
3029187	ps-probnp	ng/l (ng/l)	7	10	0.00%	Distribution not available
3029187	natriureettinenpeptidi(p-probnp)	ng/l (ng/l)	6	6	0.00%
3029187	p-probnp-p	ng/l (ng/l)	6	7	0.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypin(32-)	— (—)	6	6	100.00%	Distribution not available
3029187	p-pbnp-hy	ng/l (ng/l)	5	5	0.00%	Distribution not available	Distribution not available
3029187	p-probnpv	— (—)	5	7	100.00%	Distribution not available	Distribution not available
3029187	p-probnp(	— (—)	5	5	100.00%	Distribution not available	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropepti(ko)	— (—)	5	5	100.00%	Distribution not available

Cohort

Number of people: 104 763 (51.32% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

People with ≥2 records: 52.40%
Median number of measurements per person: 2.0
Median duration from first to last measurement: 2.25 years

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Reference range

N people

N records

—

85774

216600

0-900/50-75v

3875

10055

<486/miehetyli75

2698

6615

<376/miehet65-74

2400

5895

<738/naisetyli75

2346

5397

<229/Miehetyli65V

2279

4465

0-1800/yli75v

2098

5064

<301/naiset65-74

1944

4215

<352/Naisetyli65V

1687

3166

0-486

1615

3699

0-738

1405

2968

Alle125ng/l,katsoohjekirja/kaikki

1360

3558

0-241

1308

2784

<194/Miehet50-65V

1275

4532

<210/miehet55-64

1079

2462

0-285

1026

2222

<222/Naiset50-65V

959

2464

<287/naiset55-64

892

1804

0-161

755

1620

<155/Naisetalle50V

746

2191

<84/Miehetalle50V

710

3085

0-247

649

1427

<194/miehet50-65v

620

1186

0-450/alle50v

585

1460

<486/miehetyli74v

579

1076

<222/naiset50-65v

521

839

<738/naisetyli74v

493

852

<249/naiset45-54

491

960

<130/naiset18-44

485

941

0-116

481

1187

<241/miehet65-74v

443

824

<121/miehet45-54

403

906

<285/naiset65-74v

401

634

0-169

381

765

0-84

347

772

0-63

282

841

<86/miehet18-44

253

594

<247/naiset55-64v

216

345

<161/miehet55-64v

203

396

<155/naisetalle50v

190

318

<84/miehetalle50v

154

224

<116/naisetalle45v

143

251

<169/naiset45-54v

102

158

<84/miehet45-54v

155

<63/miehetalle45v

121

<194

<222

<155

katsoohjekirjastakohtaTulkinta/kaikki

<84

Value range per person

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Artificial joint operation, meniscal resection

16272

79293

1.48

320.81

3.0

1231.50

1472.16

ng/l

9.38

13907

67703

Dental operations

11669

42107

1.59

318.90

3.3

3.0

1710.46

1719.74

ng/l

0.06

10020

36059

Symptoms and signs involving the skin and subcutaneous tissue

11710

82174

1.56

318.81

3.2

2.9

1294.99

1359.54

ng/l

0.74

10071

69783

Any mental disorder

18461

69714

1.43

318.20

3.1

2.9

1363.90

1363.12

ng/l

0.01

15495

59572

Gout, unspecified

4381

26270

2.31

317.88

5.0

3.1

3247.20

1622.60

ng/l

35.74

3933

22802

Congenital malformations of cardiac septa

1247

4174

4.39

315.69

5.4

3.1

1126.32

1136.20

ng/l

0.03

1121

3464

Gout, strict definition

3943

23105

2.44

314.97

5.1

3.1

3291.94

1648.05

ng/l

33.30

3552

20130

Infections of the skin and subcutaneous tissue

9123

61810

1.64

314.87

3.6

2.9

1896.78

1245.67

ng/l

17.75

7763

52254

Other or ill-defined heart diseases

1034

3187

4.89

313.22

5.9

1.8

1921.98

520.09

ng/l

10.31

916

2507

Missing teeth due to accident, extraction or parodontitis

10747

72534

1.61

311.17

3.3

2.9

1239.42

1391.43

ng/l

3.27

9020

62584

Insulin, fast-acting

6195

39479

1.85

310.10

4.0

3.0

2778.03

1353.21

ng/l

37.71

5402

33637

Primary gonarthrosis, bilateral

9790

59258

1.67

308.48

3.1

3.0

1343.82

1551.52

ng/l

4.44

8413

51172

Tramadol

16633

52600

2.41

307.65

3.2

2.7

1446.98

1316.03

ng/l

2.13

14097

44235

Osteopathies and chondropathies

10169

63403

1.75

307.65

3.5

2.9

1706.11

1365.13

ng/l

8.95

8761

53899

Vocal cord dysfunction

2295

5639

4.82

307.65

3.3

1.6

1138.80

339.24

ng/l

18.15

1954

4520

COPD

9654

48900

2.06

307.65

3.9

2.9

2039.26

1612.16

ng/l

10.67

8533

42144

Heart failure and coronary heart disease

14108

34445

6.81

307.65

6.5

2.4

3519.62

1256.24

ng/l

223.94

13310

28733

Dorsalgia

17948

60479

1.81

307.65

3.1

2.9

1148.18

1514.62

ng/l

22.60

15190

51065

Any reimbursement code in KELA

7989

17243

2.63

307.65

3.2

1.8

1078.58

472.15

ng/l

29.94

6627

13300

Viral Sepsis

4647

22448

3.05

307.65

5.1

2.8

2638.70

1383.47

ng/l

23.60

4169

19118

Pain in joint

9778

38503

1.84

307.65

2.9

1099.68

1375.02

ng/l

7.96

8076

32840

Antihypertensive medication - note that there are other indications

8677

14494

3.74

307.65

3.4

1.7

1142.29

383.26

ng/l

37.71

7155

11027

Dilated cardiomyopathy

3599

13179

7.64

307.65

8.3

3.0

2678.84

1611.62

ng/l

21.13

3450

11367

Hypertension

15287

39607

2.71

307.65

3.3

2.5

1450.35

823.13

ng/l

34.09

13016

32613

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

17939

66152

1.91

307.65

3.3

2.6

1765.39

1141.42

ng/l

34.67

15159

55782

Anaemias

3818

2862

11.55

307.65

4.0

1.3

1751.82

182.21

ng/l

47.87

3304

2054

Other retinal disorders

12435

67058

1.69

307.65

3.4

3.0

2207.79

1470.07

ng/l

28.05

10736

57613

Hard cardiovascular diseases

21716

48558

4.02

307.65

4.0

2.2

1490.72

884.17

ng/l

50.83

19391

39545

Septicaemia

9474

49249

2.39

307.65

4.3

2.8

3151.03

1341.26

ng/l

82.24

8561

41980

Hernia

16582

77501

1.61

307.65

3.2

2.9

1455.60

1364.42

ng/l

1.56

14223

65468

Depression medications

3209

3047

6.05

307.65

2.8

1.3

815.08

156.25

ng/l

13.71

2509

2145

Status post-ami

6013

22391

2.98

307.65

5.0

2.4

2778.96

1318.76

ng/l

54.16

5512

18640

Stroke, excluding SAH

11756

60998

1.65

307.65

3.6

3.0

2122.48

1485.94

ng/l

25.63

10340

52387

Hypertension, essential

15820

39176

2.92

307.65

3.0

2.4

1438.44

825.02

ng/l

34.94

13464

32276

Ischaemic heart disease, wide definition

19669

54610

3.30

307.65

3.6

2.5

1631.56

1008.26

ng/l

46.33

17627

45562

Percutaneous Coronary Intervention

23131

48530

4.99

307.65

4.2

2.2

1532.58

935.89

ng/l

54.13

20887

39663

Implicit viral Sepsis

6622

33586

2.79

307.65

4.7

2.8

2319.92

1334.46

ng/l

26.12

5902

28586

Certain infectious and parasitic diseases

12779

41903

1.69

307.65

3.3

2.6

1602.48

1086.35

ng/l

22.37

10946

35061

Cardiomyopathy, other and unspecified

2374

5383

12.93

307.65

7.6

1.8

2402.77

515.04

ng/l

45.55

2238

4335

Myocardial infarction, strict

10977

35248

3.28

307.65

4.1

2.3

2432.91

1111.98

ng/l

76.99

10028

29144

Chronic apical periodontitis

18836

79310

1.48

307.65

3.0

2.9

1326.67

1380.22

ng/l

0.72

15924

67318

Other arrhythmias

15797

37353

4.76

307.65

3.7

1.7

1224.91

448.74

ng/l

109.19

13795

29554

Sensorineural hearing loss

14569

68961

1.65

307.65

3.2

3.0

1428.57

1495.04

ng/l

1.00

12336

59312

Asthma/COPD (KELA code 203)

17576

75985

1.82

307.65

3.3

2.8

1230.45

1361.83

ng/l

3.58

15056

63938

Left bundle-branch block

2018

5489

8.56

307.65

4.9

1.8

1597.38

551.72

ng/l

31.27

1821

4439

Coronary atherosclerosis

16949

43279

3.87

307.65

3.8

2.2

1806.44

1005.64

ng/l

59.13

15276

35577

Hypo-osmolality and hyponatraemia

3772

20413

2.56

307.65

4.0

2.9

2170.67

1494.09

ng/l

12.65

3305

17436

Care involving use of rehabilitation procedures

10830

67075

1.68

307.65

3.4

2.7

1614.90

1117.52

ng/l

17.47

9447

56171

Bacterial Sepsis

11442

51115

2.69

307.65

4.7

2.8

2970.19

1319.02

ng/l

103.62

10310

43636

Stroke, including SAH

12204

63128

1.63

307.65

3.5

2.9

2086.54

1448.29

ng/l

27.28

10727

54127

Hypertensive Heart Disease

6503

20021

4.34

307.65

4.6

2.6

2782.66

1190.04

ng/l

81.51

5870

16965

Unstable angina pectoris

8472

33388

2.85

307.65

4.0

2.4

2057.18

1259.13

ng/l

28.92

7639

27847

AV-block

5191

13761

6.48

307.65

5.2

1.8

2296.50

652.13

ng/l

84.88

4742

11156

Asthma, hospital admission 2, infections

11686

65119

2.15

307.65

3.9

2.9

1419.34

1519.52

ng/l

1.55

10155

55089

Explicit Sepsis

9649

50011

2.36

307.65

4.3

2.8

3122.85

1315.20

ng/l

83.21

8709

42567

Cholelithiasis

15001

74448

1.55

307.65

3.1

2.9

1475.99

1416.99

ng/l

0.73

12696

63512

Coronary artery bypass grafting

6077

21806

3.08

307.65

4.2

2.4

2679.31

1320.09

ng/l

49.33

5615

18180

Paroxysmal tachycardia

5318

8144

8.91

307.65

5.3

1.5

1421.51

263.42

ng/l

107.27

4793

6119

Transient ischemic attack

10466

58968

1.71

307.65

3.6

3.0

1809.78

1515.63

ng/l

6.41

9270

50713

Acute renal failure

4966

26863

2.69

307.65

5.6

2.9

4213.74

1265.02

ng/l

90.72

4541

23091

Secondary hypertension

1371

3095

6.38

307.65

3.5

1.5

5566.62

305.00

ng/l

37.92

1224

2347

Statin medication

11068

33448

2.14

307.65

3.4

2.5

1457.95

998.14

ng/l

15.10

9274

27580

Amiodarone users

2692

11748

5.03

307.65

7.7

3.0

2354.85

1650.38

ng/l

10.84

2565

10209

Cardiac arrest

1330

2648

6.65

307.65

5.2

1.5

3013.07

337.21

ng/l

31.92

1218

2020

Senile cataract

11746

47917

1.77

307.65

3.3

2.8

1799.47

1209.02

ng/l

23.68

10190

41061

Obesity due to excess calories

9199

43995

2.72

307.65

3.5

2.8

1190.31

1112.53

ng/l

0.96

7567

37283

Other and unspecified iron deficiency

6804

39973

2.17

307.65

4.2

3.0

2302.51

1549.65

ng/l

21.46

5949

34233

Obesity, other/unspecified

5773

29126

2.45

307.65

3.4

2.7

1088.65

1106.54

ng/l

0.12

4765

24592

Other and unspecified anaemias

9482

54866

2.15

307.65

4.1

3.0

2658.60

1608.34

ng/l

46.54

8496

47212

Sleep apnoea

19327

71886

2.14

307.65

3.3

2.8

1043.13

1378.82

ng/l

21.32

15917

61751

Any operation in hilmo

527

236

13.08

307.65

3.0

1.3

1605.11

502.32

ng/l

4.65

428

172

Autoimmune diseases excluding thyroid diseases, strict definition

16898

66467

1.52

307.65

3.2

2.9

1721.97

1330.25

ng/l

14.95

14563

56034

Left ventricular outflow tract obstruction, narrow definition

1264

3543

8.31

307.65

5.3

3.2

872.32

1196.94

ng/l

2.36

1175

2980

Hypothyroidism, drug reimbursement

1790

2252

6.85

307.65

3.1

1.3

939.87

176.79

ng/l

10.74

1501

1666

Congenital malformations of heart and great arteries

2745

9247

4.61

307.65

4.8

3.0

1026.03

1227.46

ng/l

1.90

2505

7706

Other bacterial diseases

21200

74619

2.44

307.65

3.9

2.7

2219.09

1073.70

ng/l

113.73

18751

62545

Nerve, nerve root and plexus disorders

19169

82106

1.60

307.65

3.1

2.9

1349.66

1416.53

ng/l

1.06

16322

69649

All pneumoniae

20853

75208

2.27

307.65

3.9

2.6

1917.13

1047.02

ng/l

82.80

18419

62686

Spondylopathies

15760

57466

1.94

307.65

3.1

2.9

1182.59

1551.77

ng/l

22.79

13540

48899

All chronic kidney diseases

12373

54393

2.47

307.65

4.7

2.8

4183.25

1061.54

ng/l

237.20

11155

46302

Asthma, hospital admissions 3, pneumonia

7784

43795

2.31

307.65

4.3

3.0

1705.94

1746.99

ng/l

0.29

6919

37418

Benign neoplasm: Colon

10507

70891

1.67

307.65

3.4

3.0

1657.80

1494.01

ng/l

2.24

9158

61165

Diverticular disease of intestine

14930

59190

1.95

307.65

3.3

2.9

1527.93

1416.54

ng/l

1.92

12910

50591

Biguanides

17905

72012

1.74

307.65

3.2

2.8

1515.22

1283.74

ng/l

8.74

15001

61316

Implicit Sepsis

17981

68444

2.67

307.65

4.2

2.7

2276.53

1125.58

ng/l

105.71

15860

57802

All influenza

4736

25992

2.30

307.65

4.3

2.8

2061.15

1292.44

ng/l

16.14

4149

21926

Other functional intestinal disorders

8612

49552

1.92

307.65

3.5

2.9

1584.18

1510.12

ng/l

0.56

7405

42321

Acute bronchitis

7702

46867

1.93

307.65

4.2

3.0

1840.71

1626.75

ng/l

3.10

6588

39897

Venous thromboembolism

11484

68901

2.01

307.65

3.5

3.0

1527.39

1568.21

ng/l

0.33

10148

58960

Condition for Implicit Sepsis (Organ dysfunction codes)

19235

70004

2.50

307.65

4.1

2.6

2047.60

1063.43

ng/l

89.67

16812

58817

Pulmonary embolism

6845

36943

2.65

307.65

3.7

3.0

1388.02

1655.34

ng/l

5.91

6134

31736

Heart failure, strict

19929

51655

6.15

307.65

5.8

2.2

3199.77

775.92

ng/l

307.65

18707

43485

Thoracic aortic aneurysm

3440

16101

3.74

307.65

3.5

3.0

1360.13

1299.20

ng/l

0.36

3111

13922

Other cataract

8603

40589

1.95

307.65

3.5

2.8

1790.96

1293.09

ng/l

12.68

7467

34850

Hyperlipidaemia, other/unspecified

9322

45510

2.69

307.65

3.6

2.8

1854.10

1380.89

ng/l

11.69

8119

38972

Use of hypnotics and sedatives

18302

76344

1.52

307.65

3.1

2.9

1410.13

1349.63

ng/l

0.86

15422

64874

Non-allergic asthma (mode), excluding more controls

3257

15141

2.66

307.65

3.4

1.9

1180.23

635.59

ng/l

9.10

2847

12490

Complications of surgical and medical care, not elsewhere classified

19863

82500

1.96

307.65

3.5

2.8

1815.83

1298.10

ng/l

29.46

17226

69687

Metabolic disorders

20984

65223

2.50

307.65

3.4

2.7

1694.13

1181.69

ng/l

31.48

18189

54692

COPD related to multimorbidity

8445

46456

1.96

307.65

4.2

3.0

2228.03

1686.47

ng/l

14.00

7507

40319

Diabetes, varying definitions

19457

67601

1.98

307.65

3.5

2.6

1694.32

1126.11

ng/l

35.22

16556

56826

COPD/asthma related infections

18631

59558

1.78

307.65

3.4

2.5

1574.44

1076.36

ng/l

31.36

16026

49935

Diarrhoea and gastroenteritis of presumed infectious origin

11657

73163

1.60

307.65

3.7

2.9

1959.82

1341.84

ng/l

20.00

9920

61754

Asthma (only as main-diagnosis), excluding more controls

13351

33713

2.79

307.65

3.4

1.9

1058.01

543.56

ng/l

49.04

11379

27448

Arthropathies

13826

49288

1.54

307.65

3.0

2.9

1421.20

1351.46

ng/l

0.74

11595

41439

Systemic connective tissue disorders

6712

41513

2.00

307.65

3.5

3.0

1305.48

1474.48

ng/l

2.72

5905

35458

Disorders of choroid and retina

15340

76130

1.65

307.65

3.3

2.9

2057.64

1366.41

ng/l

33.00

13213

65073

8011

43804

2.20

307.65

3.9

2.9

1207.39

1414.57

ng/l

5.24

6870

36807

Other neurological diseases

14201

75282

1.74

307.65

3.4

3.0

1619.95

1489.84

ng/l

2.31

12442

64278

18702

59555

2.34

307.65

3.8

2.5

1891.75

1076.42

ng/l

64.75

16514

49932

COPD differential diagnosis

13966

40863

1.96

307.65

3.3

2.4

1362.86

1022.46

ng/l

13.36

11918

34099

Other heart diseases

13701

12600

12.45

307.65

4.3

1.5

1389.66

229.93

ng/l

105.14

12290

9259

COPD/asthma/ILD related infections

18631

59558

1.78

307.65

3.4

2.5

1574.44

1076.36

ng/l

31.36

16026

49935

Implicit Sepsis

19122

70120

2.63

307.65

4.1

2.6

2132.36

1087.74

ng/l

98.35

16759

59027

Cardiovascular diseases (excluding rheumatic etc)

11526

14450

5.93

307.65

3.4

1.4

986.30

219.55

ng/l

56.88

9659

10491

Autoimmune diseases

18349

68705

1.47

307.65

3.2

2.9

1556.11

1323.73

ng/l

7.59

15578

57935

Cardiodefibrillation

9397

47614

3.29

307.65

4.8

3.0

2028.86

1580.91

ng/l

19.78

8640

41117

Influenza and pneumonia

21448

73787

2.25

307.65

3.8

2.6

1850.66

1032.94

ng/l

76.06

18877

61427

Coxarthrosis [arthrosis of hip](FG)

10756

49361

1.81

307.65

3.2

2.8

1480.98

1456.31

ng/l

0.21

9390

42147

Disorders of eyelid, lacrimal system and orbit

15144

82031

1.57

307.65

3.1

3.0

1261.04

1449.17

ng/l

6.26

12882

69925

COPD (mode)

7149

28016

2.81

307.65

3.9

2.5

2102.20

1214.95

ng/l

29.12

6327

23902

Diabetes medication

18960

72643

1.77

307.65

3.2

2.8

1683.82

1214.11

ng/l

22.91

15936

61503

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

21318

79176

2.32

307.65

4.0

2.7

2021.67

1175.12

ng/l

83.14

18733

66564

Autoimmune diseases excluding thyroid diseases

17467

68412

1.52

307.65

3.2

2.9

1711.71

1325.62

ng/l

15.15

15053

57698

Chronic lower respiratory diseases

22472

76062

1.80

307.65

3.4

2.8

1334.60

1362.54

ng/l

0.35

19226

63997

Other diseases of intestines

18723

67636

1.78

307.65

3.2

2.8

1391.86

1320.39

ng/l

1.11

15835

56923

Soft tissue disorders

17359

61399

1.60

307.65

3.1

2.9

1332.37

1473.99

ng/l

3.18

14576

51887

Other headache syndromes

6662

39684

1.94

307.65

2.8

2.7

865.80

1281.56

ng/l

16.09

5567

33690

Hernia of abdominal wall, postoperative

3453

17521

2.54

307.65

3.3

2.6

1715.09

1155.86

ng/l

5.86

2987

15066

Congenital malformations of the circulatory system

2838

10661

3.82

307.65

4.7

3.0

959.49

1233.49

ng/l

3.46

2575

8943

Benign neoplasm of colon, rectum, anus and anal canal

12526

75017

1.72

307.65

3.4

3.0

1641.28

1473.99

ng/l

2.81

10906

64477

Depression or dysthymia

11604

44428

1.60

307.65

3.1

3.0

1152.43

1424.46

ng/l

8.65

9621

38403

Bacterial infection, other or unspecified

12372

58112

2.48

307.65

4.2

2.8

2764.80

1237.57

ng/l

87.89

11077

49379

Diseases of oesophagus, stomach and duodenum

20826

75710

1.93

307.65

3.2

2.9

1464.86

1353.47

ng/l

2.12

17608

64195

Dorsopathies

17040

60669

1.56

307.65

3.0

2.9

1160.32

1513.02

ng/l

23.61

14351

51217

Artrosis, including avohilmo

14108

53583

1.60

307.65

2.9

3.0

1285.32

1523.39

ng/l

7.78

11898

45500

Cardiomyopathy (excluding other)

4073

9685

12.24

307.65

8.2

1.8

2659.59

545.31

ng/l

101.51

3901

7820

Other disorders of ear

16712

75842

1.63

307.65

3.1

2.9

1360.90

1413.82

ng/l

0.75

14083

64696

STROKE

11039

33137

2.95

307.65

3.5

2.0

1567.65

723.98

ng/l

55.86

9675

26762

Pain (limb, back, neck, head abdominally)

12537

41348

1.68

307.65

3.2

2.9

1455.32

1509.83

ng/l

0.51

10624

35230

Angina pectoris

13750

40760

3.31

307.65

3.7

2.2

1707.17

1036.50

ng/l

37.57

12299

33622

Diseases of arteries, arterioles and capillaries (FINNGEN)

5987

7675

9.19

307.65

3.7

1.5

2368.91

272.14

ng/l

79.84

5427

5787

Episodal and paroxysmal disorders

20159

63758

1.83

307.65

3.2

2.9

1201.59

1502.31

ng/l

16.21

16850

54239

Shoulder lesions

14017

56878

1.71

307.65

3.0

2.9

1108.17

1463.21

ng/l

20.46

12001

48488

Other systemic involvement of connective tissue (FG)

4944

27404

2.26

307.65

3.4

2.8

1232.34

1434.99

ng/l

3.66

4315

23286

Chronic kidney disease

7572

39647

2.78

307.65

5.5

3.0

5649.75

1384.18

ng/l

190.53

6945

34085

Heart failure and bmi 25plus

11008

29181

5.57

307.65

5.9

2.2

2869.84

722.32

ng/l

253.93

10293

24023

Polyarthropathies

13229

47050

2.22

307.65

3.7

2.9

2089.84

1381.59

ng/l

28.28

11507

39832

Renal failure

11472

54819

2.67

307.65

5.2

2.9

4698.73

1256.09

ng/l

245.60

10455

47119

Left ventricular outflow tract obstruction (LVOTO), broad definition

2622

7990

7.04

307.65

4.6

3.0

1211.62

1068.34

ng/l

0.81

2416

6691

Disorders of lipoprotein metabolism and other lipidaemias

18699

61436

2.43

307.65

3.3

2.7

1652.11

1225.04

ng/l

20.87

16240

51804

Asthma-related pneumonia

7771

43720

2.31

307.65

4.3

3.0

1706.35

1747.36

ng/l

0.29

6909

37355

Nonischemic cardiomyopathy

3124

8722

10.96

307.65

6.8

2.4

2378.93

1109.85

ng/l

23.50

2987

7243

Other dorsopathies, not elsewhere classified

17507

60546

1.69

307.65

3.0

2.9

1153.50

1512.56

ng/l

22.36

14781

51120

Aortic aneurysm

5240

29215

2.45

307.65

3.6

3.1

1856.02

1616.55

ng/l

2.45

4712

25180

Renal tubulo-interstitial diseases

18780

75998

2.31

307.65

4.1

2.7

2945.42

943.19

ng/l

219.84

16628

64013

Other diseases of the respiratory system

4346

25606

2.28

307.65

4.9

3.1

2179.48

1825.12

ng/l

3.56

3927

22088

Other diseases of urinary system

17122

68861

1.54

307.65

3.2

2.9

1585.35

1341.61

ng/l

7.27

14599

58495

Aplastic and other anaemias

10200

57945

2.12

307.65

4.2

3.0

2783.68

1570.98

ng/l

61.82

9151

49821

Other joint disorders

13566

49233

1.58

307.65

2.9

1213.55

1348.49

ng/l

2.74

11267

41396

Conduction disorders

8513

20528

6.27

307.65

4.9

1.8

1958.09

569.58

ng/l

123.32

7654

16578

Other (not insulin) diabetes medications

18205

70791

1.75

307.65

3.2

2.8

1549.23

1230.31

ng/l

12.98

15260

60164

Dipeptidyl peptidase 4 (DPP-4) inhibitors

12055

58732

2.12

307.65

3.8

2.9

2247.40

1406.25

ng/l

41.01

10438

50679

Non-ischemic cardiomyopathy

9923

25532

7.43

307.65

5.2

2.1

2635.91

703.70

ng/l

206.97

9265

21000

Bronchitis

18778

83675

1.57

307.65

3.7

2.8

1598.04

1352.04

ng/l

8.99

16008

70790

Sleep apnoea, including avohilmo

19841

72416

2.04

307.65

3.2

2.8

1017.59

1386.84

ng/l

27.30

16308

62183

Calcific aortic valvular stenosis, operated

8726

40691

3.89

307.65

4.3

3.1

2465.48

1845.22

ng/l

16.01

8100

35077

Other soft tissue disorders, not elsewhere classified

18130

60842

2.07

307.65

3.2

2.9

1368.68

1463.64

ng/l

1.54

15260

51468

Endocrine, nutritional and metabolic diseases

13101

35458

2.13

307.65

3.3

2.4

1476.65

973.75

ng/l

19.45

10912

29488

Coronary revascularization (ANGIO or CABG)

22998

48543

4.91

307.65

4.2

2.2

1526.03

935.72

ng/l

52.65

20771

39675

Obesity

12089

60700

2.40

307.65

3.4

2.8

1197.01

1148.04

ng/l

0.59

9992

51398

Other diseases of pleura

10197

53761

2.20

307.65

4.4

3.0

2283.37

1619.32

ng/l

23.91

9211

46358

Bleeding

16830

75392

1.90

307.65

3.8

2.8

1954.13

1315.84

ng/l

39.51

14756

64033

Major coronary heart disease event

23668

53232

4.31

307.65

4.1

2.2

1568.63

993.03

ng/l

49.81

21352

43681

Cardiac arrhythmias

14872

21358

6.83

307.65

3.8

1.7

1294.96

373.06

ng/l

118.66

13061

16488

Cardiomyopathy

5722

13273

11.89

307.65

7.4

1.8

2534.49

568.80

ng/l

121.37

5432

10658

Obesity related asthma

7377

35394

2.90

307.65

3.7

2.8

1060.32

1259.38

ng/l

3.79

6267

30063

Arthrosis

12646

45998

1.70

307.65

3.0

2.8

1288.09

1403.75

ng/l

2.10

10744

39065

Lower back pain or/and sciatica

19538

83554

1.75

307.65

3.1

2.9

1136.87

1432.73

ng/l

17.43

16587

70749

Iron deficiency anaemia

8736

52042

2.08

307.65

4.4

2.9

2374.76

1534.19

ng/l

31.62

7674

44463

Valvular heart disease excluding rheumatic fever

15453

28703

8.41

307.65

4.3

1.8

1821.69

507.57

ng/l

169.31

14208

22988

Other acute lower respiratory infections

9694

58831

1.84

307.65

4.2

3.0

1845.73

1554.52

ng/l

6.05

8326

49924

Obesity and other hyperalimentation

12138

61029

2.39

307.65

3.4

2.8

1196.33

1150.13

ng/l

0.55

10033

51678

Pure hypercholesterolaemia

16522

59195

2.34

307.65

3.2

2.7

1604.40

1245.09

ng/l

16.54

14427

50113

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

17487

77747

1.63

307.65

3.2

2.9

1451.43

1385.22

ng/l

0.89

15020

65956

Neurological diseases

14039

44255

1.77

307.65

3.1

2.8

1225.06

1433.51

ng/l

5.26

11653

37660

Atrial fibrillation and flutter

9033

9316

11.72

307.65

4.2

1.4

1645.74

249.94

ng/l

141.60

8254

7000

Peripheral artery disease

9110

49568

1.79

307.65

4.0

3.0

3451.00

1529.30

ng/l

85.52

8206

42700

Atrial fibrillation and flutter with reimbursement

7982

7858

13.88

307.65

4.4

1.5

1618.48

268.20

ng/l

182.74

7376

5943

Any gastric operation

13260

39356

1.89

307.65

3.3

2.5

1514.08

1132.87

ng/l

12.33

11079

32946

Other bacterial diseases

21889

72705

2.39

307.65

3.7

2.7

2044.31

1045.32

ng/l

93.64

19235

60638

Other disorders of fluid, electrolyte and acid-base balance

7186

35627

2.70

307.65

4.2

2.8

2602.24

1431.65

ng/l

42.49

6377

30348

Gout, idiopatic and unspecified

5346

32548

2.24

307.65

4.9

3.1

3170.07

1621.51

ng/l

40.49

4791

28236

Bacterial infection, other or unspecified

13314

60346

2.49

307.65

4.1

2.7

2678.85

1204.63

ng/l

91.22

11911

51146

Gout, FINNGEN

6309

38915

2.13

307.65

4.8

3.1

3106.89

1654.14

ng/l

42.53

5664

33716

Used for control exclusion in common control thyroid runs

17431

63797

1.50

307.65

3.3

2.9

1545.27

1338.58

ng/l

5.76

14782

53773

Asthma, unspecified (mode)

11960

39182

3.03

307.65

3.6

2.4

1289.58

1032.90

ng/l

9.63

10313

32794

Erysipelas

15964

66597

2.33

307.65

3.8

2.7

2108.54

1109.12

ng/l

79.22

14028

55981

All kidney diseases

20034

76339

2.18

307.65

3.9

2.6

2510.19

899.18

ng/l

177.09

17498

63981

Bicuspidal aortic valve syndrome

953

2735

8.54

307.65

4.0

3.1

783.39

1197.27

ng/l

2.79

885

2301

Glucagon-like peptide-1 (GLP-1) analogues

5087

28016

2.30

307.65

3.4

2.8

874.86

966.93

ng/l

1.38

4153

23991

Codeine or tramadol medication

22102

74117

1.90

307.65

3.3

2.8

1376.60

1403.29

ng/l

0.33

18817

62607

Continuous positive airway pressure

4395

8425

7.08

307.65

4.0

1.7

1878.36

453.84

ng/l

59.55

3500

6741

Cerebrovascular diseases (FINNGEN)

5825

9791

5.79

307.65

3.4

1.4

1602.40

244.12

ng/l

71.55

5079

7361

Pulmonary heart disease

6845

37112

2.63

307.65

3.7

3.1

1388.02

1670.57

ng/l

6.54

6134

31901

Spondylosis

10173

53429

1.83

307.65

3.0

2.9

1048.12

1527.89

ng/l

30.82

8719

45737

Gonarthrosis

12159

44475

1.80

307.65

3.0

2.9

1264.36

1430.91

ng/l

3.65

10340

37947

Pain in limb

16142

59994

2.17

307.65

3.2

2.9

1418.25

1457.96

ng/l

0.40

13699

50834

Spinal stenosis

10930

50474

2.07

307.65

3.3

3.0

1307.10

1657.13

ng/l

15.87

9538

43367

Acute tubulo-interstitial nephritis

11971

64553

1.90

307.65

3.6

2.7

2228.73

1025.51

ng/l

85.48

10440

54672

Rotator cuff syndrome

10959

54195

1.65

307.65

3.0

2.9

1083.13

1452.67

ng/l

18.46

9479

46380

Gout

6309

29910

2.57

307.65

4.8

3.0

3106.89

1718.45

ng/l

38.26

5664

25874

Other intervertebral disc disorders

14764

58749

1.71

307.65

3.0

2.9

1040.41

1520.89

ng/l

37.12

12533

49825

Other disorders of urethra and urinary system

12723

59654

1.77

307.65

3.2

2.9

1650.49

1406.06

ng/l

5.40

10857

50789

Low back pain

14075

59323

2.00

307.65

3.1

2.9

1181.22

1490.34

ng/l

12.02

11848

50169

Other/unspecified dorsalgia

6484

39544

1.91

307.65

3.3

2.9

1171.07

1534.50

ng/l

12.02

5486

33519

GASTRO-related operations

13260

39356

1.89

307.65

3.3

2.5

1514.08

1132.87

ng/l

12.33

11079

32946

Cardiovascular diseases

9907

11071

6.00

307.65

3.3

1.4

945.70

226.79

ng/l

44.19

8173

7967

Heart failure, not strict

24509

52088

6.51

307.65

4.9

1.9

2292.72

510.69

ng/l

307.65

22501

42959

Other arthrosis

9224

42448

1.73

307.65

3.0

2.9

1167.23

1373.22

ng/l

4.23

7863

36270

Emergency coronary revascularization (for ACS)

25125

56312

4.47

307.65

4.2

2.3

1636.17

1163.32

ng/l

32.62

22649

46383

Sciatica+with lumbago

8790

50940

1.84

307.65

3.0

2.9

944.28

1385.04

ng/l

29.86

7572

43279

Coxarthrosis

9799

41227

1.86

307.65

3.2

2.9

1492.54

1493.61

ng/l

0.01

8545

35371

Calcific aortic valvular stenosis, diagnosis (helper)

8705

40669

3.88

307.65

4.3

3.1

2468.79

1845.51

ng/l

16.09

8080

35057

DVT of lower extremities and pulmonary embolism

9179

54298

2.20

307.65

3.6

3.0

1457.83

1643.49

ng/l

3.02

8130

46562

Aortic valve malfunction, age under 60 years

2434

7505

7.04

307.65

4.3

3.0

1203.38

1077.32

ng/l

0.63

2245

6296

Endocarditis

859

2297

7.81

307.65

5.4

1.8

3456.42

517.27

ng/l

15.75

808

1843

Heart failure and antihypertensive medication

9065

8572

20.34

307.65

6.4

1.7

2882.05

502.34

ng/l

161.04

8564

6860

Operations 2 for CAVS

8705

40669

3.88

307.65

4.3

3.1

2468.79

1845.51

ng/l

16.09

8080

35057

Calcific aortic valvular stenosis, including rheumatic fever

8732

40789

3.86

307.65

4.3

3.1

2465.55

1845.62

ng/l

16.02

8105

35160

Calcific aortic valvular stenosis

8726

40691

3.89

307.65

4.3

3.1

2465.48

1845.22

ng/l

16.01

8100

35077

Conductive and sensorineural hearing loss

15013

70735

1.64

307.65

3.2

3.0

1417.83

1471.72

ng/l

0.73

12715

60708

Erysipelas

12103

61688

2.20

307.65

3.9

2.7

2259.39

1191.45

ng/l

65.36

10650

52262

Asthma, excluding more controls

14522

33713

2.75

307.65

3.3

1.9

1040.52

543.56

ng/l

47.73

12412

27448

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3145

12386

3.51

307.65

4.5

3.0

1558.19

1257.12

ng/l

2.07

2876

10371

Other disorders of skin and subcutaneous tissue

13191

78333

1.75

307.65

3.5

2.9

2151.48

1361.34

ng/l

34.49

11478

66763

Insulin, intermediate and long-acting

10611

66521

1.86

307.65

3.8

3.0

2514.44

1413.36

ng/l

48.57

9242

56891

Covid-19 confirmed case

8130

43295

2.57

307.65

4.4

3.0

1942.50

1568.94

ng/l

9.07

7384

37027

Type 2 diabetes, wide definition

17094

61261

2.25

307.65

3.5

2.6

1903.82

1188.32

ng/l

47.71

14777

51963

Other CVD

4394

26100

2.33

307.65

4.2

3.2

2141.06

1893.14

ng/l

1.73

3872

22566

Type 2 diabetes, definitions combined

18670

65495

1.98

307.65

3.5

2.6

1523.49

1141.19

ng/l

20.90

15840

55292

Pulmonary heart disease, diseases of pulmonary circulation

7673

40805

2.73

307.65

4.2

3.0

1554.43

1686.21

ng/l

1.78

6908

35028

Ischemic heart diseases

22767

49535

4.37

307.65

4.0

2.2

1481.21

925.48

ng/l

46.32

20449

40413

Non-rheumatic valve diseases

15338

28623

8.34

307.65

4.3

1.8

1825.20

506.04

ng/l

168.49

14098

22920

Benign neoplasms

15644

63106

1.48

307.65

3.2

2.9

1506.78

1379.04

ng/l

2.05

13255

53232

Asthma-related infections

11686

65119

2.15

307.65

3.9

2.9

1419.34

1519.52

ng/l

1.55

10155

55089

Liquid cancers, helper endpoint

7535

42330

1.91

307.65

3.6

3.1

1800.67

1497.08

ng/l

5.47

6782

36169

Insulin medication

11494

60312

1.91

307.65

3.9

2.9

2504.51

1348.70

ng/l

57.19

10021

51534

Asthma (diagnoses ohter than nonallergic)

17043

84708

1.98

307.65

3.5

2.9

1242.17

1432.03

ng/l

7.77

14683

71586

Hypothyroidism (congenital or acquired)

3102

2946

7.00

307.65

3.2

1.3

859.03

162.90

ng/l

15.78

2470

2102

Sleep disorders (combined)

20993

71744

1.75

307.65

3.2

2.9

1152.11

1480.39

ng/l

22.60

17430

61494

Myocardial infarction, without ST-elevation

10136

51665

2.60

307.65

4.2

3.1

3014.10

1605.93

ng/l

67.23

9222

44554

ILD medications

22501

70286

2.05

307.65

3.8

2.6

1490.34

1314.98

ng/l

5.01

19387

58814

Inflammatory bowel disease treatment related agents

23044

74466

2.05

307.65

3.8

2.7

1400.93

1361.66

ng/l

0.55

19930

62373

Diseases of the respiratory system

10935

34451

1.78

307.65

3.2

2.5

1433.80

1085.12

ng/l

10.37

9321

28890

Constipation

17186

77707

1.79

307.65

3.2

2.9

1371.43

1441.71

ng/l

1.09

14554

66418

Infections, IBD-co-morbidities

2960

6544

4.29

307.65

4.2

2.4

2321.39

1058.98

ng/l

18.21

2614

5583

Other septicaemia

8425

45468

2.37

307.65

4.3

2.8

3247.26

1382.84

ng/l

72.71

7626

38796

Asthma, including avohilmo

21775

80752

1.71

307.65

3.3

2.9

1172.52

1455.08

ng/l

17.01

18508

68237

Adjustment and management of implanted device

5318

23376

4.38

307.65

5.7

3.0

2470.36

1604.02

ng/l

24.65

4907

20021

Symptoms and signs involving the circulatory and respiratory systems

20124

46035

2.67

307.65

3.2

2.5

1291.97

1330.43

ng/l

0.48

16894

38537

Disorders of gallbladder, biliary tract and pancreas

17974

79281

1.61

307.65

3.2

2.9

1519.97

1376.36

ng/l

3.08

15370

67454

Insulin, combination of fast acting with intermediate-acting or long-acting

11528

71269

1.72

307.65

3.9

3.0

2505.36

1424.76

ng/l

50.88

10050

60810

Gastrointestinal diseases

8649

27296

1.73

307.65

3.1

2.6

1355.59

1153.70

ng/l

2.68

7166

22792

ILD medications: prednisolone, methylprednisolone, prednisone

22465

69985

2.16

307.65

3.8

2.6

1508.97

1317.76

ng/l

5.85

19419

58596

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2665

5281

5.85

307.65

4.1

2.4

1550.54

1234.82

ng/l

2.48

2397

4539

Pneumonia, organism unspecified

19446

71792

2.38

307.65

4.0

2.6

1968.58

1047.85

ng/l

87.54

17217

59977

COPD, hospital admissions

9294

52613

1.85

307.65

4.0

3.0

2042.49

1623.85

ng/l

10.61

8226

45578

Other respiratory disorders and diseases

4346

25606

2.28

307.65

4.9

3.1

2179.48

1825.12

ng/l

3.56

3927

22088

Condition for Implicit Sepsis (Organ dysfunction codes)

19678

68837

2.51

307.65

3.9

2.6

1901.73

1028.70

ng/l

75.78

17159

57531

ILD medications: immunosuppressive drugs

10944

61188

1.94

307.65

4.1

2.6

1650.93

1136.90

ng/l

15.06

9622

51262

Implicit bacterial Sepsis

11164

50022

2.76

307.65

4.8

2.8

2919.22

1332.11

ng/l

94.46

10059

42732

Caries of dentine

4031

20493

2.39

307.65

4.5

2.9

2461.05

1369.81

ng/l

15.77

3567

17557

20767

73647

1.63

307.65

3.5

2.7

1536.44

1349.79

ng/l

5.76

17685

62360

Other chronic obstructive pulmonary disease, including avohilmo

11143

60274

1.89

307.65

3.8

3.0

1906.62

1526.43

ng/l

10.79

9764

52100

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

18702

59555

2.34

307.65

3.8

2.5

1891.75

1076.42

ng/l

64.75

16514

49932

Hypothyroidism, levothyroxine purchases

3062

2939

6.92

307.65

3.2

1.3

840.92

162.97

ng/l

14.95

2434

2101

Diabetes, insulin treatment (Kela reimbursement)

19189

74572

1.80

307.65

3.3

2.8

1795.76

1233.88

ng/l

30.41

16251

63228

Symptoms and signs involving the digestive system and abdomen

17524

60957

1.59

307.65

3.3

2.9

1423.13

1414.37

ng/l

0.08

14818

51755

Asthma, hospital admissions , main diagnosis only

14834

84092

1.79

307.65

3.4

2.9

1159.18

1429.03

ng/l

13.16

12690

71021

Nutritional anaemias

10001

61245

1.92

307.65

4.3

2.9

2340.83

1547.85

ng/l

33.49

8800

52415

Cholelithiasis, broad definition with cholecystitis

15639

75400

1.57

307.65

3.2

2.9

1510.05

1408.88

ng/l

1.66

13273

64301

Implicit bacterial Sepsis

10185

47351

2.73

307.65

4.9

2.8

3053.16

1369.43

ng/l

91.00

9194

40472

Dental caries

4508

23056

2.32

307.65

4.5

2.9

2342.85

1363.91

ng/l

15.52

3990

19733

Other anaemias

9564

55222

2.15

307.65

4.1

3.0

2649.29

1604.07

ng/l

46.80

8571

47514

Pneumonias (Asthma/COPD co-morbidities)

20783

75242

2.28

307.65

3.9

2.6

1912.15

1048.27

ng/l

82.36

18361

62724

Undetermined asthma, excluding more controls

2252

9603

3.07

307.65

3.4

1.9

1114.25

598.87

ng/l

11.05

1906

7929

COPD, early/later onset

9362

52962

1.84

307.65

4.0

3.0

2069.96

1616.86

ng/l

11.59

8282

45884

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

21363

67999

2.61

307.65

4.2

2.4

1688.96

1125.02

ng/l

39.34

18830

56592

Implicit viral Sepsis

4643

22422

3.05

307.65

5.1

2.8

2641.06

1384.54

ng/l

23.61

4165

19093

Certain infectious and parasitic diseases

17110

56187

1.70

307.65

3.4

2.6

1640.50

1036.10

ng/l

40.27

14698

46959

Cerebrovascular diseases

14571

70677

1.70

307.65

3.5

2.9

1976.20

1369.79

ng/l

31.12

12787

60528

Asthma-related pneumonia or sepsis

7784

43795

2.31

307.65

4.3

3.0

1705.94

1746.99

ng/l

0.29

6919

37418

Asthma (mode)

14720

40853

2.30

307.65

3.3

2.4

1068.85

1022.55

ng/l

0.66

12553

34091

Symptoms and signs involving the urinary system

15048

74289

1.82

307.65

3.3

3.0

1750.10

1391.87

ng/l

12.48

12850

63397

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

20433

75648

2.26

307.65

3.9

2.6

1930.49

1061.62

ng/l

81.26

18067

63151

Excluding asthma or asthma-COPD overlap

14068

40907

1.97

307.65

3.3

2.4

1367.49

1017.82

ng/l

14.04

12001

34138

Hypertensive diseases (excluding secondary)

9454

12681

5.71

307.65

3.3

1.4

1302.11

225.72

ng/l

63.58

7955

9342

Other heart diseases, wide

24895

41457

5.66

307.65

3.8

1.7

1440.84

438.38

ng/l

161.03

22068

32435

General symptoms and signs

20864

57880

2.12

307.65

3.4

2.6

1399.75

1227.91

ng/l

4.57

17811

48488

Other specific joint derangements/joint disorders

11570

47000

1.79

307.65

2.9

2.8

1083.49

1252.15

ng/l

4.04

9562

39537

Other nutritional deficiencies

12620

63036

2.34

307.65

3.5

2.8

1203.19

1157.83

ng/l

0.54

10447

53407

Gonarthrosis [arthrosis of knee](FG)

14400

54714

1.77

307.65

3.0

2.8

1248.12

1377.01

ng/l

2.79

12262

46396

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

13514

76567

1.93

307.65

3.6

2.9

1517.45

1475.61

ng/l

0.48

11896

65417

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3302

13492

3.33

307.65

4.4

3.0

1544.04

1265.72

ng/l

1.95

3006

11300

Fitting and adjustment of other devices

7788

43224

2.08

307.65

3.5

2.8

1646.58

1447.72

ng/l

3.52

6779

36866

Diseases of the skin and subcutaneous tissue

17078

61898

1.51

307.65

3.2

2.8

1597.38

1272.23

ng/l

11.76

14500

52286

Complications of medical and surgical care

13877

83081

1.80

307.65

3.6

2.9

1863.39

1340.10

ng/l

22.32

11965

70689

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6934

12141

4.49

307.65

2.9

1.4

1096.78

226.19

ng/l

37.91

5886

9005

Valvular operations

4574

11256

11.12

307.65

5.0

1.8

1827.68

599.57

ng/l

64.89

4360

9062

ILD differential diagnosis

13956

40853

1.95

307.65

3.3

2.4

1360.30

1022.55

ng/l

13.16

11909

34091

Asthma (only as main-diagnosis)

13935

40539

2.40

307.65

3.4

2.4

1109.32

1019.44

ng/l

1.76

11885

33823

Asthma

15294

40539

2.38

307.65

3.3

2.4

1101.60

1019.44

ng/l

1.55

13085

33823

Gonarthrosis,primary

16964

74591

1.60

307.65

3.0

1250.46

1506.05

ng/l

10.98

14475

63974

Cardiomyopathies, Primary/intrinsic

4002

8909

13.85

307.65

8.2

1.8

2645.12

553.61

ng/l

98.48

3833

7192

Myocarditis

1085

1596

12.52

307.65

8.9

1.4

1185.47

270.26

ng/l

15.55

993

1172

Symptoms and signs involving cognition, perception, emotional state and behaviour

19052

78696

1.95

307.65

3.2

2.9

1372.98

1369.07

ng/l

0.04

16151

66730

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

5087

28016

2.30

307.65

3.4

2.8

874.86

966.93

ng/l

1.38

4153

23991

Diabetes mellitus

19506

67598

1.97

307.65

3.5

2.6

1696.62

1123.92

ng/l

35.82

16587

56821

Ulcer of lower limb, not elsewhere classified

3239

17373

2.81

307.65

4.1

3.2

3968.22

1644.26

ng/l

34.89

2931

15006

Major coronary heart disease event excluding revascularizations

14875

44659

3.27

307.65

4.0

2.3

2225.51

1096.11

ng/l

84.19

13504

36912

Gastro-oesophageal reflux disease

13146

70233

1.92

307.65

3.1

2.9

1252.27

1345.64

ng/l

1.30

10822

59976

Type 2 diabetes

19297

66460

2.01

307.65

3.5

2.6

1697.93

1131.12

ng/l

34.49

16398

55985

First line medication for Crohn's disease

21644

67867

2.02

307.65

3.7

2.6

1462.79

1325.43

ng/l

3.21

18694

56622

Disorders of lens

12584

51242

1.80

307.65

3.3

2.8

1803.18

1160.53

ng/l

27.32

10920

43769

All-cause Heart Failure

19551

50918

6.08

307.65

5.7

2.2

3189.09

776.39

ng/l

307.65

18336

42833

Other chronic obstructive pulmonary disease

9242

47549

2.04

307.65

4.0

2.9

2052.42

1630.33

ng/l

9.97

8176

40988

Pain, not elsewhere classified

4971

25455

2.42

307.65

3.3

2.6

1224.07

1221.91

ng/l

0.01

4317

21435

Other diseases of pericardium

1119

2955

8.28

307.65

5.2

1.8

2087.18

482.51

ng/l

10.31

1053

2374

Diseases of the musculoskeletal system and connective tissue

7819

24464

1.75

307.65

3.1

2.8

1370.28

1417.07

ng/l

0.33

6469

20522

Type 2 diabetes, strict (exclude DM1)

18734

65874

1.98

307.65

3.5

2.6

1531.93

1142.40

ng/l

21.64

15897

55620

Unspecified haematuria

8182

45229

1.79

307.65

3.4

3.1

2120.38

1572.64

ng/l

13.28

7136

39111

Ischaemic Stroke, excluding all haemorrhages

11143

59190

1.65

307.65

3.6

3.0

2231.19

1521.93

ng/l

27.88

9790

50929

Hypertensive diseases

15308

39618

2.71

307.65

3.3

2.5

1448.79

822.93

ng/l

34.05

13038

32622

Hypothyroidism and >3 levothyroxin purchases

3062

2939

6.92

307.65

3.2

1.3

840.92

162.97

ng/l

14.95

2434

2101

Hypertensive heart and/or renal disease

7145

21010

4.27

307.65

4.6

2.6

3176.50

1164.32

ng/l

94.21

6456

17798

General examination and investigation of persons without complaint and reported diagnosis

11779

34121

2.09

307.65

3.5

2.7

1429.63

1457.51

ng/l

0.22

10072

28847

Fever of other and unknown origin

11640

51674

2.53

307.65

4.0

2.7

1890.74

1296.90

ng/l

19.54

10285

43539

Myocardial infarction

12067

36948

3.49

307.65

4.1

2.3

2447.23

1086.99

ng/l

87.39

11027

30514

Other CVD (FINNGEN)

2743

4321

8.82

307.65

4.1

1.4

1984.41

318.25

ng/l

40.12

2434

3289

Diseases of arteries, arterioles and capillaries

15133

66545

2.18

307.65

3.8

2.9

2552.79

1336.68

ng/l

78.14

13598

56847

Dyspnoea

25264

74166

3.85

307.65

4.0

2.6

1595.00

1340.39

ng/l

11.74

22002

62549

Asthma, unspecified (mode), excluding more controls

11451

32638

3.53

307.65

3.5

1.9

1224.65

550.11

ng/l

71.56

9860

26666

Later onset COPD, excluding more controls

4762

20803

2.48

307.65

4.1

2.6

2406.47

1437.05

ng/l

22.93

4263

17893

Transplanted organ and tissue status

1858

7507

3.68

307.65

7.9

2.4

4416.45

1067.56

ng/l

27.93

1765

6247

Persons encountering health services in other circumstances, wide

22206

74303

1.75

307.65

3.3

2.9

1493.86

1373.61

ng/l

2.92

18964

62766

Persons encountering health services for specific procedures and health care

21853

72141

2.19

307.65

3.7

2.7

1877.92

1090.83

ng/l

62.72

19146

59937

Presence of other functional implants

12100

51950

1.98

307.65

3.4

2.6

1840.05

1333.59

ng/l

18.23

10301

44146

Persons encountering health services for examination and investigation

11337

34279

1.87

307.65

3.2

2.7

1532.47

1468.47

ng/l

0.60

9607

28956

Other special examinations and investigations of persons without complaint or reported diagnosis

12099

34275

2.06

307.65

3.3

2.7

1469.92

1468.34

ng/l

0.01

10306

28955

Neurological diseases, wide definition

4043

8070

2.85

307.65

3.2

2.5

1219.07

945.43

ng/l

2.65

3267

6713

Other medical care

9263

51233

2.01

307.65

3.8

2.8

2042.38

1302.91

ng/l

34.79

8452

43427

Presence of cardiac and vascular implants and grafts

14240

42762

4.83

307.65

5.5

2.7

2245.80

1482.18

ng/l

47.75

13214

36552

Persons encountering health services for other counselling and medical advice, not elsewhere classified

20615

73553

1.73

307.65

3.2

2.9

1503.10

1349.94

ng/l

3.55

17703

62186

Medical observation and evaluation for suspected diseases and conditions

13684

34263

2.48

307.65

3.4

2.7

1416.78

1467.62

ng/l

0.51

11468

28949

Examination and observation for other reasons

11218

33719

2.30

307.65

3.4

2.7

1416.28

1432.02

ng/l

0.11

9717

28529

Persons encountering health services in other circumstances

7014

40170

2.07

307.65

3.4

2.9

1448.66

1302.41

ng/l

2.02

5895

33955

Non-invasive ventilation

3356

10266

3.57

307.65

4.2

1.7

2136.32

377.42

ng/l

60.08

3051

8185

Factors influencing health status and contact with health services

5371

12816

2.44

307.65

3.2

2.2

1646.07

1260.67

ng/l

5.41

4535

10687

Follow-up examination after treatment for conditions other than malignant neoplasms

7035

28229

1.87

307.65

3.0

2.6

1331.82

1422.77

ng/l

0.80

5929

23878

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

11016

74935

1.67

307.65

3.5

2.9

1932.63

1360.44

ng/l

20.45

9505

63998

Other antidepressants

18448

65399

1.61

307.65

3.1

3.0

1246.16

1499.79

ng/l

11.64

15378

56111

Fall on same level

19182

74148

1.55

307.65

3.2

2.8

1569.87

1231.36

ng/l

15.94

16183

62673

Codes for special purposes

10435

59161

2.19

307.65

4.1

2.9

1760.38

1430.06

ng/l

9.53

9398

50041

Provisional assignment of new diseases of uncertain etiology

10421

59090

2.19

307.65

4.1

2.9

1761.24

1429.71

ng/l

9.57

9386

49985

Heart failure,strict

18343

40372

7.90

307.65

5.9

1.9

3120.96

574.65

ng/l

307.65

17286

33576

Early onset COPD, excluding more controls

4013

19095

2.83

307.65

3.7

2.4

1453.14

1104.72

ng/l

4.16

3518

16258

Pacemaker

9762

44136

4.02

307.65

5.8

3.0

2400.47

1798.69

ng/l

22.49

8984

38075

Disorders of thyroid, IBD co-morbidities

2903

6812

3.70

307.65

4.1

2.3

1142.96

987.88

ng/l

1.56

2501

5769

Intracranial trauma

9863

36509

2.22

307.65

3.2

2.7

1396.03

1278.52

ng/l

1.76

8295

30977

Congenital malformations of aortic and mitral valves

1091

2970

9.03

307.65

5.1

3.1

778.77

1180.46

ng/l

3.11

1019

2494

Other pulmonary diagnosis

14145

40907

1.99

307.65

3.3

2.4

1390.63

1017.82

ng/l

15.68

12066

34138

Complications of procedures, not elsewhere classified

15171

80636

1.81

307.65

3.4

2.8

1841.73

1288.74

ng/l

24.96

13159

68244

Injuries to the head

19234

83502

1.57

307.65

3.2

2.9

1548.62

1328.06

ng/l

8.43

16279

70688

Codeine

17952

53791

2.14

307.65

3.2

2.7

1344.99

1292.19

ng/l

0.75

15242

45058

Oral corticosteroids

22834

73773

2.25

307.65

3.8

2.7

1399.45

1367.62

ng/l

0.42

19856

61866

Type 2 diabetes, definitions combined, including avohilmo

18478

64733

1.96

307.65

3.5

2.6

1501.84

1140.45

ng/l

18.45

15623

54658

Finngen Rheumatological endpoints

16863

60065

1.81

307.65

3.1

2.8

1386.19

1308.40

ng/l

1.09

14336

50304

Malaise and fatigue

12084

45910

2.87

307.65

3.8

2.7

1888.81

1389.91

ng/l

19.79

10431

38897

Abnormalities of heart beat

8153

31747

3.56

307.65

3.6

2.5

1381.25

1448.65

ng/l

0.64

6913

26817

Haemorrhage from respiratory passages

7723

32369

2.95

307.65

4.2

2.6

2046.33

1584.27

ng/l

10.39

6785

27628

Pain in throat and chest

19466

45577

3.40

307.65

3.3

2.5

1241.47

1332.56

ng/l

1.60

16497

38195

Abdominal and pelvic pain

17407

60954

1.58

307.65

3.2

2.9

1363.09

1414.02

ng/l

0.60

14711

51752

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5572

11423

2.80

307.65

3.0

2.3

1264.24

995.65

ng/l

3.69

4606

9443

Headache

11159

51448

2.00

307.65

3.0

2.6

963.13

1162.07

ng/l

6.58

9293

43024

Respiratory insufficiency

1912

8296

3.67

307.65

5.8

2.6

2165.96

1541.47

ng/l

5.12

1755

7134

Nausea and vomiting

5045

28623

2.11

307.65

3.8

2.9

2007.61

1598.02

ng/l

4.32

4341

24467

Syncope and collapse

10048

44024

2.55

307.65

3.7

2.7

1694.30

1424.33

ng/l

6.45

8696

37408

Opioids

17684

54192

1.94

307.65

3.1

2.7

1405.94

1297.12

ng/l

1.91

15004

45342

Benzodiazepine use

17768

85320

1.60

307.65

3.1

2.9

1288.54

1410.92

ng/l

2.88

14787

72572

Abnormal findings on diagnostic imaging of lung

10039

62359

1.92

307.65

3.7

3.0

1551.32

1572.63

ng/l

0.18

8916

53680

Cough

7514

35105

2.52

307.65

3.3

2.5

1209.98

1344.16

ng/l

1.78

6375

29682

Dizziness and giddiness

15219

72788

2.00

307.65

3.3

2.9

1364.45

1425.02

ng/l

0.87

13020

62024

Parasetamol

13207

32840

2.37

307.65

3.2

2.6

1500.25

1238.18

ng/l

5.80

11085

27251

Abnormalities of breathing

21835

45990

3.76

307.65

3.6

2.5

1404.66

1331.19

ng/l

1.18

18645

38505

Oedema, not elsewhere classified

7624

34831

3.11

307.65

3.7

2.7

1692.05

1403.53

ng/l

4.16

6638

29615

Concussion

8417

36234

2.21

307.65

3.2

2.8

1382.63

1282.93

ng/l

1.23

7025

30762

Oxycodone

8696

41368

2.57

307.65

3.8

2.8

1717.86

1496.91

ng/l

3.35

7774

35322

Familial hypercholesterolemia, with ischemic heart disease

2133

10253

3.43

305.89

4.5

2.7

2083.14

1459.68

ng/l

6.95

1900

8706

Gonarthrosis, primary, with knee surgery

11023

63363

1.62

305.32

3.1

3.0

1330.62

1567.82

ng/l

6.34

9438

54786

Diseases of pulp and periapical tissues and dental caries

12386

45392

1.55

304.44

3.2

3.0

1736.17

1639.38

ng/l

1.05

10618

38866

Lumbar disc prolapse

10246

54962

1.59

303.73

2.9

925.26

1404.67

ng/l

33.49

8703

46696

Periodontitis

16241

81949

1.45

303.51

3.1

2.9

1368.69

1330.15

ng/l

0.42

13743

69806

Diseases of the ear and mastoid process

18472

70302

1.42

302.84

3.0

2.9

1252.58

1385.51

ng/l

3.06

15349

59632

Intestinal infectious diseases

15352

87139

1.45

301.83

3.6

2.9

1921.26

1306.61

ng/l

27.81

13071

73675

Caries of dentine, including avohilmo

14243

53353

1.50

301.53

3.2

3.0

1612.45

1573.58

ng/l

0.36

12167

45708

Non-allergic asthma (mode)

3258

17190

2.29

300.34

3.4

2.5

1180.05

1160.52

ng/l

0.08

2848

14519

Chronic periodontitis, including avohilmo

16175

81947

1.45

298.52

3.1

2.9

1362.69

1330.16

ng/l

0.34

13684

69811

Dental caries, including avohilmo

13580

50668

1.51

298.28

3.2

3.0

1663.80

1606.99

ng/l

0.56

11602

43411

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10053

71422

1.60

296.36

3.5

2.9

1894.08

1380.52

ng/l

16.24

8667

61082

Intracranial injury

9902

65952

1.59

296.26

3.3

3.0

1631.47

1468.17

ng/l

2.99

8353

56240

Pleural effusion

3363

19019

2.51

295.97

4.4

3.0

2789.03

1763.43

ng/l

14.82

3076

16396

Atherosclerosis, excluding cerebral and coronary sclerosis

8541

47220

1.74

294.85

4.1

3.0

3542.83

1564.93

ng/l

83.52

7707

40702

Intestinal infectious diseases

19044

83670

1.40

294.10

3.4

2.9

1694.72

1323.00

ng/l

15.18

16201

70895

Visual disturbances and blindness

8892

61876

1.64

293.37

3.4

3.0

1394.20

1439.05

ng/l

0.37

7563

52825

Psychiatric diseases

16533

62169

1.44

292.45

3.1

2.9

1373.94

1362.73

ng/l

0.09

13879

53236

Meniscus derangement

9317

43392

1.62

291.26

2.9

1061.62

1364.57

ng/l

11.32

7866

37017

Polyarthrosis

3927

21241

2.20

288.95

3.3

2.8

1273.16

1471.06

ng/l

2.25

3395

18209

Familial hypercholesterolemia

3250

18265

2.47

286.70

4.0

2.9

1774.65

1503.28

ng/l

2.87

2879

15705

Hypotension

3819

22789

2.35

284.36

4.2

3.2

2125.53

1950.71

ng/l

1.06

3354

19737

Diseases of oral cavity, salivary glands and jaws

11100

40541

1.56

284.11

3.3

3.0

1748.76

1707.39

ng/l

0.31

9528

34743

Undetermined asthma

2252

10761

2.68

283.87

3.4

2.4

1114.25

1101.42

ng/l

0.06

1906

9091

Falls/tendency to fall

17032

64523

1.42

281.63

3.1

2.8

1488.03

1222.64

ng/l

10.09

14331

54616

ILD, hospital admission 2, with pulmonary infections

2175

10769

3.10

281.53

4.5

2.8

1957.97

1483.39

ng/l

3.75

1972

9268

Hypertrophic cardiomyopathy

1097

4116

6.42

280.50

7.7

3.1

2345.02

1453.04

ng/l

6.63

1040

3537

Myalgia

3690

20898

2.10

278.25

3.0

2.8

948.07

1270.81

ng/l

6.96

3011

17739

Dermatitis

10201

73010

1.56

276.87

3.3

2.9

1527.59

1342.37

ng/l

3.11

8741

62217

Symptoms and signs involving the nervous and musculoskeletal systems

9785

70007

1.58

275.01

3.1

3.0

1278.14

1441.55

ng/l

2.63

8404

59775

Dialysis, with operation codes

2448

12601

2.73

274.29

6.6

2.9

8397.09

1024.53

ng/l

89.25

2303

10760

Mycoses

13446

87425

1.46

271.83

3.1

2.9

1173.33

1335.58

ng/l

5.24

11298

74151

Disorders of the thyroid gland

15444

76268

1.43

271.77

3.3

2.9

1342.13

1440.91

ng/l

1.82

13084

64895

COPD, hospital admission 2, with asthma infections

6467

37258

1.83

271.76

4.4

3.0

2250.39

1775.85

ng/l

8.57

5761

32220

Other systemic involvement of connective tissue

5018

31700

1.94

271.46

3.4

3.0

1228.96

1488.26

ng/l

5.86

4379

27151

Congenital malformations, deformations and chromosomal abnormalities

8008

51949

1.61

270.92

3.3

2.8

1286.16

1135.37

ng/l

1.89

6902

43296

Dysphagia

4639

28722

1.98

270.65

3.4

2.9

1398.57

1562.53

ng/l

1.76

3972

24734

Conotruncal defects

360

541

20.89

270.07

8.0

5.0

851.88

886.87

ng/l

0.09

348

445

Cystitis

13861

61485

1.46

267.00

3.1

2.9

1384.80

1390.50

ng/l

0.05

11836

52341

Diaphragmatic hernia

6694

45406

1.77

266.12

3.3

2.9

1338.13

1459.30

ng/l

1.44

5778

38961

Diseases of pulp and periapical tissues, including avohilmo

17416

69313

1.40

265.09

3.1

3.0

1392.11

1467.39

ng/l

1.12

14735

58936

Mood disorders, excluding more controls

14961

67428

1.43

263.99

3.0

2.9

1092.13

1311.20

ng/l

6.73

12277

57526

Viral pneumonia

2394

12230

2.59

263.06

4.6

2.8

2379.34

1309.72

ng/l

12.43

2160

10379

Allergic asthma (mode), excluding more controls

2776

13936

2.19

263.01

2.9

1.9

854.09

492.71

ng/l

8.34

2319

11273

Hypokalaemia

2375

12246

2.68

262.29

3.9

2.8

1757.37

1329.25

ng/l

5.66

2110

10407

Pericarditis

747

2136

6.06

261.70

4.7

1.8

2107.44

535.57

ng/l

4.29

687

1695

Diseases of the eye and adnexa

11281

40307

1.50

260.63

3.0

2.7

1347.83

1053.74

ng/l

7.82

9395

33663

Autoimmune diseases related-to ILD

13479

86733

1.44

260.11

3.2

2.9

1315.31

1369.47

ng/l

0.69

11512

73219

Other external causes of accidental injury

13179

48615

1.46

259.72

3.1

2.8

1533.86

1238.13

ng/l

8.37

11068

41477

Diseases of the digestive system

8327

58527

1.63

259.09

3.7

3.1

2166.29

1605.62

ng/l

11.83

7251

50192

Hypothyroidism, strict autoimmune

11936

57653

1.49

258.28

3.1

2.8

1350.33

1371.14

ng/l

0.18

10022

48862

Insulin, fast-acting or short human

6219

41318

1.75

258.10

4.0

3.0

2785.35

1430.52

ng/l

34.34

5423

35233

Certain disorders involving the immune mechanism

3247

18458

2.22

256.37

4.9

2.9

1569.64

1305.87

ng/l

2.09

2850

15741

Early onset COPD

4013

24381

2.07

256.31

3.7

2.9

1453.14

1377.54

ng/l

0.41

3518

20929

Cardiomyopathy, Hypertrophic obstructive

496

1101

12.63

255.44

9.4

1.8

2505.69

489.97

ng/l

15.82

476

895

Visual disturbances

8009

56124

1.62

254.05

3.3

3.0

1245.49

1389.18

ng/l

2.49

6826

47936

Migraine

6144

32301

1.68

250.39

2.8

2.6

626.50

1058.71

ng/l

23.88

5051

27070

Accidents

13112

48615

1.45

250.05

3.1

2.8

1535.37

1238.13

ng/l

8.11

11026

41477

L04AD Calcineurin inhibitors

1816

8511

2.88

247.87

7.9

2.9

4065.88

996.32

ng/l

24.98

1737

7139

Other reaction to severe stress, and adjustment disorders

4675

28811

1.81

246.94

3.4

2.7

1039.28

979.49

ng/l

0.37

3880

23953

Other respiratory diseases principally affecting the interstitium

3716

22725

2.19

246.56

4.2

3.1

2058.08

1784.58

ng/l

2.11

3355

19697

Genitourinary diseases

8653

29816

1.57

246.54

3.3

2.7

1717.07

934.03

ng/l

29.14

7256

25047

Retention of urine

6588

36909

1.74

245.96

3.6

3.1

2206.04

1696.83

ng/l

9.12

5760

31971

Other and unspecified dermatitis

8403

59617

1.58

245.20

3.3

2.9

1523.54

1310.37

ng/l

3.33

7210

50820

Malignant neoplasm, wide definition for exclusion

13814

61154

1.44

245.02

2.9

1292.18

1258.48

ng/l

0.37

11930

51295

Disorder of lipoprotein metabolism, unspecified

2723

15175

2.47

244.51

3.7

2.8

2066.86

1459.84

ng/l

5.58

2402

12996

Polycystic ovarian syndrome, consortium definition

9910

41946

1.53

243.75

2.8

2.7

1020.37

1118.33

ng/l

1.34

8167

35116

L04AA Selective immunosuppressants

3514

20562

2.07

243.72

5.5

2.8

2618.18

1084.78

ng/l

20.65

3213

17409

ILD, hospital admissions

3155

18630

2.37

242.40

4.1

3.2

1695.11

1756.22

ng/l

0.28

2843

16187

Other interstitial pulmonary diseases

3199

19019

2.34

239.41

4.1

3.2

1726.24

1767.57

ng/l

0.18

2886

16525

Interstitial lung disease

3199

19022

2.34

239.28

4.1

3.2

1726.24

1776.69

ng/l

0.22

2886

16529

Interstitial lung disease endpoints

3199

19022

2.34

239.28

4.1

3.2

1726.24

1776.69

ng/l

0.22

2886

16529

L04AX Other immunosuppressants

8631

61779

1.55

236.30

3.6

2.8

1255.96

1203.42

ng/l

0.45

7520

52237

Malignant neoplasm

13487

60460

1.43

234.71

2.9

1284.46

1266.68

ng/l

0.17

11671

50804

Degeneration of macula and posterior pole

9436

55425

1.59

234.56

3.3

3.1

1883.57

1623.62

ng/l

4.77

8142

48058

Second line medication for Crohn's disease

8790

63214

1.54

233.27

3.6

2.8

1245.33

1196.51

ng/l

0.42

7648

53424

Nephropathy related operations

2292

12244

2.59

231.45

6.5

3.1

8553.31

1273.57

ng/l

79.52

2168

10496

Systemic sclerosis (FG)

628

1838

8.76

231.42

4.6

2.8

665.15

1052.97

ng/l

3.61

587

1538

Exposure to unspecified factor

15732

88076

1.38

231.37

3.1

3.0

1544.63

1342.88

ng/l

4.90

13036

74888

Injuries to the thorax

7853

55897

1.60

230.96

3.4

3.1

1631.55

1558.79

ng/l

0.68

6746

47866

Coxarthrosis, primary

11163

71533

1.51

230.37

3.2

3.0

1462.16

1571.83

ng/l

1.92

9777

61579

Diagnoses used for exclusion with ILD

4690

30351

1.88

229.85

4.5

3.1

1554.82

1679.07

ng/l

1.20

4122

26104

Unspecified kidney failure

2252

12213

2.72

228.47

5.1

3.0

5161.98

1433.54

ng/l

54.63

2064

10531

Other disorders of veins

6663

45827

1.66

228.06

3.2

2.8

1353.18

1291.92

ng/l

0.48

5641

38984

Hypothyroidism, other/unspecified

14162

71537

1.41

227.63

3.2

2.9

1319.03

1442.85

ng/l

2.41

11924

60869

Congenital malformations, deformations and chromosomal abnormalities

8752

57659

1.52

227.51

3.3

2.8

1274.12

1155.98

ng/l

1.43

7505

48135

Enlarged lymph nodes

2554

13793

2.26

227.35

3.7

2.6

1371.11

1249.10

ng/l

0.46

2241

11663

Other symptoms and signs involving cognitive functions and awareness

8280

54368

1.59

227.19

3.2

3.0

1697.87

1621.92

ng/l

0.62

7028

46782

Hypothyroidism, strict autoimmune, 3 medication purchases required

13402

69110

1.42

226.51

3.0

2.9

1308.52

1419.90

ng/l

1.94

11240

58794

Septal defects

1081

4054

3.74

226.09

4.8

3.4

1133.15

1175.45

ng/l

0.13

963

3386

Other diseases of the digestive system

6112

42070

1.73

225.91

4.0

3.1

2355.39

1729.60

ng/l

11.74

5347

36318

Osteoporosis

5181

32492

1.86

225.54

3.9

3.0

1699.89

1590.05

ng/l

0.92

4525

27910

Dronedarone medication

691

2182

7.17

224.94

4.4

1.8

1606.72

491.56

ng/l

12.30

613

1782

Viral infections characterized by skin and mucous membrane lesions

13339

87436

1.41

224.93

3.3

2.9

1341.15

1331.91

ng/l

0.08

11412

73959

Carpal tunnel syndrome

9988

65070

1.50

224.84

3.0

2.9

1201.11

1301.64

ng/l

1.34

8479

55364

Other diseases of hard tissues of teeth

10480

39717

1.50

224.55

3.2

3.0

1478.99

1659.67

ng/l

2.88

8916

34113

Migraine with aura

2929

16222

2.03

224.35

2.7

2.6

593.54

1026.81

ng/l

11.53

2425

13544

Hypothyreosis and Thyroxine purchase for inclusion criteria

14706

74703

1.39

222.92

3.1

2.9

1316.37

1439.16

ng/l

2.48

12374

63607

COPD, hospital admissions 1, only main diagnosis

6773

40906

1.70

221.45

4.2

3.1

2051.03

1769.64

ng/l

4.01

6002

35480

Other pulmonary heart/vessel disease

1147

4949

4.61

219.82

8.6

3.2

2481.24

1888.38

ng/l

3.35

1086

4252

Substance abuse, excluding more controls

8484

51882

1.53

219.28

3.1

2.9

1586.83

1376.12

ng/l

2.94

7152

44389

Volume depletion

1976

10222

2.72

219.06

4.6

2.9

2747.38

1725.87

ng/l

11.13

1760

8728

ILD, hospital admissions 1, main diag only

2815

16594

2.39

218.73

4.1

3.2

1671.25

1735.89

ng/l

0.28

2552

14418

Other symptoms and signs involving the circulatory and respiratory systems

1184

4848

3.41

217.24

4.0

2.6

1654.60

1437.50

ng/l

0.49

1050

4107

Neoplasms

10242

39356

1.47

217.04

3.0

2.9

1334.86

1203.37

ng/l

1.53

8577

32592

Acute upper respiratory infections of multiple and unspecified sites

11300

62769

1.44

215.21

3.7

2.8

1318.25

1356.70

ng/l

0.40

9572

53018

External causes of morbidity and mortality

10244

37340

1.48

215.12

3.1

2.8

1468.00

1191.40

ng/l

6.07

8650

31739

Other arthritis (FG)

4835

31495

1.76

214.76

3.3

2.8

1656.88

1270.32

ng/l

4.42

4176

26687

Secondary right heart disease

1059

4483

4.96

213.60

8.8

3.1

2449.18

1825.62

ng/l

3.63

1008

3847

GI-bleeding

6074

42250

1.70

211.81

4.0

3.1

2378.42

1746.37

ng/l

11.91

5345

36458

Rheumatoid arthritis

5276

31489

1.72

211.31

3.2

2.8

1504.65

1426.76

ng/l

0.63

4609

26861

Care involving dialysis

1531

7286

3.07

211.15

5.0

2.8

11056.10

1159.70

ng/l

72.28

1445

6176

Injuries to the knee and lower leg

18825

83560

1.33

210.82

3.0

1364.15

1378.74

ng/l

0.15

15865

70876

Other specified/unspecified arthritis

4200

26601

1.83

210.39

3.3

2.8

1635.30

1285.40

ng/l

3.39

3618

22679

Injuries to the shoulder and upper arm

13695

85833

1.39

209.28

3.1

3.0

1386.95

1407.41

ng/l

0.21

11621

72965

Congenital malformations of great arteries

427

918

8.59

209.12

7.5

3.5

1163.21

1057.31

ng/l

0.23

400

757

Other abnormal uterine and vaginal bleeding

3716

16229

1.94

208.54

3.1

2.8

1220.87

1503.82

ng/l

3.02

3049

13793

Personality disorders, excluding more controls

3050

17471

1.95

208.49

2.7

2.6

878.16

892.18

ng/l

0.06

2430

14514

Right bundle-branch block

758

2552

4.96

208.30

4.1

1.8

1445.74

532.60

ng/l

11.04

651

2050

Hyperkalaemia

1303

5962

3.61

207.67

5.9

2.9

4477.89

1702.46

ng/l

23.57

1202

5121

Selective serotonin reuptake inhibitors

16012

65551

1.36

206.79

2.9

3.0

1141.22

1499.14

ng/l

19.77

13190

56232

Functional dyspepsia

4290

27540

1.82

206.57

3.2

2.8

1199.56

1301.39

ng/l

0.67

3605

23535

Acute sinusitis

7131

46455

1.55

203.59

3.1

2.8

1120.25

1172.59

ng/l

0.39

5915

39026

Paracetamol or NSAID medication

2489

6442

2.16

202.58

3.2

1793.77

1830.25

ng/l

0.10

2095

5537

COPD-related respiratory insufficiency

2461

14228

2.43

202.50

5.2

3.1

2541.48

1859.17

ng/l

6.16

2234

12348

Oter anti-inflammatory and antirheumatic agents, non-steroids

4275

14892

1.86

201.00

3.2

3.4

1523.56

2316.93

ng/l

17.36

3665

13160

ILD, hospital admissions 3, with pneumonia sepsis

1835

9719

2.83

199.86

4.6

2.9

2037.22

1502.87

ng/l

5.02

1679

8376

Presence of other devices

4458

29334

1.82

199.32

3.3

2.7

1532.32

1660.00

ng/l

1.24

3971

25106

Systemic sclerosis

628

2059

7.58

197.72

4.6

2.8

665.15

1020.64

ng/l

3.45

587

1721

Other disorders of lacrimal gland

5657

39009

1.67

197.62

3.2

2.9

1079.65

1335.17

ng/l

5.38

4791

33290

Cholecystectomy

11778

78412

1.42

197.10

3.0

2.9

1344.79

1458.73

ng/l

1.77

10008

66982

Any event in cancer register

14012

64314

1.37

195.54

2.9

1298.70

1259.15

ng/l

0.47

12052

54059

COPD, hospital admissions 3, with asthma pneumonia sepsis

5385

31865

1.75

195.48

4.6

3.1

2377.65

1870.79

ng/l

8.29

4831

27591

Oxicams

4261

15304

1.82

195.18

3.0

3.4

1383.69

2277.42

ng/l

27.63

3629

13493

Extreme obesity with alveolar hypoventilation

901

3574

4.58

194.94

4.8

2.9

1593.25

1247.74

ng/l

0.98

775

3061

Other diseases of anus and rectum

5261

35847

1.70

194.40

3.5

2.9

1765.48

1558.87

ng/l

1.91

4448

30763

Sarcoidosis

2308

12946

2.31

194.21

5.2

2.9

1124.23

1301.29

ng/l

1.68

2017

11016

Disorders of other endocrine glands

6739

47038

1.57

194.13

3.4

3.0

1959.31

1367.46

ng/l

8.26

5706

39868

Allergic asthma (mode)

2776

15400

1.96

193.85

2.9

2.3

854.09

917.69

ng/l

0.45

2319

12739

Systemic sclerosis, icd10

624

2071

7.60

193.65

4.6

2.9

667.21

954.17

ng/l

2.63

583

1725

Bacterial pneumoniae

6873

43230

1.58

193.30

3.9

2.7

2337.73

1310.52

ng/l

33.76

6133

36669

Varicose veins

10710

61843

1.45

191.60

3.2

2.9

1457.87

1497.03

ng/l

0.39

9236

52867

Other gastritis (incl. Duodenitis)

4027

26232

1.85

190.74

3.7

2.9

1739.94

1516.35

ng/l

1.92

3539

22626

Irritable bowel syndrome

4040

25884

1.78

189.95

2.9

2.7

936.88

1195.21

ng/l

5.72

3319

21867

Injury, poisoning and certain other consequences of external causes

8235

29534

1.50

189.57

3.1

2.8

1489.79

1212.30

ng/l

4.87

6954

24990

Implicit fungal Sepsis

1379

6641

3.15

189.36

4.9

2.7

2052.59

1237.75

ng/l

5.84

1225

5672

Open wound of head

8872

63793

1.48

189.35

3.3

3.1

1880.69

1498.30

ng/l

8.99

7558

54556

Non-selective monoamine reuptake inhibitors

6310

43110

1.60

186.89

3.1

2.9

1152.41

1477.24

ng/l

9.07

5303

37183

Hernia of abdominal wall

7540

55283

1.54

186.71

3.2

3.0

1571.34

1390.60

ng/l

2.13

6497

47386

Diarrhoea and gastroenteritis of presumed infectious origin

15862

83498

1.33

184.98

3.4

2.9

1677.57

1320.10

ng/l

11.64

13384

70716

Cellulitis

3509

22107

1.88

184.45

3.8

3.0

2183.88

1345.83

ng/l

10.46

3029

18845

Glomerular diseases

3075

18935

2.00

184.18

4.2

3.1

5604.05

1412.61

ng/l

56.22

2780

16268

Anxiety disorders, excluding more controls

12100

60705

1.39

184.12

3.1

2.8

1018.58

1218.19

ng/l

4.22

9941

51604

Chronic gastritis

5055

34905

1.72

184.08

3.4

3.0

1787.08

1620.87

ng/l

1.35

4356

30181

Solid cancers, helper endpoint

13052

60111

1.38

183.20

2.8

2.9

1303.25

1268.95

ng/l

0.36

11245

50541

Disorders of lacrimal system

6882

49714

1.56

181.96

3.2

2.9

1159.39

1361.40

ng/l

3.86

5822

42415

Peripheral arterial reconstruction

3500

22835

2.00

180.96

4.3

3.2

4017.24

1849.06

ng/l

33.86

3184

19886

Other and unspecified polyneuropathies, also in other diseases

3532

22883

1.94

179.70

3.8

3.1

2007.03

1632.40

ng/l

3.03

3130

19802

Polyneuropathies and other disorders of the peripheral nervous system

3940

26106

1.86

178.98

3.7

3.1

1949.11

1607.84

ng/l

2.95

3490

22564

Other symptoms and signs involving the nervous and musculoskeletal systems

6412

45870

1.56

177.87

3.1

3.0

1097.68

1366.12

ng/l

4.79

5502

39072

Candidiasis

4273

28274

1.73

177.86

3.4

2.9

1189.71

1294.73

ng/l

1.01

3607

24020

ILD medications: azathioprine

2095

11417

2.18

177.52

5.0

2.6

1762.66

1169.32

ng/l

3.00

1870

9547

Gingivitis and periodontal diseases

16784

69686

1.32

177.34

3.1

3.0

1387.61

1458.27

ng/l

0.98

14211

59492

Iron deficiency anaemia secondary to blood loss (chronic)

3024

18850

2.02

177.34

5.2

3.0

2619.13

1602.68

ng/l

14.95

2697

16198

Streptococcal septicaemia

1694

8978

2.60

174.55

4.4

2.8

3021.46

1324.15

ng/l

16.80

1517

7679

Depression

14114

75820

1.34

174.50

3.0

2.9

1045.23

1263.83

ng/l

6.50

11510

64292

Reimbursement for rheumatic diseases

8910

67164

1.45

172.80

3.1

2.9

1262.85

1321.94

ng/l

0.65

7775

56862

Bacterial pneumonia, not elsewhere classified

6493

41223

1.56

172.18

3.9

2.7

2362.78

1330.36

ng/l

31.73

5801

34998

Explicit bacterial Sepsis

1924

10594

2.36

171.31

4.3

2.8

2982.44

1382.93

ng/l

15.98

1726

9039

Mood disorders

15535

80745

1.32

170.88

3.0

2.9

1069.02

1332.20

ng/l

10.05

12694

68609

Cervical disc disorders

5742

40666

1.59

170.38

3.0

2.9

945.76

1452.51

ng/l

27.58

4870

34828

Deforming dorsopathies

4213

27994

1.71

170.13

3.2

2.9

1072.40

1359.51

ng/l

5.43

3568

23790

Mood [affective] disorders

15484

80625

1.32

170.07

3.0

2.9

1070.40

1326.40

ng/l

9.51

12653

68499

Substance use, excluding alcohol

2643

15587

1.95

169.93

3.1

2.9

1399.59

1123.98

ng/l

1.63

2147

12994

Excessive, frequent and irregular menstruation

5069

18589

1.64

169.65

2.8

2.7

965.66

1372.70

ng/l

12.34

4184

15603

Rheumatism, unspecified

2226

12739

2.16

169.53

2.8

2.7

845.38

1181.50

ng/l

3.62

1861

10856

Internal derangement of knee

5460

37873

1.59

169.38

2.9

1160.11

1296.87

ng/l

1.63

4513

32205

Fracture of rib(s), sternum and thoracic spine

5229

36785

1.65

169.27

3.5

3.1

1726.56

1628.60

ng/l

0.76

4523

31659

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2567

15478

2.10

169.18

4.0

3.0

2615.98

1421.45

ng/l

12.27

2174

13269

6081

38814

1.64

166.30

3.4

3.2

2067.70

1882.77

ng/l

1.96

5252

33821

Acute upper respiratory infections

16509

82535

1.31

165.60

3.4

2.9

1293.54

1429.30

ng/l

3.25

13920

70185

Azathioprine

2095

11714

2.11

163.89

5.0

2.7

1762.66

1241.59

ng/l

2.40

1870

9778

Glomerular disorders in diseases classified elsewhere

2063

11835

2.28

163.88

4.6

3.1

6394.95

1450.88

ng/l

50.39

1872

10176

Subjective visual disturbances

3935

26167

1.75

163.66

3.2

2.9

1041.60

1306.36

ng/l

4.99

3311

22386

Atrial septal defect

677

2410

4.26

163.45

5.9

3.2

1170.63

1063.68

ng/l

0.33

617

1997

CR(E)ST syndrome

436

1299

11.20

163.41

4.6

2.8

615.04

956.13

ng/l

2.40

409

1076

Zoster [herpes zoster]

8337

62443

1.47

162.72

3.4

3.0

1441.49

1446.08

ng/l

0.03

7233

53451

Dermatitis and eczema

17127

86644

1.30

162.45

3.1

2.9

1420.17

1377.06

ng/l

0.48

14421

73483

Anosmia

315

599

6.89

162.27

2.9

1.3

650.46

250.31

ng/l

7.80

259

449

Coxibs

4545

15840

1.68

161.89

2.9

3.4

1434.61

2247.63

ng/l

23.58

3739

13899

Disorders of synovium and tendon

7724

50230

1.46

161.67

2.8

2.9

1150.38

1320.61

ng/l

2.37

6527

42674

Soft tissue disorders related to use, overuse and pressure

4329

29407

1.69

161.41

3.3

2.9

1252.38

1384.13

ng/l

1.19

3762

25163

Cutaneous abscess, furuncle and carbuncle

3691

24096

1.74

160.69

3.6

3.0

2071.39

1219.28

ng/l

9.90

3139

20377

Recurrent or chronic depression

5229

25231

1.58

160.40

2.8

835.23

1041.50

ng/l

2.60

4184

21511

Fibromyalgia

1266

5977

2.61

160.33

2.5

2.6

495.30

960.78

ng/l

14.51

1016

5001

Injuries to the hip and thigh

8313

57370

1.46

157.91

3.4

3.1

2093.11

1640.70

ng/l

9.73

7210

49230

Other symptoms and signs involving the digestive system and abdomen

2700

16548

1.94

157.65

3.2

2.8

1164.05

1338.38

ng/l

1.49

2261

14182

Pain in thoracic spine

2276

13253

2.03

157.19

2.9

2.8

855.33

1418.78

ng/l

12.71

1940

11235

Primary_lymphoid and hematopoietic malignant neoplasms

4310

29854

1.73

156.71

3.7

3.1

1778.53

1604.26

ng/l

1.50

3891

25772

Other pleural conditions

2061

12171

2.31

155.38

4.7

3.0

2784.84

1804.88

ng/l

7.72

1882

10502

Injuries to the abdomen, lower back, lumbar spine and pelvis

6445

46834

1.52

155.11

3.5

3.1

1860.20

1585.78

ng/l

4.42

5517

39991

Menorrhagia

4763

17905

1.63

154.47

2.9

2.7

976.47

1408.60

ng/l

12.88

3918

15112

Disturbances of skin sensation

3727

24535

1.71

154.26

2.8

804.82

1127.57

ng/l

7.55

3097

20677

Abnormal findings on examination of blood, without diagnosis

7888

55153

1.47

152.36

3.4

3.1

1876.09

1559.91

ng/l

5.38

6925

47550

Sequelae of cerebrovascular disease

6718

43344

1.54

152.27

3.8

3.1

2243.58

1695.88

ng/l

12.27

5865

37465

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4641

32200

1.62

152.13

3.5

3.0

1649.62

1368.98

ng/l

2.94

3983

27374

All influenza (not pneumonia)

2227

13029

2.02

151.47

4.2

2.7

1836.38

1206.17

ng/l

5.81

1909

10901

Other diseases of upper respiratory tract

17747

76154

1.28

150.36

3.1

3.0

1230.77

1515.41

ng/l

13.01

14954

64998

Cardiac murmurs and other cardiac sounds

1205

5598

2.53

150.26

2.8

1149.54

1271.52

ng/l

0.39

996

4688

Type 1 diabetes, wide definition, subgroup 1

2681

16343

1.85

149.85

3.6

2.7

3541.49

1090.48

ng/l

30.77

2326

13642

Right ventricular outflow tract obstruction

201

301

17.65

149.13

9.4

5.1

736.58

901.24

ng/l

0.50

195

246

Sequelae of external causes of morbidity and mortality

4233

29275

1.69

149.01

3.5

3.0

1996.64

1430.93

ng/l

7.20

3775

25146

Gastroduodenal ulcer

4776

33784

1.64

148.97

3.9

3.0

2250.64

1778.35

ng/l

5.89

4235

29232

Acetic acid derivatives and related substances

4521

15790

1.64

148.70

3.0

3.4

1592.57

2251.80

ng/l

11.42

3772

13862

Symptoms and signs concerning food and fluid intake

1737

9571

2.26

148.55

3.6

2.7

1609.11

1420.61

ng/l

0.80

1500

8150

Superficial injury of lower leg

3623

23981

1.71

148.49

3.4

3.0

1427.43

1333.88

ng/l

0.60

3016

20359

Polyuria

3878

26493

1.74

148.47

3.2

3.1

1402.40

1546.00

ng/l

1.44

3290

22925

Disorders of vestibular function (Vertigo)

7825

58856

1.46

148.20

3.1

3.0

1205.20

1457.05

ng/l

5.25

6612

50496

Heartburn

1769

9812

2.22

147.61

3.5

2.8

1158.37

1348.63

ng/l

1.05

1485

8411

Cervicobrachial syndrome

3198

20630

1.77

147.05

2.7

2.8

890.36

1307.91

ng/l

5.45

2777

17499

Mycoses

4111

28277

1.67

145.05

3.8

3.0

1480.23

1392.21

ng/l

0.61

3544

24193

Cervicalgia

3206

20860

1.78

144.97

3.1

2.9

1168.41

1508.86

ng/l

4.40

2720

17789

Mental and behavioural disorders due to psychoactive substance use

8748

62435

1.40

144.35

3.1

3.0

1599.58

1381.94

ng/l

3.21

7372

53089

Phlebitis and thrombophlebitis (not including DVT)

3635

24481

1.73

144.21

3.1

2.9

1509.07

1440.30

ng/l

0.25

3139

20996

Other bacterial intestinal infections

3741

25332

1.71

143.46

4.0

3.0

2416.93

1495.47

ng/l

13.49

3287

21676

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

3093

19535

1.72

142.64

2.8

2.7

965.98

1004.41

ng/l

0.20

2481

16335

Unspecified fall

7954

60041

1.43

142.23

3.3

3.1

1764.99

1499.25

ng/l

4.99

6639

51297

Ventricular septal defect, a heart condition

391

1070

5.73

141.29

6.7

4.2

1218.27

981.03

ng/l

0.55

360

883

Viral infections characterized by skin and mucous membrane lesions

6155

45362

1.49

140.84

3.6

3.0

1595.81

1327.78

ng/l

3.40

5305

38543

Other bacterial intestinal infections

3097

20327

1.82

140.79

4.2

3.0

2638.33

1594.05

ng/l

12.84

2734

17414

Substance abuse

8484

61396

1.40

140.55

3.1

3.0

1586.83

1387.94

ng/l

2.69

7152

52224

Hyperplasia of prostate

6219

25945

1.53

140.17

3.2

3.1

1729.19

1659.15

ng/l

0.44

5336

22626

Diseases of inner ear

8946

67735

1.41

139.89

3.1

3.0

1232.98

1459.37

ng/l

4.41

7545

58100

Diseases of liver

5383

39160

1.55

139.29

3.6

3.0

1811.01

1334.61

ng/l

7.12

4563

33598

Type of accident

4306

29970

1.62

139.26

3.5

3.0

1599.56

1396.33

ng/l

1.88

3690

25511

Congenital malformations of pulmonary and tricuspid valves

187

281

18.15

138.78

9.1

4.4

673.84

740.97

ng/l

0.21

182

229

Personality disorders

3050

19476

1.72

138.63

2.7

2.8

878.16

914.35

ng/l

0.18

2430

16061

Mixed connective tissue disease

1101

5404

2.83

137.89

3.6

2.9

917.80

1198.35

ng/l

2.28

985

4565

Convulsions, not elsewhere classified

3083

19585

1.73

137.51

3.0

2.7

1492.18

1309.32

ng/l

1.23

2611

16422

Myocardial infarction, with ST-elevation

3345

22721

1.81

137.23

4.0

3.2

2567.71

1865.19

ng/l

7.72

3064

19650

Other anxiety disorders

5303

32726

1.50

136.06

2.9

2.7

885.32

1034.80

ng/l

1.64

4198

27208

Migraine without aura

1922

10835

1.94

135.55

2.7

2.5

475.98

846.16

ng/l

10.44

1569

8897

Disease of hard tissues of teeth, NOS

9152

37039

1.40

135.07

2.9

899.16

1504.05

ng/l

51.97

7676

31874

Coagulation defects, purpura and other haemorrhagic conditions

2980

19480

1.79

134.43

3.8

3.1

1790.02

1475.93

ng/l

3.13

2611

16644

Gastric ulcer

3256

21949

1.78

134.10

4.0

3.0

2210.04

1768.26

ng/l

3.73

2891

18965

Poisoning by drugs, medicaments and biological substances

2848

18095

1.75

133.97

3.0

2.9

1032.28

1077.66

ng/l

0.24

2310

15045

Exclusions for E4_PCOS_CONSORTIUM

9557

46646

1.36

132.55

2.8

1076.30

1199.67

ng/l

1.76

7927

39142

Chronic rhinitis, nasopharyngitis and pharyngitis

4406

30929

1.58

132.54

2.8

2.9

830.71

1210.04

ng/l

13.23

3608

26292

Ventral hernia

3972

27757

1.66

132.31

3.3

3.0

1683.20

1451.49

ng/l

1.79

3448

23838

Disorders of adult personality and behaviour

3141

20405

1.68

131.74

2.6

2.8

907.05

921.56

ng/l

0.06

2519

16819

7687

55131

1.46

131.32

3.2

3.1

1848.88

1737.42

ng/l

0.99

6665

47826

Other hearing loss

5068

36354

1.57

130.92

3.3

3.1

1909.14

1913.96

ng/l

0.02

4262

31572

Anxiety (asthma-related co-morbidities)

7337

42785

1.41

130.60

2.9

2.8

922.33

1023.40

ng/l

0.90

5826

35805

Neurotic, stress-related and somatoform disorders

12315

69522

1.31

129.98

3.1

2.8

999.04

1183.30

ng/l

3.80

10062

58626

Superficial injury of head

3700

25409

1.66

129.80

3.4

3.1

1778.41

1576.29

ng/l

1.97

3131

21727

Problems related to lifestyle

1399

7386

2.24

129.66

2.9

2.8

1322.04

1076.12

ng/l

1.41

1171

6186

Systemic sclerosis,strict definition

274

693

18.41

129.06

5.3

3.1

551.11

862.11

ng/l

1.90

258

581

Anxiety disorders

12490

70397

1.30

129.03

3.1

2.8

1000.86

1195.15

ng/l

4.24

10217

59414

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7512

55984

1.41

128.89

3.1

2.9

1114.17

1305.96

ng/l

3.10

6199

47787

Malignant neoplasm of skin

8654

46532

1.41

128.62

3.1

3.0

1772.02

1467.57

ng/l

5.87

7426

39754

Sequelae with surgical and medical care as external cause

3400

23296

1.73

128.45

3.5

3.0

2084.63

1472.28

ng/l

6.33

3035

20041

Complications of internal orthopaedic prosthetic devices, implants and grafts

4052

28856

1.66

127.67

3.3

3.0

1765.58

1507.07

ng/l

2.63

3522

24912

Hallux valgus (acquired)

5066

26266

1.54

127.49

2.8

1109.54

1319.46

ng/l

3.99

4301

22378

Somatoform disorder

2260

13929

1.88

125.79

2.9

2.8

845.49

1201.51

ng/l

3.66

1858

11800

Use of pramipexole

3759

26434

1.68

125.22

3.3

3.0

1471.40

1498.36

ng/l

0.10

3200

22842

Type 1 diabetes

3241

21534

1.66

125.21

3.6

2.8

3458.01

1197.53

ng/l

32.02

2822

18055

Chronic sinusitis

6016

44856

1.46

125.12

2.9

985.23

1278.64

ng/l

7.90

5003

38172

Other diseases of blood and blood-forming organs, wide

3447

23673

1.69

125.03

3.7

3.0

1711.91

1374.49

ng/l

2.97

3018

20352

Nonorganic sleeping disorders, excluding more controls

2342

14429

1.82

124.96

3.2

2.8

1081.06

1150.22

ng/l

0.36

1902

12178

Chronic laryngitis and laryngotracheitis

2248

14063

1.93

124.50

3.2

3.0

988.29

1436.25

ng/l

7.62

1799

12121

Idiopathic gout

1798

10955

2.24

123.15

4.7

3.1

2913.02

1624.79

ng/l

13.17

1622

9544

Extracorporeal dialysis

1113

5801

2.75

123.09

5.2

3.1

12508.66

1301.72

ng/l

57.26

1051

4988

Skin changes due to chronic exposure to nonionizing radiation

7320

53023

1.46

122.62

3.2

3.1

1864.93

1760.20

ng/l

0.86

6343

46043

Asthma and allergy, excluding more controls

1196

5854

2.22

122.57

2.7

1.8

604.84

392.40

ng/l

1.95

964

4664

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

8487

45372

1.40

122.41

3.2

3.0

1834.76

1489.22

ng/l

6.91

7330

38820

Heart failure and hypertrophic cardiomyopathy

489

1913

7.40

122.06

12.2

3.1

3898.54

1547.49

ng/l

11.93

472

1643

Chronic periodontitis, complicated

8529

66887

1.38

121.59

3.2

2.9

1489.40

1264.68

ng/l

3.35

7284

57376

Other sleep disorders

1655

9506

2.09

121.47

3.5

2.9

1268.88

1561.57

ng/l

1.69

1405

8192

Diseases of the myoneural junction and muscle

2092

13063

2.00

121.36

3.5

3.1

1966.89

1634.47

ng/l

1.50

1777

11237

Haemorrhoids and perianal venous thrombosis

5273

38985

1.51

121.23

3.3

2.9

1325.68

1519.47

ng/l

2.82

4533

33506

DVT of lower extremities

3203

21896

1.73

121.06

3.2

3.0

1559.58

1626.45

ng/l

0.24

2771

18838

1740

10036

2.00

120.97

4.7

2.8

1315.67

1079.27

ng/l

1.47

1498

8433

Hypertensive Renal Disease

731

3219

3.41

120.94

4.3

2.7

7458.55

1422.63

ng/l

22.15

661

2736

Actinic keratosis

7161

52060

1.46

120.85

3.3

3.2

1876.74

1772.90

ng/l

0.83

6214

45232

Complex cardiac defects

166

263

22.64

120.59

11.1

3.6

756.23

786.78

ng/l

0.09

161

220

Unspecified acute lower respiratory infection

2266

14213

1.87

120.54

4.5

3.0

1860.59

1485.93

ng/l

2.52

1997

12068

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4841

35297

1.52

120.43

3.6

2.9

1233.14

1240.52

ng/l

0.04

4149

30015

Poisoning by medicine

2519

15937

1.76

120.42

2.9

974.63

1083.36

ng/l

0.73

2053

13248

Other specified/unspecified systemic involvement of connective tissue

980

4836

2.77

120.24

3.6

2.9

934.23

1194.66

ng/l

1.90

877

4077

Glucosamine medication

8675

55275

1.40

120.22

3.1

3.0

1404.42

1596.01

ng/l

3.47

7391

47751

4288

29579

1.64

118.82

3.5

3.2

2015.61

1947.45

ng/l

0.37

3666

25760

Zoster [herpes zoster]

3131

21464

1.74

118.62

3.8

3.1

1775.57

1608.80

ng/l

0.88

2734

18492

Bacterial pneumonia (organism specified)

7383

52091

1.41

118.59

4.0

3.0

2360.81

1623.18

ng/l

19.08

6576

44497

Bacterial intestinal infections, IBD co-morbidities

3073

20906

1.73

118.43

4.2

3.1

2645.24

1645.23

ng/l

11.67

2717

17925

Specific personality disorders

2576

16446

1.72

117.07

2.6

2.8

927.33

946.27

ng/l

0.07

2054

13544

Exclusions for E4_PCOS_BROAD

2323

14682

1.82

116.73

3.4

3.1

1329.56

1276.28

ng/l

0.14

1969

12403

Misadventures to patients during surgical and medical care

2276

14527

1.88

116.49

3.9

2.9

2055.91

1355.15

ng/l

6.63

1996

12464

All anxiety disorders

7382

44756

1.38

116.27

2.9

2.8

919.10

1044.00

ng/l

1.24

5859

37394

Combinations of oral blood glucose lowering drugs

4551

33361

1.56

116.26

3.3

2.9

1437.67

1308.55

ng/l

1.26

3910

28958

Coxarthrosis, primary, with hip surgery

8345

62425

1.39

115.96

3.2

3.1

1534.10

1615.89

ng/l

0.98

7303

53847

Atrial septal defect, secundum type

484

1741

4.15

115.03

5.4

3.6

1309.43

1120.87

ng/l

0.45

446

1455

Umbilical hernia

4012

28645

1.58

114.38

3.2

3.0

1479.39

1329.53

ng/l

1.05

3413

24474

Mental and behavioural disorders due to tobacco

1339

7434

2.27

113.80

3.3

2.9

1585.33

1138.40

ng/l

2.49

1114

6299

Type 1 diabetes, wide definition

2751

18019

1.69

113.42

3.6

2.8

3572.27

1194.41

ng/l

29.55

2390

15085

Smoking dependency

1339

7444

2.27

113.33

3.3

2.9

1585.33

1141.82

ng/l

2.46

1114

6302

Paralytic ileus and intestinal obstruction

4300

31229

1.56

113.23

3.3

3.0

1773.81

1618.78

ng/l

1.04

3759

26852

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

2579

17183

1.82

113.03

3.4

3.1

1525.02

1453.96

ng/l

0.38

2346

14740

Impingement syndrome of shoulder

3575

25061

1.62

112.92

3.0

2.8

829.94

1231.92

ng/l

13.08

3010

21513

Dermatophytosis

8858

70585

1.34

112.68

3.0

2.9

1175.00

1330.23

ng/l

3.36

7435

60078

Other degenerative diseases of the nervous system

4377

23548

1.54

111.96

2.9

2.8

1846.38

1606.78

ng/l

2.04

3707

20381

Abnormal results of function studies

1370

7702

2.23

111.64

3.9

3.0

1744.35

1314.51

ng/l

1.78

1185

6546

Other skin changes

3065

21191

1.71

110.63

3.6

3.1

1659.78

1579.66

ng/l

0.35

2697

18301

Other complications of surgical and medical care, not elsewhere classified

1497

8654

2.12

109.80

3.5

2.9

1500.76

1239.61

ng/l

1.17

1298

7364

Idiopathic pulmonary fibrosis

1564

9553

2.29

108.88

4.4

3.2

1651.45

1923.49

ng/l

1.68

1430

8314

Viral hepatitis, IBD co-morbidity

536

1981

3.12

108.51

2.9

2.3

1671.54

720.84

ng/l

1.35

445

1650

Haemorrhage, not elsewhere classified

778

3722

3.14

108.31

4.8

2.8

3174.69

1667.57

ng/l

4.60

696

3196

Diseases of male genital organs

7594

29699

1.38

108.19

3.2

1678.02

1563.24

ng/l

0.83

6392

25435

Emphysema

1368

7919

2.31

108.16

4.0

3.0

1792.44

1856.18

ng/l

0.20

1232

6832

Thyrotoxicosis, other and/or unspecified

2836

19113

1.69

108.01

4.3

2.8

1352.73

1266.53

ng/l

0.60

2451

16292

Disorders of mineral metabolism

1345

7616

2.23

108.01

3.5

2.8

2617.63

1221.30

ng/l

6.08

1167

6466

Other diseases of liver

2642

17651

1.73

107.58

3.4

2.9

1522.52

1273.10

ng/l

1.37

2174

15079

Other disorders of eyelid

7623

57753

1.39

107.11

3.1

3.0

1444.40

1580.62

ng/l

1.92

6542

49771

Congenital aortic valve stenosis

132

182

24.81

106.97

7.7

5.4

647.23

911.51

ng/l

0.83

124

148

Other enthesopathies

4087

29419

1.53

106.91

2.8

896.46

1243.07

ng/l

10.92

3477

24999

Chronic ulcer of skin, not elsewhere classified

1295

7426

2.38

106.89

4.5

3.1

3380.51

1630.86

ng/l

9.40

1169

6394

Postmenopausal bleeding

4214

16147

1.57

106.86

3.1

2.8

1126.84

1516.57

ng/l

9.62

3568

13794

Ovarian cyst

4386

18048

1.51

106.63

2.8

2.7

939.16

1334.00

ng/l

9.38

3628

15184

Fungal Sepsis

788

3830

3.10

106.00

5.5

2.8

2426.47

1252.02

ng/l

5.82

709

3263

Other malignant neoplasms of skin (=non-melanoma skin cancer)

7977

43576

1.38

105.99

3.1

1880.49

1520.55

ng/l

6.93

6858

37308

Diabetic maculopathy, excluding more controls

1662

10007

2.00

105.06

4.0

2.8

4211.45

1382.26

ng/l

22.78

1471

8507

Viral pneumonia (unknown virus, not influenza)

1077

5719

2.40

104.51

4.5

3.0

1837.13

1392.61

ng/l

1.89

969

4808

Implicit fungal Sepsis

735

3505

3.22

104.19

5.7

2.8

2500.66

1257.19

ng/l

5.71

661

2979

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1818

10982

1.85

104.19

2.9

2.8

1026.70

953.46

ng/l

0.28

1453

9017

Basal cell carcinoma, including avohilmo

7948

43690

1.38

104.18

3.1

3.0

1780.20

1516.83

ng/l

4.24

6832

37397

Other noninflammatory disorders of uterus, except cervix

3361

15807

1.64

104.05

2.9

2.8

1191.02

1530.30

ng/l

5.89

2846

13492

Diabetic nephropathy, excluding more controls

2578

14405

1.81

103.91

4.4

3.4

5472.72

1357.31

ng/l

57.14

2344

12107

Diabetic retinopathy, excluding more controls

4368

18017

1.58

103.87

3.8

3.3

3003.15

1232.54

ng/l

33.88

3824

14993

Bipolar affective disorders

2093

13102

1.76

103.62

2.6

2.8

753.53

1020.00

ng/l

3.05

1685

10934

Open wound of lower leg

2300

15040

1.79

103.59

3.9

3.1

1986.01

1517.02

ng/l

4.17

1999

12803

Symptoms and signs involving speech and voice

5085

38415

1.47

103.57

3.3

3.0

1208.53

1425.50

ng/l

3.36

4371

32984

Coarctation of the aorta

238

597

8.56

103.12

7.1

3.7

1334.91

903.97

ng/l

0.99

222

504

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1403

8137

2.13

102.84

3.7

3.0

1513.01

1254.31

ng/l

1.10

1205

6909

Peripheral artery operations in Hilmo

2330

15539

1.83

102.32

4.1

3.1

4500.46

1722.92

ng/l

29.98

2104

13371

Exposure to other specified factors

10379

77864

1.29

102.02

3.0

2.9

1361.51

1247.39

ng/l

1.48

8572

65941

Benign neoplasm: Colon, unspecified

4319

32258

1.55

101.97

3.4

3.1

1815.21

1547.75

ng/l

2.38

3718

28000

Seropositive rheumatoid arthritis

3850

27799

1.55

100.95

3.2

2.8

1525.68

1381.54

ng/l

1.31

3397

23633

Unspecified urinary incontinence

1526

9229

2.11

100.91

3.2

3.0

1318.14

1451.46

ng/l

0.61

1165

7940

Other diseases of intestine

2338

15541

1.79

100.86

3.5

2.9

1905.71

1463.27

ng/l

2.79

2048

13398

Epilepsy

4276

31206

1.49

100.46

3.0

1397.60

1638.53

ng/l

2.95

3664

26788

Asthma and allergy

1196

6301

2.05

99.42

2.7

2.3

604.84

693.37

ng/l

0.45

964

5105

Operations for atrial fibrillation

390

1515

7.57

98.86

4.7

3.1

1577.18

1434.07

ng/l

0.27

381

1313

Covid-19 suspected case

2568

17113

1.65

97.93

3.3

2.8

1252.58

1146.39

ng/l

0.51

2267

14230

Urticaria and erythema

4628

34397

1.46

97.90

3.3

2.9

1216.69

1187.75

ng/l

0.13

3836

29079

Alcohol use disorder, Swedish definition

7943

58278

1.34

97.26

3.1

1635.62

1427.71

ng/l

2.95

6768

49742

Basal cell carcinoma

7679

42600

1.37

97.25

3.1

1809.26

1537.12

ng/l

4.61

6577

36497

Kidney transplant status

813

4031

2.69

97.11

3.9

3.1

7892.93

883.23

ng/l

27.66

791

3409

Panic disorder

1506

8758

1.90

97.09

2.9

2.7

945.73

927.35

ng/l

0.04

1199

7179

Trochanteric bursitis

2164

14191

1.79

96.88

3.0

2.8

1083.81

1370.19

ng/l

2.18

1867

12160

Elevated blood glucose level

1337

7833

2.14

96.42

3.8

3.0

2186.17

1498.20

ng/l

3.20

1142

6685

8692

61865

1.32

96.17

3.1

3.0

1621.65

1418.69

ng/l

3.12

7401

52718

Traumatic subdural haemorrhage

2278

14571

1.78

96.10

3.6

3.0

2128.96

1912.16

ng/l

1.33

2000

12730

Benign paroxysmal vertigo

4643

35139

1.49

96.05

3.1

3.0

1156.12

1465.57

ng/l

6.21

3907

30285

Primary coxarthrosis, bilateral

5032

38807

1.48

95.82

3.3

3.1

1514.59

1656.40

ng/l

1.68

4398

33525

Enterocolitis due to Clostridium difficile

1882

12153

1.91

95.41

4.8

3.2

3384.97

1761.02

ng/l

13.15

1688

10439

Amputation

1869

12138

1.95

95.31

4.2

3.1

5124.35

1717.82

ng/l

28.03

1690

10504

Other postsurgical states

1001

5365

2.39

95.10

4.4

2.5

998.06

1281.10

ng/l

2.31

917

4532

Other hammer toe(s) (acquired)

2818

18165

1.66

93.69

2.9

1227.29

1476.74

ng/l

3.08

2396

15570

Other congenital malformations of heart

159

304

12.23

93.42

9.8

3.2

887.10

824.42

ng/l

0.11

151

245

Injuries to the elbow and forearm

10022

72440

1.29

93.37

3.1

2.9

1518.51

1288.44

ng/l

4.35

8456

61224

Other viral diseases

4114

29843

1.46

92.86

3.4

2.9

1238.85

1108.89

ng/l

1.02

3497

24773

Other and unspecified effects of external causes

3286

23250

1.54

92.47

3.0

2.9

1163.80

1190.53

ng/l

0.13

2736

19493

Noninfective enteritis and colitis

6390

50065

1.37

92.43

3.2

3.0

1507.61

1337.02

ng/l

1.71

5452

42433

Thyrotoxicosis

3604

26223

1.53

91.72

4.0

2.8

1359.42

1291.51

ng/l

0.50

3120

22327

Diseases of external ear

4960

37914

1.44

91.29

3.2

3.0

1386.33

1431.09

ng/l

0.32

4004

32584

Candidiasis

1941

12561

1.80

91.14

3.8

2.9

1397.08

1319.36

ng/l

0.34

1645

10666

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

4020

29773

1.53

91.12

2.9

3.1

1307.96

1508.58

ng/l

1.88

3642

25692

Migraine with aura and triptan purchases

1507

8917

1.86

91.12

2.6

2.7

456.34

730.29

ng/l

4.35

1204

7272

Other noninfective gastroenteritis and colitis

3516

25443

1.53

90.99

3.4

3.1

1645.96

1465.80

ng/l

1.02

3029

21672

Other metabolic disorders

1712

10665

1.84

90.59

3.6

2.6

1149.27

984.51

ng/l

0.77

1482

8940

Any event in hilmo or specialist outpatient

39.09

90.00

3.1

1.4

716.69

341.93

ng/l

—

8284

60667

1.31

89.90

3.1

3.0

1653.22

1426.96

ng/l

3.53

7066

51721

Spondylolisthesis/Spondylolysis

2655

18387

1.64

89.58

3.0

2.9

995.39

1385.30

ng/l

7.80

2266

15721

Schizophrenia or delusion, excluding more controls

3660

26220

1.49

89.49

2.7

2.8

1095.92

1202.37

ng/l

0.71

2968

22154

Emotionally unstable personality disorder

1151

6326

2.02

89.33

2.3

2.7

658.91

694.42

ng/l

0.12

874

5072

Other diseases of lip and oral mucosa

5658

44090

1.39

89.23

2.9

1103.85

1224.89

ng/l

1.24

4782

37523

Mouth breathing

5493

42574

1.40

88.90

3.0

954.58

1206.52

ng/l

4.90

4608

36445

Fracture of lumbar spine and pelvis

3769

28025

1.54

88.87

3.7

3.1

2094.21

1774.37

ng/l

3.38

3275

24107

Other and unspecified drugs and medicaments

1316

7846

2.07

88.59

3.7

3.1

1568.95

1368.44

ng/l

0.69

1134

6670

Later onset COPD

5420

34020

1.46

88.49

4.2

3.1

2534.84

1948.13

ng/l

10.02

4826

29651

Localized swelling, mass and lump of skin and subcutaneous tissue

4587

34814

1.45

88.47

3.3

3.0

1329.70

1364.15

ng/l

0.20

3979

29751

Osteoporosis with pathological fracture (FG)

1327

8111

2.18

88.36

3.9

2.9

1509.01

1609.96

ng/l

0.50

1148

6912

Other shoulder lesions

1282

7466

2.02

88.30

3.2

2.9

958.27

1330.78

ng/l

3.11

1064

6325

Hypertension, Pulmonary Arterial

224

625

9.26

88.21

12.2

2.8

1483.90

1163.54

ng/l

1.02

217

520

Adhesive capsulitis of shoulder

2475

16994

1.67

87.94

3.1

2.9

1227.21

1401.47

ng/l

1.46

2144

14589

Vascular disorders of the intestines

1296

7849

2.17

87.94

4.4

3.0

2927.45

1840.86

ng/l

4.70

1184

6793

Persons with potential health hazards related to communicable diseases

3746

26901

1.46

87.73

3.2

2.8

1639.92

989.68

ng/l

5.34

3113

22166

Other or unspecified ileus, impaction or obstruction

3043

21829

1.59

87.24

3.3

3.0

1797.55

1674.52

ng/l

0.56

2664

18792

Special screening examination for other diseases and disorders

1447

8672

1.90

87.18

3.3

2.7

1849.96

1380.29

ng/l

1.77

1241

7375

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3093

21776

1.53

87.07

2.8

965.98

1034.21

ng/l

0.41

2481

18067

Endometriosis

4170

17924

1.46

86.95

2.6

2.7

946.14

1347.35

ng/l

7.34

3460

15096

Other viral diseases, not elsewhere classified

2975

20747

1.54

86.75

3.4

3.0

1108.55

1199.90

ng/l

0.56

2528

17283

Radiculopathy

2559

17783

1.66

86.72

3.2

3.0

1241.75

1758.94

ng/l

8.70

2189

15312

Need for other prophylactic measures

915

4934

2.40

86.60

3.7

3.1

1556.69

1298.78

ng/l

0.64

827

4186

Preparatory care for dialysis

789

4154

2.76

86.12

4.1

3.1

10712.70

1251.23

ng/l

36.24

746

3574

Other bursopathies

2012

13341

1.76

85.89

3.2

2.9

1607.92

1541.69

ng/l

0.18

1728

11449

ILD-related respiratory insufficiency

701

3639

3.22

85.76

5.8

3.2

2323.28

1801.12

ng/l

1.68

663

3172

Amputation of toe

1327

8196

2.16

85.58

4.0

3.2

5080.11

1757.75

ng/l

19.80

1201

7085

Disorders of skin appendages

5977

46790

1.36

85.29

3.1

2.9

1296.98

1180.30

ng/l

1.10

5037

39397

Other symptoms and signs involving the urinary system

1685

10834

1.89

85.25

3.3

3.1

1776.80

1543.55

ng/l

0.69

1520

9361

Benign neoplasm: Sigmoid colon

3145

22993

1.60

85.07

3.4

3.1

1457.70

1521.94

ng/l

0.29

2780

19921

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

962

5496

2.55

84.69

4.0

3.1

2218.65

1675.37

ng/l

1.61

873

4741

Purpura and other haemorrhagic conditions

2016

13434

1.76

84.61

3.8

3.1

1887.03

1507.11

ng/l

2.87

1800

11513

Disorders of vitreous body and globe

8063

63565

1.32

84.31

3.0

2.9

1456.96

1341.60

ng/l

1.16

6951

54704

Disorders of muscles

1435

8770

1.92

83.85

3.5

3.0

1293.85

1509.59

ng/l

0.89

1246

7481

Leisure time condition

2561

17831

1.62

83.72

3.5

3.1

1597.00

1458.65

ng/l

0.85

2148

15222

Necrosis of pulp, including avohilmo

7235

57969

1.32

83.66

2.7

2.9

904.30

1105.65

ng/l

4.91

5933

48868

Excessive earwax

8592

69188

1.30

83.58

3.0

3.1

1235.37

1480.69

ng/l

8.23

7375

59498

Family history of certain disabilities and chronic diseases leading to disablement

557

2426

2.75

83.44

2.8

2.2

671.50

670.83

ng/l

0.00

423

1928

Lesion of ulnar nerve

1975

13076

1.74

83.29

3.2

2.9

1361.57

1349.35

ng/l

0.04

1659

11213

SLE (Finngen)

552

2485

3.02

83.25

3.5

2.8

1307.73

1077.31

ng/l

0.59

492

2075

Polymyalgia rheumatica

2448

17355

1.73

83.20

3.7

3.1

1657.38

1766.28

ng/l

0.66

2164

15027

Any death

10482

63191

1.28

83.12

4.1

2.8

3183.37

929.89

ng/l

142.93

9486

54293

Organic, including symptomatic, mental disorders

9069

53690

1.31

83.12

3.1

3.2

1910.79

1694.39

ng/l

3.28

7772

46689

Other extrapyramidal and movement disorders in other diseases

3668

27384

1.51

83.03

3.1

3.0

1209.11

1503.36

ng/l

3.02

3109

23651

Vasomotor and allergic rhinitis

4326

31848

1.42

82.85

2.8

2.9

915.48

1120.22

ng/l

1.94

3492

26791

Urticaria

3585

26252

1.48

82.77

3.2

2.9

1047.14

1143.89

ng/l

0.75

2948

22138

Nonorganic sleeping disorders

2342

15875

1.62

82.70

3.2

3.0

1081.06

1214.84

ng/l

0.86

1902

13284

Persistent mood disorders

2610

18192

1.60

82.66

3.1

2.9

1036.21

1352.94

ng/l

4.59

2125

15473

Extrapyramidal and movement disorders

6088

48650

1.37

82.42

3.0

3.1

1231.42

1585.72

ng/l

7.98

5176

41944

Disorders of calcium metabolism

1024

5831

2.24

81.91

3.6

2.8

2897.88

1250.97

ng/l

5.73

903

4934

Non-Hodgkin lymphoma, all, including Hilmo

2225

15394

1.73

81.74

3.5

3.1

1788.46

1541.73

ng/l

1.36

2009

13235

Abnormal involuntary movements

1982

13246

1.75

81.69

3.3

3.0

1158.08

1430.22

ng/l

2.44

1694

11353

Disorders of vitreous body

7815

61989

1.32

81.46

3.0

2.9

1429.13

1322.87

ng/l

1.02

6730

53362

Nonalcoholic fatty liver disease

1322

7993

1.96

81.46

2.9

1058.35

1057.49

ng/l

0.00

1043

6711

Mental and behavioural disorders due to alcohol

7130

55283

1.32

81.20

3.1

3.0

1634.70

1402.33

ng/l

3.19

6054

47122

Viral and other specified intestinal infections

2908

19716

1.52

81.02

3.9

2.9

1570.04

1283.89

ng/l

1.48

2496

16216

Childhood asthma (age<16), excluding more controls

729

2677

2.26

80.99

3.6

1.7

428.00

252.07

ng/l

1.45

547

1960

Inguinal hernia

8928

49103

1.29

80.96

3.3

3.1

1677.37

1521.12

ng/l

1.94

7714

41839

Diseases of salivary glands

4404

33599

1.43

80.90

3.0

2.9

1241.76

1246.39

ng/l

0.02

3754

28601

Presbycusis

2704

19348

1.65

80.76

3.3

3.2

2186.06

2248.60

ng/l

0.24

2223

16922

Sicca syndrome [Sjögren]

1317

8076

2.01

80.61

3.1

2.8

905.77

1193.96

ng/l

3.21

1131

6859

Unspecified mental disorder

5001

38582

1.38

80.54

2.7

2.9

995.13

1221.69

ng/l

4.22

4092

32448

Fracture of lower leg, including ankle

7942

64300

1.30

80.52

3.0

2.9

1489.66

1309.25

ng/l

2.49

6740

54621

Other blood glucose lowering drugs, excl. Insulins

2708

19475

1.63

79.90

3.6

3.0

1952.37

1507.71

ng/l

3.10

2324

16860

Cholecystitis

2356

16467

1.67

79.85

3.6

3.1

1846.51

1800.26

ng/l

0.17

2049

14173

Enthesopathies of lower limb, excluding foot

2875

20481

1.54

79.73

2.8

904.83

1293.93

ng/l

6.94

2393

17376

Benign neoplasm: Transverse colon

1814

12191

1.85

79.66

3.4

3.1

1655.74

1524.27

ng/l

0.39

1607

10571

Mental and behavioural disorders due to alcohol, excluding acute intoxication

6217

49341

1.34

79.59

3.0

1645.44

1372.50

ng/l

3.61

5278

42060

Suicide or other Intentional self-harm

2788

19666

1.54

79.46

2.9

1038.27

1105.65

ng/l

0.35

2240

16465

Charcot foot

313

1098

4.45

79.41

4.0

2.1

4297.29

859.75

ng/l

11.93

275

868

Ascites

1244

7588

2.06

79.01

4.8

2.9

3252.35

1522.65

ng/l

9.74

1144

6572

Disorders of sclera, cornea, iris and ciliary body

7669

62637

1.30

78.86

3.1

2.9

1431.30

1316.11

ng/l

1.28

6521

53153

Generalized anxiety disorder

1490

9123

1.77

78.62

2.8

2.6

659.47

876.64

ng/l

1.25

1145

7445

Other peripheral vascular diseases

1208

7245

2.03

78.41

3.3

2.9

1320.22

1233.09

ng/l

0.31

1051

6107

Other disorders of kidney and ureter

2076

14268

1.73

78.09

3.7

3.1

4400.47

1472.11

ng/l

26.10

1861

12315

Other viral diseases

3213

23190

1.48

77.81

3.7

2.9

1371.01

1176.82

ng/l

1.51

2762

19264

Wet age-related macular degeneration

3402

25040

1.57

77.08

3.4

3.3

2103.36

2002.28

ng/l

0.54

2951

21790

Benign neoplasm of other and ill-defined parts of digestive system

2823

20536

1.59

77.05

3.4

3.0

1484.60

1456.45

ng/l

0.11

2447

17704

Arthropathies in other diseases classified elsewhere

598

2893

2.81

76.91

3.9

3.0

3259.19

1332.58

ng/l

7.90

506

2463

Voice disturbances

3815

28839

1.46

76.86

3.0

2.9

1042.77

1337.05

ng/l

5.04

3260

24729

Persons encountering health services for specific procedures, not carried out

1096

6346

2.02

76.79

2.8

2.7

1755.42

949.91

ng/l

3.94

921

5266

Alcohol use disorder, ICD-based

5715

45334

1.35

76.69

3.1

3.0

1641.95

1367.79

ng/l

3.28

4847

38617

Other and unspecified myopathies

1478

9529

1.93

76.52

3.5

3.2

2238.89

1711.94

ng/l

2.05

1260

8221

Other embolism and thrombosis

2003

13636

1.72

76.48

3.3

3.0

1730.67

1593.56

ng/l

0.48

1754

11698

Pain and other conditions associated with female genital organs and menstrual cycle

1902

11394

1.65

76.09

2.4

2.5

661.75

914.30

ng/l

1.78

1517

9421

Flat foot [pes planus] (acquired)

1336

8264

1.90

75.07

2.7

2.8

881.51

1180.33

ng/l

2.18

1119

7062

Sulfasalazine

3764

28294

1.44

74.63

2.9

2.6

1285.20

1258.81

ng/l

0.16

3229

23822

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1519

9832

1.87

74.61

3.8

3.1

2317.96

1457.58

ng/l

4.94

1340

8442

Other general symptoms and signs

641

3089

2.46

74.44

2.9

2.7

1511.42

1214.28

ng/l

0.37

519

2579

Parkinson's disease, excluding more controls

2185

14300

1.66

74.34

2.9

1307.41

1702.23

ng/l

5.44

1871

12533

Secondary and unspecified malignant neoplasm of lymph nodes

1353

8567

1.96

74.30

3.7

3.1

1814.92

1527.26

ng/l

1.53

1221

7339

Other and unspecified disorders of skin and subcutaneous tissue

1029

6055

2.16

74.26

3.6

3.0

1858.39

1359.16

ng/l

2.25

796

5157

Inflammatory diseases of female pelvic organs

7374

44014

1.30

74.19

2.7

878.13

1051.07

ng/l

4.25

5960

36967

Cervicocranial syndrome

1487

9458

1.82

74.06

2.9

2.8

911.27

1474.64

ng/l

6.34

1291

8074

Dialysis

647

3289

2.67

73.89

4.2

3.0

11286.63

949.37

ng/l

32.45

617

2804

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

3019

22398

1.55

73.76

2.9

3.1

1137.36

1474.80

ng/l

6.96

2738

19312

Irregular menses

4836

29409

1.37

73.70

2.6

2.5

750.33

839.14

ng/l

0.74

3935

24356

Benign neoplasm: Ascending colon

2310

16483

1.68

73.69

3.5

3.1

1554.94

1523.57

ng/l

0.13

2055

14282

Osteomyelitis

1070

6403

2.13

73.63

3.9

3.1

3824.28

1616.32

ng/l

14.99

958

5521

Other necrotizing vasculopathies (FG)

1011

5960

2.19

73.55

3.5

2.9

1652.40

1520.84

ng/l

0.41

906

5106

Pain associated with micturition

1692

11184

1.76

73.01

3.3

3.0

1082.49

1401.92

ng/l

2.86

1406

9598

Other viral diseases, not elsewhere classified

2187

14982

1.60

72.83

3.8

3.1

1221.93

1308.25

ng/l

0.44

1890

12581

Kela-code for severe mental illness

4520

34920

1.38

72.65

2.7

2.9

1002.16

1257.44

ng/l

4.65

3705

29390

Superficial injury of hip and thigh

2352

16700

1.62

71.66

3.5

3.2

2032.08

1754.60

ng/l

1.25

2021

14331

Adverse effects, not elsewhere classified

2335

16324

1.57

71.24

3.0

2.9

1184.09

1162.93

ng/l

0.08

1956

13719

Lung cancer and mesothelioma

3033

19177

1.52

71.08

3.1

2.5

1450.62

1340.21

ng/l

0.85

2768

16464

Intestinal stricture

4935

39168

1.39

71.05

3.3

3.1

1768.35

1604.50

ng/l

1.29

4319

33756

Childhood asthma (age<16)

730

2827

2.14

70.92

3.6

2.2

428.43

418.98

ng/l

0.03

548

2111

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2642

18498

1.50

70.62

3.7

2.8

999.35

1087.58

ng/l

0.65

2188

15238

Other local infections of skin and subcutaneous tissue

1461

9409

1.82

70.62

3.8

3.1

2260.44

1369.28

ng/l

3.92

1263

8008

Injuries to the ankle and foot

8696

64250

1.26

70.28

3.0

2.9

1292.89

1147.73

ng/l

1.94

7199

53983

Diplopia

1936

13305

1.69

70.12

3.3

3.0

1170.58

1481.87

ng/l

2.88

1668

11427

Cardiomyopathy in other diseases

147

358

12.72

69.68

11.9

1.9

4933.89

392.85

ng/l

14.28

136

297

Other and unspecified local infections of skin and subcutaneous tissue

1379

8801

1.85

69.41

3.8

3.0

2339.07

1350.43

ng/l

4.29

1194

7491

Rheumatoid arthritis, including avohilmo

5734

46271

1.34

69.37

3.1

3.0

1463.29

1403.24

ng/l

0.49

4998

39516

Conjunctivitis (acute, non atopic)

3422

25518

1.44

69.31

3.2

3.0

1205.82

1224.09

ng/l

0.08

2877

21594

Congenital stenosis of pulmonary valve

146

334

8.47

69.29

6.9

4.3

676.59

683.39

ng/l

0.02

138

282

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

3890

29334

1.39

68.98

2.9

2.8

858.84

998.12

ng/l

1.79

3132

24281

Abnormalities of gait and mobility

1972

13800

1.71

68.75

3.0

3.2

1929.24

1689.99

ng/l

0.91

1722

11992

Injuries to the neck

2753

19942

1.50

68.69

2.9

3.0

1106.98

1316.29

ng/l

2.43

2276

16849

Other dialysis

528

2589

2.96

68.52

4.2

3.2

11917.26

1161.39

ng/l

24.78

505

2224

Fissure and fistula of anal and rectal regions

3283

24554

1.46

68.51

2.9

2.8

1117.09

1303.97

ng/l

2.36

2771

20950

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1511

9764

1.75

68.34

3.6

2.6

1187.69

984.07

ng/l

0.90

1308

8174

Transport accidents

5925

40812

1.31

68.28

2.9

2.8

1193.99

1155.55

ng/l

0.27

4889

34763

Temporomandibular joint disorders, including avohilmo

4702

36120

1.35

68.23

2.6

2.7

639.48

971.59

ng/l

14.22

3822

30135

Other disorders of adrenal gland

692

3677

2.43

68.11

4.3

3.1

1446.02

1202.30

ng/l

0.50

610

3111

Fentanyl

1712

11538

1.73

68.08

3.8

2.9

1902.81

1845.60

ng/l

0.13

1531

9847

Abnormal findings on diagnostic imaging of other body structures

2033

14220

1.65

67.54

3.1

2.9

1373.44

1324.86

ng/l

0.17

1757

12180

Scoliosis

1053

6227

1.94

67.54

3.3

2.9

972.83

1397.36

ng/l

3.57

877

5242

Parkinson's disease, strict definition, excluding more controls

2037

13573

1.65

67.11

2.9

1337.05

1738.18

ng/l

5.09

1743

11908

Unknown and unspecified causes of morbidity

969

5641

2.01

66.88

3.1

2.6

1590.71

1477.09

ng/l

0.25

874

4748

Mixed hyperlipidaemia

693

3754

2.48

66.84

3.9

2.8

2543.40

1327.14

ng/l

3.21

604

3215

Other and unspecified visual disturbances

1462

9574

1.80

66.42

3.2

3.0

1229.47

1340.12

ng/l

0.47

1264

8204

Post-traumatic stress disorder

703

3609

2.15

66.33

2.5

2.6

727.65

738.53

ng/l

0.01

563

2920

Adrenocortical insufficiency

586

2988

2.65

66.32

4.5

3.0

1249.03

1127.05

ng/l

0.25

522

2531

Viral and other specified intestinal infections

2123

14267

1.55

66.13

4.2

2.9

1823.79

1331.14

ng/l

2.26

1826

11648

Fibrosis and cirrhosis of liver

1243

7962

1.95

66.04

3.9

3.1

2054.45

1446.98

ng/l

2.73

1118

6865

Other disorders of bone

2433

17410

1.53

65.84

2.9

1047.81

1150.42

ng/l

0.59

2003

14685

Alzheimer’s disease (Atypical or mixed), excluding more controls

1609

8630

1.80

65.78

3.3

3.1

2119.64

2177.37

ng/l

0.17

1361

7543

Fracture of femur

4762

34491

1.39

65.56

3.5

3.2

2516.79

1896.40

ng/l

10.42

4161

29742

Other disorders of patella

1900

12919

1.60

65.36

2.6

2.8

862.68

945.14

ng/l

0.32

1507

10881

Systemic lupus erythematosus

552

2755

2.66

65.11

3.5

2.8

1307.73

1008.07

ng/l

0.97

492

2286

Delirium, not induced by alcohol and other psychoactive substances

2116

15157

1.66

64.95

3.5

3.3

2656.41

2025.98

ng/l

3.94

1836

13205

Neuralgia and neuritis, unspecified

737

4030

2.26

64.78

3.0

942.17

1325.03

ng/l

2.74

638

3420

Retinal vascular occlusion

2083

14945

1.67

64.75

3.6

3.2

2347.88

1779.04

ng/l

4.39

1822

13007

Noninfectious colitis NAS

1870

12876

1.64

64.67

3.2

3.1

1665.46

1452.72

ng/l

0.74

1606

10949

Raynaud syndrome

1124

6908

1.91

64.66

3.1

3.0

694.85

1134.77

ng/l

6.26

968

5797

Female genital prolapse

3945

17048

1.41

64.59

2.8

959.07

1459.21

ng/l

15.91

3354

14488

Benign neoplasm: Caecum

1775

12416

1.74

64.02

3.5

3.1

1744.59

1502.93

ng/l

0.90

1566

10777

Propionic acid derivatives

4192

16116

1.39

63.85

3.2

3.5

1587.71

2219.97

ng/l

10.40

3500

14136

Superficial injury of thorax

2099

14835

1.60

63.73

3.4

3.1

1427.77

1569.71

ng/l

0.69

1799

12662

Bronchiectasis

1336

8805

1.89

63.69

3.9

3.0

1595.79

1665.40

ng/l

0.23

1173

7612

Acute pancreatitis

2890

21592

1.49

63.62

3.3

3.0

1727.68

1527.08

ng/l

1.27

2528

18533

Other overlap syndromes

339

1423

3.78

63.50

3.7

3.0

813.65

1230.51

ng/l

1.92

310

1199

Disorders of parathyroid gland

3392

25802

1.46

63.37

3.5

3.0

2755.29

1609.57

ng/l

10.69

2922

22198

Retinal vascular disorders

2113

15245

1.65

63.31

3.6

3.2

2384.43

1807.95

ng/l

4.30

1848

13273

Polyp of the female genital tract

3949

17371

1.40

63.21

2.8

2.7

1045.98

1414.01

ng/l

6.74

3286

14717

Speech therapy

3925

30673

1.41

63.19

3.2

3.0

1547.05

1455.33

ng/l

0.59

3567

26365

Thiazolidinediones

1851

13009

1.70

63.17

3.3

3.0

1890.55

1475.41

ng/l

2.25

1581

11339

Non-follicular lymphoma

1582

10834

1.78

62.80

3.7

3.1

1819.53

1605.58

ng/l

1.13

1453

9390

Acute gastritis

1192

7587

1.90

62.57

3.6

3.0

1895.68

1644.92

ng/l

0.53

1044

6513

Visual impairment including blindness (binocular or monocular)

1137

7197

1.95

62.53

3.7

3.2

2559.63

1837.16

ng/l

1.93

948

6178

Secondary uncertain malignant neoplasm

2107

15113

1.62

62.46

3.4

3.2

1774.47

1669.52

ng/l

0.51

1887

12996

498

9579

0.44

62.36

2.8

3.2

2912.96

1863.97

ng/l

2.21

423

8284

SLE, ICD10

533

2682

2.66

61.89

3.4

2.7

1312.89

964.43

ng/l

1.17

472

2215

SLE, strict definition

533

2682

2.66

61.89

3.4

2.7

1312.89

964.43

ng/l

1.17

472

2215

Other condition

1831

12638

1.62

61.71

3.6

3.0

1541.14

1317.83

ng/l

1.02

1618

10701

Disorders resulting from impaired renal tubular function

616

3318

2.57

61.69

3.7

3.1

8822.80

1302.45

ng/l

26.35

580

2839

Benign neoplasm: Rectum, anus and anal canal

3232

24874

1.47

61.49

3.3

3.1

1500.90

1541.05

ng/l

0.21

2800

21581

Alcohol abuse, main dg, excluding more controls

1787

12210

1.62

61.48

3.1

3.0

1527.82

1227.55

ng/l

1.72

1509

10410

Other specified congenital malformation syndromes affecting multiple systems

227

744

4.19

61.27

4.7

4.1

1109.76

802.61

ng/l

0.65

200

605

Benign neoplasm: Rectum

2875

21815

1.51

61.00

3.3

3.1

1453.48

1528.88

ng/l

0.46

2488

18938

Superficial injury of abdomen, lower back and pelvis

1958

13697

1.59

60.96

3.5

3.0

1528.19

1466.01

ng/l

0.25

1655

11603

Glaucoma

9322

68642

1.25

60.90

3.1

1625.18

1598.51

ng/l

0.20

7970

59198

Stomatitis and related lesions

2488

18167

1.51

60.85

3.2

3.0

1166.30

1315.52

ng/l

1.03

2091

15422

Amyloidosis

438

2127

3.22

60.59

7.3

2.9

3517.35

1508.76

ng/l

8.46

410

1810

Restless leg syndrome

1899

13369

1.63

60.58

3.1

3.0

1197.54

1362.31

ng/l

0.59

1597

11454

Faecal incontinence

1441

9653

1.77

60.57

2.8

1439.98

1448.49

ng/l

0.02

1182

8361

Cirrhosis of liver, NAS

907

5540

2.15

60.21

4.0

3.1

2057.22

1458.42

ng/l

2.41

823

4769

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1342

8959

1.84

59.95

3.9

3.1

2370.88

1704.47

ng/l

3.25

1170

7728

Other coagulation defects

998

6083

1.94

59.67

3.8

3.0

1597.60

1366.71

ng/l

0.99

839

5137

Fibroblastic disorders

3477

26878

1.42

59.62

3.1

3.0

1456.65

1649.63

ng/l

1.88

2970

23208

Periapical abscess

5907

48345

1.30

59.49

2.9

1173.14

1184.38

ng/l

0.06

4995

41089

Failure and rejection of transplanted organs and tissues

248

911

4.44

59.44

6.9

3.1

5066.85

711.33

ng/l

5.81

237

746

In situ neoplasms

5821

47916

1.31

59.07

3.2

3.0

1801.88

1554.29

ng/l

2.40

5056

41152

Otitis externa

2831

21185

1.46

59.06

3.1

3.0

1208.32

1323.43

ng/l

0.85

2301

18074

Other diseases of oesophagus

1514

10295

1.73

59.05

3.6

3.0

1920.11

1746.38

ng/l

0.47

1323

8887

Dislocation, sprain and strain of joints and ligaments at neck level

1586

10628

1.63

58.85

2.6

2.9

759.68

1072.01

ng/l

3.92

1285

8809

Other enthesopathy of foot (+metatarsalgia)

1296

8393

1.75

58.82

2.9

2.8

868.51

1189.77

ng/l

4.10

1103

7153

Pruritus

1498

10069

1.70

58.79

3.3

2.9

1847.57

1395.24

ng/l

2.28

1277

8551

Mixed and other personality disorders

853

4920

1.97

58.73

2.6

2.8

834.56

840.94

ng/l

0.02

679

4003

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2242

16550

1.60

58.60

3.5

3.3

2427.61

2009.92

ng/l

3.06

1977

14324

Synovial cyst of popliteal space [Baker]

1123

7149

1.89

58.56

3.4

2.9

1524.74

1553.27

ng/l

0.05

975

6122

Metatarsalgia

1225

7851

1.79

58.53

2.9

2.8

877.94

1209.45

ng/l

4.00

1045

6695

Other problems related to primary support group, including family circumstances

1038

6091

1.82

58.51

4.7

2.9

925.55

854.30

ng/l

0.29

857

4951

Lung diseases due to external agents

2298

16931

1.56

58.08

3.8

3.2

1998.99

1956.86

ng/l

0.15

2029

14656

Excessive attrition of teeth

6769

56148

1.26

57.72

2.9

2.8

957.42

1091.07

ng/l

1.56

5586

47412

Viral pneumonia (known virus, not influenza)

480

2438

2.88

57.69

5.0

3.1

3132.25

1513.12

ng/l

3.76

442

2101

Systemic lupus erythematosus, unspecified

465

2287

2.75

57.55

3.3

2.8

1254.54

959.71

ng/l

0.81

419

1897

Pleural plaque

1730

12348

1.72

57.27

3.8

3.1

1687.41

1938.54

ng/l

2.01

1516

10782

Hydronephrosis

1721

12033

1.65

57.22

3.1

2.8

2639.43

1144.94

ng/l

13.69

1519

10330

Multiple myeloma, including Hilmo

816

4941

2.23

57.15

4.8

3.1

1909.87

1688.13

ng/l

0.73

747

4263

Diabetic retinopathy

5714

29493

1.34

57.12

4.0

3.6

3055.55

1663.21

ng/l

29.45

5004

25353

Anti-inflammatory and antirheumatic products, non-steroids

4136

16116

1.36

57.02

3.2

3.5

1702.34

2219.97

ng/l

6.69

3468

14136

Other necrotizing vasculopathies

1174

7701

1.89

56.84

3.5

3.1

1849.43

1589.74

ng/l

0.75

1053

6649

Decubitus ulcer and pressure area

1074

6919

1.96

56.83

4.5

3.2

3673.16

1867.80

ng/l

8.79

954

5971

Hyperkinetic disorders, excluding more controls

646

3204

2.04

56.64

3.3

2.8

728.90

482.98

ng/l

0.49

450

2437

Papulosquamous disorders

5459

44676

1.31

56.64

3.0

2.9

1253.09

1284.99

ng/l

0.23

4643

38196

Fracture of shoulder and upper arm

5225

42547

1.31

56.35

3.1

3.0

1737.35

1485.70

ng/l

3.01

4431

36294

Alzheimer disease, excluding more controls

2965

14861

1.47

55.80

2.9

2.8

2054.31

1749.04

ng/l

2.01

2516

13003

Drug-induced adrenocortical insufficiency

329

1448

3.53

55.79

5.1

3.2

1195.06

1033.34

ng/l

0.21

294

1233

Immunodeficiencies

670

3751

2.22

55.41

4.2

3.0

1558.69

1225.00

ng/l

0.87

598

3152

Amyloidosis, other/unspecified

369

1749

3.48

55.29

7.8

2.9

3578.32

1397.01

ng/l

7.90

348

1493

Seronegative rheumatoid arthritis

1658

11547

1.64

55.14

3.2

2.8

1536.37

1340.33

ng/l

1.02

1436

9862

Diffuse large B-cell lymphoma, including Hilmo

795

4821

2.20

54.89

4.0

3.1

1924.44

1544.63

ng/l

1.50

736

4126

Diffuse large B-cell lymphoma

795

4821

2.20

54.89

4.0

3.1

1924.44

1544.63

ng/l

1.50

736

4126

Diffuse large B-cell lymphoma, helper endpoint

795

4821

2.20

54.89

4.0

3.1

1924.44

1544.63

ng/l

1.50

736

4126

Any prescribed medicine buy

15.06

54.84

3.3

2.7

1309.95

518.55

ng/l

2.35

Keratitis

4695

37843

1.32

54.82

3.1

3.0

1377.57

1295.11

ng/l

0.64

3983

32148

KRA_PSY_EATING, excluding more controls

549

2728

2.15

54.68

3.0

2.6

972.78

558.81

ng/l

0.47

421

2173

Other disorders of nervous system

1019

6485

1.92

54.41

3.0

1144.07

1376.45

ng/l

1.36

860

5520

Thyroiditis, ILD-related definition

1390

9286

1.68

54.40

3.1

2.9

1181.39

1139.84

ng/l

0.11

1161

7823

Trigger finger

1867

13241

1.57

54.38

2.9

2.8

1204.50

1294.11

ng/l

0.26

1581

11327

Superficial injury of wrist and hand

2203

15940

1.49

54.22

3.1

3.0

1233.60

1192.71

ng/l

0.14

1778

13407

Other and unspecified urticaria

2263

16506

1.49

54.19

3.2

2.9

1093.93

1165.70

ng/l

0.32

1833

13918

Tobacco use

716

4102

2.12

54.07

3.0

2.9

1440.23

1134.89

ng/l

1.25

621

3464

Schizophrenia or delusion

3660

28603

1.36

53.55

2.7

2.9

1095.92

1216.82

ng/l

0.85

2968

23985

Disorders of conjunctiva

10992

76539

1.20

53.49

3.0

2.9

1126.33

1282.39

ng/l

3.31

9185

64632

Exclusion endpoint for clefts

253

948

3.46

53.30

4.7

3.9

1187.60

832.92

ng/l

0.81

222

767

Schizophrenia, schizotypal and delusional disorders

3686

28860

1.36

53.18

2.7

2.9

1077.75

1216.38

ng/l

1.07

2989

24202

Dermatophytosis

1882

13595

1.58

52.33

3.7

3.1

1586.70

1515.84

ng/l

0.25

1635

11685

Asthma and opportunity respiratory infection

791

4846

2.16

52.30

3.9

3.0

1395.04

1591.45

ng/l

0.66

691

4183

Morphin

390

1902

3.04

52.03

5.2

2.9

1574.93

1783.87

ng/l

0.47

357

1636

Other aneurysm

914

5773

1.99

51.80

4.2

3.0

2206.47

1609.64

ng/l

2.25

837

4951

Budesonide

1652

11506

1.58

51.74

3.0

2.6

1155.20

1249.73

ng/l

0.37

1393

9615

Weight loss

1475

10245

1.68

51.73

3.2

3.1

1587.05

1559.19

ng/l

0.08

1260

8813

Migraine without aura and triptan purchases

1353

8929

1.62

51.65

2.5

2.6

396.50

669.75

ng/l

5.41

1077

7258

Pneumonia due to other infectious organisms, not elsewhere classified

528

2836

2.44

51.28

4.6

2.6

1963.42

1159.18

ng/l

2.96

468

2397

Spontaneous rupture of synovium and tendon

1193

7919

1.77

51.23

3.0

2.9

1201.90

1524.59

ng/l

2.21

1015

6815

Asthma mixed form (mode), excluding more controls

627

3444

2.10

51.14

3.2

1.9

1200.72

655.33

ng/l

3.61

533

2864

Anaemia in chronic diseases classified elsewhere

441

2285

2.85

50.89

5.2

3.1

7895.19

1464.09

ng/l

20.88

420

1969

Other disorders of glucose regulation and pancreatic internal secretion

1154

7591

1.76

50.48

3.5

3.1

3507.75

1553.83

ng/l

7.55

1007

6434

Embolic stroke with flimmer

467

2437

2.62

50.41

4.4

2.4

3109.08

1281.04

ng/l

9.51

420

2060

Glomerulonephritis

1370

9381

1.68

50.32

3.6

3.2

5039.16

1431.05

ng/l

17.54

1241

7994

Spondylopathies (FG)

1520

10441

1.59

50.30

2.8

1025.21

1170.30

ng/l

0.68

1266

8750

Phobic anxiety disorders

1098

6939

1.69

50.24

2.9

2.7

807.68

801.66

ng/l

0.01

873

5606

Follow-up examination after treatment for malignant neoplasms

1510

10529

1.63

50.03

3.0

2.8

1757.73

1711.97

ng/l

0.11

1325

9027

Allergic rhinitis

2970

22409

1.38

49.83

2.7

2.9

728.46

952.92

ng/l

2.56

2357

18572

Multiple myeloma and malignant plasma cell neoplasms

840

5331

2.08

49.37

4.8

3.2

1871.81

1710.75

ng/l

0.50

768

4631

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

429

2099

2.44

49.35

3.0

2.7

3427.39

575.00

ng/l

5.12

375

1710

Benign neoplasm: Stomach

1507

10668

1.67

49.34

3.8

3.0

1377.14

1487.35

ng/l

0.53

1303

9174

Injuries to unspecified part of trunk, limb or body region

1411

9743

1.66

49.27

4.0

3.1

2080.29

1506.62

ng/l

3.30

1225

8335

Open wound of ankle and foot

1327

8998

1.66

49.27

3.7

3.1

2462.05

1359.07

ng/l

5.51

1137

7602

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2154

16094

1.52

49.23

3.6

3.1

1986.60

1509.65

ng/l

3.54

1908

13898

Moderate visual impairment, binocular

581

3342

2.42

48.88

3.9

3.2

2922.43

1997.61

ng/l

2.28

479

2886

Thrombocytopenia, unspecified

1066

7018

1.82

48.84

3.9

3.1

2016.40

1515.33

ng/l

2.74

961

6018

Inflammatory diseases of prostate (prostatitis)

1836

13352

1.56

48.76

3.2

1438.19

1613.90

ng/l

0.62

1513

11645

Bronchitis, not specified as acute or chronic

1175

7810

1.72

48.52

3.6

2.9

1498.33

1525.63

ng/l

0.07

1021

6606

Psoriatic and enteropathic arthropathies

1407

9645

1.62

48.45

2.9

2.8

1276.31

1162.16

ng/l

0.46

1200

8174

Complications of cardiac and vascular prosthetic devices, implants and grafts

407

2101

2.95

48.36

6.4

3.0

3764.53

1634.16

ng/l

6.14

382

1820

Acute pancreatitis (for exclusion)

2890

22472

1.42

48.30

3.3

3.1

1727.68

1533.97

ng/l

1.21

2528

19290

Psoriatic arthropathies

1239

8292

1.68

48.29

2.9

1274.17

1176.32

ng/l

0.34

1053

7081

Convalescence

732

4371

2.00

47.80

3.4

2.6

1398.32

987.25

ng/l

1.11

602

3662

Other specified and unspecified personality disorders

962

6060

1.77

47.68

2.8

930.23

967.26

ng/l

0.11

785

4982

Pyogenic arthritis

956

6118

1.83

47.67

3.8

3.0

2053.45

1558.17

ng/l

2.43

839

5268

Hallux rigidus

1968

14498

1.52

47.65

2.8

2.9

955.91

1330.92

ng/l

6.54

1663

12464

Hyperparathyroidism

2939

22806

1.42

47.57

3.4

3.0

2974.95

1638.15

ng/l

11.12

2536

19607

Acute suppurative otitis media

2133

14477

1.44

47.56

3.3

2.8

1126.02

975.82

ng/l

0.57

1721

11620

Redundant prepuce, phimosis and paraphimosis

2459

18350

1.43

47.47

3.3

3.2

1538.75

1468.68

ng/l

0.29

2050

15561

Methotrexate

1858

13499

1.52

47.23

3.1

2.6

1308.66

1311.61

ng/l

0.01

1646

11427

Benign neoplasm of other and unspecified endocrine glands

1822

13301

1.55

47.20

3.2

3.0

1676.67

1319.05

ng/l

1.33

1589

11388

Fall on same level involving ice and snow

7931

68133

1.22

47.00

2.9

1308.69

1321.14

ng/l

0.09

6664

57945

Immunodeficiency with predominantly antibody defects

381

1866

2.68

46.91

4.7

3.0

1525.67

1025.53

ng/l

0.86

351

1559

Blepharochalasis

4561

37643

1.32

46.90

3.0

1210.26

1454.07

ng/l

4.59

3893

32493

Retinal detachments and breaks

5478

45913

1.28

46.77

3.3

3.0

1839.35

1464.48

ng/l

6.02

4728

39639

Other and unspecified injuries of head

1008

6583

1.81

46.74

3.5

3.1

1584.88

1534.80

ng/l

0.16

861

5620

Other and unspecified coagulation defects

629

3608

2.08

46.57

3.2

2.8

1205.85

1075.60

ng/l

0.37

534

3002

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1119

7504

1.76

46.54

4.0

3.1

2193.80

1473.51

ng/l

3.35

977

6423

Other infectious diseases

1343

9338

1.67

46.43

4.3

3.2

2356.81

1696.95

ng/l

3.90

1205

8014

Other specified/unspecified soft tissue disorders

751

4584

1.99

46.42

3.5

3.0

1481.33

1699.22

ng/l

0.75

637

3901

Abnormal weight loss

1361

9523

1.67

46.42

3.3

3.2

1519.84

1560.89

ng/l

0.11

1167

8203

Patent foramen ovale

320

1468

2.91

46.17

3.9

3.6

793.57

1108.52

ng/l

1.24

260

1229

Other and unspecified tonsillitis

2935

18883

1.36

46.10

2.9

2.7

901.29

849.49

ng/l

0.25

2301

15348

Hypermobility syndrome

482

2491

2.19

46.03

2.3

2.6

548.03

623.13

ng/l

0.18

395

2001

Agranulocytosis

1512

10732

1.61

46.03

3.7

3.0

1546.07

1318.04

ng/l

0.98

1355

9174

Striking against or struck by other objects

3747

29878

1.32

45.98

3.2

3.0

1394.42

1232.49

ng/l

0.97

3024

25153

Other/unspecified synovitis and tenosynovitis

1452

10136

1.59

45.97

3.1

2.9

1417.48

1427.60

ng/l

0.02

1198

8634

Neuromuscular dysfunction of bladder

1291

8927

1.67

45.39

3.0

1394.94

1488.06

ng/l

0.32

1085

7724

Other and unspecified disorders of vitreous body

6207

52000

1.26

45.35

2.9

975.41

1263.78

ng/l

7.35

5304

44766

Acidosis

366

1832

2.88

45.33

3.8

2.9

3447.29

1290.79

ng/l

5.90

332

1566

Fracture of foot, except ankle

2773

21385

1.38

45.30

2.9

1353.22

1153.52

ng/l

1.25

2326

18007

Brachial plexus disorders

979

6266

1.73

45.25

2.5

2.7

638.46

888.55

ng/l

1.94

822

5239

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

772

4689

1.88

45.05

3.2

3.0

1241.10

1289.64

ng/l

0.11

638

3909

Other (seronegative) rheumatoid arthritis, wide

2755

21520

1.41

45.04

3.2

3.0

1544.58

1444.93

ng/l

0.62

2396

18490

Collagenous colitis

1265

8731

1.67

45.04

3.6

3.0

1522.30

1318.58

ng/l

0.97

1098

7442

Artificial joint re-operation

1152

7967

1.79

45.00

3.1

1607.63

1487.35

ng/l

0.31

978

6890

Other other unspecified disorders of the circulatory system

606

3575

2.21

44.85

4.4

3.1

2239.18

1509.65

ng/l

1.13

545

3060

Other benign neoplasms of skin

5453

45757

1.27

44.79

3.2

3.0

1627.39

1486.99

ng/l

1.02

4641

39250

Other disorders of bladder

1802

13303

1.54

44.72

3.2

3.1

1650.14

1645.59

ng/l

0.01

1492

11589

Vitreous haemorrhage

1476

10537

1.62

44.57

3.5

3.0

3394.01

1536.94

ng/l

11.98

1312

9057

Recurrent aphthous stomatitis , including avohilmo

1813

13269

1.51

44.56

3.2

3.1

1101.81

1350.44

ng/l

2.38

1527

11316

Benign neoplasm: Adrenal gland

1144

7828

1.75

44.47

3.3

3.0

1649.22

1291.14

ng/l

1.19

1009

6720

Other diseases of arteries and capillaries

1314

9190

1.65

44.07

4.0

2.9

2821.73

1412.36

ng/l

8.95

1157

7842

Pneumocystosis

357

1832

3.08

43.96

4.6

3.0

2109.78

1331.99

ng/l

1.81

332

1573

Spondyloarthritis

2278

17235

1.43

43.73

3.3

3.0

1529.59

1545.85

ng/l

0.05

1950

14656

Respiratory disorders in diseases classified elsewhere

272

1248

3.58

43.67

5.2

3.0

1105.91

1244.73

ng/l

0.41

254

1069

Fenamates

2005

9995

1.47

43.66

2.9

3.3

1300.64

2072.46

ng/l

8.54

1680

8821

Psoriasis

3680

29670

1.33

43.60

2.9

1331.20

1260.90

ng/l

0.43

3120

25320

Arterial embolism and thrombosis

964

6395

1.83

43.57

4.6

3.0

3650.22

1744.72

ng/l

8.15

880

5505

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1211

7116

1.58

43.56

3.7

2.9

766.88

729.28

ng/l

0.09

885

5454

Carbimazole or st.post thyroidectomy, condition for graves disease

2561

19743

1.40

43.50

4.0

2.8

1169.29

1142.08

ng/l

0.15

2194

16767

Other diseases of stomach and duodenum

975

6459

1.80

43.39

3.4

3.0

1825.60

1596.17

ng/l

0.35

853

5560

Plantar fascial fibromatosis

1192

8102

1.65

43.32

2.7

2.8

739.95

1228.21

ng/l

8.79

980

6913

Barrett oesophagus

779

4948

1.97

43.26

3.3

2.9

1523.01

1382.53

ng/l

0.38

662

4259

Other epidermal thickening

659

3980

2.06

43.15

4.1

3.0

1971.28

1288.31

ng/l

2.03

592

3372

Hypopituitarism

823

5157

1.82

42.98

3.1

3.2

1193.54

1153.52

ng/l

0.05

678

4314

Intestinal adhesions without obstruction

1268

8866

1.66

42.82

3.3

2.9

1799.68

1533.25

ng/l

0.91

1112

7637

Inflammatory disease of uterus

1333

9181

1.57

42.76

2.4

2.6

656.22

867.64

ng/l

2.81

1068

7635

Hydrocele

1727

12689

1.53

42.68

3.8

3.3

2285.67

1909.97

ng/l

1.70

1485

11062

Leiomyoma of uterus

7986

38926

1.21

42.59

2.7

1019.31

1168.61

ng/l

2.62

6633

32881

Nail disorders

1037

6897

1.71

42.58

3.3

3.0

1567.93

1209.81

ng/l

1.10

888

5798

Injury of unspecified body region

1063

7174

1.72

42.11

4.2

3.1

2182.24

1535.54

ng/l

3.08

925

6119

Injury of muscle and tendon at shoulder and upper arm level

5091

42735

1.27

42.09

3.0

1112.88

1350.40

ng/l

4.29

4354

36873

Mental and behavioural disorders due to sedatives or hypnotics

773

4786

1.84

42.01

2.8

2.9

1395.06

1090.59

ng/l

0.52

620

3958

Other and unspecified injuries of lower leg

876

5593

1.77

41.97

3.3

2.9

1381.34

1189.64

ng/l

0.66

724

4693

Mental and behavioural disorders due to opioids

366

1776

2.37

41.95

3.3

3.1

1176.65

902.75

ng/l

0.44

297

1402

Ulcer of oesophagus

1103

7595

1.74

41.93

3.6

3.0

1973.15

1694.53

ng/l

0.87

954

6581

Malignant neoplasm of breast, HER2-negative, including Hilmo

5547

30097

1.26

41.51

2.6

2.7

1073.57

1076.56

ng/l

0.02

4699

25106

Malignant neoplasm of breast, including Hilmo

5546

30097

1.26

41.38

2.6

2.7

1073.57

1076.56

ng/l

0.02

4699

25106

Disorders of ocular muscles, binocular movement, accommodation and refraction

5461

45392

1.24

41.34

3.1

2.9

1091.34

1213.03

ng/l

1.37

4531

38296

Open wound of wrist and hand

5382

44067

1.25

41.30

3.0

1195.54

1264.92

ng/l

0.52

4398

37387

Other and unspecified nerve root and plexus disorders, also in other diseases

2440

18822

1.40

41.14

2.9

822.12

1189.76

ng/l

5.31

2021

16051

Chronic pancreatitis

1718

12710

1.52

41.13

3.0

1881.77

1429.75

ng/l

2.08

1510

10906

Squamous cell neoplasms and carcinomas of the skin

1457

10650

1.63

41.09

3.5

3.3

2598.39

2021.37

ng/l

3.36

1277

9206

Fracture of skull and facial bones

2636

20513

1.38

41.02

3.2

3.0

1477.29

1365.90

ng/l

0.59

2237

17432

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

3739

30556

1.32

40.99

3.2

3.0

1510.54

1398.43

ng/l

0.94

3296

26240

Nontoxic multinodular goitre

2848

22613

1.38

40.90

3.0

2.9

1234.42

1436.33

ng/l

1.83

2452

19411

Lateral epicondylitis

1499

10703

1.53

40.88

2.5

2.7

707.40

1069.79

ng/l

5.55

1255

9073

Disorders of oesophagus in diseases classified elsewhere

382

2035

2.71

40.74

4.3

2.9

1968.76

1421.77

ng/l

1.27

337

1758

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

321

1499

2.51

40.71

4.8

3.9

1101.08

973.04

ng/l

0.23

276

1222

Superficial injury of shoulder and upper arm

1443

10315

1.55

40.62

3.2

3.1

1221.97

1493.04

ng/l

2.10

1211

8763

Amenorrhoea

522

2859

1.98

40.53

2.5

2.7

591.55

914.49

ng/l

2.25

416

2313

Diseases of tongue

864

5615

1.80

40.48

3.0

1123.21

1416.72

ng/l

1.13

722

4844

Other noninfective disorders of lymphatic vessels and lymph nodes

538

3120

2.15

40.43

3.9

2.9

1229.58

1319.22

ng/l

0.27

477

2607

Reactive arthropathies

1051

7054

1.67

40.41

3.2

3.0

1535.17

1306.24

ng/l

0.66

923

6007

Seropositive rheumatoid arthritis, wide

3850

31609

1.31

40.32

3.2

3.0

1525.68

1411.64

ng/l

0.93

3397

27135

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1570

11256

1.49

40.29

2.7

2.6

818.66

913.93

ng/l

0.51

1245

9370

Abnormal blood-pressure reading, without diagnosis

530

2998

2.05

40.08

2.7

2.5

900.34

1191.65

ng/l

1.13

446

2523

Monoamine oxidase A inhibitors

1538

11156

1.53

40.07

3.1

2.9

922.66

1365.79

ng/l

6.44

1273

9632

Unspecified misadventure during surgical and medical care

806

5226

1.87

39.89

4.0

3.1

1898.76

1360.68

ng/l

1.74

717

4478

Suggestive for eosinophilic asthma

1235

8671

1.62

39.78

3.2

2.9

1172.56

1446.15

ng/l

1.53

1070

7413

Seborrhoeic dermatitis

1298

9194

1.60

39.75

3.4

3.0

1633.94

1455.60

ng/l

0.43

1094

7851

Degenerative macular diseases

1976

15161

1.50

39.73

3.3

3.2

1786.78

1729.27

ng/l

0.20

1710

13156

Diabetic nephropathy

2597

20463

1.43

39.73

4.4

3.7

5478.58

1781.73

ng/l

47.08

2359

17711

Tubulo-interstitial nephritis, not specified as acute or chronic

999

6737

1.72

39.61

3.3

2.9

2330.52

1313.45

ng/l

6.20

852

5739

Open wound of forearm

1228

8578

1.61

39.48

3.8

3.0

1916.12

1478.29

ng/l

1.28

1029

7286

Other disorders of conjunctiva

2067

15857

1.46

39.42

3.7

3.0

1403.04

1524.08

ng/l

0.74

1800

13712

Cerebral palsy and other paralytic syndromes

1447

10418

1.55

39.36

3.3

3.1

1220.29

1553.36

ng/l

2.32

1252

8871

Other and unspecified vascular occlusions

1551

11523

1.58

39.16

3.6

3.2

2255.64

1796.63

ng/l

2.42

1342

10020

Deviated nasal septum

4325

35795

1.28

39.15

3.0

1016.69

1352.09

ng/l

8.41

3588

30750

Malignant neoplasm of breast

5444

29875

1.25

39.14

2.6

2.7

1063.14

1081.92

ng/l

0.13

4612

24940

Other/unspecified seropositive rheumatoid arthritis

3797

31226

1.31

39.12

3.2

3.0

1537.41

1412.27

ng/l

1.04

3348

26819

Other disorders of the musculoskeletal system and connective tissue

2047

15672

1.45

38.88

3.1

3.0

1436.13

1443.17

ng/l

0.02

1778

13447

Car occupant injured in other and unspecified transport accidents

2016

15194

1.42

38.61

3.0

1118.57

1264.57

ng/l

0.86

1661

12734

Alcohol dependence

3529

28721

1.31

38.48

3.1

1615.46

1441.33

ng/l

1.02

3000

24566

Other female pelvic inflammatory diseases

1896

14270

1.45

38.33

2.7

999.59

1025.57

ng/l

0.11

1504

12149

Osteonecrosis

902

6054

1.78

38.28

3.5

3.0

1563.31

1326.17

ng/l

0.52

796

5176

Other crystal arthropathies

357

1909

2.75

38.19

4.3

3.1

2027.11

1765.35

ng/l

0.56

312

1656

ILD medications: pirfenidone

228

1066

4.22

37.97

3.9

2.8

1087.21

1390.08

ng/l

0.69

209

929

Eosinophilic disease (BM)

234

1024

3.12

37.93

3.8

2.4

2136.10

1045.69

ng/l

0.94

210

873

Other inflammation of eyelid

1777

13328

1.47

37.91

3.1

3.0

1193.31

1429.10

ng/l

1.76

1507

11418

Other disorders of white blood cells

775

5025

1.85

37.86

3.5

3.0

2011.83

1440.06

ng/l

1.28

671

4284

Spinal instabilities

393

2093

2.35

37.83

3.1

2.9

668.89

1086.34

ng/l

3.27

335

1760

Disorders of continuity of bone

1158

8044

1.60

37.83

3.3

2.9

1360.11

1139.94

ng/l

0.98

1006

6771

Hypoglycaemia, other or unspecified

890

5893

1.73

37.77

3.5

3.2

3547.15

1579.08

ng/l

5.89

782

4989

Sulfonylureas

5858

40027

1.25

37.66

3.9

3.1

2943.14

1725.55

ng/l

29.81

5062

34761

Chondropathies

1735

12891

1.46

37.50

2.9

3.0

1054.86

1248.37

ng/l

1.07

1411

10899

Psychotic depression

698

4324

1.81

37.41

2.8

3.0

1179.94

1292.00

ng/l

0.27

593

3727

Crystal arthropathies, rheuma endpoint

357

1925

2.72

37.33

4.3

3.1

2027.11

1755.16

ng/l

0.59

312

1660

Noninflammatory disorders of female genital tract

4527

18665

1.26

37.32

2.9

2.7

980.18

1370.45

ng/l

7.58

3759

15661

Dissection of aorta

545

3299

2.15

37.19

4.0

2.9

1995.36

1600.48

ng/l

1.00

499

2828

Alcohol abuse, main dg

1787

13374

1.45

36.87

3.1

3.0

1527.82

1281.75

ng/l

1.25

1509

11302

Fall on and from stairs and steps

3441

28091

1.31

36.82

3.1

3.0

1427.58

1429.78

ng/l

0.01

2900

24011

Molar incisor enamel hypoplasia, with caries

190

5.73

36.77

15.0

5.3

1857.68

1105.51

ng/l

0.57

160

Fracture of forearm

7468

59523

1.20

36.58

3.0

2.9

1479.65

1285.91

ng/l

2.92

6313

50399

Dislocation, sprain and strain of joints and ligaments of knee

6964

55368

1.20

36.54

2.7

2.8

786.49

1039.78

ng/l

9.85

5735

46483

Malignant neoplasm of breast, HER2-negative

5374

29734

1.24

36.53

2.6

2.7

1080.72

1085.76

ng/l

0.03

4547

24832

Pleural plaque with presence of asbestos

1271

9328

1.65

36.50

3.9

3.3

1716.94

2060.57

ng/l

2.51

1100

8252

Olecranon bursitis

860

5742

1.75

36.10

3.8

3.1

1564.71

1613.39

ng/l

0.12

776

4936

Ingrowing nail

658

4096

1.86

36.03

3.3

3.0

1720.79

1147.05

ng/l

1.26

566

3403

Disorders of breast

5788

44838

1.22

35.94

2.5

2.7

961.32

1067.03

ng/l

1.24

4889

37572

Colonic or urogenital fistula

3501

28693

1.30

35.92

2.9

3.0

1160.31

1362.18

ng/l

2.59

2959

24525

Congenital malformations and deformations of the musculoskeletal system

999

6686

1.61

35.87

3.2

934.78

965.41

ng/l

0.11

810

5503

Congenital malformations and deformations of the musculoskeletal system

776

4911

1.71

35.86

3.2

3.3

928.01

957.69

ng/l

0.08

637

4034

Sequelae of other external causes

751

4870

1.80

35.60

3.6

3.0

2118.34

1369.43

ng/l

2.52

680

4127

conjunctival haemorrhage

1139

8130

1.64

35.59

4.1

3.1

1400.68

1550.13

ng/l

0.67

992

7013

Dermatitis due to substances taken internally

712

4546

1.82

35.54

3.4

3.0

1515.92

1337.82

ng/l

0.44

605

3831

Chondrocostal junction syndrome [Tietze]

526

3139

2.05

35.48

3.1

2.9

921.05

1170.18

ng/l

0.91

433

2631

Appendectomy

7897

65958

1.18

35.45

2.8

2.9

968.21

1188.48

ng/l

7.11

6628

55469

Ankylosing spondylitis

1012

6913

1.62

35.42

2.9

3.0

991.01

1541.79

ng/l

5.11

838

5882

Other and unspecified nonorganic psychotic disorders

1809

13537

1.41

35.38

2.5

2.9

923.94

1080.10

ng/l

0.97

1401

11139

Benign neoplasm: Descending colon

1086

7737

1.68

35.29

3.5

3.1

1662.62

1531.94

ng/l

0.35

978

6671

Speech disturbances, not elsewhere classified

1342

9847

1.57

35.12

4.0

3.1

1631.60

1734.71

ng/l

0.34

1170

8482

Hyperhidrosis

341

1738

2.29

34.96

3.7

2.5

949.97

993.16

ng/l

0.10

277

1416

Hypotension due to drugs

296

1556

3.06

34.92

4.9

3.3

2728.51

1781.47

ng/l

1.45

267

1353

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3627

29846

1.29

34.89

2.9

3.0

1238.95

1319.20

ng/l

0.52

3068

25346

Marfan's syndrome

104

313

5.98

34.85

4.4

3.0

841.42

899.80

ng/l

0.10

260

Other infectious diseases

1118

7946

1.62

34.65

4.3

3.1

2518.75

1731.23

ng/l

4.07

998

6817

Other and unspecified mood [affective] disorders

625

3795

1.79

34.63

2.8

823.68

841.31

ng/l

0.06

490

3109

Thyrotoxicosis with diffuse goitre

1591

11809

1.46

34.60

3.3

2.7

1205.16

1119.36

ng/l

0.40

1358

10017

Herpesviral [herpes simplex] infections

2665

21153

1.33

34.58

3.0

2.8

1215.10

1145.01

ng/l

0.35

2223

17765

Discitis, unspecified

299

1547

2.81

34.56

5.2

3.2

2734.70

1628.45

ng/l

2.09

274

1347

Other/unspecified cytomegaloviral diseases

292

1470

2.69

34.51

5.7

3.2

3584.47

926.75

ng/l

5.75

278

1235

Other eating disorders

345

1734

2.16

34.37

3.4

3.0

1222.08

646.25

ng/l

0.39

263

1361

Use of disulfiram, acamprosate or naltrexone

975

6670

1.63

34.21

2.5

2.9

918.24

1074.36

ng/l

0.59

774

5568

Lichen simplex chronicus and prurigo

871

5907

1.72

34.18

3.5

3.0

2377.69

1364.24

ng/l

2.37

758

5025

Asthma mixed form (mode)

627

3877

1.83

34.11

3.2

2.5

1200.72

1300.46

ng/l

0.26

533

3290

Other peripheral vertigo

1302

9538

1.56

34.03

3.1

3.0

1085.47

1473.51

ng/l

4.36

1091

8238

Cytomegalovirus infection, IBD co-morbidity

334

1773

2.47

33.80

5.5

3.2

3415.88

1006.37

ng/l

5.98

318

1497

Nontoxic goitre/thyroid nodule

4209

35466

1.27

33.74

2.9

1220.46

1357.13

ng/l

1.39

3624

30322

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

471

2847

2.24

33.59

5.2

3.1

2265.43

1689.10

ng/l

2.00

436

2437

Multiple myeloma

471

2847

2.24

33.59

5.2

3.1

2265.43

1689.10

ng/l

2.00

436

2437

Cluster headache, strict

384

2068

2.15

33.57

2.6

2.8

621.98

1072.19

ng/l

2.09

304

1748

Follow-up care involving plastic surgery

504

2996

2.01

33.56

3.2

2.5

1634.60

843.52

ng/l

2.30

381

2499

Oesophagitis

788

5274

1.76

33.28

3.4

3.0

1559.91

1531.14

ng/l

0.06

689

4510

Other follicular disorders

772

5044

1.70

33.22

3.2

2.9

1928.64

1080.22

ng/l

2.07

641

4226

Artificial opening status

738

4865

1.79

33.17

3.5

2.6

1664.20

1412.82

ng/l

0.49

660

4137

Nephrotic syndrome

446

2599

2.14

33.16

3.3

6934.22

1266.21

ng/l

9.70

410

2231

Other mental disorders due to brain damage and dysfunction and to physical disease

1847

14381

1.46

33.11

3.5

3.3

1742.53

1835.32

ng/l

0.33

1580

12520

Early lumbar disc prolapse, operated

718

4537

1.68

33.06

2.3

2.8

590.27

786.84

ng/l

0.41

552

3649

Other specified/unspecified spondylopathies

422

2456

2.26

33.03

3.8

3.1

1486.04

1881.49

ng/l

0.91

372

2110

Conjunctivitis

9297

68799

1.16

32.96

2.9

1058.29

1209.37

ng/l

2.66

7701

57910

Acute pharyngitis

1272

8991

1.48

32.94

3.1

2.8

1049.27

944.53

ng/l

0.19

1001

7317

Corns and callosities

933

6470

1.67

32.89

3.6

3.0

2152.35

1289.28

ng/l

4.62

822

5508

Cluster headache, wide

421

2353

2.06

32.87

2.7

2.8

784.59

1138.97

ng/l

0.99

337

1985

Superficial injury of forearm

1075

7531

1.56

32.78

3.3

3.0

1666.19

1256.68

ng/l

1.50

904

6337

Seborrhoeic keratosis

3361

27891

1.31

32.77

3.2

3.0

1499.00

1409.21

ng/l

0.44

2969

24096

Contact with and exposure to communicable diseases

2428

18936

1.32

32.76

2.8

889.92

859.42

ng/l

0.09

1947

15354

Other diseases of biliary tract

1290

9503

1.55

32.76

3.0

3.1

1653.11

1595.26

ng/l

0.16

1130

8167

Postmenopausal osteoporosis with pathological fracture

1077

7838

1.68

32.73

3.6

3.1

1482.12

1629.17

ng/l

0.73

925

6722

Pure hyperglyceridaemia

346

1878

2.39

32.71

4.0

2.9

2038.39

1276.06

ng/l

1.07

310

1592

Strabismus

3020

24457

1.30

32.56

3.2

3.0

1187.62

1293.69

ng/l

0.63

2541

20741

Special screening examination for infectious and parasitic diseases

1833

10095

1.38

32.53

2.4

691.55

797.44

ng/l

0.42

1325

8269

Speech and linguistic disorders, excluding more controls

636

3685

1.74

32.44

4.6

3.2

1313.14

1154.34

ng/l

0.37

542

2993

Haemolytic anaemias

512

3126

2.03

32.42

4.6

3.1

1883.44

1491.76

ng/l

1.10

450

2680

Myositis

385

2163

2.26

32.41

3.7

3.1

1316.20

1503.09

ng/l

0.46

342

1834

Assault

1163

8210

1.51

32.35

2.6

2.9

1232.55

960.31

ng/l

1.14

909

6678

Otitis externa, unspecified

1262

9141

1.51

32.34

3.0

1111.94

1303.31

ng/l

1.06

1030

7723

Lack of expected normal physiological development

123

333

3.55

32.29

9.3

5.1

1521.23

788.12

ng/l

0.60

112

254

Atypical facial pain

666

4297

1.81

32.20

2.5

2.9

604.93

1130.96

ng/l

7.24

557

3636

Infective dermatitis

1474

11020

1.48

32.17

3.5

3.0

1856.49

1427.50

ng/l

1.72

1262

9426

Erythema intertrigo

385

2200

2.33

32.11

3.5

3.1

1582.79

1379.59

ng/l

0.26

344

1894

Acute laryngitis and tracheitis

940

6241

1.57

32.09

3.6

2.8

899.73

1032.33

ng/l

0.39

762

5002

Invasive ventilation

993

6997

1.63

32.08

3.6

3.1

3493.27

1533.08

ng/l

7.13

834

5991

Carcinoma in situ of skin of other and unspecified parts of face

1486

11413

1.55

32.03

3.4

3.3

2484.15

1937.01

ng/l

1.82

1305

9971

Hypocalcemia

354

1966

2.39

32.02

3.3

3.1

3324.47

1195.07

ng/l

2.56

315

1674

Cytomegaloviral disease

337

1824

2.38

31.94

5.4

3.1

3394.81

993.50

ng/l

6.01

320

1532

Pneumonia due to Streptococcus pneumoniae

562

3484

1.90

31.92

3.9

2.7

2006.46

1263.65

ng/l

2.92

489

2935

Hodgkin lymphoma, hilmo

392

2213

2.20

31.89

3.8

3.0

1506.13

1294.46

ng/l

0.39

352

1875

Inflammatory bowel disease

3634

30109

1.27

31.87

3.1

2.9

1310.01

1230.31

ng/l

0.49

3083

25405

Special screening examination for neoplasms

738

4855

1.73

31.84

3.0

2.7

1423.82

1450.04

ng/l

0.05

618

4151

Obsessive-compulsive disorder

500

2912

1.85

31.75

2.3

2.7

878.80

806.02

ng/l

0.07

382

2352

Insulin, fast-acting (human)

1514

11266

1.44

31.65

3.4

2.9

3623.35

1313.58

ng/l

17.53

1322

9356

Ganglion

2310

18212

1.34

31.62

2.5

2.7

839.09

1171.81

ng/l

7.01

1929

15424

Intestinal malabsorption

604

3829

1.86

31.60

3.2

2.9

2128.78

1145.85

ng/l

2.11

539

3213

Examination and encounter for administrative purposes

631

4031

1.82

31.54

3.1

2.7

1143.82

1489.43

ng/l

1.96

555

3469

Other symptoms and signs involving general sensations and perceptions

588

3732

1.89

31.45

3.4

3.2

1351.95

1620.11

ng/l

1.37

495

3183

Other disorders of eye and adnexa

1624

12289

1.43

31.45

3.2

3.0

1346.77

1299.57

ng/l

0.11

1375

10405

Neuroendocrine tumor and carcinoma of small intestine

254

1301

3.04

31.37

4.2

2.9

1309.80

1357.42

ng/l

0.06

226

1112

Personal history of other diseases and conditions

876

5850

1.59

31.24

4.1

2.3

1227.71

785.03

ng/l

2.15

726

4713

Injuries to the wrist and hand

13592

85412

1.13

31.22

3.0

2.9

1217.33

1322.24

ng/l

1.76

11251

72602

Eating disorder

551

3291

1.77

31.16

3.0

2.8

971.19

548.56

ng/l

0.49

423

2582

Psoriasis vulgaris

2296

18252

1.35

31.06

3.0

1298.33

1334.33

ng/l

0.16

1950

15581

Other/unspecified rheumatoid arthritis

1818

14176

1.43

31.06

3.4

3.0

1786.28

1564.84

ng/l

1.23

1606

12162

Postprocedural disorders of nervous system

642

4050

1.73

31.04

2.4

2.7

406.67

781.35

ng/l

6.12

526

3278

Duodenal ulcer

1672

12884

1.45

30.97

3.8

3.1

2577.30

1917.65

ng/l

3.26

1479

11194

Sequelae of injuries, of poisoning and of other consequences of external causes

2764

22383

1.31

30.97

2.8

3.0

1119.76

1218.77

ng/l

0.71

2304

19016

Herpesviral [herpes simplex] infections

1378

10218

1.48

30.93

3.3

3.0

1582.40

1321.58

ng/l

1.05

1191

8654

Achilles tendinitis

1247

9105

1.51

30.87

2.9

1022.46

1395.93

ng/l

2.21

1034

7809

Other/unspecified enthesopathies of lower limb, excluding foot

792

5295

1.66

30.83

2.9

837.76

1333.17

ng/l

4.91

656

4483

Dementia, including avohilmo

7946

48603

1.19

30.83

3.0

3.2

1875.09

1797.19

ng/l

0.71

6766

42491

Acquired haemolytic anaemia

391

2272

2.27

30.81

4.4

3.2

2087.47

1500.96

ng/l

1.56

349

1949

Amputation of foot

447

2735

2.22

30.72

4.5

3.2

6429.29

1692.93

ng/l

9.54

419

2390

Autoimmune hyperthyroidism

700

4569

1.72

30.61

3.1

2.8

1273.03

1052.74

ng/l

0.72

599

3851

Diseases of peritoneum

1392

10441

1.49

30.61

3.8

3.1

4663.63

1480.31

ng/l

14.88

1216

8950

Iridocyclitis

2853

23270

1.31

30.59

3.1

3.0

1482.51

1340.93

ng/l

0.80

2444

19855

Pneumonitis due to solids and liquids

1267

9413

1.53

30.56

3.6

3.2

2261.64

2010.88

ng/l

0.86

1099

8121

Cholangitis (primary sclerosing, PSC)

878

6104

1.66

30.54

3.1

1565.80

1656.38

ng/l

0.25

785

5217

Orchitis and epididymitis

1216

8894

1.52

30.53

3.9

3.2

1848.65

1674.11

ng/l

0.36

1055

7753

Otalgia

902

6228

1.61

30.50

3.2

3.1

858.07

1248.92

ng/l

3.32

739

5305

5-aminosalicylic acid

2205

17349

1.34

30.36

3.1

2.6

1364.34

1179.14

ng/l

0.99

1844

14463

Panniculitis affecting regions of neck and back

477

2866

1.96

30.26

3.2

3.0

882.00

1435.15

ng/l

4.38

405

2428

Urolithiasis

4576

39140

1.24

30.26

3.0

3.1

1459.70

1614.19

ng/l

1.50

3882

33832

Impacted cerumen

1479

11278

1.48

30.22

3.5

3.2

1655.42

1676.87

ng/l

0.06

1132

9782

Myocardial infarction, unclassifiable

3823

28865

1.28

30.21

4.6

3.3

3192.30

2092.77

ng/l

18.13

3404

25006

Other diseases of blood and blood-forming organs

950

6723

1.63

30.20

3.5

3.1

1727.46

1414.29

ng/l

1.23

785

5729

Visual field defects

1186

8716

1.54

30.18

3.4

3.0

1769.92

1622.76

ng/l

0.48

1014

7499

Gout due to impairment of renal function

219

1090

3.39

30.13

5.6

3.1

7179.61

1625.12

ng/l

9.30

209

941

Ocular pain

943

6581

1.59

30.07

3.4

3.0

1076.49

1142.88

ng/l

0.15

806

5503

Attention to artificial openings

601

3897

1.87

29.90

3.7

2.9

1855.65

1405.04

ng/l

1.48

540

3349

Other specified/unspecified hearing loss

1209

8926

1.53

29.83

3.3

3.1

1609.80

1787.27

ng/l

0.75

1083

7747

432

2648

2.22

29.65

4.3

3.1

1825.16

1808.21

ng/l

0.03

394

2297

Schizophrenia

1684

12865

1.40

29.64

2.5

3.0

1028.73

1145.93

ng/l

0.40

1372

10755

Early complications of trauma

575

3671

1.84

29.35

4.0

3.1

1950.27

1452.38

ng/l

1.42

500

3128

!Aliquae complicationes praecoces traumatis

575

3671

1.84

29.35

4.0

3.1

1950.27

1452.38

ng/l

1.42

500

3128

Malignant neoplasm of digestive organs

5950

41044

1.21

29.32

2.9

3.1

1525.56

1575.88

ng/l

0.36

5214

35231

Sudden idiopathic hearing loss

1377

10395

1.48

29.22

3.3

3.0

1721.44

1534.04

ng/l

0.41

1144

8986

Suppurative and unspecified otitis media

3281

23890

1.26

29.08

3.3

2.9

1278.32

1184.02

ng/l

0.45

2668

19682

Primary hyperparathyroidism

1555

12004

1.46

29.01

3.0

1705.84

1368.03

ng/l

1.17

1329

10339

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

587

3675

1.73

28.99

2.8

2.9

1206.81

988.87

ng/l

0.47

464

2938

Other congenital malformations

808

5461

1.61

28.92

3.5

3.2

1128.49

1019.48

ng/l

0.32

704

4527

Drug-induced cataract

352

2008

2.27

28.88

4.8

3.0

1939.12

1043.26

ng/l

1.59

318

1686

Restrictive cardiomyopathy

360

9.17

28.74

14.3

3.1

3802.41

1751.88

ng/l

1.94

308

Hepatic failure, not elsewhere classified

557

3595

1.90

28.65

4.5

3.1

2745.53

1456.56

ng/l

3.33

494

3077

Small fibre neuropathy

451

2786

2.08

28.58

3.5

3.0

1696.24

1309.00

ng/l

1.01

390

2394

Other diseases of pancreas

1140

8415

1.54

28.51

3.2

3.0

1454.79

1459.56

ng/l

0.01

999

7220

Schizoaffective disorder

775

5236

1.63

28.39

2.6

2.9

841.38

964.97

ng/l

0.53

625

4330

Drug-induced osteoporosis with pathological fracture

294

1638

2.62

28.33

5.7

3.1

1717.54

1210.19

ng/l

1.77

263

1388

Tinnitus

3005

24872

1.29

28.27

2.7

2.9

1037.97

1296.10

ng/l

1.68

2504

21397

Drug-induced neutropenia

936

6685

1.60

28.16

3.4

3.0

1493.65

1206.37

ng/l

0.99

847

5709

Adenomyosis (Endometriosis of uterus)

1589

12201

1.41

28.03

2.6

2.7

979.78

1376.07

ng/l

4.58

1333

10437

Other noninflammatory disorders of vagina

881

6137

1.58

28.01

2.9

2.8

1104.89

1348.19

ng/l

0.72

728

5206

Pre-eclampsia

1763

13607

1.36

27.91

2.7

2.5

898.01

685.62

ng/l

1.41

1469

11231

Other otitis externa (chronic)

828

5763

1.63

27.91

3.1

3.0

1120.82

1318.23

ng/l

0.98

646

4885

Giant cell arteritis

690

4760

1.81

27.82

3.3

3.0

1528.03

1581.27

ng/l

0.12

616

4118

Disorders of psychological development

843

5302

1.55

27.79

4.9

3.3

1140.91

1086.58

ng/l

0.15

687

4193

ILD medications: nintedanib

134

573

5.33

27.78

4.0

3.0

961.02

1394.31

ng/l

1.04

120

492

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

734

4895

1.62

27.76

2.6

2.9

858.15

1008.28

ng/l

0.43

584

4065

Diseases of spleen

288

1572

2.46

27.68

4.5

3.0

1941.50

1367.47

ng/l

1.03

273

1346

Malignant neoplasm of small intestine

366

2173

2.27

27.62

3.9

3.0

1655.87

1463.64

ng/l

0.27

325

1850

Ptosis of eyelid

1607

12551

1.43

27.51

2.9

3.0

1418.48

1546.36

ng/l

0.54

1371

10857

Lesion of lateral popliteal nerve

658

4404

1.74

27.43

3.3

3.0

1563.79

1391.12

ng/l

0.38

588

3768

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2955

24306

1.27

27.38

2.8

2.9

1088.31

1082.05

ng/l

0.02

2384

20461

Viral warts

2204

17596

1.32

27.26

3.4

3.0

1369.10

1184.93

ng/l

0.78

1898

14759

Other noninflammatory disorders of vulva and perineum

960

6802

1.53

27.21

2.9

2.7

938.64

1234.89

ng/l

2.33

802

5750

Unspecified privation

1353

10242

1.45

27.17

3.4

3.1

2130.45

1482.26

ng/l

3.92

1187

8731

Cramp and spasm

578

3760

1.78

26.90

3.0

3.1

991.10

1307.17

ng/l

1.24

482

3184

Congenital iodine-deficiency syndrome/hypothyroidism

442

2738

2.00

26.75

4.0

3.0

1632.17

1494.04

ng/l

0.28

388

2323

Sub-endpoint used in defining T1D endpoints

3596

29776

1.24

26.75

3.6

3.2

3553.62

1617.96

ng/l

25.78

3129

25159

Corneal ulcer

2120

16947

1.33

26.74

3.0

1255.72

1293.54

ng/l

0.15

1799

14382

Abnormal findings on examination of urine, without diagnosis

592

3903

1.78

26.71

4.1

3.1

4098.59

1464.34

ng/l

4.71

534

3342

Focal epilepsy

2668

21918

1.29

26.64

3.1

3.2

1459.14

1529.03

ng/l

0.32

2311

18782

Acute and subacute iridocyclitis

2325

18833

1.32

26.58

3.2

3.0

1492.73

1338.77

ng/l

0.72

1995

16061

Malignant neoplasm of small intestine, including Hilmo

476

3039

1.97

26.43

3.7

3.0

1537.09

1487.72

ng/l

0.07

426

2598

Hyperkinetic disorders

654

4144

1.61

26.40

3.3

723.74

585.34

ng/l

0.24

456

3141

Acute generalized exanthematous pustulosis

582

3825

1.78

26.35

3.5

3.0

1566.24

1247.86

ng/l

0.82

500

3234

Dissociative [conversion] disorders

365

2077

1.97

26.33

2.8

2.7

652.82

1014.16

ng/l

1.77

290

1716

Abdominal aortic aneurysm (AAA)

1635

12747

1.41

26.32

3.6

3.2

3287.49

2030.19

ng/l

8.28

1464

11078

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

551

3469

1.71

26.28

2.4

929.31

432.79

ng/l

0.98

464

2807

Other endocrine disorders

521

3137

1.77

26.22

4.2

3.8

925.33

1183.29

ng/l

1.34

437

2648

Rash and other nonspecific skin eruption

1199

8964

1.47

26.20

3.3

3.0

1558.33

1408.41

ng/l

0.32

1061

7669

Trigeminal neuralgia

753

5213

1.64

26.09

2.9

3.0

962.73

1380.58

ng/l

3.52

642

4434

Rare circulating lymphoid malignancy, including Hilmo

433

2684

1.99

26.03

3.5

3.3

1294.22

1679.96

ng/l

1.57

382

2292

severe traumatic brain injury, does not include concussion

3320

28070

1.27

26.02

3.4

3.2

1986.66

1847.32

ng/l

0.87

2870

24241

Emotional disorders starting during childhood or adolecense, excluding more controls

220

1002

2.27

26.01

2.9

3.4

609.29

435.75

ng/l

0.40

150

752

Vascular diseases of the intestine

624

4237

1.79

25.99

4.1

3.0

3132.03

1642.55

ng/l

4.67

571

3634

Behavioural syndromes associated with physiological disturbances and physical factors

11986

77328

1.13

25.95

2.8

2.9

1122.40

1267.31

ng/l

2.77

9840

65460

Personal history of medical treatment

166

749

3.13

25.92

3.3

2.7

2268.58

1382.40

ng/l

1.02

145

628

Pre-eclampsia or eclampsia

1933

15255

1.33

25.86

2.8

2.5

886.95

699.62

ng/l

1.32

1616

12642

Disturbance of activity and attention

608

3813

1.63

25.78

3.3

3.1

741.53

528.64

ng/l

0.36

419

2895

Postprocedural musculoskeletal disorders, not elsewhere classified

1018

7532

1.56

25.77

3.2

3.1

1366.56

1461.61

ng/l

0.33

892

6489

Viral warts

1056

7707

1.49

25.73

3.9

3.0

1713.96

1170.05

ng/l

1.88

919

6459

Protozoal diseases

438

2748

1.99

25.69

4.5

3.0

1930.26

1314.65

ng/l

1.66

402

2347

Anterior Iridocyclitis

2471

20229

1.30

25.64

3.2

3.0

1485.81

1361.61

ng/l

0.57

2120

17263

Endometriosis of pelvic peritoneum

1428

10318

1.39

25.44

2.4

2.5

591.43

952.80

ng/l

5.56

1142

8609

Progressive systemic sclerosis

110

440

5.45

25.33

5.9

3.2

754.68

969.18

ng/l

0.80

101

366

Suppurative and necrotic conditions of lower respiratory tract

781

5525

1.64

25.31

3.9

3.1

2092.80

1668.22

ng/l

1.57

717

4767

Arterial embolism and thrombosis of lower extremity artery

565

3776

1.82

25.18

4.6

3.0

3896.37

1655.49

ng/l

5.59

508

3244

Hypertrophy of breast in women and men

2031

16235

1.32

25.10

2.5

2.7

918.94

954.34

ng/l

0.14

1659

13651

Algoneurodystrophy

359

2087

1.99

25.09

2.3

2.6

864.02

792.20

ng/l

0.12

295

1713

Fall involving bed

547

3677

1.88

25.06

4.1

3.3

2559.26

1995.83

ng/l

1.48

485

3199

Myeloproliferative diseases

1196

9105

1.49

24.91

3.3

3.1

2168.53

1541.25

ng/l

2.14

1049

7848

Generalized skin eruption due to drugs and medicaments

509

3290

1.82

24.85

3.6

3.1

1592.87

1227.57

ng/l

0.86

435

2786

Calculus of kidney and ureter

4134

35631

1.22

24.84

3.0

3.1

1423.56

1583.26

ng/l

1.48

3504

30744

Unspecified/other endometriosis

707

4764

1.57

24.75

2.6

2.5

823.51

963.37

ng/l

0.36

578

3921

Other abnormalities of plasma proteins

271

1524

2.48

24.71

4.4

3.1

3279.27

1351.99

ng/l

3.22

254

1308

Postmenopausal atrophic vaginitis

3380

15671

1.26

24.68

2.6

2.7

745.40

1389.71

ng/l

32.57

2901

13416

Acute peritonitis

882

6389

1.58

24.66

4.1

3.1

6540.29

1604.19

ng/l

15.74

792

5465

Xerosis cutis

275

1561

2.47

24.56

4.8

3.0

2164.93

1328.47

ng/l

1.50

252

1342

Erosion of teeth , including avohilmo

2402

19563

1.28

24.50

3.0

2.9

985.48

1073.05

ng/l

0.48

1965

16340

Crohn disease

1332

10123

1.41

24.46

2.9

3.0

1300.59

1155.20

ng/l

0.55

1132

8453

L01XE Protein kinase inhibitors

783

5618

1.65

24.40

3.2

3.1

1567.24

1332.16

ng/l

0.75

717

4841

Focal brain injury

804

5668

1.57

24.38

3.2

2.9

1633.32

1733.77

ng/l

0.27

676

4934

Monoarthritis, not elsewhere classified

501

3208

1.78

24.38

3.5

3.0

1774.93

1382.96

ng/l

0.60

429

2723

Other ill-defined and unspecified causes of mortality

1234

9514

1.48

24.23

4.5

3.2

3104.11

2053.47

ng/l

5.50

1110

8261

Medial epicondylitis

424

2605

1.86

24.22

2.6

2.9

738.71

1086.94

ng/l

1.90

352

2183

Non-allergic asthma

1086

8094

1.48

24.22

3.2

1156.37

1486.57

ng/l

1.92

941

6940

Eating disorders

769

5283

1.53

24.13

3.2

2.8

1454.64

925.63

ng/l

0.87

614

4250

Carcinoid syndrome

188

962

3.19

24.03

4.7

3.1

889.41

1245.64

ng/l

1.24

170

835

Ectropion of eyelid

692

4894

1.71

24.01

3.3

1927.53

2239.88

ng/l

1.18

601

4265

Vitamin deficiency, wide

605

4079

1.70

23.95

3.8

3.0

1826.26

1536.80

ng/l

0.63

522

3480

Vitamin deficiency

605

4079

1.70

23.95

3.8

3.0

1826.26

1536.80

ng/l

0.63

522

3480

Superficial injury of ankle and foot

1113

8235

1.44

23.94

2.9

3.0

1323.47

1031.17

ng/l

1.49

924

6813

Reactive arthropathies, FINNGEN

770

5392

1.57

23.92

3.3

2.9

1601.93

1237.05

ng/l

0.89

677

4527

Macular pucker

2333

19379

1.33

23.91

3.2

3.1

1716.57

1462.87

ng/l

1.22

2026

16913

Oesophageal varices

588

3996

1.75

23.83

3.4

3.0

1590.67

1472.01

ng/l

0.20

520

3420

Other strabismus

2230

18041

1.29

23.72

3.1

3.0

1058.85

1206.23

ng/l

0.81

1854

15190

Malignant neoplasm of bladder, including Hilmo

1879

15130

1.36

23.68

3.2

3.3

2293.96

1967.14

ng/l

1.37

1643

13148

Allergic urticaria

851

6067

1.53

23.68

3.7

3.0

1089.53

1206.68

ng/l

0.43

707

5073

Pre-eclampsia or poor fetal growth

2406

19539

1.27

23.54

2.6

2.4

784.67

646.04

ng/l

1.10

1991

15970

Ulcerative colitis, NAS

1491

11584

1.37

23.52

3.3

3.0

1379.05

1241.72

ng/l

0.50

1263

9734

Cerebral aneurysm, nonruptured

1113

8396

1.47

23.46

2.7

2.9

1083.42

1249.50

ng/l

0.80

966

7139

Other arterial embolism and thrombosis

439

2813

1.92

23.46

4.3

3.0

3737.91

1679.15

ng/l

3.58

405

2410

therapeutic use

489

3237

1.88

23.45

4.2

3.0

1511.51

1240.04

ng/l

0.77

402

2762

Acute bronchiolitis

424

2303

1.77

23.44

5.7

3.9

1994.96

1306.70

ng/l

1.05

363

1847

Meralgia paraesthetica

449

2865

1.86

23.36

2.8

2.9

637.68

1051.56

ng/l

5.05

378

2446

Focal epilepsy, strict definition

2490

20610

1.28

23.33

3.1

3.2

1511.43

1530.64

ng/l

0.07

2161

17674

Other congenital malformations

1188

8918

1.42

23.33

3.2

3.1

1141.90

1100.10

ng/l

0.13

1020

7431

Palmar fascial fibromatosis [Dupuytren]

2242

18468

1.31

23.26

3.3

3.1

1717.42

1882.87

ng/l

0.96

1946

16032

Malignant neoplasm of colon, including Hilmo

2877

24300

1.28

23.25

3.0

3.2

1597.73

1719.89

ng/l

0.67

2504

20967

Gluteal tendinitis

469

3003

1.80

23.20

2.5

2.9

785.04

1163.73

ng/l

1.87

382

2539

Vasculitis limited to skin, not elsewhere classified

397

2496

1.98

23.08

4.1

3.1

1852.10

1400.90

ng/l

1.39

355

2120

Cyst of kidney

1035

7831

1.51

22.94

3.3

3.1

2095.93

1507.00

ng/l

1.87

904

6768

Nonhereditary hypogammaglobulinemia

161

753

2.92

22.93

4.3

2.9

1513.07

826.76

ng/l

0.92

153

619

Mental retardation, excluding more controls

363

2091

1.89

22.90

3.4

3.3

1579.95

1071.47

ng/l

0.55

303

1780

Arthropathic psoriasis

1310

10095

1.41

22.89

2.9

3.0

1247.98

1232.02

ng/l

0.05

1115

8576

Colectomy operation

2418

20142

1.30

22.81

3.1

1704.25

1628.76

ng/l

0.25

2103

17410

Biological medication for rheuma

1567

12251

1.35

22.77

2.6

2.9

945.54

929.96

ng/l

0.05

1343

10129

Isolated proteinuria

373

2288

1.96

22.77

4.3

3.0

5284.07

1331.99

ng/l

4.46

333

1942

Other disorders of penis

1147

8688

1.44

22.75

3.4

3.3

1505.83

1550.17

ng/l

0.09

981

7531

Excessive vomiting in pregnancy

636

4283

1.59

22.72

2.3

2.6

371.93

626.60

ng/l

5.24

494

3491

Ulcerative colitis

2730

22760

1.26

22.65

3.1

3.0

1376.68

1245.08

ng/l

0.74

2312

19226

Sleep disorders

11353

74942

1.12

22.64

2.8

2.9

1082.64

1259.20

ng/l

4.45

9312

63396

Scabies

1204

9076

1.40

22.62

3.1

3.0

1218.70

988.95

ng/l

1.00

976

7445

Other and unspecified vasculitis limited to skin

362

2238

2.03

22.54

4.1

3.1

1908.67

1389.11

ng/l

1.54

325

1899

Temporal arteritis

600

4207

1.77

22.46

3.3

3.0

1526.30

1616.10

ng/l

0.19

534

3628

Toxic effects of substances chiefly nonmedicinal as to source

1206

9169

1.41

22.45

3.0

1288.38

1244.13

ng/l

0.11

1013

7686

Pneumothorax

937

6946

1.51

22.40

3.6

3.0

1695.87

1647.56

ng/l

0.10

842

5937

Thyroiditis

803

5759

1.54

22.38

3.2

2.8

1045.52

1135.25

ng/l

0.29

684

4837

Mental disorders, not otherwise specified

737

5145

1.54

22.35

2.6

2.8

837.75

905.11

ng/l

0.20

582

4234

Acute appendicitis, no complications

6313

55780

1.16

22.34

2.8

2.9

982.28

1148.91

ng/l

2.72

5266

46955

Pregnancy hypertension

3657

27894

1.21

22.34

2.6

2.4

842.79

714.07

ng/l

1.14

3063

22952

Alzheimer’s disease (Late onset), excluding more controls

2374

12880

1.30

22.29

2.9

2161.26

1866.56

ng/l

1.56

2021

11275

Other abnormal findings of blood chemistry

588

4019

1.69

22.21

3.2

3.0

1614.22

1293.33

ng/l

1.12

502

3428

Coeliac disease

1365

10597

1.38

22.17

3.1

3.0

1538.75

1220.62

ng/l

0.81

1164

9008

Hypoparathyroidism

528

3575

1.78

22.15

4.1

3.1

1277.36

1240.18

ng/l

0.11

450

3037

Allergic contact dermatitis

1397

10837

1.37

22.15

2.9

2.8

897.40

1039.77

ng/l

1.03

1139

9102

Fluid overload

272

6.75

22.08

5.5

3.0

10299.94

1311.82

ng/l

3.54

232

Complications of other internal prosthetic devices, implants and grafts

587

4044

1.71

22.07

3.2

3.0

1694.08

1512.86

ng/l

0.42

515

3440

Social phobias

581

3841

1.60

22.04

2.7

2.6

871.01

714.81

ng/l

0.27

454

3070

Lymphoid leukaemia

801

5857

1.58

22.00

3.2

1913.08

1729.92

ng/l

0.51

711

5061

Cerebral cysts

631

4333

1.62

21.96

3.4

3.0

1452.39

1452.31

ng/l

0.00

535

3632

289

1645

2.06

21.96

2.5

2.8

534.80

682.77

ng/l

0.71

233

1367

Pollen allergy

1359

10283

1.36

21.90

2.7

3.0

737.00

760.87

ng/l

0.06

1014

8296

Acute alcohol intoxication, ICD10

2243

18431

1.28

21.89

3.0

1550.99

1288.91

ng/l

1.63

1871

15641

Pyothorax

613

4276

1.69

21.81

3.9

3.1

2187.09

1699.27

ng/l

1.56

557

3692

Other orthopaedic follow-up care

685

4815

1.60

21.73

3.0

2.7

1213.85

1067.52

ng/l

0.56

581

4048

Nummular dermatitis

1066

8096

1.46

21.69

3.3

3.0

1557.92

1431.53

ng/l

0.28

916

6943

malignant neoplasm of male genital organs

4404

23390

1.21

21.65

3.0

3.2

1823.37

1695.84

ng/l

0.73

3790

20242

Dislocation of lens

261

1500

2.30

21.53

3.7

3.1

2663.42

1814.31

ng/l

1.04

230

1300

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

4247

31921

1.19

21.52

2.6

2.5

852.35

749.86

ng/l

0.94

3561

26303

Secondary parkinsonism, excluding more controls

349

2134

1.96

21.50

3.2

2.8

1125.00

1642.26

ng/l

2.91

301

1855

Sacroiliitis, not elsewhere classified

394

2412

1.78

21.45

2.5

2.9

537.42

966.65

ng/l

2.32

314

1962

Other specified/unspecified bacterial intestinal infections

874

6462

1.52

21.41

3.4

3.1

1442.17

1443.12

ng/l

0.00

759

5509

Other/unspecified disorders of vestibular function

585

4065

1.70

21.36

3.3

3.0

1335.18

1500.03

ng/l

0.49

509

3487

Lichen ruber planus, wide definition including periferal and oral lichen planus

2858

24223

1.25

21.36

2.8

2.9

1048.23

1288.11

ng/l

2.15

2409

20795

Speech and linguistic disorders

651

4263

1.55

21.35

4.8

3.6

1308.13

1157.96

ng/l

0.35

555

3409

Secondary polycythaemia

335

2047

2.02

21.31

3.9

3.0

1488.80

1352.36

ng/l

0.28

278

1732

Bicipital tendinitis

578

3951

1.66

21.29

3.3

3.0

776.29

1283.89

ng/l

4.29

503

3362

Polyarthritis, unspecified

454

2954

1.78

21.23

3.5

3.0

1463.74

1344.10

ng/l

0.26

396

2524

Benign neoplasm: Skin of other and unspecified parts of face

1461

11609

1.38

21.22

3.2

3.1

1657.50

1614.06

ng/l

0.10

1237

9999

Dislocation, sprain and strain of joints and ligaments of thorax

424

2718

1.81

21.22

3.5

3.0

1285.97

1334.77

ng/l

0.10

369

2297

Dermatopolymyositis (FG)

213

1143

2.44

21.17

4.6

2.9

1078.10

1287.33

ng/l

0.48

196

963

Other fall from one level to another

2494

20764

1.26

21.16

3.1

3.2

1346.53

1370.60

ng/l

0.08

2105

17671

Other specified/unspecified dorsopathies

439

2836

1.79

21.12

2.9

3.0

1174.42

1521.17

ng/l

1.15

366

2396

Paralytic ileus

546

3734

1.71

21.09

3.9

3.0

2222.81

1611.70

ng/l

1.67

482

3228

Carcinoma in situ of skin

1338

10654

1.43

21.07

3.4

3.2

2305.65

1676.61

ng/l

2.00

1170

9272

Abscess of anal and rectal regions

910

6698

1.47

21.00

2.9

1302.01

1210.82

ng/l

0.22

777

5629

Other/unspecified enthesopathies, not elsewhere classified

1061

8047

1.44

21.00

3.2

3.0

1214.55

1641.02

ng/l

2.98

907

6903

Assault by bodily force

644

4425

1.56

20.99

2.6

2.9

1125.34

918.81

ng/l

0.52

511

3585

FESS (DNB20)

1363

10658

1.37

20.94

2.8

2.9

808.42

1187.31

ng/l

4.09

1094

8987

Focal epilepsy, mode (most common among epilepsy diagnosis)

2321

19285

1.28

20.88

3.1

3.2

1462.36

1520.42

ng/l

0.23

2023

16506

Other and unspecified primary disorders of muscles

122

532

3.34

20.85

3.8

3.4

1251.79

1178.01

ng/l

0.04

113

450

Maternal care for other conditions predominantly related to pregnancy

1354

10224

1.34

20.85

2.2

2.3

568.09

450.67

ng/l

0.45

1032

8197

Disorders of refraction and accommodation

2643

22005

1.24

20.83

3.1

2.9

935.22

1115.77

ng/l

1.93

2150

18486

Benign neoplasm: Small intestine

601

4249

1.70

20.79

3.5

3.1

1968.73

1423.52

ng/l

1.14

529

3655

Giant cell arteritis with polymyalgia rheumatica

600

4274

1.73

20.73

3.3

3.1

1526.30

1614.00

ng/l

0.18

534

3678

Psoriatic arthropathies, ICD10

1194

9213

1.40

20.72

2.9

1270.66

1177.50

ng/l

0.30

1013

7796

Hypercalcemia

629

4473

1.67

20.69

3.9

3.1

2559.37

1442.59

ng/l

2.62

556

3840

Other and unspecified immunodeficiencies with predominantly antibody defects

172

856

2.62

20.66

4.9

2.9

1431.64

910.01

ng/l

0.86

160

706

Other disorders starting during childhood or adolecense, excluding more controls

243

1229

2.00

20.63

6.9

3.5

1531.55

702.00

ng/l

1.19

188

940

Radial styloid tenosynovitis [de Quervain]

548

3688

1.62

20.47

2.7

2.8

901.38

1053.55

ng/l

0.63

452

3077

Ethmoidectomy

1418

11177

1.36

20.46

2.8

2.9

866.38

1201.09

ng/l

2.96

1138

9440

Calcific tendinitis of shoulder

642

4489

1.58

20.46

3.1

2.9

722.44

1179.55

ng/l

3.78

549

3806

Acute posthaemorrhagic anaemia

525

3600

1.73

20.42

4.9

3.0

2782.44

1715.86

ng/l

4.68

463

3100

Infections with a predominantly sexual mode of transmission

2512

20834

1.24

20.41

2.7

1186.40

871.78

ng/l

2.54

1972

17060

Other specified disorders of muscle

366

2286

1.87

20.35

3.6

3.1

1366.49

1530.74

ng/l

0.29

320

1921

Nasal polyp

2428

20335

1.27

20.27

2.8

3.0

1228.27

1480.32

ng/l

2.22

2083

17562

Other and unspecified disorders of white blood cells

541

3724

1.69

20.22

3.3

3.0

1970.27

1408.34

ng/l

1.28

461

3178

Orthopaedic devices associated with adverse incidents

318

2004

2.16

20.18

3.8

3.1

1746.13

1252.94

ng/l

1.04

254

1721

Pneumonia derived septicemia

453

2995

1.76

20.15

3.9

3.1

2551.40

1607.28

ng/l

2.81

391

2558

Infective bursitis

385

2459

1.86

20.10

3.4

3.1

1550.54

1498.54

ng/l

0.07

324

2123

Other psoriatic arthropathies

1161

8964

1.40

20.08

2.9

1290.30

1152.18

ng/l

0.49

982

7584

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1472

11826

1.37

20.04

3.2

2413.53

1635.47

ng/l

4.43

1319

10174

Cluster headache, strict, including avohilmo

480

3161

1.68

20.04

2.5

2.9

592.98

918.81

ng/l

1.84

383

2610

Ehlers-Danlos syndrome

378

3.19

19.99

2.0

2.8

764.66

766.25

ng/l

0.00

298

Myeloproliferative diseases (CML excluded)

1073

8310

1.45

19.91

3.2

3.1

2213.90

1558.03

ng/l

2.10

930

7161

Additional codes for the location of defect, injury or illness

707

5093

1.56

19.89

3.1

1451.02

1328.59

ng/l

0.20

637

4326

Iron deficiency

221

1171

2.10

19.84

4.0

3.0

788.06

888.56

ng/l

0.28

179

969

Rosacea

1287

10074

1.37

19.83

3.0

2.9

1120.13

1207.63

ng/l

0.29

1080

8567

Colorectal cancer

3514

29869

1.22

19.78

2.8

3.2

1582.38

1691.38

ng/l

0.68

3061

25731

Dermatographic urticaria

655

4604

1.55

19.77

2.7

2.8

658.95

942.66

ng/l

2.77

540

3806

Infection of intervertebral disc (pyogenic)

217

1216

2.43

19.77

3.9

3.1

2830.61

1578.82

ng/l

1.57

185

1069

Pulmonary artery stenosis

17.80

19.74

11.2

9.0

712.98

1167.23

ng/l

0.56

Other and unspecified epidermal thickening

349

2184

1.90

19.73

3.9

3.1

1984.82

1266.23

ng/l

1.19

312

1855

Acute lymphadenitis

584

4018

1.59

19.71

2.9

3.0

1061.64

1130.63

ng/l

0.19

488

3350

Pediculosis, acariasis and other infestations

1494

11826

1.33

19.69

3.1

3.0

1251.87

1095.25

ng/l

0.64

1231

9793

Mixed conductive and sensorineural hearing loss

1671

13607

1.33

19.60

3.2

3.1

1489.38

1638.51

ng/l

0.78

1418

11817

Post-traumatic wound infection, not elsewhere classified

348

2178

1.90

19.59

3.6

3.1

1900.11

1340.87

ng/l

1.61

300

1848

Disorders of magnesium metabolism

134

637

3.18

19.55

3.8

3.0

2451.64

1132.67

ng/l

3.22

125

538

Bell's palsy

1411

11207

1.35

19.53

3.2

3.0

1399.43

1431.71

ng/l

0.10

1182

9577

Lichen planus, including avohilmo

2450

20668

1.26

19.52

2.8

2.9

1117.96

1333.66

ng/l

1.46

2073

17731

Ill-defined and unknown causes of mortality

1326

10595

1.40

19.50

4.5

3.2

3072.59

2005.66

ng/l

6.26

1193

9197

Seropositive rheumatoid arthritis, strict definition

1889

15540

1.30

19.48

3.0

2.9

1383.09

1262.42

ng/l

0.67

1674

13311

Benign lipomatous neoplasm

3841

33507

1.20

19.47

3.0

1175.65

1356.01

ng/l

2.55

3274

28768

Disorders of plasma-protein metabolism, not elsewhere classified

111

476

3.32

19.43

3.9

3.0

827.81

970.25

ng/l

0.23

101

405

Dementia

7369

46088

1.15

19.42

3.0

3.2

1889.54

1804.63

ng/l

0.75

6261

40264

Hidradenitis suppurativa

325

1955

1.84

19.42

2.4

2.8

1146.20

753.83

ng/l

0.75

262

1590

Lichen planus

1689

13780

1.33

19.39

3.0

1086.36

1348.23

ng/l

2.61

1447

11839

Recurrent dislocation of patella

343

2066

1.77

19.36

2.2

2.8

1040.84

780.96

ng/l

0.37

248

1639

Myelodysplastic syndrome, including Hilmo

476

3267

1.78

19.36

3.6

3.2

2061.07

1932.67

ng/l

0.26

438

2843

Endometriosis of rectovaginal septum and vagina

862

6397

1.47

19.36

2.8

844.15

1395.25

ng/l

6.16

714

5472

Personal history of certain other diseases

150

694

2.43

19.33

3.8

2.6

1408.11

918.33

ng/l

0.81

121

529

Other keratitis

1209

9401

1.38

19.24

3.0

2.9

1520.19

1283.20

ng/l

0.91

1028

7894

Nonsuppurative otitis media

1950

13722

1.27

19.23

3.4

3.0

1216.65

1260.61

ng/l

0.13

1599

11306

Renal tubulo-interstitial disorders in diseases classified elsewhere

165

853

2.76

19.21

4.4

2.8

3591.57

974.28

ng/l

6.62

152

718

Cluster headache, wide,, including avohilmo

517

3498

1.63

19.10

2.5

2.9

727.01

951.72

ng/l

0.71

416

2895

L02BX Other hormone antagonists and related agents

847

6472

1.55

19.06

3.4

3.3

1819.92

1861.47

ng/l

0.10

763

5735

Recurrent dislocation and subluxation of joint

585

4022

1.56

19.06

2.5

2.9

850.15

1008.83

ng/l

0.36

462

3325

Benign neoplasm: Duodenum

406

2716

1.88

19.05

3.6

3.1

1926.17

1382.30

ng/l

0.84

354

2340

Ehlers-Danlos syndrome

113

470

2.84

19.02

1.9

2.8

708.94

680.68

ng/l

0.02

375

Prepatellar bursitis

551

3820

1.63

18.99

3.6

3.1

1405.46

1508.17

ng/l

0.21

474

3261

Other infective otitis externa

706

5115

1.53

18.97

2.9

3.0

1404.48

1315.22

ng/l

0.20

581

4346

Selective deficiency of immunoglobulin G [IgG] subclasses

108

462

3.31

18.96

3.8

3.0

683.15

697.27

ng/l

0.03

382

Malnutrition

310

1925

2.01

18.95

5.0

3.4

2235.49

1568.92

ng/l

1.78

278

1643

Malignant neoplasm of breast, ER-positive, including Hilmo

4125

27839

1.19

18.94

2.6

2.7

982.84

1098.38

ng/l

1.16

3504

23346

Viral infections of the central nervous system

843

6258

1.47

18.90

3.1

3.0

942.84

1309.96

ng/l

3.64

693

5256

Other disorders of the genitourinary system

1722

14144

1.32

18.86

2.9

1368.39

1358.49

ng/l

0.03

1436

12166

Acquired absence of limb

159

809

2.71

18.84

4.5

2.7

5389.65

1325.65

ng/l

3.11

142

684

Salpingitis and oophoritis

1925

15847

1.28

18.82

2.7

2.6

952.19

928.47

ng/l

0.11

1585

13477

Atopic dermatitis, strict definition with reimbursement

2468

19903

1.23

18.70

2.9

2.8

1136.50

929.65

ng/l

0.84

1970

16355

Rheumatic fever incl heart disease

468

3191

1.74

18.70

4.9

3.2

2532.80

1966.30

ng/l

1.36

428

2741

Other and unspecified rosacea

989

7554

1.43

18.67

3.1

2.9

1204.08

1181.78

ng/l

0.05

832

6417

Acute and transient psychotic disorders

1174

9113

1.37

18.67

2.6

2.9

896.29

1179.21

ng/l

2.64

958

7602

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

470

3131

1.65

18.67

2.7

3.0

926.17

1165.78

ng/l

0.68

405

2618

Malignant neoplasm of urinary organs

1388

11171

1.37

18.65

3.2

2367.84

1650.26

ng/l

4.38

1248

9637

Appendicitis, broad definition

9179

75907

1.12

18.64

2.9

1086.63

1253.16

ng/l

3.51

7710

64121

Congenital malformations of trachea and bronchus

157

804

2.75

18.57

5.9

3.3

704.86

1418.50

ng/l

4.52

142

675

Other retinal artery occlusion

374

2467

1.90

18.49

3.7

3.2

2515.11

1770.12

ng/l

1.64

325

2130

Oligomenorrhoea

304

1815

1.84

18.47

2.7

737.60

1016.20

ng/l

0.70

243

1477

Diseases of appendix

9270

76474

1.12

18.40

2.9

1088.81

1261.16

ng/l

3.75

7787

64612

Ovarian dysfunction

462

3026

1.61

18.35

2.3

2.5

499.92

553.50

ng/l

0.20

367

2387

Acute appendicitis

8489

72341

1.12

18.34

2.9

1070.78

1237.47

ng/l

3.67

7134

61070

Entropion and trichiasis of eyelid

1311

10540

1.39

18.33

3.1

3.2

1924.89

1936.24

ng/l

0.02

1154

9158

Other and unspecified mononeuropathies, also in other diseases

409

2715

1.78

18.33

3.5

3.0

1810.33

1422.35

ng/l

0.83

343

2322

Use of biperiden

628

4494

1.57

18.29

2.5

2.9

810.71

1232.25

ng/l

2.85

522

3785

Residual foreign body in soft tissue

539

3717

1.59

18.24

2.9

3.0

1153.74

1366.26

ng/l

0.58

468

3134

Gingival hyperplasia

439

2947

1.73

18.21

5.5

3.1

1869.76

1199.18

ng/l

1.81

389

2520

Malignant melanoma, including Hilmo

2446

20799

1.26

18.19

3.0

3.1

1635.77

1561.21

ng/l

0.24

2108

17926

Insomnia

10834

72682

1.11

18.11

2.8

2.9

1067.54

1248.90

ng/l

4.46

8874

61428

Vitamin D deficiency

217

1208

2.14

18.04

3.7

2.9

2389.74

1042.92

ng/l

1.57

181

994

Rheumatic valve diseases

359

2341

1.87

17.98

5.2

3.1

2671.87

2125.59

ng/l

1.01

328

1997

Bulimia nervosa (incl. atypical)

202

1061

2.04

17.97

2.0

2.6

390.32

455.48

ng/l

0.20

150

814

Eosinophilia

235

1374

2.17

17.90

4.0

3.1

2127.93

1234.19

ng/l

0.72

211

1195

Malignant neoplasm of kidney, except renal pelvis

1261

10092

1.38

17.84

3.2

2317.24

1642.50

ng/l

3.51

1129

8719

Female infertility, associated with anovulation

402

2555

1.64

17.83

2.3

339.50

484.11

ng/l

0.94

315

1992

Benign neoplasm: Skin of eyelid, including canthus

2096

17615

1.28

17.82

3.1

3.0

1532.63

1476.82

ng/l

0.19

1795

15216

Atrophic disorders of skin

1739

14289

1.30

17.77

3.0

2.8

1071.03

1101.54

ng/l

0.14

1482

12103

Primary open-angle glaucoma

5142

44646

1.17

17.74

3.1

3.2

1742.26

1784.89

ng/l

0.24

4372

38722

Ménière disease

1253

10001

1.37

17.74

3.1

3.0

1279.51

1509.08

ng/l

0.65

1068

8605

Acute alcohol intoxication

3118

26911

1.21

17.69

3.2

3.1

1644.44

1505.94

ng/l

0.71

2651

23004

Other chondrocalcinosis

232

1402

2.37

17.67

4.3

3.2

2162.26

1647.51

ng/l

1.08

207

1222

Agoraphobia

227

1252

1.97

17.67

2.6

639.83

715.10

ng/l

0.16

174

1007

Other disorders involving the immune mechanism, not elsewhere classified

361

2326

1.79

17.64

4.3

3.2

4379.97

1284.35

ng/l

6.49

321

1958

Lesion of plantar nerve

775

5803

1.49

17.60

2.8

2.9

712.80

1189.36

ng/l

8.39

657

4949

Muscle strain

348

2205

1.78

17.57

3.3

3.1

907.67

1238.58

ng/l

1.06

300

1859

Bacterial, viral and other infectious agents

904

6837

1.42

17.48

3.5

3.0

1415.69

1211.55

ng/l

0.68

771

5675

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

6039

52713

1.14

17.47

2.7

2.8

959.34

1114.70

ng/l

2.04

4954

44125

Ankylosing spondylitis, ICD10

937

7146

1.41

17.46

2.9

931.39

1209.25

ng/l

1.87

770

5992

Background retinopathy and retinal vascular changes

302

1903

1.95

17.32

3.5

3.1

2198.73

1621.65

ng/l

1.24

257

1622

Dental pulpitis, including avohilmo

10714

64051

1.11

17.28

2.7

2.9

862.73

1112.51

ng/l

7.70

8687

54063

L04AC Interleukin inhibitors

552

3855

1.56

17.28

2.7

2.9

740.53

983.33

ng/l

1.23

471

3192

Vasomotor rhinitis (mode)

846

6407

1.45

17.21

3.0

1343.18

1219.91

ng/l

0.18

696

5469

Haemorrhage in early pregnancy

2351

19227

1.23

17.16

2.4

2.5

499.56

713.83

ng/l

5.96

1946

15896

Central retinal artery occlusion

359

2392

1.89

17.13

4.0

3.2

2855.11

1983.89

ng/l

1.72

333

2068

Fracture of neck

820

6243

1.48

17.04

3.2

3.1

1697.54

1726.57

ng/l

0.07

712

5386

Bruxism

188

1009

2.16

17.00

2.6

3.0

597.58

674.95

ng/l

0.23

149

828

Tongue abnormality

800

6068

1.48

17.00

3.0

3.1

1084.36

1361.57

ng/l

1.00

672

5172

Dermatopolymyositis

216

1251

2.20

16.98

4.6

3.0

1072.92

1261.37

ng/l

0.43

197

1062

Prurigo nodularis

352

2316

1.84

16.91

4.0

3.0

2411.04

1311.73

ng/l

1.66

306

1975

Event of undetermined intent

630

4528

1.51

16.89

3.0

1556.16

1166.06

ng/l

1.01

513

3795

Arthropod-borne viral fevers and viral haemorrhagic fevers

2131

17932

1.26

16.85

2.9

3.1

1175.22

1379.91

ng/l

1.70

1904

15330

Malignant melanoma of skin, including Hilmo

2002

16846

1.27

16.85

2.9

3.1

1503.73

1541.46

ng/l

0.13

1736

14496

Gestational [pregnancy-induced] hypertension

1933

15921

1.25

16.82

2.5

2.4

776.66

653.29

ng/l

0.84

1613

13006

Other and unspecified follicular disorders

448

3048

1.65

16.81

3.8

3.0

2445.87

1245.17

ng/l

1.78

382

2581

Effects of foreign body entering through natural orifice

2669

22826

1.22

16.79

3.1

1279.16

1292.08

ng/l

0.05

2237

19371

Hypertrophic disorders of skin

551

3868

1.55

16.78

2.9

1266.35

971.92

ng/l

0.46

448

3198

Infarction of spleen

126

637

3.24

16.75

4.4

3.1

1700.94

1302.07

ng/l

0.90

118

532

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1144

9091

1.38

16.69

2.8

3.0

1252.90

1322.69

ng/l

0.16

967

7770

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

852

6441

1.42

16.68

2.7

2.6

944.72

798.40

ng/l

0.41

717

5393

Viral infections of the central nervous system

779

5829

1.45

16.66

3.1

3.0

968.04

1251.29

ng/l

2.27

637

4896

Other specified/unspecified inflammatory spondylopathies

424

2819

1.63

16.65

2.7

2.9

1169.87

1129.49

ng/l

0.05

363

2342

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1630

8307

1.27

16.55

2.1

2.2

323.98

337.33

ng/l

0.08

1246

6427

Injury of other and unspecified intrathoracic organs

808

6131

1.46

16.55

3.2

3.1

1894.88

1595.39

ng/l

0.86

708

5267

Vertigo of central origin

254

1567

2.09

16.54

3.2

1117.95

1583.63

ng/l

2.01

205

1334

163

826

2.18

16.52

2.5

2.7

458.06

559.63

ng/l

0.48

143

662

Carcinoma in situ of skin of ear and external auricular canal

266

1694

2.16

16.52

3.3

3.5

4053.55

2307.39

ng/l

1.87

240

1512

Congenital malformations of the urinary system

604

4345

1.52

16.51

3.1

3.2

4058.14

1232.34

ng/l

8.45

548

3651

Sacrococcygeal disorders, not elsewhere classified

324

2053

1.78

16.40

2.4

2.8

577.97

1067.34

ng/l

4.91

260

1722

Problems related to social environment

363

2385

1.75

16.36

4.3

3.1

1833.30

1810.56

ng/l

0.03

313

2024

Fracture at wrist and hand level

3837

33663

1.17

16.25

3.0

1380.02

1256.77

ng/l

0.57

3207

28509

Complications of genitourinary prosthetic devices, implants and grafts

332

2157

1.81

16.19

3.3

2.9

1871.26

1194.62

ng/l

1.29

276

1828

Hepatomegaly and splenomegaly, not elsewhere classified

139

702

2.57

16.17

4.4

3.1

1423.26

1189.80

ng/l

0.29

122

613

Other obstructive and reflux uropathy

478

3307

1.60

16.17

3.1

2.7

2481.76

1135.17

ng/l

4.76

410

2773

Postzoster neuralgia

264

1667

2.08

16.17

4.4

3.0

1832.43

1551.91

ng/l

0.48

236

1447

Allergic conjunctivitis

6294

55435

1.13

16.15

2.7

2.8

964.42

1113.15

ng/l

1.93

5163

46410

Acne

589

4141

1.48

16.14

3.5

3.0

1368.17

622.86

ng/l

2.40

463

3227

Retinal haemorrhage

377

2556

1.79

16.12

3.5

3.2

1996.41

1668.46

ng/l

0.56

332

2208

Myotonic disorders

115

540

2.82

16.10

2.7

3.0

929.01

916.88

ng/l

0.01

448

Malignant neoplasm of colon

2189

18673

1.26

16.08

3.0

3.2

1703.92

1728.84

ng/l

0.08

1897

16135

Tumor necrosis factor alpha inhibitors

1339

10722

1.31

16.06

2.4

2.9

949.92

912.32

ng/l

0.11

1141

8846

Other obstetric conditions, not elsewhere classified

1691

8700

1.26

16.05

2.1

2.2

331.47

344.08

ng/l

0.08

1295

6748

Congenital malformations of the respiratory system

238

1422

2.01

16.04

5.0

3.6

1165.66

1309.37

ng/l

0.17

212

1195

Pneumococcal septicemia

431

2965

1.68

16.04

3.9

3.1

2576.97

1571.67

ng/l

2.94

369

2541

Malignant neoplasm of prostate, including Hilmo

4421

23382

1.18

16.03

3.0

3.2

1832.86

1692.09

ng/l

0.84

3804

20271

Varicose veins of other sites

763

5748

1.45

16.00

3.3

3.1

1060.49

1373.47

ng/l

1.79

645

4834

Hypertrophy of breast

1621

13285

1.28

15.98

2.2

2.6

630.95

782.54

ng/l

1.15

1317

11088

Other operation for atrial fibrillation

111

558

3.76

15.97

4.4

3.4

2173.34

1543.56

ng/l

0.52

105

468

Kyphosis

199

1147

2.21

15.96

3.9

3.1

1096.01

1335.94

ng/l

0.57

176

982

Complications predominantly related to the puerperium

2092

17516

1.23

15.91

2.3

2.5

567.69

654.24

ng/l

0.83

1696

14445

Malignant neoplasm of prostate

4305

22902

1.18

15.89

3.0

3.2

1844.19

1705.68

ng/l

0.81

3711

19874

Any dementia, excluding more controls

6010

37601

1.15

15.86

3.1

3.2

2144.87

1853.55

ng/l

3.80

5117

32899

Lactose intolerance

331

2127

1.75

15.85

2.8

2.9

1412.66

1009.60

ng/l

0.73

279

1745

Corticotropin deficiency

132

670

2.72

15.83

3.9

3.3

928.61

1082.85

ng/l

0.22

115

576

Mental retardation

363

2355

1.69

15.80

3.4

3.8

1579.95

1163.97

ng/l

0.41

303

1970

Scabies

462

3184

1.60

15.77

3.7

3.0

1401.28

1048.31

ng/l

1.16

370

2668

Bacterial, viral and other infectious agents

844

6423

1.41

15.73

3.5

3.0

1419.50

1208.48

ng/l

0.66

723

5328

Drug-induced osteoporosis

198

1157

2.26

15.71

5.8

3.1

1899.26

1082.57

ng/l

1.20

181

971

Folate deficiency anaemia

163

904

2.52

15.70

4.0

3.1

2710.49

1454.12

ng/l

2.09

139

785

Injury of muscle and tendon at lower leg level

1723

14311

1.27

15.67

3.2

3.0

1539.05

1314.66

ng/l

0.87

1447

12255

Urethral stricture

801

6153

1.46

15.66

3.5

3.2

2026.14

1771.39

ng/l

0.42

674

5391

Hypogonadotropic hypogonadism

291

1819

1.81

15.66

2.6

3.0

544.35

1067.16

ng/l

2.78

213

1488

Arthropod-borne viral fevers and viral haemorrhagic fevers

1122

8934

1.36

15.63

3.0

3.1

995.21

1363.72

ng/l

2.93

995

7608

Other forms of systemic lupus erythematosus

120

582

2.72

15.59

3.0

3.2

1365.41

985.76

ng/l

0.53

108

489

Secondary thrombocytopenia

189

1087

2.27

15.58

4.2

2.9

1422.48

989.54

ng/l

0.86

172

923

Hyperaldosteronism

381

2590

1.74

15.58

3.4

3.0

1740.20

1195.65

ng/l

1.22

324

2234

Bullous disorders

792

6084

1.46

15.57

3.3

3.1

1788.29

1631.50

ng/l

0.40

690

5234

Early lumbar disc prolapse operation

740

5474

1.41

15.56

2.3

2.7

581.81

681.84

ng/l

0.19

572

4361

Neovascular glaucoma

559

4067

1.57

15.55

3.5

3.2

2943.82

1733.68

ng/l

3.10

486

3484

Exposure to other and unspecified inanimate mechanical forces

756

5686

1.43

15.49

3.1

3.0

1170.24

1219.11

ng/l

0.15

627

4744

Dependent personality disorder

249

1520

1.94

15.46

2.9

1167.94

876.90

ng/l

0.42

207

1268

Dependence on enabling machines and devices, not elsewhere classified

149

776

2.39

15.42

7.8

2.8

5375.00

1304.49

ng/l

3.93

143

657

Other superficial mycoses

933

7194

1.37

15.41

2.7

2.9

951.58

1080.55

ng/l

0.55

749

5947

Malignant neoplasm of breast, HER-positive

4011

27704

1.17

15.39

2.6

2.7

991.38

1101.91

ng/l

1.05

3402

23229

Malignant melanoma

1987

16854

1.26

15.37

3.1

1585.41

1519.65

ng/l

0.19

1706

14511

Somnolence, stupor and coma

539

3877

1.55

15.35

3.5

3.1

2335.65

1697.14

ng/l

0.81

465

3304

Congenital malformations of the respiratory system

220

1305

2.04

15.34

5.2

3.7

1160.25

1315.09

ng/l

0.17

199

1104

Respiratory conditions due to other external agents

321

2136

1.87

15.32

4.2

3.0

1335.40

1466.06

ng/l

0.34

297

1843

Disorders of optic nerve and visual pathways

985

7697

1.37

15.31

3.2

3.1

1552.26

1340.57

ng/l

0.70

824

6500

Other specified/unspecified necrotizing vasculopathies

212

1270

2.15

15.24

3.9

3.1

2204.16

1441.23

ng/l

1.34

189

1081

Glaucoma secondary to other eye disorders

562

4107

1.56

15.23

3.5

3.2

2935.63

1835.79

ng/l

2.66

489

3526

Vitamin B12 deficiency anaemia

1500

12412

1.31

15.23

3.2

3.0

2197.29

1758.40

ng/l

2.68

1326

10700

Aortic stenosis

9.57

15.22

11.1

5.2

2571.16

1602.64

ng/l

0.54

Sequelae of injuries of neck and trunk

356

2369

1.72

15.22

2.6

3.1

892.03

1136.11

ng/l

1.07

297

2015

Other deformities of toe(s)

433

3002

1.64

15.20

2.8

3.0

1174.76

1301.00

ng/l

0.27

358

2577

Abnormal findings in nipple discharge synovial fluid wound secretions

202

1178

2.11

15.14

3.1

3.2

2463.90

1209.64

ng/l

0.58

180

999

Kela reimbursement Agammaglobulinemia (D80-84)

107

496

2.76

15.13

5.1

2.6

1621.73

643.86

ng/l

0.72

391

Infections with a predominantly sexual mode of transmission

3111

25102

1.18

15.11

2.7

1052.67

871.39

ng/l

1.40

2432

20478

Complications following infusion, transfusion and therapeutic injection

214

1277

2.08

15.06

3.7

2.9

1821.62

1057.47

ng/l

1.21

191

1077

Late syphilis

226

1370

2.04

15.06

4.0

3.0

3449.47

1173.41

ng/l

5.65

194

1163

Cystic kidney disease

386

2626

1.69

15.03

3.1

5310.87

1221.09

ng/l

8.28

350

2234

Other immunodeficiencies

140

724

2.41

14.97

4.0

3.2

1330.60

1048.90

ng/l

0.44

121

609

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1854

15581

1.26

14.92

2.9

3.1

1203.24

1364.56

ng/l

1.04

1656

13318

Congenital malformations of the urinary system

640

4730

1.47

14.90

3.1

3.2

3952.26

1220.02

ng/l

8.65

575

3985

Disorders of iron metabolism

193

1109

2.10

14.89

2.4

2.8

622.53

850.58

ng/l

0.77

151

934

Acute lymphocytic leukaemia, including Hilmo

281

3.26

14.84

3.0

4.4

718.03

1174.24

ng/l

0.99

232

Acute lymphocytic leukaemia

281

3.26

14.84

3.0

4.4

718.03

1174.24

ng/l

0.99

232

Acute lymphocytic leukaemia, helper endpoint

281

3.26

14.84

3.0

4.4

718.03

1174.24

ng/l

0.99

232

Endometriosis of ovary

1642

13238

1.26

14.83

2.6

2.7

851.95

1202.33

ng/l

4.44

1342

11196

Muscular dystrophy

123

621

2.69

14.83

3.3

1531.41

1165.36

ng/l

0.21

106

513

Traumatic subarachnoid haemorrhage

476

3378

1.59

14.83

3.5

2.9

2437.08

1745.70

ng/l

1.02

408

2929

Cushing syndrome

165

917

2.30

14.80

3.3

3.0

1647.94

1013.94

ng/l

0.94

144

771

Thyrotoxicosis with toxic multinodular goitre

824

6416

1.44

14.76

3.3

3.0

1506.00

1429.59

ng/l

0.22

730

5490

Clear cell adenocarcinoma of kidney

635

4785

1.52

14.75

3.1

3.0

1880.62

1493.01

ng/l

1.09

574

4111

Emotional disorders and disorders of social functioning with onset specific to childhood

234

1337

1.80

14.73

3.0

3.9

479.26

661.06

ng/l

0.42

156

1009

Biomechanical lesions, not elsewhere classified

627

4679

1.50

14.72

3.0

1683.85

1445.55

ng/l

0.38

536

4000

Paralytic strabismus

921

7253

1.40

14.70

3.3

3.1

1458.94

1578.47

ng/l

0.35

791

6217

Puerperal sepsis

1263

10209

1.31

14.68

2.3

2.6

645.75

737.70

ng/l

0.59

1045

8596

Other and specified injuries of hip and thigh

322

2141

1.80

14.67

3.5

3.2

2090.16

1625.85

ng/l

0.57

282

1825

Other and unspecified types of non-Hodgkin lymphoma, hilmo

588

4382

1.54

14.63

4.1

3.2

2109.80

1650.99

ng/l

0.79

540

3767

Carcinoma in situ of skin of scalp and neck

424

3052

1.75

14.57

3.5

3.3

2277.96

1991.82

ng/l

0.56

383

2681

Single delivery by forceps and vacuum extractor

472

4099

0.67

14.56

1.9

2.4

227.23

513.24

ng/l

3.52

356

3236

Other disorders of optic [2nd] nerve and visual pathways

725

5504

1.44

14.53

3.5

3.2

1747.83

1350.51

ng/l

1.27

611

4666

Primary open-angle glaucoma, strict

4145

37151

1.17

14.49

3.2

1753.21

1764.12

ng/l

0.05

3543

32209

Personal history of malignant neoplasm

714

5392

1.43

14.45

2.9

2.4

1088.07

973.89

ng/l

0.22

611

4497

Congenital malformations of the musculoskeletal system, not elsewhere classified

157

834

2.14

14.45

2.3

3.1

870.29

741.10

ng/l

0.15

123

678

Senility

173

973

2.19

14.43

3.4

3.1

3142.39

2811.43

ng/l

0.22

145

831

Diabetic neuropathy

1669

14065

1.30

14.39

4.0

3.7

3041.77

1942.14

ng/l

5.53

1518

12165

Blood alcohol or alcohol intoxication level

249

1529

1.84

14.36

2.9

1278.06

1010.26

ng/l

0.40

217

1268

Carcinoma in situ of skin of trunk

516

3829

1.63

14.35

3.6

3.3

2514.52

1916.36

ng/l

1.60

459

3359

Injury of eye and orbit

1433

11740

1.28

14.33

2.8

3.0

1017.12

1278.56

ng/l

2.08

1185

9871

Melanocytic naevi

3251

28552

1.18

14.30

3.2

2.9

1398.84

1244.02

ng/l

0.84

2773

24277

Single spontaneous delivery

3988

23771

0.86

14.25

2.7

2.9

1058.96

1260.23

ng/l

3.10

3375

20110

Other viral hepatitis

522

3725

1.50

14.24

3.0

1663.46

933.16

ng/l

0.89

437

3047

Late syphilis

190

1119

2.14

14.19

4.2

3.1

3836.53

1235.39

ng/l

5.41

162

944

Heterophoria

755

5735

1.40

14.19

3.2

3.0

670.77

1123.49

ng/l

3.82

622

4802

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

427

3049

1.67

14.18

3.0

1847.19

1663.40

ng/l

0.39

388

2624

Chronic lymphocytic leukaemia, helper endpoint

427

3049

1.67

14.18

3.0

1847.19

1663.40

ng/l

0.39

388

2624

Chronic lymphocytic leukaemia

427

3049

1.67

14.18

3.0

1847.19

1663.40

ng/l

0.39

388

2624

Polyarteritis nodosa and related conditions

192

1127

2.10

14.18

4.0

3.1

2139.79

1340.95

ng/l

0.49

178

963

Collapsed vertebra, not elsewhere classified

147

824

2.58

14.17

3.9

3.2

2223.47

1967.25

ng/l

0.18

125

695

Carcinoma in situ of skin of upper limb, including shoulder

418

3020

1.74

14.13

3.2

3.3

2330.73

1758.37

ng/l

1.48

366

2625

Alzheimer’s disease (Atypical or mixed)

1735

14663

1.29

14.13

3.3

3.5

2189.65

2425.34

ng/l

1.05

1461

12804

Chronic tubulo-interstitial nephritis

487

3503

1.57

14.11

3.4

2.7

2797.49

1130.00

ng/l

6.98

419

2944

Personal history of risk-factors, not elsewhere classified

137

704

2.26

14.10

3.7

2.5

1008.56

994.42

ng/l

0.02

117

561

Hyperfunction of pituitary gland

447

3117

1.55

14.10

3.2

2.9

814.56

1039.54

ng/l

1.07

381

2586

Benign neoplasm of mouth and pharynx

1341

11031

1.30

14.09

3.0

1471.88

1425.76

ng/l

0.14

1147

9457

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

298

1841

1.67

14.05

6.3

3.7

1323.41

722.59

ng/l

0.98

234

1442

Amputation of ankle bones

331

2250

1.78

14.01

4.3

3.1

7955.69

1811.98

ng/l

8.38

304

1956

Other and unspecified psoriasis

798

6184

1.41

13.99

3.0

3.1

1535.37

1338.32

ng/l

0.41

690

5289

Colorectal adenocarcinoma

2892

25376

1.20

13.97

2.8

3.2

1607.81

1720.44

ng/l

0.60

2527

21920

Inflammatory diseases of the central nervous system

922

7254

1.37

13.91

3.0

1189.16

1376.60

ng/l

0.47

780

6139

D07AA Corticosteroids, weak (group I)

1413

11555

1.27

13.90

3.0

3.1

1155.64

1286.42

ng/l

0.64

1199

9639

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

728

5615

1.45

13.88

2.7

2.9

863.63

1162.15

ng/l

2.27

606

4794

Specific development disorders of scholastic skills

230

1341

1.79

13.87

5.4

3.8

1163.57

670.59

ng/l

0.58

190

1021

Delivery

4017

23807

0.86

13.86

2.7

2.9

1065.93

1260.69

ng/l

2.79

3400

20140

Acne vulgaris

430

2938

1.52

13.85

3.6

3.0

1152.59

539.11

ng/l

1.47

328

2254

Nontoxic single thyroid nodule

831

6471

1.39

13.85

3.2

2.8

1004.99

1170.44

ng/l

0.81

705

5518

Benign neoplasm: Skin of ear and external auricular canal

544

4031

1.54

13.81

3.4

3.1

2185.39

1767.46

ng/l

0.99

454

3484

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

322

2138

1.71

13.80

4.3

3.2

4742.30

1188.68

ng/l

6.84

286

1795

Mitochondrial myopathy

261

3.72

13.79

2.7

3.3

2132.08

681.27

ng/l

0.59

215

Bursitis of shoulder

294

1916

1.76

13.78

3.3

3.0

1104.56

1283.97

ng/l

0.42

259

1611

L01XX Other antineoplastic agents

825

6513

1.43

13.74

3.4

3.1

2087.92

1559.56

ng/l

1.21

732

5639

Mental retardation, wide definition

389

2644

1.60

13.73

3.4

3.7

1501.78

1185.20

ng/l

0.32

326

2229

Maltreatment syndromes

374

2511

1.58

13.71

3.1

3.0

931.37

844.63

ng/l

0.14

301

2016

Pemphigoid

422

3036

1.67

13.70

3.5

3.2

2213.72

1828.34

ng/l

0.67

364

2645

Pediculosis, acariasis and other infestations

610

4532

1.46

13.69

3.6

3.0

1323.42

1137.71

ng/l

0.65

498

3790

Benign neoplasm: Rectosigmoid junction

586

4425

1.53

13.65

3.4

3.1

2116.42

1482.32

ng/l

1.26

513

3819

Other inflammatory liver diseases

777

6018

1.41

13.63

3.5

3.0

1657.13

1312.22

ng/l

0.97

662

5100

Malignant neoplasm of oral cavity, including Hilmo

605

4559

1.50

13.60

2.8

3.0

1315.06

1432.95

ng/l

0.29

554

3891

Cystic kidney disease

410

2880

1.61

13.56

3.0

3.1

5110.40

1224.98

ng/l

8.28

369

2445

Aneurysms, operations, SAH

2139

18403

1.23

13.55

2.8

3.0

1481.00

1465.38

ng/l

0.06

1871

15813

Injury of muscle and tendon at hip and thigh level

1066

8561

1.33

13.53

3.0

1241.81

1211.44

ng/l

0.06

909

7255

Congenital malformations of the musculoskeletal system, not elsewhere classified

140

735

2.20

13.53

2.3

3.0

908.18

772.72

ng/l

0.14

113

598

Chromosomal abnormalities, not elsewhere classified

160

866

2.04

13.53

4.2

4.5

764.17

753.56

ng/l

0.02

137

711

Other disorders of breast

1285

10499

1.29

13.52

2.5

2.8

955.79

1016.81

ng/l

0.18

1059

8843

Chronic viral hepatitis

414

2856

1.55

13.51

3.0

2.9

1797.33

886.14

ng/l

0.87

340

2288

Myotonic dystrophy (Steinert)

226

4.19

13.50

2.6

3.2

578.61

881.90

ng/l

0.51

190

Nonspecific lymphadenitis

579

4267

1.46

13.44

2.7

2.8

831.71

998.23

ng/l

0.72

490

3524

Melanocytic naevi, other sites/unspecified

845

6598

1.37

13.44

3.7

3.0

1388.09

1256.29

ng/l

0.35

736

5579

Other and unspecified abdominal hernia

545

4050

1.52

13.43

2.8

3.0

1401.26

1572.94

ng/l

0.39

468

3487

Symptoms and signs involving emotional state

298

1939

1.70

13.41

3.8

3.2

1330.87

1030.39

ng/l

0.74

249

1612

Burns and corrosions

1377

11327

1.28

13.39

2.9

3.1

1580.63

1320.12

ng/l

0.79

1144

9526

Mixed specific developmental disorders

112

486

2.29

13.38

8.9

5.5

885.00

1051.99

ng/l

0.17

384

Osteonecrosis due to drugs

226

1442

2.04

13.36

4.1

3.1

2004.82

1325.62

ng/l

0.51

208

1243

Hypertrophic scar

489

3505

1.51

13.33

3.0

2.9

1359.34

948.64

ng/l

0.62

398

2884

Other autoimmune haemolytic anaemias

201

1244

2.12

13.29

3.3

3.1

1814.83

1469.05

ng/l

0.52

176

1070

Contusion of other and unspecified parts of foot

432

3022

1.53

13.23

2.9

3.0

1088.95

972.53

ng/l

0.32

358

2490

Other abnormal immunological findings in serum

225

1385

1.88

13.22

3.2

2.9

682.40

1010.61

ng/l

1.95

187

1154

Emotional disorders starting during childhood or adolescence

224

1317

1.76

13.21

3.0

4.3

606.38

725.59

ng/l

0.19

151

1006

Vulvovaginal ulceration/inflammation in other diseases

456

3213

1.51

13.20

2.6

594.27

738.27

ng/l

0.66

357

2629

Intermittent heterotropia

477

3391

1.50

13.18

3.4

3.3

1060.00

1147.99

ng/l

0.20

394

2797

Carcinoma in situ of other and unspecified digestive organs

483

3567

1.59

13.16

3.5

3.1

1413.74

1488.45

ng/l

0.18

441

3082

Other bursitis of hip

273

1784

1.80

13.14

3.5

3.0

978.87

1392.90

ng/l

1.68

223

1502

Dentofacial anomalies [including malocclusion]

7427

54801

1.11

13.14

2.8

674.47

1037.40

ng/l

21.51

6022

45855

Drug-induced hypoglycaemia without coma

225

1410

1.93

13.13

4.0

3.0

4213.83

1687.02

ng/l

2.58

192

1197

Other specified and unspecified retinal disorders

469

3419

1.57

13.08

3.1

2285.42

1518.07

ng/l

0.85

413

2915

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

478

3490

1.56

13.08

3.8

3.0

1481.73

1405.70

ng/l

0.18

407

2952

Non-Hodgkin lymphoma, all

627

4798

1.48

13.07

3.8

3.2

2651.92

1854.54

ng/l

1.68

567

4134

Graves disease, strict definition

958

7596

1.33

13.04

2.9

977.32

980.86

ng/l

0.01

793

6358

Viral haemorrhagic fevers, not elsewhere classified/unspecified

894

7087

1.36

12.98

3.0

995.08

1337.25

ng/l

2.12

793

6003

Other localized connective tissue disorders

253

1631

1.84

12.97

3.4

2.8

2610.26

1036.26

ng/l

1.23

215

1351

Chronic nephritic syndrome

479

3492

1.54

12.96

3.6

3.1

7310.12

1285.62

ng/l

11.27

434

2975

Crohn's disease NAS

627

4706

1.43

12.96

3.0

3.1

1673.96

1123.96

ng/l

1.82

530

3926

Perforation of tympanic membrane

1135

9233

1.31

12.93

3.2

3.0

1449.68

1413.41

ng/l

0.10

973

7890

Bitten or struck by other mammals

1013

8079

1.32

12.89

3.1

2.9

1079.91

1012.80

ng/l

0.20

823

6736

Pleural plaque without asbestos

576

4404

1.53

12.87

3.7

3.3

1534.40

2016.93

ng/l

2.86

517

3864

Spondylopathies in diseases classified elsewhere

192

1180

2.11

12.86

3.6

3.1

1183.71

1684.59

ng/l

1.68

169

1022

Nosocomial condition (hospital)

106

546

2.85

12.84

4.0

3.3

2640.43

1731.85

ng/l

0.47

460

Causalgia

181

1059

1.99

12.79

2.3

2.9

671.48

780.37

ng/l

0.24

148

883

Urethritis and urethral syndrome

267

1734

1.77

12.78

3.0

1122.60

1214.54

ng/l

0.20

218

1436

IBD patients in KELA-register

2225

19139

1.20

12.75

2.9

1298.92

1125.74

ng/l

0.91

1847

16025

Inflammatory disease of cervix uteri

745

5802

1.40

12.70

2.9

2.8

1039.53

1188.48

ng/l

0.59

621

4944

Hypoplasia of dental enamel, prenatal

6.90

12.69

10.3

12.1

2907.00

1263.09

ng/l

0.81

Postprocedural disorders of digestive system, not elsewhere classified

423

3043

1.59

12.61

2.9

3.1

1920.25

1461.56

ng/l

0.55

369

2606

Viral hepatitis

641

4837

1.41

12.55

2.9

1647.46

1035.38

ng/l

0.87

530

3989

Malignant melanoma of skin

1467

12344

1.27

12.55

3.0

3.1

1355.49

1513.22

ng/l

0.89

1260

10614

Other and unspecified injuries of thorax

226

1422

1.86

12.54

3.1

1426.39

1246.12

ng/l

0.31

187

1203

Glaucoma suspect

5210

47600

1.14

12.50

3.1

3.0

1446.51

1516.91

ng/l

0.48

4478

41061

Other diseases of spinal cord

364

2541

1.63

12.48

3.1

3.0

1109.21

1310.11

ng/l

0.63

305

2142

Crohn's disease of small intestine

647

4903

1.41

12.46

2.8

3.0

1204.56

1029.22

ng/l

0.53

550

4090

Intentional self-harm by unspecified means

110

542

2.31

12.45

2.3

3.0

485.32

752.43

ng/l

0.99

426

Mild mental retardation

240

1513

1.77

12.44

3.3

3.5

1419.06

1079.56

ng/l

0.36

200

1242

Polymyositis

130

718

2.43

12.42

4.8

3.1

1151.95

1231.50

ng/l

0.10

119

615

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

972

7859

1.35

12.41

3.5

3.1

1887.28

1852.21

ng/l

0.07

854

6794

Other and unspecified haemorrhagic conditions

213

1333

1.92

12.41

3.4

3.1

2212.26

1355.66

ng/l

1.16

183

1127

Postviral fatigue syndrome

297

2.83

12.40

2.0

3.2

878.35

455.85

ng/l

0.30

239

Other and/or unspecified nontoxic goitre

986

7964

1.34

12.38

2.6

2.9

1068.67

1297.70

ng/l

1.13

865

6835

Gangrene, not elsewhere classified

122

660

2.48

12.31

4.4

2.6

5477.40

1426.44

ng/l

3.31

108

566

Impotence

671

5192

1.43

12.27

3.8

3.1

1918.67

1615.34

ng/l

0.53

577

4558

Polycystic kidney disease

316

2161

1.68

12.15

2.8

3.1

5706.09

1191.77

ng/l

8.01

290

1834

Endometriosis ASRM stages 1,2

1461

12169

1.24

12.09

2.4

2.6

708.42

750.16

ng/l

0.14

1172

10071

Colon adenocarcinoma

1706

14622

1.25

12.09

2.9

3.2

1764.71

1725.39

ng/l

0.10

1480

12606

Persistent delusional disorders

907

7271

1.34

12.08

3.0

1154.01

1499.78

ng/l

2.34

737

6181

Mental and behavioural disorders due to use of other stimulants, including caffeine

183

1065

1.85

12.05

2.4

3.1

1444.26

684.93

ng/l

1.01

140

806

Lesion of radial nerve

447

3259

1.53

11.94

3.3

2.9

1430.34

1360.62

ng/l

0.13

380

2765

Lactose intolerance, other/unspecified

286

1901

1.68

11.91

2.9

1537.23

1051.32

ng/l

0.78

242

1564

Myeloid leukaemia

371

2652

1.63

11.91

3.5

3.2

1437.23

1682.44

ng/l

0.44

347

2280

Benign neoplasm of meninges

1322

11081

1.28

11.86

3.1

3.0

1427.52

1388.33

ng/l

0.12

1127

9516

Other predominantly sexually transmitted diseases, not elsewhere classified

1413

11710

1.24

11.84

2.8

2.7

879.28

779.93

ng/l

0.33

1094

9410

Injuries involving multiple body regions

405

2891

1.54

11.82

3.1

1433.32

1378.96

ng/l

0.08

336

2403

Other secondary gonarthrosis

650

5035

1.42

11.77

3.0

1766.66

1382.68

ng/l

0.67

562

4317

Lichen sclerosus et atrophicus

1238

10291

1.29

11.77

2.8

1073.47

1145.02

ng/l

0.28

1055

8700

Other disorders starting during childhood or adolescence

245

1521

1.67

11.75

6.9

4.2

1519.76

763.32

ng/l

1.02

190

1167

Pulmonary oedema

283

1935

1.77

11.73

6.6

3.2

5642.83

2201.65

ng/l

6.70

260

1674

Testicular dysfunction

376

2653

1.57

11.73

3.1

3.0

821.63

1234.45

ng/l

1.87

293

2211

Motor disorders, excluding more controls

316

2.53

11.71

13.8

5.4

909.19

861.12

ng/l

0.07

257

Pedal cyclist injured in other and unspecified transport accidents

1165

9582

1.28

11.64

2.9

3.0

1257.95

1321.78

ng/l

0.20

975

8054

Hemiplegia

596

4548

1.43

11.63

3.4

3.0

1300.13

1725.77

ng/l

1.63

512

3867

Disorders of sphingolipid metabolism and other lipid storage disorders

249

3.60

11.63

4.6

3.4

870.13

957.33

ng/l

0.11

212

Disturbances of smell and taste

492

3659

1.49

11.63

2.8

631.48

1056.92

ng/l

7.18

410

3088

Atopic dermatitis, strict definition

2260

19127

1.18

11.61

2.9

1061.21

907.29

ng/l

0.59

1802

15673

Other surgical follow-up care

349

2428

1.58

11.61

3.2

2.7

1874.87

1084.75

ng/l

1.52

314

2014

Testicular hypofunction

337

2336

1.60

11.59

3.2

3.0

801.92

1176.59

ng/l

1.60

259

1940

Other disorders of prostate

464

3440

1.52

11.59

3.3

3.2

2349.90

1929.59

ng/l

0.59

416

3030

Polycystic ovarian syndrome, broad definition

541

3976

1.40

11.59

2.2

2.3

362.35

403.66

ng/l

0.21

420

3093

Other erythematous conditions

423

3080

1.54

11.57

3.3

3.0

1435.87

1218.91

ng/l

0.63

368

2613

Eustachian salpingitis and obstruction

585

4389

1.40

11.55

2.7

2.8

718.05

884.55

ng/l

0.71

461

3562

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

151

875

2.09

11.54

3.6

3.1

1665.29

986.02

ng/l

0.47

133

723

Specific development disorders of speech and language

465

3243

1.46

11.54

4.4

3.6

1297.39

1284.35

ng/l

0.02

404

2655

Status epilepticus

426

3092

1.53

11.54

3.6

3.0

2298.33

1768.22

ng/l

0.67

366

2628

Biological medicines for asthma

194

1188

1.86

11.51

3.1

2.8

353.98

675.65

ng/l

4.03

165

969

Alzheimer’s disease (Early onset)

400

5452

0.67

11.46

3.0

3.3

2217.34

2316.02

ng/l

0.13

319

4708

Femoral hernia

587

4516

1.45

11.43

3.3

3.0

1585.92

1577.91

ng/l

0.02

516

3893

Other misadventures during surgical and medical care

300

2067

1.69

11.42

3.7

3.0

2045.08

1239.31

ng/l

2.31

263

1775

Other and unspecified trigeminal disorders

197

1230

1.89

11.41

3.3

2.9

769.14

1061.90

ng/l

1.28

164

1040

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

243

1560

1.70

11.41

2.5

2.7

963.57

1144.01

ng/l

0.27

209

1287

Abnormal findings on diagnostic imaging of central nervous system

496

3681

1.47

11.41

2.9

876.57

1095.70

ng/l

1.16

421

3083

Tracheo-bronchomalasia

130

3.76

11.38

2.8

1.4

564.88

255.02

ng/l

0.89

108

All dysplastic lesions of the vulva

431

3132

1.51

11.36

2.9

2.8

880.98

873.27

ng/l

0.02

367

2619

Other and unspecified injuries of ankle and foot

379

2672

1.53

11.35

3.3

2.9

1522.10

954.46

ng/l

1.55

301

2207

Otitis media, unspecified

841

6099

1.32

11.35

4.1

3.0

950.28

1105.40

ng/l

0.78

692

5009

Other predominantly sexually transmitted diseases, not elsewhere classified

1238

10196

1.25

11.23

2.7

962.92

795.13

ng/l

0.55

949

8267

Primary biliary cholangitis (PBC)

266

1789

1.72

11.16

3.6

2.9

2021.16

1139.25

ng/l

1.57

240

1508

Blindness, monocular

144

849

2.21

11.15

3.8

3.4

3891.21

1534.12

ng/l

0.83

124

730

Hyperosmolality and hypernatraemia

207

1336

1.90

11.11

3.5

3.0

2451.47

1798.34

ng/l

0.51

186

1138

Hypersomnia

166

994

1.97

11.11

3.7

3.2

1000.04

954.12

ng/l

0.06

139

844

Follicular lymphoma, hilmo

573

4436

1.46

11.10

3.0

1479.20

1388.78

ng/l

0.23

503

3812

Essential (haemorrhagic) thrombocythaemia

494

3731

1.49

11.10

3.1

3.0

2640.17

1355.97

ng/l

2.20

435

3175

Carcinoma in situ of skin, other sites/unspecified

249

1720

1.91

11.07

3.3

2214.81

1817.52

ng/l

0.63

226

1495

Acute nasopharyngitis (common cold)

1071

8683

1.28

11.05

2.9

2.8

1010.27

949.61

ng/l

0.19

898

7149

Embolic stroke

700

5549

1.40

11.04

3.8

3.2

2654.70

1985.16

ng/l

1.77

617

4827

Follicular cysts of skin and subcutaneous tissue

2063

17926

1.20

11.02

3.1

3.0

1292.27

1360.43

ng/l

0.32

1774

15264

Astigmatism

586

4459

1.40

11.00

3.7

3.2

1003.72

1248.38

ng/l

0.97

475

3735

Spermatocele

984

8065

1.32

11.00

3.5

3.2

1493.47

1739.19

ng/l

1.22

854

7111

Behavioural disorders, excluding more controls

128

684

2.01

10.99

3.4

3.6

788.41

783.98

ng/l

0.01

104

537

Polycystic ovarian syndrome

276

1810

1.59

10.98

2.3

2.4

371.52

416.62

ng/l

0.14

214

1396

Other diseases of gallbladder

589

4556

1.43

10.98

3.3

3.0

1295.20

1572.48

ng/l

1.22

507

3903

Peritonsillar abscess

1877

16105

1.20

10.97

2.9

1146.98

1146.80

ng/l

0.00

1567

13486

Other/unspecified reactive arthropathies

682

5327

1.38

10.97

3.4

3.0

1552.73

1271.22

ng/l

0.59

598

4495

Mixed disorders of conduct and emotions, excluding more controls

447

2.21

10.95

4.0

3.4

1441.57

450.50

ng/l

0.87

319

Carrier of infectious disease

263

1757

1.69

10.95

3.6

3.0

2870.36

1300.32

ng/l

1.86

215

1458

Nontoxic diffuse goitre

394

2867

1.55

10.92

3.0

2.8

1099.92

1269.51

ng/l

0.45

345

2438

Juvenile arthritis (FINNGEN)

307

2075

1.56

10.91

3.1

1539.67

933.06

ng/l

1.16

262

1655

Hypersensitivity pneumonitis due to organic dust

225

1484

1.83

10.90

3.6

3.2

1225.38

1410.27

ng/l

0.30

203

1271

Hordeolum and other deep inflammation of eyelid

586

4482

1.40

10.88

3.1

3.0

1208.77

1214.52

ng/l

0.01

501

3745

Alzheimer’s disease (undefined)

1191

0.37

10.85

3.0

3.5

3283.16

3228.25

ng/l

0.02

1035

Inflammatory bowel disease, strict (require KELA)

2225

19387

1.18

10.81

2.9

3.0

1298.92

1143.63

ng/l

0.78

1847

16233

Other specified disorders of kidney and ureter

408

2995

1.54

10.81

4.3

3.0

3961.18

1280.58

ng/l

4.76

366

2546

Chronic hepatitis, not elsewhere classified

392

2849

1.53

10.71

2.7

2.9

1674.77

1032.64

ng/l

0.91

326

2370

Organ-limited amyloidosis

479

2.86

10.71

7.2

3.1

5075.12

1620.52

ng/l

5.44

409

Mantle cell lymphoma, including Hilmo

216

1431

1.88

10.70

3.4

3.1

1490.43

1597.75

ng/l

0.18

200

1227

Other and unspecified acquired haemolytic anaemias

144

859

2.16

10.69

5.9

3.1

2176.63

1527.35

ng/l

1.13

130

729

Complications following abortion and ectopic and molar pregnancy

389

2826

1.54

10.68

3.0

2.8

928.44

929.23

ng/l

0.00

321

2390

Other noninflammatory disorders of cervix uteri

569

4376

1.42

10.67

2.8

930.42

1401.91

ng/l

4.00

467

3757

Conductive hearing loss, unspecified

902

7312

1.31

10.63

3.3

3.0

1492.81

1445.07

ng/l

0.09

751

6262

Complications of labour and delivery

5353

32552

0.90

10.62

2.4

2.6

679.10

845.50

ng/l

3.30

4384

27177

Molar incisor enamel hypoplasia

171

969

1.80

10.61

9.7

4.9

1379.84

884.27

ng/l

0.82

153

761

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

257

1689

1.63

10.59

4.2

3.5

873.35

938.93

ng/l

0.14

207

1363

Vascular syndromes of brain in cerebrovascular disorders

651

5161

1.42

10.59

3.9

3.2

1908.43

1855.67

ng/l

0.10

589

4513

Use of memantine

4643

35340

1.14

10.58

3.0

3.4

2055.33

2159.24

ng/l

0.68

3896

30882

Use of other anti-dementia drugs

4643

35340

1.14

10.58

3.0

3.4

2055.33

2159.24

ng/l

0.68

3896

30882

Lichen simplex chronicus

407

2991

1.52

10.53

3.2

2.9

1934.14

1264.32

ng/l

1.34

357

2526

Manic episode

300

2063

1.59

10.52

2.5

3.1

1102.78

1117.27

ng/l

0.03

244

1734

Other/unspecified soft tissue disorders related to use, overuse and pressure

290

1985

1.61

10.50

2.9

2.8

971.18

1098.20

ng/l

0.27

249

1645

Laparoscopic right hemicolectomy

812

6623

1.37

10.49

2.8

3.1

1539.23

1536.29

ng/l

0.01

695

5755

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

293

2056

1.68

10.49

2.6

3.1

1099.85

1444.31

ng/l

1.16

267

1748

Sleep disorders, other/unspecified

289

1961

1.59

10.48

2.9

3.2

998.70

927.86

ng/l

0.12

233

1612

Campylobacter enteritis

307

2143

1.61

10.47

3.3

3.1

1750.54

1286.31

ng/l

1.08

259

1806

Chalazion

1198

9994

1.26

10.44

2.9

3.0

974.64

1362.39

ng/l

3.93

1010

8479

Benign neoplasm of eye and adnexa

1257

10601

1.27

10.43

3.1

1464.98

1450.90

ng/l

0.03

1066

9118

Hypothyroidism due to medicaments and other exogenous substances

159

973

2.02

10.43

3.6

3.0

1805.53

1120.17

ng/l

1.43

146

826

Family history of other conditions

117

628

2.08

10.42

2.6

2.3

977.15

716.07

ng/l

0.34

499

Malignant neoplasm of bladder

994

8220

1.31

10.42

3.0

3.3

2407.80

2130.67

ng/l

0.70

874

7134

Other specified disorders of external ear

489

3730

1.48

10.41

2.9

3.2

1610.18

1540.55

ng/l

0.12

401

3243

Amputation of thigh

452

3425

1.52

10.39

4.6

3.3

5016.50

2199.60

ng/l

5.74

406

2975

Need for immunization against other single viral diseases

230

1524

1.75

10.36

4.1

3.1

7957.70

1190.80

ng/l

5.52

210

1270

Other and unspecified injuries of shoulder and upper arm

350

2505

1.55

10.35

3.5

3.0

1533.88

1233.69

ng/l

0.52

295

2097

Pilonidal cyst

673

5238

1.34

10.29

2.6

2.8

1366.44

971.37

ng/l

0.60

521

4249

Infection due to other mycobacteria

224

1494

1.79

10.28

4.2

2.9

1506.76

1340.83

ng/l

0.22

205

1268

Burns and corrosions of external body surface, specified by site

1062

8761

1.27

10.23

3.1

1659.95

1334.87

ng/l

0.82

896

7345

Evidence of alcohol involvement determined by blood alcohol level

166

1013

1.89

10.21

2.8

2.9

1080.83

924.86

ng/l

0.27

147

852

Oesophageal obstruction

472

3587

1.48

10.20

2.9

3.0

1896.70

1687.42

ng/l

0.43

408

3105

Etanercept

582

4476

1.38

10.18

2.7

2.9

1154.17

896.47

ng/l

0.76

506

3704

Dystonia

595

4623

1.39

10.18

2.8

2.9

1061.23

1206.77

ng/l

0.45

502

3879

Toxic effect of carbon monoxide

222

1469

1.76

10.18

2.8

3.1

1470.99

1311.20

ng/l

0.17

204

1250

Shock, not elsewhere classified

137

809

2.10

10.15

8.1

3.0

4319.74

1574.81

ng/l

2.86

129

686

Alcohol-induced chronic pancreatitis

735

5881

1.35

10.14

2.9

3.0

1888.22

1364.39

ng/l

1.63

644

5011

Melanocytic naevi of trunk

1244

10449

1.25

10.11

3.1

3.0

1444.83

1306.75

ng/l

0.46

1078

8891

Disorders of myoneural junction and muscle in diseases classified elsewhere

118

673

2.27

10.10

4.8

3.1

2550.88

1109.08

ng/l

1.23

101

562

Disorders of speech understanding and production

378

2671

1.49

10.09

4.5

3.9

1465.21

1425.02

ng/l

0.07

334

2236

Diseases of middle ear and mastoid

6023

45398

1.10

10.09

3.1

2.9

1284.57

1280.14

ng/l

0.02

4958

38097

Other juvenile arthritis

252

1661

1.60

10.08

3.2

3.3

1581.60

936.95

ng/l

0.99

215

1338

Drug-induced obesity

101

534

2.27

10.04

3.2

3.1

1219.45

853.12

ng/l

0.66

436

Lesion of sciatic nerve

633

5025

1.40

10.04

3.3

3.1

1611.30

1921.09

ng/l

0.91

563

4362

Stenosis and insufficiency of lacrimal passages

1152

9664

1.27

10.03

2.9

3.0

1467.74

1530.01

ng/l

0.16

977

8247

Hypertrichosis

150

875

1.86

10.02

2.0

2.7

397.89

529.34

ng/l

0.66

120

701

Chronic Coagulation defects

230

1515

1.69

10.02

2.8

3.1

1241.11

1025.75

ng/l

0.36

182

1249

Benign neoplasm of other and unspecified intrathoracic organs

160

998

2.01

10.01

3.7

3.2

882.15

1332.70

ng/l

1.96

144

830

Idiopathic thrombocytopenic purpura

361

2627

1.54

9.99

3.7

3.1

1337.93

1410.50

ng/l

0.15

322

2253

Disorders of tooth development and eruption

1468

10047

1.22

9.97

3.0

2.8

1200.16

1192.51

ng/l

0.02

1246

8513

Cholangitis (primary sclerosing, PSC), with reimbursement 202

193

1231

1.78

9.91

2.7

3.4

1193.82

949.17

ng/l

0.51

170

1038

Poisoning by narcotics and psychodysleptics [hallucinogens]

134

764

1.95

9.91

3.1

3.2

1132.22

1219.73

ng/l

0.09

605

Anankastic personality disorder

318

2227

1.53

9.86

2.8

2.7

464.72

745.52

ng/l

2.49

264

1823

Unspecified protein-energy malnutrition

531

2.54

9.86

4.6

3.6

2614.59

1745.14

ng/l

0.83

444

Scleritis and episcleritis

596

4633

1.37

9.85

2.9

2.8

788.91

1043.77

ng/l

1.47

504

3878

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

460

3355

1.41

9.77

3.6

3.4

725.91

984.37

ng/l

1.30

366

2720

Acute myeloid leukaemia and myelodysplastic syndromes

292

2078

1.65

9.76

3.9

3.1

2155.70

1905.26

ng/l

0.42

274

1793

Malignant neoplasm of oral cavity

444

3370

1.49

9.75

2.7

3.0

1365.36

1467.67

ng/l

0.18

404

2862

Benign mammary dysplasia

1712

14867

1.21

9.75

2.6

2.9

1039.82

1239.32

ng/l

1.38

1476

12689

Persons encountering health services in circumstances related to reproduction

4880

35925

0.90

9.72

2.9

2.8

644.55

915.99

ng/l

6.27

4021

29787

Paranoid personality disorder

202

1310

1.75

9.71

2.4

3.1

1173.71

1106.78

ng/l

0.07

163

1096

Aortic stenosis

191

4.43

9.70

9.6

5.0

2763.67

1673.89

ng/l

0.79

157

Male infertility

338

2390

1.50

9.68

3.2

3.0

1463.52

1023.10

ng/l

0.41

285

1885

Foreign body in alimentary tract

611

4801

1.38

9.68

3.4

3.2

1805.77

1469.07

ng/l

0.67

522

4092

Other specified/unspecified deforming dorsopathies

194

1244

1.76

9.68

3.3

3.1

859.91

1249.15

ng/l

1.01

156

1042

Superficial injuries involving multiple body regions

282

1959

1.60

9.68

3.2

3.1

1337.74

1313.82

ng/l

0.04

232

1631

Thyrotropin deficiency

123

703

2.07

9.67

2.6

3.0

2453.04

839.71

ng/l

0.43

100

591

Drug-induced systemic lupus erythematosus

487

2.43

9.67

3.4

3.2

1374.38

870.71

ng/l

0.70

409

6-mercaptopurine

254

1702

1.60

9.67

2.4

2.7

740.35

1035.31

ng/l

0.96

204

1367

Benign neoplasm: Cerebral meninges

1182

10002

1.26

9.63

3.0

1410.54

1391.64

ng/l

0.05

1005

8579

Polycythaemia vera

475

3659

1.47

9.63

3.6

3.0

2015.35

1594.64

ng/l

1.10

416

3136

Erosion and ectropion of cervix uteri

329

2365

1.55

9.63

2.7

2.8

923.69

1387.35

ng/l

2.11

266

2011

Secondary malignant neoplasm of other and unspecified sites

259

1821

1.72

9.62

2.7

3.0

1460.75

1519.44

ng/l

0.08

232

1555

Other factor of the environment

156

961

1.93

9.61

3.6

3.0

3708.89

1091.61

ng/l

1.78

141

814

Hypoplasia of dental enamel , including avohilmo

158

909

1.78

9.60

9.6

4.7

1390.34

839.10

ng/l

0.87

141

718

Primary adrenocortical insufficiency

140

840

2.01

9.60

4.4

3.3

1051.66

972.23

ng/l

0.15

125

715

Cauda equina syndrome

168

1060

1.89

9.57

3.1

3.0

1046.09

1138.56

ng/l

0.11

137

889

Malignant immunoproliferative diseases

168

1092

2.02

9.55

3.8

3.5

1751.33

1524.21

ng/l

0.27

150

946

Other and unspecified erythematous conditions

373

2750

1.52

9.54

3.3

3.0

1478.04

1226.00

ng/l

0.67

324

2332

Bullous pemphigoid

327

2407

1.62

9.51

3.4

3.3

2164.10

1925.59

ng/l

0.32

283

2104

Defects in the complement system

420

2.44

9.49

3.7

3.4

486.27

858.31

ng/l

1.54

349

Magnesium deficiency

269

3.45

9.40

3.6

3.1

2843.92

1065.72

ng/l

1.60

225

Other and unspecified mononeuropathies of lower limb

344

2515

1.54

9.39

3.7

2.8

1016.51

1156.74

ng/l

0.46

278

2117

Deficiency of other B group vitamins

277

1956

1.63

9.37

3.2

3.1

1553.32

1667.33

ng/l

0.20

239

1694

Malignant neoplasm of other and unspecified parts of tongue

199

1326

1.81

9.34

2.5

3.0

1051.36

1294.15

ng/l

0.52

182

1126

Alcohol withdrawal state with delirium

803

6553

1.32

9.34

2.9

3.1

1573.77

1509.21

ng/l

0.17

705

5612

Disorders of adrenal gland, other and/or unspecified

398

2.65

9.33

3.6

3.2

1043.73

1010.68

ng/l

0.04

337

Carcinoma in situ of skin of lower limb, including hip

339

2535

1.62

9.33

3.5

3.2

2122.66

1637.39

ng/l

1.03

291

2209

Previous suicide attempt

520

2.16

9.32

2.7

2.9

973.42

736.64

ng/l

0.31

415

Acquired absence of organs, not elsewhere classified

156

973

1.92

9.31

3.0

2.8

2277.28

1368.90

ng/l

0.91

139

827

Benign lipomatous neoplasm of other sites/unspecified

1125

9511

1.27

9.30

3.2

3.1

1466.50

1609.53

ng/l

0.56

966

8190

Injury of muscle and tendon at wrist and hand level

1433

12271

1.22

9.29

2.9

3.0

1118.13

1263.21

ng/l

0.66

1210

10432

Anogenital herpesviral [herpes simplex] infection

709

5614

1.31

9.28

2.4

2.7

517.66

776.43

ng/l

1.41

540

4527

Gastrojejunal ulcer

179

1163

1.86

9.27

3.7

3.1

1460.57

1639.17

ng/l

0.30

161

1000

Impetigo

368

2675

1.47

9.24

3.7

3.3

1362.99

1066.27

ng/l

0.50

310

2226

malignant neoplasm of female genital organs

1983

17392

1.19

9.23

2.8

3.0

1589.81

1378.05

ng/l

0.86

1733

14759

Benign neoplasm: Pituitary gland, craniopharyngeal duct

550

4288

1.38

9.18

2.6

3.0

1238.58

1199.53

ng/l

0.06

471

3603

Non-small cell lung cancer, adenocarcinoma

835

6899

1.32

9.16

3.0

3.2

1398.63

1684.13

ng/l

1.45

756

5963

Adalimumab

789

6367

1.29

9.15

2.4

2.9

786.22

865.56

ng/l

0.20

683

5232

Disorders of purine and pyrimidine metabolism

522

2.48

9.15

6.1

3.1

3145.21

1208.64

ng/l

1.83

441

Lipomatosis, not elsewhere classified

216

3.53

9.15

3.5

2.9

933.07

954.35

ng/l

0.02

183

Dementia in Alzheimer disease

2961

22624

1.16

9.13

3.3

3.4

2070.88

2284.00

ng/l

1.53

2376

19781

Dislocation, sprain and strain of joints and ligaments of head

356

2583

1.47

9.13

2.9

1143.47

1039.22

ng/l

0.15

297

2159

Implicit parasitic Sepsis

458

2.49

9.12

4.2

2.9

1263.85

1244.31

ng/l

0.02

380

Toxic effect of other and unspecified substances

117

661

2.00

9.11

2.7

3.2

1397.10

893.42

ng/l

0.36

528

Abnormal serum enzyme levels

4219

37769

1.13

9.11

3.1

3.2

1710.78

1610.89

ng/l

0.59

3762

32822

Otorrhagia

109

631

2.27

9.08

4.8

3.0

2246.62

1527.96

ng/l

0.57

538

Viral encephalitis, not elsewhere classified/unspecified

252

1756

1.65

9.06

3.2

3.1

1346.96

1406.58

ng/l

0.11

211

1495

Amblyopia ex anopsia

379

2790

1.46

9.06

3.6

3.2

1787.05

1231.95

ng/l

0.99

316

2328

Other congenital malformations of the digestive system

483

3663

1.40

9.04

4.0

3.5

1201.65

1315.85

ng/l

0.25

423

3086

Prolapse and hernia of ovary and fallopian tube

584

4622

1.40

9.02

3.2

1657.28

2190.97

ng/l

2.53

509

3931

Enteropathic arthropathies

215

1427

1.66

9.01

3.1

3.0

1191.63

990.94

ng/l

0.45

190

1187

Other specified and unspecified disorders of lens

147

935

2.05

9.00

3.6

3.1

2270.52

1967.46

ng/l

0.22

109

816

Other renal tubulo-interstitial diseases

258

1790

1.60

8.99

3.0

2.8

2733.89

969.02

ng/l

3.87

221

1483

Hirsutism in women

124

707

1.90

8.96

1.8

2.6

320.90

491.54

ng/l

0.94

563

Other disorders of iris and ciliary body

341

2512

1.53

8.93

3.4

3.1

2835.26

1605.76

ng/l

1.87

296

2141

Carcinoma in situ of colon

282

2046

1.65

8.90

3.4

3.0

1250.68

1430.17

ng/l

0.39

256

1777

Carcinoma in situ of other and unspecified genital organs

225

1540

1.69

8.90

3.1

2.9

1055.98

988.98

ng/l

0.10

196

1290

Infections of genitourinary tract in pregnancy

758

6106

1.29

8.89

2.6

791.73

743.23

ng/l

0.16

653

5034

Alcoholic liver disease

1218

10388

1.24

8.89

3.1

1880.63

1495.34

ng/l

1.64

1069

8907

Other and unspecified glaucoma

1003

8468

1.28

8.85

3.1

3.2

2016.44

1865.87

ng/l

0.36

869

7333

Papilloedema, unspecified

235

1605

1.63

8.85

3.5

3.2

1523.62

1088.32

ng/l

0.91

198

1329

Outcome of delivery

603

4786

0.76

8.85

2.0

2.2

235.03

456.52

ng/l

3.08

476

3779

Haemorrhagic disorder due to circulating anticoagulants

222

1553

1.78

8.83

6.0

3.1

2835.40

2135.25

ng/l

1.47

190

1347

Other and unspecified iridocyclitis

482

3714

1.41

8.82

2.9

3.0

1290.88

1159.94

ng/l

0.29

413

3116

Sequelae of injuries of upper limb

989

8243

1.26

8.81

2.7

3.0

896.97

1181.71

ng/l

2.49

822

6925

Metabolic disorder, other/unspecified

177

3.43

8.81

3.8

3.4

929.24

808.04

ng/l

0.15

141

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

286

2025

1.54

8.75

2.6

3.0

844.27

1153.98

ng/l

0.93

230

1694

Specific developmental disorder of motor function

372

2.20

8.73

13.8

6.1

909.19

1114.59

ng/l

0.19

301

Preterm labour and delivery

2173

19179

1.16

8.72

2.4

2.5

592.88

734.76

ng/l

1.95

1777

15951

Spinal osteochondrosis

122

716

1.98

8.69

3.1

3.3

2218.30

1360.69

ng/l

0.52

107

594

Nonalcoholic steatohepatitis

107

613

2.14

8.67

2.9

865.22

735.25

ng/l

0.17

506

Prolonged pregnancy

496

5675

0.75

8.66

1.7

2.3

220.19

381.62

ng/l

2.34

389

4470

Simple and mucopurulent chronic bronchitis

519

4062

1.39

8.65

4.2

3.1

2091.53

2017.67

ng/l

0.08

444

3493

Crohn's disease of large intestine

466

3561

1.39

8.65

2.8

2.9

1415.19

1028.69

ng/l

1.09

397

2962

Malignant neoplasm of rectum, including Hilmo

1665

14597

1.21

8.64

2.7

3.2

1368.11

1586.28

ng/l

1.71

1471

12595

Malignant neoplasm of other connective and soft tissue, including Hilmo

526

4145

1.40

8.63

3.2

3.1

1846.02

1464.80

ng/l

1.03

464

3535

Habit and impulse disorders

138

828

1.84

8.62

2.3

2.9

1101.13

845.27

ng/l

0.16

109

666

Congenital deformities of feet

316

2269

1.49

8.62

3.7

3.1

800.08

933.95

ng/l

0.38

260

1858

Viral meningitis

309

2214

1.50

8.61

3.2

2.9

718.35

948.50

ng/l

0.96

247

1810

Hepatocellular carcinoma, including Hilmo

396

3020

1.48

8.59

2.9

3.1

1320.21

1793.60

ng/l

0.93

350

2609

Herpesviral keratitis and keratoconjunctivitis

510

3992

1.39

8.58

3.1

3.0

1531.15

1376.65

ng/l

0.32

441

3388

Other disorders of cornea

1106

9369

1.25

8.57

3.1

1469.38

1407.93

ng/l

0.17

941

7980

Haemangioma, any site

908

7548

1.27

8.53

3.0

3.1

1116.96

1253.67

ng/l

0.49

764

6413

Achalasia of cardia

234

1631

1.66

8.52

3.7

3.0

1230.14

1574.09

ng/l

0.98

207

1405

Deep endometriosis

937

7796

1.26

8.51

2.7

2.9

801.47

1151.01

ng/l

3.34

772

6565

Fall on and from ladder

939

7880

1.28

8.49

3.0

3.1

1350.51

1513.25

ng/l

0.52

805

6828

Other lesions of median nerve

379

2878

1.49

8.46

3.1

1649.23

1520.44

ng/l

0.23

323

2459

Abnormal findings in secretions and smears from cervix uteri vagina vulva

3761

31209

0.90

8.46

2.5

870.04

809.66

ng/l

0.29

3115

25782

Use of antiglaucoma preparations and miotics

1172

10062

1.25

8.44

3.2

2062.00

1944.17

ng/l

0.32

1006

8721

Vestibular neuronitis

1047

8854

1.26

8.43

3.1

3.0

1274.47

1365.61

ng/l

0.22

906

7607

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

442

2.57

8.42

6.2

3.1

3184.13

1104.67

ng/l

1.70

372

Overexertion and strenuous or repetitive movements

996

8342

1.25

8.42

2.8

3.0

1446.12

1183.31

ng/l

0.68

838

6994

Other and unspecified paralytic syndromes

174

1139

1.78

8.41

3.6

3.1

974.19

1395.70

ng/l

1.41

153

956

Necrotizing fasciitis

400

2.55

8.40

3.3

3573.80

1146.63

ng/l

1.41

335

Uterine polyps

961

8019

1.26

8.39

2.6

891.50

1213.82

ng/l

3.15

800

6835

Haemangioma and lymphangioma, any site

961

8041

1.26

8.38

3.0

3.1

1199.80

1267.61

ng/l

0.18

812

6836

Fistulae involving female genital tract

183

1206

1.73

8.37

2.9

1343.86

1186.24

ng/l

0.14

156

1019

Implicit parasitic Sepsis

395

2.57

8.33

4.3

3.0

1369.31

1367.12

ng/l

0.00

326

Unspecified chronic bronchitis

444

3420

1.42

8.33

4.5

3.0

1530.64

1922.14

ng/l

0.87

394

2933

Dyshidrosis [pompholyx]

158

1001

1.77

8.29

2.8

2.9

1389.40

859.94

ng/l

0.44

116

823

Other acquired deformities of ankle and foot

104

598

2.11

8.28

2.9

3.2

724.80

1134.92

ng/l

1.74

510

Retinal detachment with retinal break

1656

14540

1.20

8.28

3.3

3.1

1824.64

1492.24

ng/l

1.59

1440

12563

Mantle cell lymphoma

141

905

2.01

8.28

3.2

1341.82

1734.57

ng/l

0.79

130

774

Unspecified event, undetermined intent

250

1748

1.57

8.27

3.0

3.1

1902.57

1181.88

ng/l

1.13

196

1466

Progressive vascular leukoencephalopathy

600

4896

1.39

8.27

3.0

3.3

2862.22

2033.82

ng/l

1.86

530

4268

Ankylosing hyperostosis [Forestier]

180

1202

1.78

8.27

3.2

926.16

1401.03

ng/l

1.75

160

1040

Malignant neoplasm of corpus uteri

1120

9602

1.26

8.26

3.0

1694.78

1400.26

ng/l

0.87

977

8219

Malignant neoplasm of head and neck

1031

8738

1.26

8.25

2.9

3.2

1650.24

1673.23

ng/l

0.05

917

7531

Calculus of lower urinary tract

706

5797

1.33

8.24

3.1

3.2

1695.50

1925.29

ng/l

0.57

605

5057

Medical abortion

7174

36358

1.09

8.23

2.7

1023.10

1098.83

ng/l

0.85

5962

30640

Parkinson's disease, including avohilmo

2298

20658

1.17

8.23

2.9

3.2

1307.80

1794.22

ng/l

8.49

1974

17979

Assault by unspecified means

164

1040

1.72

8.20

2.6

3.1

1099.01

814.86

ng/l

0.43

118

836

Endocrine disorders, other/unspecified

220

1515

1.64

8.20

3.2

2.9

1113.99

1062.44

ng/l

0.09

167

1273

Anomalies of dental arch relationship, including avohilmo

1563

12188

1.19

8.19

3.3

2.9

731.10

985.93

ng/l

1.92

1266

10050

Episcleritis

490

3807

1.37

8.18

2.6

2.9

748.68

987.52

ng/l

1.13

411

3160

Sequelae of injuries of head

539

4251

1.36

8.17

3.0

1495.70

1310.33

ng/l

0.30

430

3607

Explicit fungal Sepsis

101

589

2.21

8.17

5.3

2.8

2671.50

1182.60

ng/l

1.31

496

Myelodysplastic syndrome

174

1173

1.85

8.16

4.2

3.1

2752.15

2091.50

ng/l

0.86

161

1015

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

131

836

2.08

8.10

3.7

3.2

1474.96

1524.48

ng/l

0.06

116

717

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1494

13008

1.20

8.06

3.0

1070.52

1298.31

ng/l

1.79

1279

11110

Other ulcerative colitis

538

4235

1.35

8.06

2.8

3.0

1527.37

1097.01

ng/l

0.91

450

3539

Chronic myeloproliferative disease

209

1470

1.75

8.04

3.3

3.1

2959.54

1475.72

ng/l

2.66

189

1279

Symptoms and signs involving appearance and behaviour

102

585

2.07

8.04

2.9

3.3

960.22

1125.32

ng/l

0.18

489

Other superficial mycoses

210

1428

1.63

8.03

3.6

3.0

1534.68

1011.60

ng/l

0.84

188

1194

Psoriasis (vulgaris), strict definition

334

2472

1.47

8.01

3.0

816.17

1094.47

ng/l

1.54

278

2077

Localized scleroderma [morphea]

175

1160

1.75

8.01

3.0

2.8

657.69

997.34

ng/l

1.54

146

970

Atopic dermatitis

5718

43491

1.09

8.00

2.8

1010.31

1021.87

ng/l

0.06

4569

36285

Androgenic alopecia

101

579

2.08

7.99

2.4

2.8

669.99

819.00

ng/l

0.23

480

Myasthenia gravis

222

1558

1.66

7.99

3.2

3.1

1356.15

1292.58

ng/l

0.09

188

1335

Unspecified nephritic syndrome

270

1952

1.56

7.95

3.4

3.0

3999.20

1331.53

ng/l

3.35

245

1670

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

570

4513

1.33

7.94

2.3

3.0

930.51

1020.94

ng/l

0.24

471

3753

Unspecified jaundice

615

4967

1.33

7.94

3.1

2079.34

1844.01

ng/l

0.37

524

4312

Other prurigo

152

987

1.85

7.92

3.3

3.0

4213.05

1367.06

ng/l

1.16

135

842

Other and unspecified acne

109

626

1.92

7.91

3.8

3.1

1455.89

648.07

ng/l

1.51

484

Panniculitis, unspecified

131

814

1.91

7.91

3.2

3.1

1426.86

1496.64

ng/l

0.06

117

684

Benign neoplasm of urinary organs

593

4795

1.35

7.91

3.0

2237.55

1491.17

ng/l

1.22

506

4126

Benign neoplasm of middle ear and respiratory system

947

7990

1.26

7.90

3.2

3.1

1197.93

1586.07

ng/l

3.08

824

6844

Open wound of abdomen, lower back and pelvis

296

2147

1.49

7.89

3.1

2044.85

1303.01

ng/l

1.12

250

1800

Lifestyle-related condition

144

918

1.85

7.88

3.5

3.0

4037.84

1123.86

ng/l

1.84

129

772

Procreative management

2840

21318

1.13

7.84

3.1

2.8

685.02

961.09

ng/l

3.26

2350

17551

Oral lichen planus, including avohilmo , including avohilmo

719

5909

1.30

7.83

2.4

2.9

603.89

1068.52

ng/l

7.67

594

5017

Other and unspecified injuries of wrist and hand

358

2677

1.43

7.83

2.8

3.0

1458.58

991.03

ng/l

0.79

277

2244

493

2.08

7.82

2.5

3.1

873.01

967.86

ng/l

0.15

404

Varicella [chickenpox]

398

3017

1.40

7.80

4.2

3.0

1217.90

1059.59

ng/l

0.36

328

2468

Other Crohn's disease

588

4687

1.32

7.77

2.5

2.9

1137.96

978.07

ng/l

0.44

500

3887

Femoral hernia, unilateral

350

2654

1.48

7.76

3.1

2.9

1403.75

1421.06

ng/l

0.03

306

2283

Inguinal hernia, unilateral

350

2654

1.48

7.76

3.1

2.9

1403.75

1421.06

ng/l

0.03

306

2283

Inguinal of femoral hernia, unilateral

350

2654

1.48

7.76

3.1

2.9

1403.75

1421.06

ng/l

0.03

306

2283

Dislocation, sprain and strain of joint and ligaments of hip

475

3754

1.40

7.76

3.3

3.1

1311.79

1654.85

ng/l

1.41

415

3224

Autoimmune thyroiditis

178

1176

1.68

7.75

2.9

2.7

670.27

834.98

ng/l

0.64

147

963

Crushed, pushed or stepped on by crowd or human stampede

559

4417

1.32

7.75

3.2

3.1

1136.97

1090.76

ng/l

0.11

446

3610

Delivery, wide proxy

3496

20332

0.89

7.74

2.8

3.0

1198.58

1378.61

ng/l

2.05

2968

17243

Diffuse brain injury

349

2601

1.43

7.73

2.8

1177.95

1520.28

ng/l

1.18

285

2222

Malignant neoplasm of corpus uteri, including Hilmo

1264

10984

1.23

7.72

2.9

3.0

1656.52

1387.72

ng/l

0.82

1092

9410

Thyroiditis, unspecified

165

1081

1.73

7.71

3.4

2.7

2203.42

960.84

ng/l

1.64

136

909

Other benign neoplasms of connective and other soft tissue

1075

9162

1.23

7.69

3.0

1293.96

1311.70

ng/l

0.05

935

7791

Subacute thyroiditis

367

2774

1.43

7.68

2.6

2.7

706.64

1158.26

ng/l

1.95

311

2319

Autism spe, excluding more controls

105

591

1.86

7.67

3.0

3.3

665.48

434.38

ng/l

0.23

449

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

867

7308

1.28

7.64

3.1

3.2

1418.65

1741.56

ng/l

1.13

765

6304

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

896

7537

1.26

7.64

3.0

1129.01

1238.90

ng/l

0.36

747

6414

Syphilis

285

2084

1.52

7.63

3.7

3.0

3012.47

1293.02

ng/l

4.73

243

1760

Syphilis

285

2084

1.52

7.63

3.7

3.0

3012.47

1293.02

ng/l

4.73

243

1760

Listeriosis

465

2.43

7.62

4.3

3.1

5276.63

1242.64

ng/l

1.63

391

Vascular dementia

1443

12208

1.21

7.61

3.2

3.5

2475.60

2524.38

ng/l

0.13

1227

10666

Unspecific neurodegenerative disorder

7055

45464

1.09

7.59

2.9

3.3

1947.68

1900.45

ng/l

0.33

5969

39773

Other contact dermatitis

808

6699

1.26

7.59

3.2

2.9

1179.75

1361.48

ng/l

0.67

669

5642

Acute epiglottitis

163

1068

1.72

7.58

2.6

3.0

1426.82

1226.84

ng/l

0.21

137

912

Other and unspecified aplastic anaemias

152

997

1.82

7.57

4.0

3.0

2778.61

1370.41

ng/l

1.89

136

842

Drug-induced polyneuropathy

128

815

1.96

7.54

3.9

3.2

937.35

1200.04

ng/l

0.69

117

692

Alzheimer’s disease (undefined), excluding more controls

1012

0.44

7.53

3.0

3.2

3283.16

3025.48

ng/l

0.10

864

Other salmonella infections

410

3167

1.41

7.53

3.3

2.8

1680.53

1307.60

ng/l

0.41

333

2665

Encephalitis

316

2351

1.47

7.51

3.0

3.1

1054.35

1306.96

ng/l

1.07

261

1982

Crohn disease (strict definition, require KELA)

530

4190

1.33

7.51

2.4

3.0

888.25

1009.94

ng/l

0.35

439

3481

Use of donepezil

2823

29533

0.88

7.51

2.7

3.4

1826.00

2144.65

ng/l

3.65

2312

25756

Other congenital malformations of the digestive system

400

3039

1.39

7.48

4.1

3.6

1281.18

1302.34

ng/l

0.03

355

2566

Severe visual impairment, binocular

464

2.35

7.47

3.9

3.4

2304.52

1783.10

ng/l

0.29

397

Other specific arthropathies, wide

232

1642

1.57

7.40

3.1

2.8

1067.31

1220.76

ng/l

0.35

199

1375

Other disorders of male genital organs

371

2819

1.41

7.39

3.5

3.2

1962.87

1511.23

ng/l

0.49

311

2396

Benign neoplasm: Parotid gland

941

7991

1.25

7.38

3.1

1572.35

1488.07

ng/l

0.16

827

6844

Unspecified threat to breathing

104

613

1.97

7.37

3.9

3.6

910.53

965.98

ng/l

0.08

509

Multifocal fibrosclerosis

105

647

2.15

7.37

3.2

3.3

1613.47

1719.59

ng/l

0.10

549

Allergic purpura

297

2186

1.47

7.36

3.5

3.2

1635.70

1208.57

ng/l

0.77

250

1833

Crohn disease (strict definition, require KELA, min 2 HDR)

522

4130

1.33

7.36

2.4

3.0

870.63

1008.98

ng/l

0.41

431

3427

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2865

18624

0.89

7.35

2.3

2.4

450.62

630.85

ng/l

3.84

2307

15240

Dermatopolymyositis, unspecified

442

2.34

7.35

5.7

3.0

845.64

1099.30

ng/l

0.67

371

Endometriosis ASRM stages 3,4

2265

20309

1.15

7.35

2.6

2.7

875.63

1028.54

ng/l

1.58

1853

17150

Impacted teeth

1008

7517

1.21

7.35

2.9

2.8

837.29

710.68

ng/l

0.39

810

5810

HSIL lesion of the vulva

195

1347

1.65

7.34

2.6

2.9

814.10

1030.87

ng/l

0.56

163

1134

Chronic constrictive pericarditis

292

3.27

7.33

6.8

3.6

3759.42

1468.61

ng/l

1.17

241

Right hemicolectomy

790

6643

1.29

7.32

3.5

3.1

1876.27

1747.25

ng/l

0.24

703

5737

Impaction of intestines

581

2.09

7.32

3.1

2012.77

1410.40

ng/l

0.65

502

Intentional self-harm by sharp object

168

1095

1.63

7.32

2.7

3.0

537.67

879.38

ng/l

1.09

120

858

Other and unspecified nail disorders

247

1779

1.55

7.31

3.7

2.9

1282.89

1017.50

ng/l

0.63

213

1501

Other diseases of peritoneum

519

4159

1.35

7.29

3.2

2.9

1282.89

1316.43

ng/l

0.07

433

3512

Motor disorders

406

2.04

7.29

13.8

6.6

909.19

1353.21

ng/l

0.47

334

Calcaneal spur

148

966

1.78

7.28

2.8

3.0

713.96

1207.84

ng/l

2.70

131

813

Malignant neoplasm of tongue, including Hilmo

334

2543

1.47

7.28

2.8

3.1

1349.95

1446.51

ng/l

0.14

305

2158

Macular hole

767

6449

1.30

7.27

3.3

3.1

1678.07

1460.75

ng/l

0.61

661

5591

Triptan medication for migraine, min. 3 purchases

4966

35102

1.09

7.26

2.4

2.6

523.58

831.30

ng/l

9.91

3944

29023

Sequelae of injuries of lower limb

929

7843

1.24

7.25

2.8

3.0

1225.86

1199.70

ng/l

0.08

779

6589

Disorders of synovium and tendon in diseases classified elsewhere

235

1678

1.56

7.25

2.6

3.1

2392.13

1350.96

ng/l

1.12

202

1435

Traumatic ischaemia of muscle

151

988

1.75

7.24

4.0

2.9

1855.81

967.77

ng/l

0.84

131

807

Congenital deformities of feet

202

1382

1.58

7.23

3.4

3.2

811.03

823.45

ng/l

0.02

169

1121

Paraplegia, diplegia of upper limbs

263

1925

1.54

7.23

3.5

3.2

1037.93

1407.95

ng/l

1.34

236

1645

Contusion of ankle

342

2568

1.42

7.22

3.0

2.9

1390.53

1001.84

ng/l

1.03

283

2129

Parkinson's disease

2186

19744

1.16

7.22

2.9

3.2

1306.92

1802.73

ng/l

8.22

1872

17189

Allergic contact dermatitis due to drugs in contact with skin

254

1848

1.54

7.16

3.1

3.0

1421.17

1172.68

ng/l

0.41

200

1569

Localized skin eruption due to drugs and medicaments

140

908

1.80

7.15

3.0

1204.35

1120.87

ng/l

0.13

118

775

Inflammatory disorders of male genital organs, not elsewhere classified

159

1057

1.73

7.15

3.4

3.1

1643.69

1785.70

ng/l

0.18

145

910

Atypical mycobacterium lung infection

173

1193

1.75

7.13

3.5

3.0

1301.03

1456.13

ng/l

0.30

156

1011

Other nonautoimmune haemolytic anaemias

213

3.94

7.11

7.1

3.4

2613.27

1141.90

ng/l

0.73

182

Glaucoma, exfoliation

1680

14987

1.19

7.11

3.1

3.3

1868.88

2035.39

ng/l

0.68

1429

13008

Pneumoconiosis due to asbestos and other mineral fibres

317

2417

1.50

7.10

4.5

3.4

2254.92

2568.55

ng/l

0.59

286

2139

IgA nephropathy (IgA glomerulonephritis)

247

1785

1.53

7.06

4.1

3.0

5889.84

1164.62

ng/l

7.26

219

1504

Myopia

979

8277

1.22

7.04

3.2

2.9

923.90

960.28

ng/l

0.11

776

6836

Malignant neoplasm of bone and articular cartilage

127

814

1.88

7.04

4.5

3.1

1228.56

1366.22

ng/l

0.15

117

680

Transient global amnesia

1237

10817

1.22

7.02

2.9

3.1

967.05

1482.35

ng/l

9.23

1079

9384

Failure of sterile precautions during surgical operation

260

2.98

7.02

4.8

2.9

1633.83

1282.69

ng/l

0.29

219

Monosomies and deletions from the autosomes, not elsewhere classified

3.81

7.01

4.0

6.8

422.26

810.48

ng/l

0.98

Disorder of external ear, unspecified

370

2856

1.42

7.00

3.2

3.0

1617.49

1262.15

ng/l

0.89

317

2438

Benign neoplasm: salivary glands, exclude unknown (D119)

1044

8982

1.23

6.99

3.1

1543.30

1485.99

ng/l

0.12

913

7702

Torticollis

146

942

1.70

6.96

3.1

3.2

1310.97

1180.48

ng/l

0.10

116

781

Adenocarcinoma of pancreas

208

2882

0.65

6.96

2.1

3.1

1470.62

1665.57

ng/l

0.26

189

2476

Diastasis of muscle

517

2.01

6.94

3.4

3.7

768.88

1156.98

ng/l

1.00

437

Exposure to other and unspecified animate mechanical forces

246

1762

1.49

6.92

3.0

3.1

1204.22

1023.73

ng/l

0.32

195

1451

Conduct disorder

134

838

1.70

6.92

3.4

3.5

794.86

1021.43

ng/l

0.30

107

666

Retained placenta and membranes, without haemorrhage

1021

8701

1.22

6.91

2.3

2.6

653.61

714.72

ng/l

0.32

822

7279

Wide developmental disorders, excluding more controls

134

818

1.67

6.89

3.2

3.7

675.71

550.36

ng/l

0.14

635

Crossbite

458

3304

1.33

6.87

4.7

3.4

660.96

875.04

ng/l

0.89

367

2716

Carcinoma in situ of other and unspecified sites

497

4038

1.37

6.86

3.3

3.2

2254.20

1864.23

ng/l

0.53

442

3566

Malignant neoplasm of mesothelium and soft tissue

500

4036

1.36

6.86

3.2

3.1

1726.37

1591.37

ng/l

0.27

451

3465

Benign neoplasm: Liver

231

1655

1.53

6.83

2.7

3.0

1341.54

1016.92

ng/l

0.46

193

1375

Juvenile rheumatoid arthirtis

152

986

1.65

6.83

2.4

3.1

1192.83

936.67

ng/l

0.28

136

798

Other and unspecified diseases of blood and blood-forming organs

316

2405

1.46

6.82

3.7

3.0

2210.40

1324.77

ng/l

1.75

260

2059

Other encephalitis

295

2207

1.46

6.82

3.0

3.2

1076.81

1324.39

ng/l

0.96

245

1866

Ulcerative rectosigmoiditis

771

6435

1.25

6.76

3.0

2.9

1167.16

1202.91

ng/l

0.09

653

5394

Hyperprolactinaemia

258

1866

1.47

6.76

3.3

2.9

662.38

751.23

ng/l

0.34

214

1541

Fourth [trochlear] nerve palsy

282

2120

1.50

6.76

3.3

3.1

1057.13

1389.69

ng/l

1.18

240

1841

Spirochaetal infections, other/unspecified

972

8332

1.23

6.74

2.8

3.0

848.18

1335.24

ng/l

4.99

769

7138

Unspecified contracted kidney

484

2.19

6.72

3.4

6955.95

1205.85

ng/l

2.08

404

Autonomic disorders

262

1935

1.50

6.72

2.8

2.9

831.70

1285.77

ng/l

2.04

224

1630

Brain glioblastoma and astrocytoma

1436

0.54

6.72

2.0

2.9

475.76

1266.88

ng/l

8.56

1207

Other intracranial haemorrhages

444

3561

1.38

6.69

4.0

3.2

1815.44

1929.82

ng/l

0.27

402

3105

Atopic conjunctivitis

385

2973

1.37

6.69

2.6

3.0

1654.10

930.85

ng/l

0.73

312

2448

Disorder of the sleep-wake schedule

156

1033

1.65

6.69

3.5

1239.63

1004.93

ng/l

0.15

120

854

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1473

12937

1.17

6.63

3.1

3.0

1468.10

1194.68

ng/l

1.10

1220

10839

Total colectomy

420

3306

1.36

6.62

3.0

2035.77

1283.23

ng/l

0.90

363

2796

Total colectomy operation

420

3306

1.36

6.62

3.0

2035.77

1283.23

ng/l

0.90

363

2796

Chronic iridocyclitis

520

4200

1.32

6.61

3.0

1343.00

1262.72

ng/l

0.13

441

3535

Isolated proteinuria with specified morphological lesion

146

980

1.76

6.59

4.4

3.1

4740.05

1138.35

ng/l

3.63

135

833

Brain glioblastoma

1227

0.51

6.56

2.0

2.9

505.75

1295.71

ng/l

6.88

1040

Granulomatous disorders of skin and subcutaneous tissue

262

1932

1.48

6.56

3.3

2.9

1083.82

982.12

ng/l

0.28

229

1599

Parkinson's disease, strict definition

2037

18436

1.16

6.55

2.9

3.2

1337.05

1839.75

ng/l

7.61

1743

16094

Any dementia

6478

42519

1.09

6.55

3.1

3.3

2230.11

1898.34

ng/l

5.00

5519

37159

Varicella [chickenpox]

430

3370

1.34

6.55

4.3

3.1

1271.85

1072.84

ng/l

0.49

353

2763

Dislocation, sprain and strain of joints and ligaments of elbow

532

4281

1.30

6.55

2.9

3.0

853.59

975.28

ng/l

0.47

447

3560

Benign neoplasm: Liver/bile ducts

258

1899

1.48

6.53

2.7

2.9

1348.00

1053.82

ng/l

0.46

218

1591

Anorexia (incl.atypical)

410

3180

1.34

6.53

3.0

2.9

2211.83

1107.68

ng/l

1.05

329

2599

Erythema nodosum

315

2396

1.43

6.53

3.8

2.9

2021.00

1142.39

ng/l

0.61

264

2012

Pedestrian injured in transport accident

727

6078

1.26

6.53

2.7

3.1

1493.10

1454.79

ng/l

0.07

595

5143

Alzheimer’s disease, strict definition

3640

32280

0.90

6.52

2.9

3.4

2319.76

2152.54

ng/l

0.96

3051

28214

Childhood allergy (age < 16)

505

3276

1.29

6.52

3.8

3.4

428.48

703.51

ng/l

1.08

346

2353

Family history of malignant neoplasm

890

7533

1.22

6.46

2.3

740.77

802.82

ng/l

0.12

753

6223

Other disorders of pigmentation

506

4103

1.33

6.45

3.0

1475.34

1228.81

ng/l

0.25

428

3460

Other congenital malformations of nervous system

411

2.02

6.43

3.5

498.68

690.76

ng/l

0.50

330

Malignant neoplasm of ovary, including Hilmo

744

6273

1.26

6.40

2.9

1246.79

1184.43

ng/l

0.09

655

5319

Diabetic retinopathy, strict definition

2308

18568

1.15

6.38

4.0

3.6

4131.19

1668.84

ng/l

23.97

1998

15922

Abrasion of teeth

3742

34631

1.10

6.38

2.7

2.8

803.51

1088.23

ng/l

9.18

3146

29396

Schizotypal disorder

191

1329

1.55

6.36

2.3

2.9

998.78

728.84

ng/l

0.24

148

1078

Other bursitis of knee

157

1067

1.66

6.32

3.8

3.3

1668.46

1344.00

ng/l

0.43

131

913

Routine general health check-up of defined subpopulation

134

858

1.65

6.30

2.4

1342.41

796.83

ng/l

0.51

119

700

Viral agents as the cause of diseases classified to other chapters

252

1860

1.48

6.30

3.5

3.1

1535.21

1079.26

ng/l

1.09

220

1564

Fibrosis of liver

618

1.99

6.29

3.9

2.9

1105.16

960.15

ng/l

0.24

521

Primary ovarian failure

135

872

1.67

6.29

2.4

2.9

697.07

581.49

ng/l

0.20

117

713

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

158

1078

1.66

6.28

3.5

3.0

1609.41

1263.68

ng/l

0.44

142

912

Protein-energy malnutrition of moderate and mild degree

125

826

1.83

6.26

4.8

3.6

2226.68

1484.61

ng/l

1.22

106

704

Malignant neoplasm of gum, including Hilmo

141

962

1.79

6.25

3.0

982.00

1597.81

ng/l

1.77

124

814

Other osteochondropathies

656

5441

1.26

6.24

2.9

3.0

1278.77

1223.57

ng/l

0.11

538

4541

Behavioural disorders

128

813

1.67

6.23

3.4

3.8

788.41

1029.27

ng/l

0.31

104

643

Calcinosis cutis

164

3.58

6.22

5.4

3.3

14442.97

1277.46

ng/l

1.64

136

Hyphaema and other vascular disorders of iris and ciliary body

253

1894

1.50

6.22

3.7

3.2

3196.09

1561.74

ng/l

2.08

223

1629

Chronic suppurative otitis media, including avohilmo

818

6939

1.24

6.21

3.6

3.2

1544.29

1531.39

ng/l

0.03

686

5906

Congenital malformation syndromes predominantly affecting facial appearance

3.35

6.21

3.1

5.0

1900.05

847.46

ng/l

0.30

Arnold-Chiari syndrome

366

2.07

6.18

3.6

3.4

528.98

689.27

ng/l

0.36

295

Inflammatory disorders of breast

474

3783

1.30

6.18

2.7

1163.33

756.86

ng/l

1.12

389

3088

Cutaneous lupus erythematosus

276

2087

1.46

6.17

3.0

2.9

1140.87

1076.49

ng/l

0.13

241

1753

Somnolence

135

892

1.71

6.17

3.5

3.0

1820.76

1249.44

ng/l

0.52

109

749

Other and unspecified bullous disorders

135

905

1.76

6.16

3.8

3.2

1243.06

1292.38

ng/l

0.07

120

777

Ulcerative colitis (strict definition, require KELA)

1524

13485

1.16

6.15

3.1

3.0

1456.52

1192.51

ng/l

1.10

1260

11301

Benign neoplasm of major salivary glands

1173

10279

1.20

6.15

3.2

3.0

1643.49

1518.31

ng/l

0.30

1024

8840

Benign leiomyoma with endometriosis

1833

16490

1.15

6.14

2.7

2.8

1127.67

1175.58

ng/l

0.21

1508

14116

Pedal cyclist injured in transport accident

2230

20181

1.13

6.13

3.0

1127.73

1253.52

ng/l

0.88

1855

17029

Pustulosis palmaris et plantaris

437

3495

1.34

6.12

2.8

2.9

1513.86

1024.43

ng/l

1.27

355

2951

Use of ropinirole

459

3738

1.36

6.11

2.9

3.0

961.00

1369.03

ng/l

2.34

383

3216

Exposure to unspecified smoke, fire and flames

110

698

1.82

6.09

2.7

3.1

1500.32

1308.18

ng/l

0.16

577

425

1.90

6.09

3.6

3.9

1454.54

392.26

ng/l

0.90

323

Toxic effect of ethanol

342

2635

1.37

6.09

3.2

3.1

1264.33

1256.84

ng/l

0.01

284

2200

Other deformity of hallux (acquired)

105

666

1.89

6.08

2.7

3.2

864.41

1211.77

ng/l

1.19

564

Female infertility, tubal origin

321

2437

1.37

6.04

2.4

701.18

641.79

ng/l

0.09

263

2022

Diabetes mellitus in pregnancy

1768

10025

1.14

6.04

2.1

2.3

520.24

403.62

ng/l

1.02

1350

7960

Other nonthrombocytopenic purpura

129

865

1.79

6.03

4.3

3.3

1797.94

1366.11

ng/l

0.63

118

730

Scar conditions and fibrosis of skin

374

2930

1.36

6.01

3.3

2.7

838.90

941.90

ng/l

0.44

320

2417

Hyperkinetic disorders (excl. ADHD)

557

1.78

6.00

3.1

4.4

730.10

740.12

ng/l

0.01

439

Pyoderma

214

1559

1.53

6.00

4.1

3.1

1780.36

1237.69

ng/l

0.85

178

1326

Open wound of shoulder and upper arm

205

1475

1.52

5.99

4.4

3.0

1576.21

1155.77

ng/l

1.14

169

1230

Cachexia

455

2.14

5.99

3.2

3.0

5392.62

1907.53

ng/l

1.48

388

Assault by hanging, strangulation and suffocation

3.51

5.98

1.5

2.8

272.21

684.12

ng/l

0.90

Malignant neoplasm of lip, including Hilmo

158

1107

1.69

5.97

3.8

3.2

3071.57

2034.74

ng/l

1.01

141

961

Microscopic polyangiitis

579

2.05

5.95

3.7

3.2

2318.37

1085.82

ng/l

2.25

481

Benign neoplasm: Other and unspecified parts of mouth

388

3089

1.37

5.94

3.1

3.0

1411.35

1208.94

ng/l

0.47

334

2630

Oral lichen planus and hypothyroidism or thyroxine medication

213

1566

1.54

5.93

2.4

2.8

639.63

904.13

ng/l

0.97

173

1298

Mixed disorders of conduct and emotions

555

1.76

5.91

4.0

4.1

1441.57

733.91

ng/l

0.49

407

Other congenital malformations, not elsewhere classified

411

2.00

5.91

5.4

3.8

839.36

772.74

ng/l

0.14

327

LSIL lesion of the vulva

260

1944

1.44

5.89

2.9

2.7

959.56

813.63

ng/l

0.33

223

1627

Type 1 diabetes, definitions combined

591

4823

1.25

5.89

2.8

2070.04

684.07

ng/l

4.78

506

3862

Other vitreous opacities

466

3794

1.33

5.86

3.1

3.0

1467.37

1347.48

ng/l

0.25

392

3248

Localized adiposity

371

2.20

5.86

3.8

2.9

753.76

991.56

ng/l

0.44

313

Diabetes insipidus

109

700

1.82

5.86

3.4

3.1

950.66

935.54

ng/l

0.02

585

Chorioretinal inflammation

300

2303

1.41

5.86

3.4

3.0

1371.25

1123.95

ng/l

0.45

256

1942

Diabetic maculopathy

1645

13952

1.17

5.84

4.0

3.6

4214.13

1701.37

ng/l

18.13

1456

11966

Mucosal proctocolitis

1124

9782

1.18

5.84

2.9

3.0

1351.23

1133.28

ng/l

0.72

921

8158

Benign intracranial hypertension

379

1.99

5.84

4.0

3.0

1334.97

719.83

ng/l

0.37

286

Narcolepsy and cataplexy

378

2.07

5.83

3.5

2.7

1085.14

1122.14

ng/l

0.02

310

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

472

2.27

5.82

3.4

3.3

1228.26

1365.40

ng/l

0.20

402

Pustular psoriasis

484

3941

1.31

5.81

3.1

2.9

1608.66

1081.16

ng/l

1.48

394

3322

Pyoderma gangrenosum

568

1.92

5.81

3.3

3.2

1849.83

1279.73

ng/l

0.64

480

Traction detachment of retina

105

672

1.85

5.80

3.0

3.1

3343.95

1327.86

ng/l

1.81

555

Thyrotoxicosis factitia

270

2.61

5.80

3.5

3.3

782.83

1008.10

ng/l

0.28

223

Non-small cell lung cancer, including Hilmo

2163

18571

1.14

5.78

3.1

3.2

1274.13

1793.79

ng/l

11.65

1959

16046

Volvulus

332

2602

1.40

5.77

3.3

3.0

1577.96

1583.12

ng/l

0.01

288

2262

Suppurative otitis media, unspecified

245

1821

1.45

5.75

3.5

3.1

1719.24

1317.51

ng/l

0.67

209

1519

Other and unspecified disorders of adult personality and behaviour

264

2.26

5.74

2.1

2.7

255.46

749.17

ng/l

2.72

212

Ankle and foot

104

664

1.83

5.74

3.4

3.3

2199.60

1126.21

ng/l

0.37

561

Unspecified visual impairment (binocular)

181

1295

1.57

5.74

3.1

3.3

1789.22

1299.82

ng/l

0.57

154

1109

Torsion of ovary, ovarian pedicle and fallopian tube

162

1110

1.55

5.73

2.8

2.6

1156.43

851.37

ng/l

0.35

137

904

Other or unspecified immunodeficiency

251

2.49

5.73

4.3

3.3

2000.58

904.99

ng/l

1.04

203

Chronic suppurative otitis media

695

5856

1.25

5.73

3.6

3.2

1651.95

1546.03

ng/l

0.26

585

4992

Neuroendocrine tumor and carcinoma of pancreas

549

2.01

5.72

3.2

3.0

712.29

1040.42

ng/l

0.58

450

Other inflammation of vagina/vulva

248

1833

1.42

5.71

2.6

2.7

513.17

752.33

ng/l

1.55

205

1509

Malignant neoplasm of heart, mediastinum and pleura

173

1241

1.62

5.71

3.2

1067.45

1842.75

ng/l

3.59

160

1073

Hypermetropia

644

5375

1.25

5.70

3.1

3.2

1056.17

1233.68

ng/l

0.79

536

4518

Effects of other external causes

228

1668

1.45

5.70

2.6

3.2

707.79

1044.19

ng/l

1.09

183

1373

Carcinoma in situ, bladder

451

3707

1.35

5.70

3.4

3.2

2317.38

1851.55

ng/l

0.59

398

3272

Other disorders of electrolyte and fluid balance, not elsewhere classified

124

833

1.77

5.69

3.8

2.9

3302.15

1375.04

ng/l

1.37

115

691

Assault by blunt object

124

811

1.68

5.68

3.1

2.9

1189.35

760.34

ng/l

0.37

656

Flatulence and related conditions

120

791

1.73

5.67

4.1

3.0

1150.77

1248.30

ng/l

0.16

104

689

Open wound of hip and thigh

302

2319

1.39

5.66

2.9

3.1

1291.39

1228.72

ng/l

0.10

255

1927

Pectus excavatum

131

2.74

5.66

4.3

3.2

618.52

2046.19

ng/l

0.59

Hereditary deficiency of other clotting factors

582

1.84

5.64

2.8

3.2

1332.24

1080.67

ng/l

0.28

483

Small cell lung cancer, helper endpoint

190

2587

0.67

5.64

2.6

3.2

1648.14

2287.34

ng/l

0.55

174

2250

Chronic conjunctivitis

313

2430

1.39

5.64

2.9

3.1

1063.96

1079.35

ng/l

0.02

265

2025

Other acute skin changes due to ultraviolet radiation

400

3213

1.35

5.64

3.2

3.0

1690.68

1526.23

ng/l

0.32

348

2743

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1649

14748

1.15

5.62

3.1

3.0

1454.97

1203.02

ng/l

1.11

1368

12362

Erectile dysfunction

1065

9378

1.21

5.61

9.5

3.2

1858.80

1850.58

ng/l

0.02

937

8260

Haemophagocytic lymphohistiocytosis

113

4.09

5.60

5.5

3.3

1509.96

911.29

ng/l

0.81

Erythema multiforme

247

1860

1.45

5.59

3.4

2.9

1474.27

1245.41

ng/l

0.31

213

1558

Calcific tendinitis

110

715

1.78

5.59

3.1

3.3

842.19

1122.57

ng/l

0.50

611

Psoas tendinitis

309

2.25

5.57

2.6

2.9

864.73

817.31

ng/l

0.06

267

Vascular dementia (mixed)

279

2176

1.46

5.55

2.9

3.4

2225.49

2307.85

ng/l

0.12

238

1925

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

131

902

1.75

5.55

4.1

3.1

1850.54

1578.35

ng/l

0.37

121

764

Sequelae of infectious and parasitic diseases

798

6825

1.22

5.55

3.3

3.0

1422.11

1579.01

ng/l

0.47

678

5764

Type 1 diabetes, strict (exclude DM2)

582

4774

1.25

5.55

2.8

2.9

2089.76

700.32

ng/l

4.71

501

3821

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

5653

47483

0.93

5.55

2.7

2.8

1217.45

1124.15

ng/l

0.54

4687

40060

Other and unspecified mental retardation

121

784

1.66

5.53

3.9

5.0

1764.91

1201.79

ng/l

0.21

103

651

Car occupant injured in noncollision transport accident

311

2403

1.37

5.51

2.8

3.1

1246.13

1169.83

ng/l

0.11

263

2006

Dissocial personality disorder

139

940

1.62

5.51

2.5

3.1

688.93

1035.82

ng/l

0.76

115

764

Vascular dementia (subcortical)

497

4141

1.33

5.51

3.1

3.4

2183.97

2366.62

ng/l

0.39

434

3659

Foreign body in respiratory tract

506

4155

1.29

5.51

3.0

3.1

1165.56

1282.73

ng/l

0.32

425

3497

Donors of organs and tissues

123

809

1.66

5.50

3.4

2.3

442.35

563.48

ng/l

0.79

103

655

Other salmonella infections

441

3571

1.31

5.49

3.2

2.8

1603.86

1257.11

ng/l

0.41

361

2994

Benign neoplasm of breast

1281

11352

1.17

5.48

2.6

2.8

1100.76

1164.41

ng/l

0.21

1069

9651

Von Willebrand disease

114

740

1.70

5.48

2.5

2.8

1303.48

774.81

ng/l

0.65

619

Hypertrophy of tongue papillae

152

1064

1.62

5.47

2.8

3.2

1142.43

1058.68

ng/l

0.13

119

908

Benign neoplasm: Pancreas

358

2877

1.39

5.47

2.8

3.0

1269.44

1328.04

ng/l

0.11

322

2454

Benign neoplasm of bone and articular cartilage

794

6787

1.22

5.45

2.7

2.9

983.20

1170.92

ng/l

0.79

660

5705

Non-small cell lung cancer, adenocarcinoma, helper endpoint

835

7244

1.23

5.45

3.0

3.2

1398.63

1772.54

ng/l

2.17

756

6290

Polyhydramnios

243

1794

1.40

5.45

2.3

2.5

993.70

419.97

ng/l

0.65

202

1430

Complications peculiar to reattachment and amputation

635

1.89

5.43

3.9

3.0

3944.67

1475.24

ng/l

1.39

533

Other conjunctival vascular disorders and cysts

276

2133

1.43

5.43

3.1

3.0

1655.38

1212.48

ng/l

0.77

238

1804

Congenital malformations of eye, ear, face and neck

485

3944

1.28

5.42

3.5

3.3

1364.03

1101.91

ng/l

0.34

400

3263

Inguinal or femoral hernia, bilateral

1372

12258

1.17

5.42

3.1

3.2

1735.41

1680.03

ng/l

0.17

1191

10661

Other mycoses, not elsewhere classified/unspecified

188

1367

1.53

5.41

3.2

3.0

1517.50

1089.23

ng/l

0.70

163

1168

Contact with sharp object, undetermined intent

212

1556

1.47

5.40

2.8

3.1

1061.70

1133.15

ng/l

0.11

176

1295

Crohn disease (strict definition, all UC cases excluded)

426

3427

1.30

5.40

2.5

3.0

952.99

1040.14

ng/l

0.19

353

2861

Other proliferative retinopathy

336

2.20

5.40

3.4

3.3

2650.33

1315.82

ng/l

1.33

287

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

132

919

1.75

5.40

3.3

3.0

1159.42

1509.57

ng/l

0.89

121

771

Other/unspecified crystal arthropathies

100

662

1.94

5.39

4.6

3.4

1838.42

1586.08

ng/l

0.24

571

Other drug-induced secondary parkinsonism

133

924

1.72

5.37

3.5

3.2

1218.27

1123.94

ng/l

0.15

114

779

Disorders of porphyrin and bilirubin metabolism

123

824

1.69

5.36

2.5

3.1

2167.99

1041.21

ng/l

0.41

103

691

Sexual dysfunction

147

1015

1.59

5.35

2.7

3.2

685.17

1169.50

ng/l

2.33

122

861

Need for immunization against other single infectious diseases

4.41

5.34

6.2

3.4

13369.42

1216.24

ng/l

1.45

Other rupture of muscle

455

1.97

5.34

3.2

3.4

1329.62

1335.11

ng/l

0.00

382

Idiopathic urticaria

177

1261

1.51

5.31

2.7

2.9

1032.00

921.74

ng/l

0.17

153

1028

Foreign body or object entering through skin

572

4763

1.26

5.29

2.9

3.0

1226.58

1193.77

ng/l

0.06

481

3991

Toxic effect of corrosive substances

282

2.20

5.28

1.9

3.4

482.55

712.02

ng/l

0.83

236

Poisoning by medicine, drug-induced

128

864

1.65

5.28

2.1

3.0

1137.61

784.16

ng/l

0.30

103

704

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

232

1762

1.47

5.27

3.4

3.1

1247.02

1818.71

ng/l

2.03

219

1514

Acute drug-induced interstitial lung disorder

119

819

1.80

5.26

4.8

3.3

1384.11

1645.14

ng/l

0.46

111

712

Contact with nonpowered hand tool

423

3430

1.31

5.26

2.9

3.1

1023.04

1285.92

ng/l

1.05

343

2916

Other facial nerve disorders

299

2332

1.39

5.25

2.7

2.9

818.11

1159.03

ng/l

1.97

248

1963

Injury of nerves at lower leg level

111

733

1.73

5.23

2.2

3.1

1289.56

1181.71

ng/l

0.11

622

Malignant neoplasm of tongue

239

1826

1.47

5.23

2.4

3.1

1302.57

1461.82

ng/l

0.18

216

1553

Short stature, not elsewhere classified

518

1.72

5.22

5.3

7.5

635.75

1346.52

ng/l

1.29

423

Iridocyclitis in diseases classified elsewhere

213

1590

1.48

5.22

3.3

3.1

1538.55

1253.76

ng/l

0.50

181

1348

Use of levodopa decarboxylase inhibitor

1963

17954

1.14

5.21

2.9

3.2

1487.37

1846.80

ng/l

2.00

1674

15678

Carcinoma in situ of vulva

100

652

1.81

5.18

3.0

2.9

997.77

933.97

ng/l

0.07

555

Other bursal cyst

178

1294

1.54

5.16

2.7

3.1

1360.73

1316.67

ng/l

0.04

150

1097

Other bursitis, not elsewhere classified

116

778

1.71

5.16

2.7

3.2

927.03

1591.41

ng/l

2.19

663

Lumbosacral root disorders, not elsewhere classified

152

1083

1.61

5.14

3.6

2.9

2171.36

1151.50

ng/l

0.48

134

934

Migraine with aura, drug-induced

111

734

1.71

5.13

2.4

3.0

819.48

779.73

ng/l

0.05

100

609

Other appendicitis

842

7273

1.20

5.13

3.0

2.9

1254.50

1182.96

ng/l

0.13

701

6126

Malignant neoplasm of breast, ER-negative, including Hilmo

2663

23424

1.11

5.12

2.8

1316.97

1233.86

ng/l

0.48

2261

19757

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

140

963

1.58

5.11

3.7

3.4

881.98

983.98

ng/l

0.16

120

809

Severe visual impairment, monocular

128

888

1.70

5.11

4.0

3.3

1844.35

1550.74

ng/l

0.34

108

755

Other and unspecified hypertrophic disorders of skin

437

1.95

5.10

2.7

746.08

666.18

ng/l

0.15

365

Secondary parkinsonism

349

2811

1.37

5.09

3.2

3.1

1125.00

1750.50

ng/l

3.91

301

2428

Benign neoplasm: Kidney

426

3503

1.32

5.07

2.8

3.0

2310.58

1389.11

ng/l

1.08

364

3006

Drug-induced headache, not elsewhere classified

363

2.06

5.05

2.4

2.9

841.58

700.23

ng/l

0.15

306

Tetraplegia

627

1.83

5.04

3.0

3.6

1136.51

1243.01

ng/l

0.15

527

Congenital malformations of the nervous system

157

1100

1.52

5.04

3.3

3.8

1013.16

868.55

ng/l

0.28

129

901

Endovascular or surgical operations to intracerebral aneurysms

702

6015

1.23

5.04

2.6

2.9

1331.96

1321.01

ng/l

0.02

625

5108

Pre-eclampsia superimposed on chronic hypertension

185

2.36

5.03

2.3

2.8

1665.06

374.29

ng/l

0.65

155

Contact with machinery

1193

10598

1.17

5.00

3.1

1175.83

1462.54

ng/l

1.62

1025

9113

Other specified/unspecified disorders of bone/cartilage

296

2324

1.38

5.00

3.1

2.8

984.66

1127.45

ng/l

0.38

250

1959

Adenocarcinoma and papilloma adenocarcinoma of rectum

1218

10869

1.17

4.99

2.5

3.2

1409.22

1613.43

ng/l

1.13

1076

9382

Secondary parkinsonism+Parkinsonism in other disease

357

2889

1.36

4.99

3.2

3.1

1109.49

1745.56

ng/l

4.19

309

2500

Occupational exposure to risk-factors

369

2981

1.34

4.99

3.7

3.1

963.93

1409.91

ng/l

2.98

328

2589

Atlantoaxial subluxation

581

1.86

4.98

3.0

3.2

1290.37

1160.02

ng/l

0.16

492

Fitting and adjustment of external prosthetic device

254

2.46

4.98

3.0

2.6

12071.53

1292.85

ng/l

1.30

212

Disorders of eyelid in diseases classified elsewhere

341

2722

1.34

4.97

3.8

3.1

1700.29

1451.81

ng/l

0.55

297

2302

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1268

11348

1.17

4.95

2.5

3.1

1419.48

1597.08

ng/l

0.96

1120

9792

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

154

1109

1.59

4.94

3.6

3.1

1039.31

1616.42

ng/l

1.84

139

946

Syndrome of inappropriate secretion of antidiuretic hormone

552

1.97

4.94

3.2

1290.42

1575.21

ng/l

0.26

467

Marginal zone B-cell lymphoma, including Hilmo

207

1569

1.50

4.93

2.9

3.0

1644.73

1405.55

ng/l

0.36

181

1332

Other congenital malformations of upper alimentary tract

633

1.82

4.90

4.7

3.4

972.47

1141.20

ng/l

0.28

535

Other sideroblastic anaemias

355

2.20

4.85

7.0

3.1

2088.72

1471.55

ng/l

0.60

291

Use of rotigotine

148

1068

1.62

4.85

2.5

3.0

1122.13

1100.30

ng/l

0.03

123

904

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

308

2421

1.34

4.85

2.5

3.0

958.39

1009.14

ng/l

0.12

260

2003

Palindromic rheumatism

119

813

1.66

4.84

3.4

3.0

1156.18

1206.21

ng/l

0.06

104

691

Malignant neoplasm of gum

463

2.10

4.82

2.8

1011.11

1419.49

ng/l

0.48

386

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

101

3.75

4.81

2.5

3.1

2216.49

1371.04

ng/l

0.68

Other and unspecified nonscarring hair loss

419

1.91

4.79

2.9

2.8

1172.21

775.65

ng/l

0.37

338

Injury of cranial nerves

471

1.90

4.78

2.7

2.9

970.95

907.45

ng/l

0.07

404

Premenstrual syndrome

418

1.82

4.77

2.3

2.7

363.23

679.06

ng/l

0.66

340

Evidence of alcohol involvement determined by level of intoxication

563

1.74

4.76

3.1

3.0

1601.40

781.04

ng/l

0.55

450

Shoulder region

171

1258

1.53

4.76

3.1

3.2

2310.34

1257.25

ng/l

1.83

151

1066

L02BB Anti-androgens

1313

11835

1.17

4.75

3.3

2204.19

2125.26

ng/l

0.22

1194

10414

Antenatal screening

1049

6745

0.86

4.75

2.1

2.3

305.84

518.85

ng/l

2.85

843

5402

Trichomoniasis

115

790

1.69

4.75

2.9

2.7

2030.31

984.52

ng/l

0.89

671

Malignant neoplasm of rectum

1225

10969

1.17

4.75

2.6

3.1

1455.42

1610.28

ng/l

0.73

1080

9453

Non-small cell lung cancer

1379

12329

1.16

4.73

3.0

3.2

1404.81

1895.30

ng/l

6.25

1254

10648

Portal vein thrombosis

188

1406

1.49

4.71

2.7

3.1

1712.06

1414.84

ng/l

0.32

151

1196

Lesion of femoral nerve

610

1.78

4.69

2.6

2.9

856.11

911.67

ng/l

0.09

520

Cerebral palsy

114

761

1.60

4.68

3.1

3.5

1291.53

775.29

ng/l

0.30

624

Other nonscarring hair loss

569

1.75

4.68

4.2

3.0

1213.71

872.92

ng/l

0.39

468

Injury of nerves at wrist and hand level

346

2776

1.32

4.68

3.1

1051.54

1138.19

ng/l

0.14

285

2341

Viral agents as the cause of diseases classified to other chapters

221

1682

1.43

4.67

3.6

3.1

1613.14

1098.66

ng/l

1.11

196

1421

Gastrointestinal stromal tumor and sarcoma

155

1141

1.59

4.65

3.0

1351.23

1401.93

ng/l

0.06

135

968

Monoplegia

180

1340

1.50

4.65

4.7

3.0

1199.76

1290.21

ng/l

0.15

168

1141

Distal bite

205

1507

1.40

4.63

4.5

3.7

833.68

704.25

ng/l

0.23

159

1232

Carcinoma in situ of rectum

157

1163

1.59

4.59

3.8

3.1

1625.55

1314.34

ng/l

0.51

145

1013

Pyogenic granuloma

181

1341

1.48

4.59

3.2

3.1

1939.33

1213.04

ng/l

1.02

149

1122

Intercostal neuropathy

101

682

1.74

4.58

3.6

3.0

1432.26

1214.52

ng/l

0.24

571

Open wound of thorax

155

1118

1.52

4.58

2.9

3.1

1491.39

1195.64

ng/l

0.41

128

946

Malignant neoplasm of other connective and soft tissue

293

2339

1.37

4.57

3.3

3.0

1918.78

1558.51

ng/l

0.62

259

1989

Behçet disease

208

2.45

4.57

2.7

3.1

533.17

970.66

ng/l

0.98

170

Perichondritis of external ear

229

1781

1.44

4.54

3.5

3.0

1360.28

1632.58

ng/l

0.53

201

1520

Cysts of oral region, not elsewhere classified

597

5083

1.23

4.53

3.1

3.0

1307.10

1227.48

ng/l

0.18

503

4308

Injury of nerves at forearm level

130

911

1.58

4.53

3.5

3.1

1091.43

863.08

ng/l

0.22

103

764

Wegener granulomatosis

180

1346

1.49

4.52

3.2

3.0

1523.42

1278.18

ng/l

0.33

167

1149

Chronic mastoiditis

322

2605

1.35

4.52

3.4

3.1

1946.20

1623.29

ng/l

0.66

278

2239

Migraine, single triptan purchase ok & required. ICD-code if available is included

8006

51780

1.06

4.51

2.5

2.8

603.17

995.56

ng/l

22.79

6479

43239

Triptan medication for migraine, single purchase ok

8006

51780

1.06

4.51

2.5

2.8

603.17

995.56

ng/l

22.79

6479

43239

Measles

562

1.71

4.51

2.5

2.9

778.16

679.01

ng/l

0.09

450

Adenocarcinoma and ductal carcinoma of pancreas

291

3615

0.75

4.50

2.1

3.1

1284.07

1661.88

ng/l

0.86

264

3106

Pectus excavatum

166

2.32

4.50

4.0

3.2

589.19

1684.30

ng/l

0.60

127

Spasmodic torticollis

315

2524

1.33

4.48

2.7

2.9

870.61

1016.47

ng/l

0.49

254

2107

Leiomyosarcoma

640

1.78

4.47

2.9

3.1

2590.42

1540.48

ng/l

1.01

535

Unspecified lump in breast

1636

14868

1.13

4.47

2.6

2.8

1079.14

1079.67

ng/l

0.00

1437

12629

Inguinal hernia, bilateral

1335

12052

1.15

4.46

3.1

3.2

1657.63

1670.55

ng/l

0.04

1160

10487

Other and unspecified pemphigoid

132

959

1.65

4.43

3.1

3.3

2266.88

1735.86

ng/l

0.45

115

828

Ankylosing spondylitis, strict definition

344

2767

1.30

4.43

2.8

3.0

553.99

949.60

ng/l

2.27

275

2271

Benign neoplasm: Tongue

320

2588

1.34

4.42

3.1

3.0

1277.86

1209.30

ng/l

0.13

279

2196

Sixth [abducent] nerve palsy

402

3333

1.30

4.42

3.2

1548.17

1546.39

ng/l

0.00

346

2869

Chondromalacia

276

2180

1.36

4.42

2.5

2.9

829.67

962.66

ng/l

0.17

213

1838

Open bite

288

2252

1.32

4.42

3.9

3.1

454.18

634.28

ng/l

1.68

232

1808

Adenocarcinoma and Papillary adenocarcinoma of kidney

146

1071

1.58

4.41

2.8

2.9

2889.19

1408.38

ng/l

1.27

128

910

Adult respiratory distress syndrome

167

1245

1.52

4.41

4.0

3.1

2781.90

1698.80

ng/l

0.96

151

1069

Hydrocephalus

973

8642

1.18

4.41

2.6

3.1

1160.18

1769.48

ng/l

5.30

831

7474

Long labour

1219

11724

0.88

4.40

2.2

2.4

415.64

520.39

ng/l

1.13

985

9494

Infectious mononucleosis

442

3625

1.25

4.40

3.3

2.8

843.93

661.25

ng/l

0.44

343

2818

Tooth eruption problems

743

6218

1.18

4.39

3.3

3.1

1060.34

779.98

ng/l

1.08

606

4881

Disorders of orbit

439

3649

1.27

4.37

2.7

2.9

1089.29

1135.49

ng/l

0.10

368

3048

Supervision of normal pregnancy

998

6507

0.86

4.36

2.0

2.3

238.14

524.40

ng/l

6.15

761

5202

Disorders of optic nerve, not elsewhere classified

256

2029

1.39

4.34

3.5

3.1

2442.97

1468.70

ng/l

1.38

218

1741

Scleritis

132

937

1.56

4.34

3.4

2.9

813.23

992.50

ng/l

0.42

117

782

Generalized epilepsy

331

2656

1.30

4.34

2.8

3.1

739.97

1164.09

ng/l

2.40

266

2210

Primary amenorrhea

202

2.14

4.33

3.4

2.6

205.18

594.90

ng/l

1.59

159

Gilbert syndrome

488

1.79

4.32

2.4

2.9

673.27

853.11

ng/l

0.39

405

Meretoja disease

298

2.22

4.32

3.6

3.1

1551.53

1304.00

ng/l

0.19

249

Burn and corrosion of trunk

297

2374

1.34

4.31

3.2

1091.94

1285.52

ng/l

0.53

256

2026

Other injuries of lower limb, level unspecified

108

745

1.66

4.30

3.4

3.1

1913.28

1199.56

ng/l

0.70

100

626

Small cell lung cancer

190

2482

0.71

4.29

2.6

3.1

1648.14

1994.49

ng/l

0.25

174

2131

Small cell lung cancer, including Hilmo

190

2482

0.71

4.29

2.6

3.1

1648.14

1994.49

ng/l

0.25

174

2131

Anogenital herpesviral [herpes simplex] infection

393

3205

1.26

4.28

2.6

2.8

647.34

759.61

ng/l

0.23

308

2602

Findings of drugs and other substances, not normally found in blood

374

2.03

4.27

3.5

3.0

1164.96

1229.27

ng/l

0.08

307

Primary angle-closure glaucoma

587

5061

1.24

4.26

2.8

3.1

1494.62

1737.90

ng/l

0.99

503

4362

Abnormal spermatozoa

1609

14731

1.14

4.26

3.1

3.3

1829.24

1705.99

ng/l

0.35

1321

12963

Other or unspecified common variable immunodeficiency

197

2.35

4.26

3.2

2.4

847.12

791.38

ng/l

0.05

158

Other and unspecified corneal deformities and disorders

329

2667

1.32

4.25

2.9

3.0

1199.22

1139.10

ng/l

0.11

296

2240

Contact with heat and hot substances

487

4087

1.24

4.25

2.9

3.2

1681.47

1313.84

ng/l

0.48

404

3466

Certain conditions originating in the perinatal period

397

2861

1.26

4.24

4.7

3.8

1590.48

737.56

ng/l

1.27

323

2208

Anxious personality disorder

130

910

1.51

4.23

2.5

2.8

1876.54

831.42

ng/l

0.51

100

731

conjunctival degenerations and deposits

256

2032

1.38

4.23

2.7

3.0

955.45

1244.26

ng/l

0.88

227

1736

Embedded teeth, including avohilmo

523

4383

1.22

4.21

2.9

1277.58

841.76

ng/l

1.35

441

3476

Poor fetal growth

571

4815

1.21

4.21

2.0

2.3

640.54

368.16

ng/l

0.57

449

3781

Undescended testicle

467

1.74

4.20

4.6

5.7

1440.72

1582.23

ng/l

0.09

381

Abscess of lung

182

1380

1.46

4.19

4.1

3.1

1594.51

1529.09

ng/l

0.07

174

1184

Anomalies of pupillary function

192

1453

1.42

4.15

2.5

3.0

914.47

927.63

ng/l

0.02

153

1203

Other bullous disorders

299

2414

1.34

4.14

3.4

3.1

1221.02

1286.21

ng/l

0.16

267

2065

Other abnormal findings in urine

203

1574

1.44

4.14

3.7

3.2

2244.70

1661.57

ng/l

0.71

188

1361

Other acute viral hepatitis

118

825

1.57

4.13

2.7

3.2

1109.75

865.42

ng/l

0.37

104

676

Acquired clawhand, clubhand, clawfoot and clubfoot

315

1.98

4.13

2.7

3.1

1405.45

1012.20

ng/l

0.29

272

Other benign neoplasms of uterus

720

6330

1.22

4.13

3.1

1552.11

1548.72

ng/l

0.01

609

5428

Other specified and unspecified disorders of conjunctiva

113

793

1.61

4.11

4.0

3.0

1745.79

1115.41

ng/l

0.71

676

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

316

2556

1.31

4.10

2.6

3.1

803.24

1075.25

ng/l

0.84

266

2146

Other puerperal infections

364

2948

1.26

4.10

1.9

2.5

348.54

459.29

ng/l

0.87

288

2321

Abnormality of white blood cells, not elsewhere classified

103

714

1.66

4.08

4.3

3.1

1073.87

1106.55

ng/l

0.04

607

Other bacterial agents as the cause of diseases classified to other chapters

128

926

1.58

4.08

4.7

3.3

2359.59

1283.72

ng/l

1.32

112

781

Corneal scars and opacities

308

2502

1.33

4.08

3.6

3.1

1574.49

1351.54

ng/l

0.48

267

2132

Drug-induced gout

500

1.94

4.07

6.6

3.4

3198.98

1881.22

ng/l

1.85

423

Other and unspecified mononeuropathies of upper limb

294

2363

1.32

4.07

2.8

3.0

1079.21

1171.49

ng/l

0.19

255

2007

Alzheimer’s disease (Late onset)

3427

30550

0.92

4.07

2.9

3.4

2349.86

2205.73

ng/l

0.73

2872

26742

676

5845

1.20

4.06

3.6

3.3

2069.98

2255.22

ng/l

0.40

596

4972

Foreign body on external eye

1388

12554

1.13

4.06

2.9

3.1

1069.59

1215.73

ng/l

0.70

1152

10614

Schizoid personality disorder

165

1227

1.46

4.06

2.9

3.0

1397.01

907.88

ng/l

0.26

138

1021

Diseases caused by chlamydiae

521

1.69

4.06

2.1

2.7

741.59

481.45

ng/l

0.33

430

Henoch-Schönlein purpura nephritis (HSPN)

237

2.18

4.06

3.3

3.1

1834.13

1252.78

ng/l

0.47

196

Other diseases caused by chlamydiae

627

1.63

4.05

2.3

2.8

750.75

669.67

ng/l

0.10

513

Effects of heat and light

659

1.69

4.03

2.6

3.3

1456.65

1521.01

ng/l

0.06

562

Granuloma annulare

153

1131

1.49

4.02

3.5

3.0

1092.04

951.80

ng/l

0.31

134

946

Migraine without aura, drug-induced

646

1.62

4.01

3.4

2.9

508.53

790.59

ng/l

0.93

527

Meningitis

475

4007

1.24

4.01

2.9

3.0

1235.07

1215.47

ng/l

0.02

405

3373

Assault by sharp object

131

933

1.50

4.00

2.8

3.0

1658.86

1016.08

ng/l

0.55

103

767

138

1008

1.52

3.99

3.3

3.0

1819.31

1438.22

ng/l

0.55

112

849

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

575

1.72

3.98

4.6

3.4

2087.64

1272.27

ng/l

0.64

485

Malignant neoplasm of thyroid gland, including Hilmo

740

6469

1.19

3.98

3.0

2.9

1068.69

1181.51

ng/l

0.40

629

5460

Anorexia

136

982

1.50

3.98

2.8

3.1

2171.49

1067.28

ng/l

1.82

116

807

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

494

1.84

3.98

4.6

3.3

1003.49

1278.04

ng/l

0.40

416

Other disorders of optic disc

136

987

1.52

3.98

3.3

3.1

1823.84

1076.61

ng/l

0.77

109

825

Leiomyosarcoma, including Hilmo

121

874

1.60

3.97

2.8

3.0

2248.23

1401.59

ng/l

1.03

109

736

Endometriosis diagnosis and infertility diagnosis occurring together

662

5700

1.19

3.96

2.3

2.5

662.16

556.58

ng/l

0.23

530

4627

Benign neoplasm: Conjunctiva

358

2962

1.29

3.96

2.8

3.0

1277.79

1328.14

ng/l

0.10

306

2527

Common variable immunodeficiency

422

1.83

3.95

3.0

2.6

1363.53

1152.57

ng/l

0.10

348

Horner syndrome

141

1038

1.52

3.95

2.6

3.0

1169.68

1218.39

ng/l

0.06

119

885

Deformity of finger(s)

472

1.80

3.94

2.6

3.2

897.76

1081.53

ng/l

0.20

410

Shigellosis

418

1.79

3.94

2.7

2.9

1339.26

990.73

ng/l

0.41

348

Autoimmune hepatitis

623

1.67

3.94

3.1

2.6

758.58

821.01

ng/l

0.15

524

Ulcer of vagina/vulva

232

1817

1.36

3.93

3.3

2.9

943.84

1037.43

ng/l

0.23

193

1508

Injury of intra-abdominal organs

225

1754

1.36

3.93

3.2

3.1

1986.71

1174.08

ng/l

1.74

191

1460

Intracranial and intraspinal abscess and granuloma

138

1017

1.53

3.91

3.4

3.2

2404.85

1249.76

ng/l

0.53

122

870

Histrionic personality disorder

388

1.91

3.91

3.3

2.9

570.87

1144.01

ng/l

1.76

328

Acute appendicitis, with complications

2176

20149

1.10

3.91

3.1

3.0

1320.29

1405.43

ng/l

0.53

1868

17262

Respiratory tuberculosis, confirmed

229

1810

1.38

3.91

4.1

3.1

2840.45

2032.46

ng/l

1.26

206

1542

Congenital deformities of hip

120

841

1.51

3.91

3.8

3.9

827.98

961.73

ng/l

0.25

689

Disorder of thyroid, unspecified

149

1107

1.49

3.90

2.7

2.8

762.77

1075.11

ng/l

1.34

125

931

Respiratory tuberculosis, bacteriologically and histologically confirmed

237

1881

1.38

3.90

4.1

3.1

2777.35

2058.95

ng/l

1.10

213

1605

Other and unspecified acute skin changes due to ultraviolet radiation

314

2579

1.32

3.89

3.1

3.0

1907.46

1698.55

ng/l

0.33

275

2212

Ovarian dysfunction, other/unspecified

296

1.94

3.88

2.0

2.7

554.46

657.71

ng/l

0.24

244

Congenital malformations of genital organs

583

4948

1.20

3.88

3.1

3.0

720.41

811.08

ng/l

0.43

474

4013

Actinomycosis

334

1.98

3.87

4.6

3.2

1055.06

1115.58

ng/l

0.10

274

Congenital deformities of hip

135

969

1.47

3.86

3.6

3.8

1020.09

940.57

ng/l

0.11

107

793

Benign neoplasm: Skin of trunk

432

3638

1.25

3.85

3.8

3.0

1751.59

1247.83

ng/l

0.61

357

3080

Autism

107

729

1.52

3.84

3.0

3.4

658.94

710.44

ng/l

0.04

534

Hereditary corneal dystrophies

404

3407

1.28

3.83

3.1

1631.21

1294.65

ng/l

0.56

329

2907

Alcoholic gastritis

174

1330

1.45

3.83

3.9

3.1

1558.85

1364.08

ng/l

0.23

151

1149

Contact with other hot fluids

262

2086

1.32

3.82

3.0

3.3

1883.15

1128.28

ng/l

0.58

211

1737

Tuberculosis, IBD comorbidity

928

8291

1.17

3.82

3.8

3.2

2045.93

1928.96

ng/l

0.30

810

7157

Adhesive middle ear disease

155

1154

1.45

3.82

3.3

3.0

1012.93

1136.98

ng/l

0.32

125

960

Malignant neoplasm of brain

219

2783

0.75

3.82

2.4

3.0

749.67

1366.12

ng/l

3.33

195

2339

Other neurotic disorders

527

4520

1.23

3.81

2.9

1844.69

1401.30

ng/l

0.60

451

3847

Fasciculation

116

826

1.55

3.80

2.5

3.1

637.13

1009.86

ng/l

1.05

684

Benign neoplasm: Anus and anal canal

349

2906

1.30

3.80

2.8

3.0

1682.11

1554.61

ng/l

0.18

310

2498

Maxillary retrognathism

114

796

1.51

3.79

3.7

3.4

877.86

595.81

ng/l

0.53

653

Use of rasagiline

327

2719

1.32

3.78

2.5

3.0

1015.60

1320.84

ng/l

1.58

282

2344

Pulmonary eosinophilia, not elsewhere classified

153

1157

1.49

3.77

4.8

3.1

1629.28

1365.12

ng/l

0.38

141

990

Pigmented purpuric dermatosis

126

924

1.56

3.76

3.4

3.0

2660.53

1073.05

ng/l

0.51

115

789

Unequal limb length (acquired)

340

1.80

3.76

2.9

3.1

958.65

799.79

ng/l

0.12

273

Panhypopituitarism

196

1524

1.40

3.75

3.2

1663.02

1410.15

ng/l

0.25

170

1298

Left side

444

1.95

3.75

3.1

3.3

1541.10

1426.52

ng/l

0.07

370

Mononeuritis multiplex

258

2.22

3.74

2.1

3.1

1186.16

1288.44

ng/l

0.06

229

Disorders of puberty, all

461

1.65

3.73

3.2

4.6

249.62

933.39

ng/l

1.27

358

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

418

1.71

3.72

2.0

2.6

615.46

476.64

ng/l

0.24

340

Osteopathy in diseases classified elsewhere

648

1.68

3.72

4.9

3.4

1420.87

905.63

ng/l

0.98

553

Abnormality of red blood cells

418

1.85

3.71

3.0

3.1

1515.14

1216.81

ng/l

0.34

348

Malignant neoplasm of testis

141

1036

1.46

3.71

3.2

1127.64

1403.37

ng/l

0.50

120

855

Tibial collateral bursitis [Pellegrini-Stieda]

118

849

1.54

3.70

3.0

1138.64

1048.32

ng/l

0.14

102

725

Other bacterial agents as the cause of diseases classified to other chapters

141

1051

1.49

3.68

4.5

3.3

2273.79

1232.87

ng/l

1.41

122

886

Benign neoplasm: Skin, unspecified

415

3502

1.25

3.67

3.2

3.0

1574.26

1267.86

ng/l

0.79

345

2990

Failed attempted abortion

356

1.75

3.66

2.5

2.3

301.95

544.15

ng/l

0.50

285

Other and unspecified injuries of neck

481

1.69

3.65

3.0

542.21

945.66

ng/l

1.87

392

Other bursitis of elbow

105

749

1.61

3.65

4.5

3.3

1619.29

1543.71

ng/l

0.07

646

Serous carcinoma of ovary, including Hilmo

384

3233

1.27

3.65

2.8

2.9

736.39

1169.35

ng/l

3.28

344

2724

Sequelae of other and unspecified infectious and parasitic diseases

463

3923

1.23

3.65

3.2

2.9

1065.69

1115.51

ng/l

0.10

384

3283

Mature T/NK-cell lymphomas, hilmo

177

1377

1.45

3.65

3.2

2512.87

1480.32

ng/l

0.60

160

1190

Other benign neoplasm of uterus: Other parts/unspecified

593

5216

1.23

3.62

3.3

3.1

1707.72

1664.60

ng/l

0.08

509

4492

Exposure to smoke, fire and flames

241

1923

1.34

3.61

2.8

3.1

1470.34

1375.95

ng/l

0.13

207

1626

Traumatic amputation of wrist and hand

462

3944

1.24

3.61

3.2

3.1

1102.96

1522.72

ng/l

1.52

405

3410

Alopecia areata

221

1739

1.34

3.59

2.8

2.9

1139.70

826.32

ng/l

0.47

187

1442

Leukaemia of unspecified cell type

116

846

1.56

3.58

3.4

3.3

1181.11

1425.42

ng/l

0.44

101

714

Disorders of pituitary gland, other and/or unspecified

469

1.77

3.57

2.7

2.9

4957.43

1263.92

ng/l

0.65

391

Abscess of Bartholin gland

191

1469

1.36

3.57

2.3

2.6

924.66

784.04

ng/l

0.15

145

1200

Benign neoplasm: Other and unspecified parts of small intestine

205

1629

1.40

3.57

3.1

1947.53

1292.97

ng/l

0.73

184

1399

Disorders of puberty, other/unspecified

135

2.32

3.56

3.4

4.8

273.92

915.96

ng/l

1.28

110

Optic neuritis

328

2695

1.27

3.56

2.5

2.9

957.12

955.39

ng/l

0.00

275

2238

Ulcerative enterocolitis

279

2261

1.30

3.55

3.3

3.0

1189.59

1146.04

ng/l

0.07

236

1880

Superficial injury of neck

150

1116

1.42

3.55

3.0

3.1

1312.09

1028.76

ng/l

0.34

118

917

Divergent concomitant strabismus

673

5884

1.18

3.55

3.2

3.0

1038.32

1167.72

ng/l

0.51

567

4925

Cardiovascular devices associated with adverse incidents

100

3.75

3.54

19.3

4.9

2103.48

1051.11

ng/l

0.64

Trichomoniasis

104

749

1.61

3.53

3.0

2.7

2220.48

1022.99

ng/l

0.96

635

Other and unspecified myoneural disorders

306

2.00

3.52

3.5

2.9

1236.35

910.08

ng/l

0.39

252

Sequelae of other and unspecified effects of external causes

413

1.80

3.52

3.6

3.3

938.62

1313.59

ng/l

0.63

339

Oral lichen planus

293

2413

1.31

3.52

2.4

2.8

655.66

1018.49

ng/l

2.18

244

2025

Actinomycosis

297

1.99

3.51

5.0

3.1

999.37

1088.61

ng/l

0.14

242

Colitis due to radiation

145

1108

1.50

3.51

3.8

3.2

1850.69

1841.82

ng/l

0.01

128

965

Sequelae of tuberculosis

253

2058

1.34

3.50

3.9

3.3

2059.45

2375.93

ng/l

0.49

227

1769

Struck by thrown, projected or falling objec

454

3859

1.22

3.50

3.4

3.1

1094.78

1185.26

ng/l

0.22

390

3254

Contact with other sharp object(s)

499

4261

1.21

3.48

2.8

3.0

824.52

1004.44

ng/l

0.84

397

3523

Drug-induced myopathy

248

2.17

3.47

3.0

3.3

2175.03

1735.12

ng/l

0.33

210

Endometriosis of intestine

535

1.58

3.47

2.2

2.6

160.87

643.71

ng/l

2.81

422

Pedestrian injured in collision with pedal cycle

314

2593

1.28

3.47

2.8

3.1

1489.41

1299.93

ng/l

0.29

264

2204

Colitis, primary sclerosing

115

826

1.50

3.47

2.4

3.1

1161.55

851.68

ng/l

0.42

676

Nystagmus and other irregular eye movements

130

957

1.47

3.47

3.1

3.6

1247.33

1085.46

ng/l

0.22

112

799

Acromegaly and pituitary gigantism

520

1.70

3.46

2.5

3.1

836.59

1052.01

ng/l

0.53

436

Sequelae of hyperalimentation

123

2.71

3.43

3.1

3.4

1347.93

1651.27

ng/l

0.15

106

Other congenital malformations of skin

337

2793

1.26

3.43

2.9

3.0

1429.05

1109.48

ng/l

0.53

293

2330

Drug-induced autoimmune haemolytic anaemia

104

3.02

3.42

2.7

2.5

1972.24

957.58

ng/l

0.63

Defects in post-translational modification of lysosomal enzymes

6.02

3.42

2.5

2.0

598.91

339.55

ng/l

0.34

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

453

1.79

3.42

3.5

3.1

1361.67

1318.39

ng/l

0.04

380

Muscle wasting and atrophy, not elsewhere classified

517

1.71

3.41

3.8

3.3

1777.97

1558.59

ng/l

0.22

444

Ectopic pregnancy

1401

12783

1.12

3.40

2.5

629.31

708.53

ng/l

0.51

1156

10722

Tuberculosis, wide

957

8628

1.16

3.40

3.7

3.3

2022.13

1973.86

ng/l

0.11

837

7451

Disorders of phosphorus metabolism and phosphatases

337

1.87

3.39

3.8

2.8

3879.58

1081.83

ng/l

0.82

280

Perioral dermatitis

168

1284

1.38

3.38

2.7

884.04

829.18

ng/l

0.09

134

1061

Encephalopathy

123

915

1.52

3.36

3.0

1612.12

1459.64

ng/l

0.17

108

778

Aphakia

163

1248

1.40

3.36

3.2

3.1

1737.69

1574.53

ng/l

0.23

142

1074

Ulcerative proctitis

518

4460

1.20

3.36

3.0

2.9

1653.33

1148.49

ng/l

1.00

437

3714

Benign neoplasm: Connective and other soft tissue, unspecified

131

980

1.48

3.35

2.9

3.1

1529.66

1227.51

ng/l

0.26

121

832

Third [oculomotor] nerve palsy

224

1809

1.36

3.35

3.5

3.1

1723.13

1588.64

ng/l

0.15

192

1552

Peptic ulcer

121

896

1.51

3.35

3.3

3.1

2133.67

1583.22

ng/l

0.53

106

769

Disorders in reading

475

1.60

3.34

5.3

4.6

295.12

805.40

ng/l

0.89

366

Factitial dermatitis

429

1.78

3.34

3.2

2.7

3039.13

1187.18

ng/l

0.42

360

Benign neoplasm: Larynx

362

3055

1.26

3.34

3.3

3.1

1129.23

1685.66

ng/l

3.00

315

2610

Burn and corrosion of ankle and foot

144

1089

1.44

3.34

3.1

2845.66

1081.84

ng/l

1.64

121

923

Autism spe

105

735

1.47

3.34

3.0

4.2

665.48

646.93

ng/l

0.01

542

Mental and behavioural disorders due to cannabinoids

141

1040

1.40

3.33

2.7

3.4

1149.52

678.17

ng/l

0.39

104

792

Malignant neoplasm of other and unspecified parts of mouth

612

1.70

3.33

3.0

3.1

1373.43

1448.76

ng/l

0.09

520

Other disorders of thyroid

154

1182

1.43

3.32

2.7

2.9

776.06

1024.88

ng/l

0.99

128

995

Other dermatomyositis

372

1.83

3.32

4.4

3.2

1025.16

1446.74

ng/l

0.66

319

Benign neoplasm of ovary

1935

17990

1.10

3.32

2.9

2.8

1093.03

1174.41

ng/l

0.41

1643

15372

Familial chondrocalcinosis

117

3.27

3.30

3.9

3.4

1797.06

1560.33

ng/l

0.11

100

Circumscribed brain atrophy

188

2351

0.74

3.29

2.7

3.1

766.67

1786.72

ng/l

11.68

156

2042

Presbyopia

599

5234

1.19

3.29

2.6

2.8

554.23

942.97

ng/l

7.19

485

4380

Burns and corrosions confined to eye and internal organs

225

1795

1.32

3.29

2.4

3.0

1215.40

988.47

ng/l

0.29

171

1491

Other meningitis

153

1166

1.41

3.28

2.9

3.1

814.90

1029.88

ng/l

0.72

126

973

Spinal enthesopathy

368

3095

1.25

3.28

3.7

3.1

1819.43

2705.66

ng/l

3.63

334

2640

Osteomyelitis of vertebra

283

2.03

3.28

6.3

3.6

3193.29

1537.02

ng/l

0.70

241

Allergic colitis

104

730

1.47

3.27

5.0

5.2

2192.90

975.83

ng/l

0.40

581

Ovarian dysfunction: estrogen excess

3.21

3.27

1.3

3.5

271.29

989.54

ng/l

—

Contact with sharp glass

283

2309

1.27

3.27

2.6

3.0

1142.94

971.17

ng/l

0.21

227

1885

Use of galantamine

1181

10831

1.14

3.26

2.9

3.4

1822.31

2201.12

ng/l

2.30

995

9463

Contusion of toe(s) without damage to nail

186

1447

1.35

3.25

2.9

1534.11

827.69

ng/l

0.94

159

1201

269

1.93

3.25

2.0

2.9

432.07

663.27

ng/l

0.74

226

Malignant neoplasm of bone and articular cartilage of limbs

327

1.89

3.25

4.4

3.1

1563.77

1142.99

ng/l

0.25

272

Ulcerative colitis (strict definition, all Crohn cases excluded)

1263

11504

1.12

3.25

3.1

3.0

1318.39

1219.20

ng/l

0.28

1039

9622

Use of entacapone

903

0.60

3.25

3.0

3.2

1608.77

1978.60

ng/l

0.27

766

Demyelinating diseases of the central nervous system

652

5715

1.17

3.24

2.5

2.8

764.53

915.87

ng/l

0.85

549

4723

Crystalline deposits in vitreous body

127

966

1.52

3.24

3.7

3.2

1064.09

1408.01

ng/l

0.92

109

843

Other disorders of Eustachian tube

287

2367

1.28

3.23

2.7

2.9

958.90

1095.16

ng/l

0.40

254

2000

Hereditary lymphedema

155

2.45

3.23

3.0

2.7

2532.87

1002.38

ng/l

0.77

122

Secondary malignant neoplasm of respiratory and digestive organs

219

1778

1.36

3.23

2.7

3.1

1161.92

1688.89

ng/l

2.25

194

1521

Tuberculosis of other organs

277

2300

1.31

3.23

3.8

3.2

1857.54

1914.58

ng/l

0.07

238

1980

Polyglandular dysfunction

160

2.32

3.23

3.3

3.6

1227.17

844.01

ng/l

0.46

138

Benign neoplasm: Spinal cord

154

1186

1.42

3.23

3.0

920.39

1069.25

ng/l

0.29

124

1006

Diseases caused by chlamydiae

630

1.53

3.23

2.2

2.8

682.83

451.40

ng/l

0.32

509

Peripheral retinal degeneration

326

2728

1.27

3.22

2.8

2.9

1108.35

1223.73

ng/l

0.21

288

2311

Disorders of globe

304

2538

1.29

3.22

3.3

3.0

2213.63

1596.63

ng/l

1.06

274

2185

Hypothermia

218

1759

1.35

3.21

3.4

3.2

2037.42

1613.26

ng/l

0.80

187

1522

Benign neoplasm: Scapula and long bones of upper limb

708

1.54

3.20

3.1

3.2

832.64

828.60

ng/l

0.01

591

Other and unspecified localized connective tissue disorders

277

2.02

3.19

3.0

835.04

1102.65

ng/l

0.39

236

Separation of retinal layers (serosa)

415

3545

1.23

3.19

2.9

3.0

1088.42

1102.25

ng/l

0.03

355

2981

Onychogryphosis

224

2.18

3.19

3.1

3.3

1815.19

1088.44

ng/l

0.57

188

Benign neoplasm: Connective and other soft tissue of thorax

370

1.83

3.18

2.9

3.3

1653.96

1084.09

ng/l

0.39

305

Other and unspecified injuries of forearm

475

1.65

3.17

4.2

3.0

2210.61

1197.04

ng/l

0.54

392

Lower leg

497

1.67

3.17

2.9

3.2

943.99

1191.06

ng/l

0.48

410

Disorders of puberty

401

1.63

3.17

3.3

4.6

284.66

1030.68

ng/l

1.17

311

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

4.12

3.16

4.4

4.0

2094.28

769.59

ng/l

—

Other congenital malformations of skin

665

5858

1.17

3.15

2.8

3.0

1199.43

1126.74

ng/l

0.17

563

4891

Other diseases caused by chlamydiae

104

743

1.48

3.15

2.3

2.8

698.76

627.74

ng/l

0.09

600

0.00

3.14

0.0

10.5

—

1071.40

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

297

1.89

3.13

2.5

3.2

650.12

1286.34

ng/l

1.36

245

Acute nephritic syndrome

224

1813

1.33

3.12

3.5

3.1

6152.88

1234.01

ng/l

3.04

200

1552

Fatigue fracture of vertebra

387

1.78

3.12

3.2

3.8

1824.20

1462.34

ng/l

0.21

335

Valgus deformity, not elsewhere classified

503

1.63

3.11

4.3

3.0

960.55

1159.51

ng/l

0.28

430

Other specified and unspecified disorders of eyelid

164

1286

1.40

3.10

2.7

3.1

727.59

1306.93

ng/l

4.66

139

1101

Other disorders of amino-acid metabolism

363

1.80

3.09

3.6

3.1

3725.64

1515.27

ng/l

0.79

301

Malignant neoplasm of breast, HER-negative

2379

21932

1.09

3.08

2.8

2.9

1337.91

1267.16

ng/l

0.38

2015

18523

Embedded and impacted teeth

1481

11185

1.10

3.08

2.9

2.8

972.56

832.75

ng/l

0.58

1199

8789

Other complications of labour and delivery, not elsewhere classified

322

3567

0.82

3.06

1.8

2.3

210.25

356.15

ng/l

1.71

238

2719

Lichenoid drug reaction

303

2.07

3.06

3.8

3.5

1806.53

1313.83

ng/l

0.33

259

Hydrocephalus in other diseases

471

1.70

3.06

2.9

3.2

668.66

1080.14

ng/l

1.67

392

Tuberculosis of other organs, strict

314

2651

1.28

3.05

3.7

3.2

1787.78

2008.32

ng/l

0.39

272

2278

Disorders of other and unspecified cranial nerves

438

1.72

3.05

3.2

3.0

3464.23

1344.54

ng/l

0.89

380

Precocious central puberty

193

1.95

3.04

2.8

3.4

587.97

897.99

ng/l

0.50

151

Whooping cough

648

1.51

3.03

2.8

1168.08

689.87

ng/l

0.52

518

Carcinoma in situ of oral cavity, oesophagus and stomach

588

1.66

3.03

4.0

3.4

1811.16

1687.06

ng/l

0.11

493

Inflammatory myopathy

164

2.56

3.01

3.9

3.5

1207.38

1792.86

ng/l

0.58

136

Crowding of teeth, including avohilmo

414

2896

1.20

3.00

4.3

3.4

694.31

755.76

ng/l

0.15

323

2275

Convergent concomitant strabismus

414

3531

1.21

2.99

2.7

3.0

1440.31

974.69

ng/l

0.64

343

2917

Urticaria due to cold and heat

472

1.62

2.99

2.8

494.64

628.64

ng/l

0.46

386

Other disorders of carbohydrate metabolism

316

1.82

2.99

2.9

3.2

6003.31

1229.73

ng/l

0.58

254

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

110

807

1.46

2.98

3.2

2269.41

954.29

ng/l

0.95

660

Contracture of joint

131

994

1.43

2.98

3.4

3.1

916.60

1282.59

ng/l

1.50

114

840

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

119

884

1.44

2.98

2.7

3.0

1329.93

997.29

ng/l

0.34

722

Other secondary coxarthrosis

369

3150

1.24

2.98

3.0

1371.55

1286.98

ng/l

0.20

323

2659

Abscess of tendon sheath

453

1.66

2.97

3.4

3.3

2692.46

1105.27

ng/l

0.70

387

Other maltreatment syndromes

214

1713

1.30

2.97

2.3

2.8

1018.32

870.08

ng/l

0.33

166

1388

Acquired keratosis [keratoderma] palmaris et plantaris

369

1.79

2.96

2.5

3.0

513.67

952.95

ng/l

2.58

313

Toxic liver disease

162

1270

1.38

2.96

2.8

3.1

1827.26

1072.66

ng/l

0.89

142

1066

Immunodeficiency associated with other major defects

196

2.13

2.95

2.9

4.0

1550.01

1008.35

ng/l

0.44

164

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

437

3784

1.22

2.95

3.2

3.0

1172.31

1378.30

ng/l

0.72

383

3231

Injury of muscle and tendon at forearm level

179

1417

1.35

2.94

2.7

3.1

1335.21

1000.17

ng/l

0.42

154

1194

Abnormal findings on diagnostic imaging of breast

158

1240

1.39

2.94

3.3

2.7

738.93

969.37

ng/l

0.94

144

1038

Optic atrophy

192

1539

1.34

2.94

3.4

3.2

1177.00

1345.00

ng/l

0.34

163

1301

Exposure to other and unspecified man-made environmental factors

144

1106

1.39

2.94

3.4

3.1

1037.85

982.35

ng/l

0.09

128

921

Retinal breaks without detachment

1843

17198

1.10

2.93

2.9

1079.96

1226.40

ng/l

1.11

1565

14829

Peroneal tendinitis

134

1016

1.40

2.93

2.5

3.0

481.69

958.93

ng/l

2.32

113

849

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

112

845

1.51

2.92

3.4

3.2

2073.53

1590.54

ng/l

0.37

717

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

707

1.46

2.92

2.1

2.6

402.09

391.21

ng/l

0.03

570

Tuberculosis

801

7220

1.16

2.92

3.8

3.2

2192.67

2034.79

ng/l

0.37

711

6207

Aspergillosis

108

810

1.51

2.92

4.9

3.2

1402.38

1352.88

ng/l

0.05

103

689

Epileptic seizures related to drugs

149

2.18

2.90

3.1

3.3

656.62

662.55

ng/l

0.01

119

Pedestrian injured in other and unspecified transport accidents

126

958

1.44

2.89

2.6

3.3

1338.65

1226.36

ng/l

0.13

104

800

Other and unspecified disorders of autonomic nervous system

272

1.88

2.89

3.5

3.0

580.71

1006.42

ng/l

1.37

222

Disorders of male genital organs in diseases classified elsewhere

431

1.67

2.89

3.3

3.5

1399.21

1252.51

ng/l

0.08

362

Recurrent and persistent haematuria

675

1.53

2.88

4.0

3.1

3390.16

1320.81

ng/l

1.17

569

Loose body in joint

231

1886

1.30

2.88

2.8

3.1

1444.12

1471.72

ng/l

0.03

185

1601

Complications associated with artificial fertilization

475

1.55

2.88

1.8

2.6

167.18

653.43

ng/l

1.89

372

Iliotibial band syndrome

102

746

1.48

2.88

2.7

3.0

1043.69

991.15

ng/l

0.04

625

All dysplastic lesions of the cervix uteri, vagina or vulva

2030

18639

1.08

2.88

2.6

2.4

668.25

698.12

ng/l

0.22

1668

15205

Combined immunodeficiencies

120

910

1.46

2.87

3.9

3.0

1853.19

1341.61

ng/l

0.65

108

773

Other and unspecified vaccines and biological substances

372

1.69

2.87

3.2

2.8

418.84

742.64

ng/l

2.39

298

Polyarteritis nodosa

612

1.58

2.87

3.9

3.1

3308.69

1518.56

ng/l

0.52

522

Nontraumatic intracranial haemmorrhage

2729

25815

1.08

2.87

3.2

3.1

1851.40

1763.12

ng/l

0.43

2389

22273

Acquired pure red cell aplasia [erythroblastopenia]

381

1.77

2.87

4.5

3.2

2199.22

1313.72

ng/l

1.08

318

Vascular dementia (undefined)

575

5038

1.18

2.86

3.4

3.5

2856.18

2732.21

ng/l

0.21

478

4419

Toxic encephalopathy

203

2.23

2.86

3.7

3.5

1576.13

1427.17

ng/l

0.08

172

Malignant neoplasm of ureter, including Hilmo

116

889

1.50

2.85

2.4

3.1

3067.55

1932.95

ng/l

0.67

105

766

Drug-induced tremor

590

1.60

2.84

3.1

3.3

2718.35

1223.85

ng/l

0.70

496

Benign neoplasm: Oesophagus

145

1136

1.42

2.84

3.3

3.0

1489.88

1381.88

ng/l

0.16

116

966

Other disorders of central nervous system

118

888

1.44

2.84

2.5

3.1

1137.85

1223.14

ng/l

0.06

743

Malignant neoplasm of testis, including Hilmo

159

1242

1.36

2.83

3.3

3.2

1335.39

1545.40

ng/l

0.31

137

1040

Dementia due to Parkinsons disease, excluding more controls

282

2373

1.28

2.83

3.2

3.0

1534.22

1971.52

ng/l

1.00

235

2071

Benign neoplasm: Choroid

712

6394

1.16

2.82

3.2

3.0

1650.29

1389.45

ng/l

0.42

602

5490

Motorcycle rider injured in other and unspecified transport accidents

402

3437

1.20

2.82

2.8

3.0

1371.82

1057.89

ng/l

0.52

311

2802

Benign neoplasm: Long bones of lower limb

275

2285

1.26

2.81

2.9

3.0

1079.77

1069.57

ng/l

0.01

226

1903

Chronic hepatitis NAS

138

1069

1.41

2.81

2.9

3.0

2790.62

1036.75

ng/l

1.13

129

900

Wide developmental disorders

134

1007

1.36

2.79

3.2

4.5

675.71

854.81

ng/l

0.19

772

Other hyperalimentation

262

1.93

2.79

3.0

3.1

1086.90

1413.40

ng/l

0.31

220

Heberden's nodes [with arthropathy]

108

816

1.50

2.79

3.0

570.56

1091.42

ng/l

3.20

686

Tic and related disorders

490

1.54

2.79

3.2

3.7

475.56

962.37

ng/l

2.56

399

Hypersensitivity angiitis

441

1.70

2.79

3.3

3.0

4711.93

1283.32

ng/l

0.76

370

Other, unspecified and serous retinal detachments

350

2997

1.24

2.78

3.9

3.1

2134.67

1476.23

ng/l

1.32

314

2558

Alcohol-induced acute pancreatitis

359

3074

1.23

2.76

3.0

3.1

2017.82

1293.23

ng/l

1.41

306

2606

Unspecified renal colic

480

1.63

2.76

3.0

2.9

2326.12

1401.64

ng/l

0.52

406

Malignant neoplasm of vulva, including Hilmo

173

1395

1.37

2.76

3.3

2.9

1669.11

1273.43

ng/l

0.67

141

1175

Malignant neoplasm of endocrine gland

680

6072

1.16

2.76

3.1

3.0

1454.83

1190.80

ng/l

0.45

575

5122

Major anomalies of jaw size

211

1708

1.29

2.76

3.0

531.43

781.25

ng/l

1.53

173

1410

Benign neoplasm: Pharynx, unspecified

631

1.54

2.75

3.0

3.1

2201.59

1232.56

ng/l

0.43

528

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

206

1689

1.33

2.75

3.1

1734.35

1481.17

ng/l

0.31

184

1423

Viral infections of central nervous system, not elsewhere classified/unspecified

134

1031

1.40

2.75

2.4

3.0

673.54

1016.89

ng/l

1.00

107

866

Mental and behavioural disorders associated with the puerperium

452

1.57

2.75

2.0

2.7

615.46

723.23

ng/l

0.14

360

Hypertrophy of (infrapatellar) fat pad

607

1.51

2.74

4.1

3.3

859.12

1150.97

ng/l

0.37

503

Other disorders of bone density and structure

226

1849

1.28

2.74

3.7

2.8

1023.81

1001.35

ng/l

0.05

185

1541

Hepatocellular carcinoma

262

2199

1.28

2.73

2.8

3.2

1473.94

1850.49

ng/l

0.49

230

1908

Failed induction of labour

238

1934

1.25

2.72

1.7

2.5

351.94

344.80

ng/l

0.02

162

1498

Mild or no visual impairment, binocular

340

1.74

2.72

3.0

3.3

1707.37

1221.84

ng/l

0.39

288

Other injuries of upper limb, level unspecified

125

958

1.42

2.72

3.2

1536.30

1253.44

ng/l

0.46

106

800

Burn and corrosion of other internal organs

207

1.99

2.72

2.3

3.3

344.11

716.42

ng/l

2.02

173

Thyrotoxicosis with toxic single thyroid nodule

727

1.50

2.72

2.8

3.0

1176.54

1089.82

ng/l

0.11

617

Other cranial nerve disorders in other disorders

210

2.05

2.71

4.2

2.9

787.73

1532.14

ng/l

0.99

180

Disorders of parathyroid gland, other and/or unspecified

693

1.55

2.71

3.4

3.0

1824.58

1464.45

ng/l

0.36

588

Malignant neoplasm of adrenal gland, including Hilmo

565

1.57

2.71

3.0

3.3

2942.06

1292.01

ng/l

0.81

465

Other acquired deformities of musculoskeletal system and connective tissue

462

4036

1.19

2.71

3.2

3.0

1176.40

1222.55

ng/l

0.10

401

3407

Optic atrophy

181

1456

1.34

2.71

3.4

3.2

1189.45

1301.01

ng/l

0.20

155

1229

Use of rivastigmine

2100

22183

0.92

2.71

2.7

3.4

1804.65

2166.81

ng/l

2.84

1785

19259

Perineal laceration during delivery

626

5933

0.87

2.71

2.0

2.3

262.80

427.79

ng/l

2.14

486

4634

Other specified and unspecified disorders of iris and ciliary body

294

1.82

2.70

2.3

3.3

2126.64

920.80

ng/l

0.48

251

Disorders of glycoprotein metabolism

2.97

2.70

2.1

2.3

782.00

548.88

ng/l

0.26

Congenital musculoskeletal deformities of head, face, spine and chest

597

1.50

2.70

3.1

3.3

649.81

1228.38

ng/l

1.22

479

Melanoma in situ

541

4809

1.19

2.69

3.0

3.2

2132.88

1536.41

ng/l

0.74

460

4166

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

322

2758

1.25

2.68

2.6

2.9

1781.26

1215.78

ng/l

0.56

294

2328

Injury of nerves and spinal cord at neck level

237

1967

1.29

2.67

3.7

3.1

1034.42

1263.96

ng/l

0.72

206

1691

Familial erythrocytosis

393

1.69

2.66

2.7

3.1

1816.24

1218.37

ng/l

0.41

336

IBD (strict) with PSC

534

1.53

2.65

2.2

3.2

796.53

591.88

ng/l

0.24

435

Foreign body entering into or through eye or natural orifice

736

6611

1.14

2.65

3.2

3.1

1592.27

1293.71

ng/l

0.87

607

5557

Galactorrhea

483

1.55

2.64

2.7

2.8

651.02

593.14

ng/l

0.09

390

Deep bite

808

6370

1.13

2.64

3.4

3.2

793.36

938.02

ng/l

0.46

666

5277

Congenital hypothyroidism without goiter

359

1.70

2.64

3.9

3.8

1586.08

1147.87

ng/l

0.25

295

Carcinoma in situ of larynx

179

2.33

2.63

3.4

3.5

896.33

1419.84

ng/l

0.49

152

Other hereditary haemolytic anaemias

433

1.63

2.63

6.4

3.2

1482.75

947.56

ng/l

0.43

358

Other specified and unspecified strabismus

108

811

1.43

2.63

2.6

3.4

1467.95

912.14

ng/l

0.35

685

Epiphora

246

2056

1.28

2.63

2.8

3.1

1126.68

1365.07

ng/l

0.53

214

1733

Burn and corrosion of hip and lower limb, except ankle and foot

212

1734

1.29

2.61

3.2

2014.55

1202.26

ng/l

0.51

176

1449

Premature rupture of membranes

979

7726

0.90

2.61

2.2

2.3

351.35

466.97

ng/l

0.74

735

6153

Malignant neoplasm of brain, including Hilmo

381

4404

0.83

2.61

2.8

3.1

773.31

1440.86

ng/l

7.04

343

3735

LSIL lesion of the cervix uteri, vagina or vulva

940

8530

1.12

2.59

2.5

665.09

715.51

ng/l

0.26

780

6984

Cyst of Bartholin Gland

285

2392

1.23

2.59

2.3

2.8

577.26

746.63

ng/l

1.12

232

1995

Deaf mutism, not elsewhere classified

421

1.66

2.59

2.8

3.0

3572.35

1341.27

ng/l

0.90

361

Macular cyst

355

3078

1.23

2.58

3.0

3.1

1559.12

1430.70

ng/l

0.22

303

2637

Undescended testis, unilateral

362

1.62

2.58

4.3

5.8

1005.18

1531.78

ng/l

0.49

299

Varus deformity, not elsewhere classified

104

780

1.44

2.57

2.6

3.2

752.15

1063.40

ng/l

0.92

663

Chronic thyroiditis

324

1.77

2.57

3.4

2.9

1693.62

1196.43

ng/l

0.31

273

Disease of thymus, other/unspecified

131

2.37

2.57

3.0

3.6

1134.58

1090.58

ng/l

0.04

102

Serous carcinoma of ovary

771

0.61

2.55

2.6

3.0

933.23

1503.73

ng/l

1.45

648

Lagophthalmos

157

1263

1.37

2.55

2.5

3.2

2125.97

1471.25

ng/l

0.69

137

1091

Congenital malformations of posterior segment of eye

354

1.69

2.54

6.1

3.4

1579.67

1300.90

ng/l

0.17

296

Impacted maxillary molar

236

1932

1.24

2.54

2.9

3.0

691.39

658.38

ng/l

0.05

185

1437

Tic disorders

484

1.52

2.54

3.1

3.8

483.05

1278.52

ng/l

1.47

380

Gonococcal infection

278

2340

1.24

2.53

2.3

2.9

966.70

824.84

ng/l

0.33

227

1937

Congenital musculoskeletal deformities of head, face, spine and chest

664

1.45

2.53

3.0

3.3

634.73

1138.11

ng/l

1.16

539

Parapsoriasis

185

1502

1.31

2.52

2.9

3.0

1297.81

1298.72

ng/l

0.00

156

1284

Malignant neoplasm of renal pelvis, including Hilmo

151

1212

1.38

2.52

3.2

3910.79

1807.73

ng/l

2.15

140

1044

Ankyloglossia

448

1.52

2.51

7.7

5.8

685.60

1364.70

ng/l

0.91

351

Malignant neoplasm of thyroid gland

631

5647

1.15

2.50

3.1

2.9

1179.08

1186.92

ng/l

0.02

536

4758

Cholera

146

2.21

2.50

2.5

2.8

1368.46

1081.40

ng/l

0.24

116

Contact urticaria

196

1.94

2.50

3.0

2237.41

1146.84

ng/l

0.36

162

Maternal care for other known or suspected fetal problems

1134

6553

1.10

2.49

2.0

2.3

295.22

366.23

ng/l

0.80

820

5136

Anuria and oliguria

657

1.52

2.49

3.7

3.4

2812.82

1769.50

ng/l

0.82

564

Normal-pressure hydrocephalus

673

6101

1.16

2.49

2.6

3.2

1119.62

1881.89

ng/l

7.35

571

5324

Benign neoplasm of other and unspecified female genital organs

432

3788

1.19

2.47

2.6

2.9

920.63

1132.32

ng/l

0.64

355

3184

Injury of urinary and pelvic organs

201

1650

1.29

2.47

3.5

3.2

2136.56

1499.84

ng/l

0.80

168

1398

Normotensive glaucoma

1162

10782

1.12

2.47

3.1

1593.63

1659.42

ng/l

0.16

1004

9351

Retinoschisis and retinal cysts

280

2391

1.25

2.45

3.1

1328.26

1401.05

ng/l

0.12

238

2057

Injury of nerves at shoulder and upper arm level

110

842

1.42

2.45

2.6

3.1

1094.31

995.34

ng/l

0.12

698

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

523

4610

1.16

2.43

2.5

663.88

564.11

ng/l

0.23

423

3764

Labour and delivery complicated by umbilical cord complications

311

2640

1.21

2.43

2.3

2.6

415.67

576.83

ng/l

1.12

263

2183

Brain meningioma, including Hilmo

554

4946

1.17

2.42

2.6

3.0

1253.66

1370.87

ng/l

0.28

476

4201

Assault by other specified means

459

1.53

2.41

3.1

2.6

1371.18

558.70

ng/l

1.21

362

Complications following myocardial infarction

725

1.46

2.40

3.8

2.6

2023.76

1698.53

ng/l

0.37

598

Melanocytic naevi of lower limb, including hip

394

3431

1.19

2.40

3.1

3.0

1398.96

1156.14

ng/l

0.48

329

2874

Myositis ossificans

225

1.90

2.39

2.6

3.1

1190.18

1418.46

ng/l

0.26

184

All dysplastic lesions of the vagina

225

1870

1.26

2.38

2.9

2.8

655.66

865.44

ng/l

1.13

190

1564

Postpartum haemorrhage due to anatomy

417

3611

1.17

2.38

2.0

2.2

223.73

342.61

ng/l

1.98

302

2816

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

247

2093

1.26

2.36

3.4

3.1

1479.99

1701.98

ng/l

0.28

215

1778

Defect, injury or illness of neck

376

1.62

2.35

2.2

2.8

736.42

1196.00

ng/l

0.60

313

Other and unspecified injuries of abdomen, lower back and pelvis

141

1119

1.34

2.35

4.3

3.1

1613.16

1276.72

ng/l

0.38

120

945

Malignant neoplasm of lip

102

787

1.45

2.34

3.9

3.2

3091.89

2245.97

ng/l

0.51

681

Congenital malformations of larynx

138

2.05

2.34

3.9

6.2

483.16

1141.86

ng/l

2.27

120

Periodontal disease, other/unspecified

254

2145

1.24

2.33

2.8

3.0

964.17

1113.50

ng/l

0.19

209

1824

HSIL lesion of the cervix uteri, vagina or vulva

1262

11663

1.09

2.33

2.6

2.5

692.10

681.54

ng/l

0.05

1027

9476

Adenocarcinoma and papillary adenocarcinoma of stomach

239

2826

0.80

2.33

2.7

3.1

2002.47

1876.69

ng/l

0.13

221

2419

Benign neoplasm: Appendix

135

1080

1.38

2.32

3.2

3.1

1127.87

1379.52

ng/l

0.49

120

923

Other and unspecified intracranial injuries

309

2656

1.22

2.32

3.3

3.0

2135.48

1761.55

ng/l

0.54

261

2266

Other adrenocortical overactivity

252

1.72

2.31

3.8

4.3

851.11

797.93

ng/l

0.06

202

Brain meningioma

535

4784

1.16

2.30

2.5

3.0

1274.10

1373.27

ng/l

0.22

459

4061

Injury of blood vessels at lower leg level

382

1.65

2.30

4.2

2.9

2420.67

1220.87

ng/l

1.15

316

Moderate mental retardation

376

1.60

2.30

3.0

3.6

835.61

1057.78

ng/l

0.32

311

Traumatic amputation of ankle and foot

205

1.95

2.29

2.8

3.2

2471.96

1064.73

ng/l

0.40

176

Benign neoplasm: Retina

467

1.58

2.29

2.7

3.3

1159.95

1391.88

ng/l

0.17

387

Benign neoplasm: Bronchus and lung

153

1241

1.34

2.29

3.1

1122.40

1476.39

ng/l

1.04

134

1062

Other and unspecified parapsoriasis

473

1.62

2.29

3.1

3.2

1442.49

1211.04

ng/l

0.32

404

Congenital myopathies

112

2.27

2.29

2.8

3.4

884.24

921.50

ng/l

0.02

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

337

2887

1.19

2.29

2.3

2.2

308.26

376.91

ng/l

0.44

266

2302

Other osteochondrodysplasias

101

769

1.41

2.29

2.8

3.3

1908.10

975.44

ng/l

0.91

647

Malignant neoplasm of eye, brain and central nervous system

323

3736

0.83

2.28

2.7

3.1

818.97

1452.68

ng/l

4.87

283

3151

Universal erythroderma, KELA reimbursement

149

1200

1.34

2.28

3.6

3.2

2787.05

1259.83

ng/l

0.71

123

1015

Mental and behavioural disorders of puerperium, not classified elsewhere

472

1.49

2.27

2.0

2.5

615.46

553.81

ng/l

0.09

377

Benign neoplasm: Bladder

121

960

1.40

2.25

3.7

3.2

1820.86

1695.97

ng/l

0.13

102

827

HSIL lesion of the vagina

126

992

1.36

2.25

3.1

2.9

898.09

987.23

ng/l

0.18

102

824

Inhalation and ingestion of other objects causing obstruction of respiratory tract

439

1.56

2.25

3.0

3.2

1370.63

1334.04

ng/l

0.03

362

Delayed puberty

181

1.79

2.24

4.3

5.8

176.30

1364.29

ng/l

0.69

128

Neuroendocrine tumor and carcinoma of lung

748

1.45

2.24

2.4

2.9

1142.37

1426.06

ng/l

0.43

629

Disorder of pancreatic internal secretion, other and/or unspecified

587

1.50

2.24

2.9

3.3

1648.50

1034.60

ng/l

0.59

497

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

177

1471

1.32

2.23

3.6

3.1

2043.52

1796.90

ng/l

0.25

151

1280

Nonpyogenic thrombosis of intracranial venous system

652

1.44

2.22

2.4

3.1

1833.09

798.02

ng/l

1.04

544

Pregnancy with abortive outcome

7291

36846

1.04

2.22

2.8

1041.52

1122.91

ng/l

1.00

6066

31040

Congenital malformations of oesophagus

478

1.56

2.22

2.8

3.3

708.84

1529.12

ng/l

3.31

407

Thalassaemia

210

1.81

2.21

3.6

3.4

574.36

1277.46

ng/l

1.15

176

Alcohol abuse counselling and surveillance

147

1181

1.32

2.20

2.2

2.9

1064.99

902.93

ng/l

0.33

117

975

Tic and related disorders

516

1.46

2.20

3.2

4.5

475.56

1328.99

ng/l

1.77

402

Chloasma

326

1.67

2.19

2.2

2.6

587.37

921.70

ng/l

1.27

272

Arthropathy in ulcerative colitis

107

825

1.38

2.19

3.4

3.1

1209.68

751.93

ng/l

0.92

693

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

431

3808

1.17

2.19

2.7

2.9

1133.00

1141.28

ng/l

0.02

379

3204

Reduction defects of lower limb

228

1.80

2.19

2.5

3.3

488.35

960.93

ng/l

1.55

192

Other and unspecified neuropathies

371

1.65

2.19

3.2

3.1

802.49

1198.71

ng/l

0.70

307

Toxic effect of other gases, fumes and vapours

408

1.57

2.18

4.8

3.3

1891.15

1207.88

ng/l

0.66

338

Acute myeloid leukaemia, including Hilmo

120

952

1.38

2.18

3.5

3.3

1289.96

1893.07

ng/l

1.57

115

809

Acute myeloid leukaemia

120

952

1.38

2.18

3.5

3.3

1289.96

1893.07

ng/l

1.57

115

809

Acute myeloid leukaemia, helper endpoint

120

952

1.38

2.18

3.5

3.3

1289.96

1893.07

ng/l

1.57

115

809

Gonococcal infection

284

2429

1.21

2.17

2.3

2.9

948.43

855.22

ng/l

0.20

233

2007

Other congenital malformations of intestine

113

885

1.38

2.17

3.0

3.4

1484.43

1040.93

ng/l

0.33

755

Malignant neoplasm of pancreas

718

7859

0.88

2.17

2.5

3.2

1230.35

1738.36

ng/l

3.70

632

6764

Venous complications and haemorrhoids in the puerperium

714

1.41

2.17

2.3

2.9

450.41

737.47

ng/l

1.80

601

Generalized epilepsy, mode (most common among epilepsy diagnosis)

231

1938

1.23

2.17

2.7

3.1

764.46

1090.42

ng/l

1.16

187

1606

Rhinophyma

643

1.50

2.16

3.3

1528.70

1676.62

ng/l

0.14

541

Other disorders of amniotic fluid and membranes

654

5738

1.12

2.14

2.2

2.4

322.94

407.98

ng/l

0.66

499

4553

Human immunodeficiency virus [HIV] disease resulting in other conditions

1103

0.72

2.14

2.5

3.1

952.43

954.73

ng/l

0.00

915

Injury of blood vessels of thorax

280

1.73

2.14

4.0

3.2

2624.29

1365.49

ng/l

0.77

237

Malignant neoplasm of cervix uteri, including Hilmo

228

1923

1.24

2.14

2.8

2691.74

1171.39

ng/l

1.29

199

1607

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

601

5445

1.15

2.13

3.0

3.2

1345.96

1831.94

ng/l

1.80

524

4714

Colour vision deficiencies

219

1.75

2.12

2.3

3.5

836.80

1207.09

ng/l

0.50

180

Golimumab

235

1977

1.23

2.12

2.1

2.9

805.24

814.22

ng/l

0.01

198

1621

Syndactyly

189

1.83

2.12

6.3

3.0

962.80

817.03

ng/l

0.17

149

Burn and corrosion of respiratory tract

2.50

2.11

3.1

3.8

3127.17

1020.71

ng/l

—

Other articular cartilage disorders

228

1928

1.24

2.10

2.9

3.0

1017.31

1288.98

ng/l

0.60

193

1637

Femoral hernia, bilateral

293

1.75

2.10

3.3

4168.29

1778.08

ng/l

0.70

246

Unspecified abortion

347

3016

1.18

2.10

2.1

2.6

693.43

647.19

ng/l

0.04

277

2534

Acanthosis nigricans

223

1.79

2.09

3.1

1608.86

833.57

ng/l

0.75

192

Benign neoplasm: Prostate

772

1.45

2.09

3.2

3.3

1701.23

1653.58

ng/l

0.06

679

Type 1 diabetes, strict definition

349

3011

1.17

2.09

2.7

2.9

1680.40

431.44

ng/l

3.01

285

2330

Injury of nerves and spinal cord at thorax level

380

1.59

2.07

2.6

3.1

834.09

1003.15

ng/l

0.21

310

Cholesteatoma of middle ear

586

5306

1.15

2.07

3.3

3.1

1870.84

1620.27

ng/l

0.30

503

4569

Other zoonotic bacterial diseases, not elsewhere classified

402

1.61

2.07

2.6

3.1

2850.60

1615.00

ng/l

1.13

341

Other congenital malformations of tongue, mouth and pharynx

689

1.37

2.06

6.8

4.8

910.96

1287.68

ng/l

0.60

555

Unspecified transport accident

279

1.67

2.06

2.2

3.3

690.53

1190.45

ng/l

1.01

228

Tarsal tunnel syndrome

111

877

1.37

2.05

2.6

2.9

1057.97

1086.14

ng/l

0.03

101

748

Human immunodeficiency virus [HIV] disease

1241

0.74

2.05

2.6

3.1

933.68

1015.21

ng/l

0.14

1032

Motor neuron disease (with DMD)

197

1650

1.26

2.04

3.0

2.9

973.53

1560.77

ng/l

1.83

164

1429

Foreign body in genitourinary tract

679

1.41

2.03

3.3

3.0

1310.35

1038.89

ng/l

0.53

571

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

102

798

1.39

2.02

4.8

3.1

1883.21

1269.52

ng/l

0.43

673

MS-disease / Multiple Sclerosis

519

4642

1.14

2.02

2.5

2.8

674.56

889.93

ng/l

1.70

434

3806

Cutis laxa senilis

706

1.43

2.01

2.6

2.8

1021.10

1110.07

ng/l

0.11

598

Xanthelasma of eyelid

775

1.40

2.01

2.6

3.1

1173.41

1371.55

ng/l

0.29

667

Other protozoal intestinal diseases

126

1006

1.33

2.01

2.7

3.0

730.91

1203.04

ng/l

2.05

853

Diseases of thymus

213

1.85

2.00

3.0

3.1

999.55

1198.12

ng/l

0.24

170

Ankylosis of joint

452

1.53

1.99

3.0

1613.79

1511.29

ng/l

0.09

387

Arthropathy in Crohn disease

636

1.41

1.99

2.5

2.9

1059.85

763.15

ng/l

0.42

531

Degeneration of the brain due to alcohol

251

2164

1.23

1.99

3.1

2717.13

1507.73

ng/l

1.34

216

1888

Other protozoal intestinal diseases

173

1428

1.26

1.99

2.7

2.8

694.62

1026.69

ng/l

1.72

137

1195

Abscess of external ear

121

963

1.33

1.99

3.7

3.2

1451.46

1037.76

ng/l

0.59

100

801

Acute mastoiditis

585

1.43

1.99

3.4

3.3

1154.48

961.59

ng/l

0.16

490

Plasmodium falciparum malaria

180

0.39

1.98

2.0

2.9

752.76

1096.35

ng/l

—

147

Lipoprotein deficiency

174

1.96

1.98

3.3

3.0

958.81

1228.93

ng/l

0.28

148

Caught, crushed, jammed or pinched in or between objects

410

3627

1.16

1.98

2.8

3.1

930.48

1112.08

ng/l

0.68

324

3042

Exposure to excessive natural heat

199

1.91

1.98

2.8

3.3

2666.50

1940.98

ng/l

0.18

160

Marginal zone B-cell lymphoma

111

888

1.38

1.98

2.6

3.1

1874.27

1415.41

ng/l

0.46

752

Degeneration of nervous system due to alcohol

251

2166

1.23

1.97

3.1

2717.13

1509.09

ng/l

1.34

216

1884

Benign neoplasm: Skin of lip

155

1282

1.30

1.97

2.6

3.0

1332.48

1323.95

ng/l

0.01

135

1093

Exfoliative dermatitis

125

1010

1.34

1.97

3.3

3023.22

1625.34

ng/l

0.58

116

872

Intentional self-harm by hanging, strangulation and suffocation

469

0.59

1.97

3.2

3.1

859.09

1376.27

ng/l

0.66

382

Melanoma in situ of other and unspecified parts of face

167

1406

1.31

1.96

2.8

3.1

2533.31

1544.89

ng/l

0.50

142

1221

Guillain-Barre syndrome

164

1359

1.28

1.96

3.2

3.1

1674.23

1345.12

ng/l

0.29

143

1169

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

100

787

1.39

1.96

2.9

3.3

1950.17

1420.28

ng/l

0.55

667

Contact with hot air and gases

486

1.49

1.96

2.5

3.3

1659.00

1379.03

ng/l

0.29

413

Epidural haemorrhage

629

1.41

1.96

3.2

2.7

1934.70

1424.89

ng/l

0.35

530

Superficial frostbite

476

1.49

1.96

3.3

3.1

1763.95

1288.26

ng/l

0.30

382

Malignant neoplasm of parotid gland, including Hilmo

115

922

1.36

1.96

2.6

3.1

1115.45

1456.94

ng/l

0.85

100

776

Mandibular retrognathia

405

3561

1.16

1.95

2.6

3.0

442.27

709.81

ng/l

2.71

326

2903

Malignant neoplasm of other and unspecified parts of biliary tract

174

1459

1.28

1.95

3.7

3.0

1404.98

1739.77

ng/l

0.51

154

1236

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

695

6362

1.13

1.94

3.0

1253.30

1325.39

ng/l

0.21

607

5431

Benign neoplasm of male genital organs

236

2032

1.23

1.91

3.2

3.3

2047.40

1933.23

ng/l

0.11

197

1770

Dacryoadenitis

647

1.42

1.91

3.2

3.3

1292.87

1630.76

ng/l

0.41

552

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

139

1125

1.29

1.90

3.6

3.5

2059.00

854.34

ng/l

1.33

126

926

Contact with lifting and transmission devices, not elsewhere classified

167

1388

1.27

1.90

2.4

3.1

800.30

1091.78

ng/l

0.97

133

1172

Hypopituitarism after medical therapy

4.75

1.90

27.4

4.8

1247.57

966.57

ng/l

—

Acute otitis externa, noninfective

167

1390

1.27

1.90

3.8

2.9

1175.74

1081.84

ng/l

0.16

146

1181

Postpartum care and examination

643

3672

1.12

1.90

2.0

2.2

375.58

377.91

ng/l

0.01

477

2837

Infections of breast associated with childbirth

186

1544

1.23

1.90

2.4

2.5

335.50

511.87

ng/l

1.02

151

1241

Apocrine sweat disorders, other sweat gland disorders

357

1.60

1.89

4.7

3.2

1690.31

1164.27

ng/l

0.65

303

Intracerebral haemorrhage

1695

16053

1.08

1.88

3.4

3.1

1866.43

1939.72

ng/l

0.26

1483

13846

Benign neoplasm of other and unspecified sites

340

3000

1.18

1.88

3.0

854.07

1299.42

ng/l

2.54

283

2556

Malignant neoplasm of ovary

507

4582

1.15

1.87

2.8

2.9

1038.76

1230.24

ng/l

0.59

447

3883

Other congenital malformations of posterior segment of eye (coloboma)

2.84

1.87

3.5

3.2

577.64

2263.69

ng/l

0.65

Burn and corrosion, body region unspecified

395

1.52

1.87

2.8

3.2

5019.89

1039.72

ng/l

0.69

333

Mesothelioma, including Hilmo

163

1368

1.29

1.86

3.5

3.1

1269.42

1843.17

ng/l

1.77

149

1186

Chromophobe cell carcinoma of kidney

507

1.51

1.86

3.7

3.2

1953.12

1326.97

ng/l

0.44

433

Beningn neoplasm: Meninges, unspecified

184

1558

1.27

1.85

3.4

3.0

1988.59

1385.03

ng/l

0.65

157

1323

Osteitis due to dental implant

709

1.42

1.85

3.2

3.1

2008.51

1179.27

ng/l

0.50

602

Glaucoma secondary to eye inflammation

720

1.39

1.85

3.4

3.2

2138.77

1428.99

ng/l

0.53

603

Malignant neoplasm of rectosigmoid junction, including Hilmo

342

3033

1.19

1.84

2.6

3.0

1472.79

1724.13

ng/l

0.68

300

2595

Other injuries of spine and trunk, level unspecified

702

1.39

1.84

3.7

3.2

2233.54

1103.33

ng/l

0.60

596

Sequelae of malnutrition and other nutritional deficiencies

186

1.87

1.83

4.7

3.3

3653.92

1908.33

ng/l

0.46

161

Inflammation of lacrimal passages (chronic)

189

1606

1.26

1.83

3.2

3.1

1553.78

1628.46

ng/l

0.09

172

1371

Other nutritional anaemias

117

946

1.34

1.83

3.7

3.1

2439.49

1801.19

ng/l

0.78

107

808

Congenital malformations of anterior segment of eye

587

1.42

1.82

2.7

3.5

624.73

1033.87

ng/l

1.75

497

Abnormal reflex

382

1.54

1.82

2.7

3.1

1262.73

816.51

ng/l

0.34

305

Other and unspecified pemphigus

293

1.66

1.82

3.8

3.7

2775.52

1208.24

ng/l

1.09

252

Aggressive periodontitis

217

1860

1.23

1.82

2.8

3.1

1735.11

1175.86

ng/l

0.84

186

1589

Enteritis due to Yersinia enterocolitica

338

1.56

1.81

3.8

3.4

656.37

1215.40

ng/l

1.24

283

Bullous keratopathy

112

910

1.36

1.81

3.1

3.3

2605.30

1489.12

ng/l

0.72

777

Social disorders starting during childhood or adolecense, excluding more controls

178

1.69

1.80

3.2

2.9

1239.87

541.94

ng/l

0.31

139

Labyrinthine fistula

287

1.69

1.80

3.1

3.6

2335.63

1216.02

ng/l

0.55

250

Female infertility

2168

12485

1.06

1.79

2.3

2.5

546.58

924.41

ng/l

8.40

1767

10362

Benign neoplasm: Other parts of oropharynx

750

1.37

1.79

3.3

3.0

1339.62

1135.74

ng/l

0.19

626

Unspecified multiple injuries

216

1.72

1.79

3.0

2.8

964.64

1430.38

ng/l

0.52

175

Seminoma of testis

535

1.43

1.79

2.6

3.0

965.00

1116.19

ng/l

0.21

432

Certolizumab pegol

111

881

1.31

1.79

1.9

2.7

605.41

608.42

ng/l

0.01

709

Type 1 diabetes, strict definition, subgroup 1

319

2772

1.16

1.79

2.5

2.9

1744.38

411.33

ng/l

2.90

260

2127

Liposarcoma, including Hilmo

116

943

1.34

1.79

3.3

3.0

1802.71

1483.28

ng/l

0.36

103

804

Dietary zinc deficiency

4.64

1.78

2.5

2.0

878.67

926.19

ng/l

—

Other congenital malformations of tongue, mouth and pharynx

482

1.41

1.78

8.3

5.5

911.47

1438.82

ng/l

0.64

381

Other congenital malformations of limb(s)

260

1.57

1.77

6.6

4.1

1489.35

687.23

ng/l

0.46

210

Motor- or nonmotor-vehicle accident in traffic area

423

1.47

1.76

3.1

791.33

1042.67

ng/l

0.43

348

Anoxic brain damage

156

1307

1.28

1.76

4.5

3.1

2608.32

1850.37

ng/l

0.82

146

1125

Burns and corrosions of multiple and unspecified body regions

200

1700

1.23

1.76

2.9

3.3

2348.10

1291.87

ng/l

0.67

170

1439

Eccrine sweat disorders

195

1.80

1.76

2.3

3.3

1156.44

1237.31

ng/l

0.05

169

Juvenile Open Angle Glaucoma

348

1.53

1.76

2.7

2.9

659.08

811.44

ng/l

0.29

286

Need for immunization against combinations of infectious diseases

3.06

1.76

3.1

8210.88

504.82

ng/l

—

Paget disease

523

1.49

1.74

3.1

2.9

1608.38

1419.26

ng/l

0.19

442

Ulcerative colitis (strict) with PSC

441

1.45

1.73

2.3

3.3

951.17

606.06

ng/l

0.33

360

Seminoma of testis, including Hilmo

625

1.38

1.73

2.9

3.1

1003.24

1229.64

ng/l

0.36

511

Other and unspecified disease of Bartholin gland

279

2445

1.19

1.73

2.5

2.9

1095.40

1150.53

ng/l

0.09

241

2067

Overjet

118

939

1.28

1.72

3.1

4.3

693.01

677.90

ng/l

0.02

778

Other superficial injuries of ankle and foot

357

1.50

1.71

2.7

3.2

890.93

846.59

ng/l

0.06

288

Sickle-cell disorders

196

1.77

1.71

3.5

3.3

469.79

1799.03

ng/l

2.43

162

Carcinoma in situ of vagina

318

1.56

1.70

4.0

3.0

1453.45

824.14

ng/l

0.35

268

Intrahepatic Cholestasis of Pregnancy (ICP)

337

2963

1.15

1.70

2.3

2.4

308.26

428.20

ng/l

0.92

266

2378

Benign neoplasm: Skin of lower limb, including hip

280

2458

1.19

1.70

3.4

2.9

1272.13

1241.33

ng/l

0.05

244

2086

Chronic diseases of tonsils and adenoids

8760

54016

1.03

1.70

2.8

2.9

834.12

1154.10

ng/l

11.29

7183

45684

Abnormal findings in cerebrospinal fluid

220

1.70

1.69

2.4

2.7

855.61

630.11

ng/l

0.29

187

Postpartum haemorrhage due to retained placenta

617

5614

1.11

1.69

1.9

2.2

311.15

375.27

ng/l

0.35

473

4495

Personal history of allergy to drugs, medicaments and biological substances

678

1.35

1.69

2.9

2.4

1688.71

828.02

ng/l

0.44

557

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

523

4730

1.12

1.68

2.5

2.6

663.88

599.75

ng/l

0.14

423

3856

Benign neoplasm: Carotid body

230

1.70

1.68

2.8

3.1

1264.15

1163.84

ng/l

0.05

194

Neuropathic heredofamilial amyloidosis

3.79

1.67

2.0

2.4

168.56

3012.00

ng/l

—

Benign neoplasm: Endocrine pancreas

622

1.42

1.67

2.9

3.2

1533.16

1323.48

ng/l

0.19

523

Sequelae of inflammatory diseases of the central nervous system

256

1.66

3.0

775.41

1027.80

ng/l

0.22

214

Complications of the puerperium, not elsewhere classified

190

1603

1.21

1.65

2.9

2.5

745.28

464.71

ng/l

0.42

142

1292

Lumbosacral plexus disorders

264

1.64

1.65

2.9

3.1

1248.39

1310.78

ng/l

0.05

214

Bacterial meningitis

317

2806

1.17

1.65

2.9

3.0

1333.74

1170.36

ng/l

0.13

272

2375

Use of amantadine

175

1488

1.24

1.65

2.5

3.1

1085.06

1287.19

ng/l

0.43

153

1257

Other specified/unspecified nutritional deficiencies

536

1.41

1.65

3.8

2.9

1390.26

1322.51

ng/l

0.09

445

Other and unspecified papulosquamous disorders

495

1.44

1.64

3.5

3.0

830.48

1502.11

ng/l

1.82

415

Disorders of amino-acid transport

135

1.96

1.64

2.1

2.8

2417.43

1588.80

ng/l

0.30

106

Use of tolcapone

0.00

1.64

0.0

3.4

—

1069.31

—

Oral leukoplakia, including avohilmo

292

2582

1.18

1.63

2.6

3.0

1051.14

1182.14

ng/l

0.40

246

2196

Postpartum hemorraghe, all women as controls

1368

12658

1.07

1.63

2.0

2.3

427.63

481.27

ng/l

0.28

1059

10115

Dysplasia of cervi uteri

1806

12391

1.06

1.63

2.6

2.5

758.74

1041.51

ng/l

4.21

1489

10324

Single delivery by caesarean section

876

5437

0.92

1.62

2.1

2.4

444.40

582.44

ng/l

0.64

684

4352

Pneumonia due to Haemophilus influenzae

290

1.59

1.62

4.4

2.4

1086.27

1015.35

ng/l

0.11

243

Certain zoonotic bacterial diseases

299

2645

1.18

1.62

3.2

3.0

1542.09

1379.69

ng/l

0.27

256

2242

Acute poliomyelitis

148

1246

1.27

1.62

3.6

3.0

1130.88

1239.68

ng/l

0.25

123

1048

Hereditary sideroblastic anaemia

343

1.56

1.62

3.9

3.1

1672.46

1624.23

ng/l

0.04

294

Hereditary retinal dystrophy

133

1101

1.27

1.61

2.7

3.3

1770.35

1177.57

ng/l

0.62

110

926

Exophthalmic conditions

110

896

1.31

1.61

2.8

3.1

1094.04

1270.70

ng/l

0.26

758

Other osteochondrodysplasias

517

1.40

1.61

2.8

3.3

2396.31

815.31

ng/l

1.08

433

Benign neoplasm: Skin of scalp and neck

252

2205

1.19

1.61

3.3

3.1

2136.13

1403.23

ng/l

0.43

224

1892

Postinfectious hypothyroidism

471

1.45

1.60

2.9

1851.43

1161.35

ng/l

0.39

401

Vitiligo

784

1.32

1.60

2.3

2.9

635.08

856.46

ng/l

0.77

653

Methaemoglobinaemia

2.98

1.60

3.2

2.7

372.89

1127.80

ng/l

—

Ulcer of oesophagus, drug-induced

541

1.46

1.59

5.0

3.5

1672.19

1804.93

ng/l

0.16

458

Pseudomembranous colitis

664

1.36

1.58

2.8

3.1

1595.24

1245.06

ng/l

0.22

560

Benign neoplasm: Nasopharynx

803

1.34

1.57

2.9

3.1

1225.07

1283.68

ng/l

0.07

677

Use of selegiline

549

5044

1.13

1.57

3.0

3.2

1080.28

1757.45

ng/l

5.48

464

4343

Other and unspecified disorders of orbit

422

1.47

1.56

3.0

3.3

1565.63

1255.70

ng/l

0.18

359

Benign neoplasm: Ciliary body

279

1.63

1.55

3.4

3.2

801.24

964.64

ng/l

0.33

237

Enduring personality changes

265

1.58

1.55

3.3

2.9

651.14

810.63

ng/l

0.33

222

Renal cell carcinoma of kidney

397

3592

1.15

1.55

3.5

3.1

2770.89

1850.31

ng/l

1.95

359

3095

Venous complications and haemorrhoids in pregnancy

628

1.33

1.55

1.7

2.7

379.88

432.44

ng/l

0.10

517

Cholesteatoma of external ear

763

1.35

1.55

3.2

3.4

1247.80

1520.59

ng/l

0.37

657

Colorectal neuroendocrine tumor and carcinoma

138

1156

1.27

1.54

3.5

2.9

1101.65

1174.22

ng/l

0.08

111

959

Nutritional marasmus

129

1.91

1.54

3.1

3.6

2126.14

1035.69

ng/l

0.42

114

Burn and corrosion of head and neck

173

1471

1.22

1.54

2.5

3.1

1363.31

1113.62

ng/l

0.32

145

1236

Contusion of toe(s) with damage to nail

689

1.33

1.53

2.3

2.9

1923.74

1079.68

ng/l

0.58

561

Acute inflammation of orbit

436

1.43

1.53

2.8

3.2

1203.89

1127.95

ng/l

0.04

367

Contracture of muscle

266

1.57

1.53

2.6

3.3

1118.80

1080.02

ng/l

0.03

219

Testicular dysfunction, other/unspecified

309

1.53

1.52

3.1

1060.46

721.49

ng/l

0.41

252

Malignant neoplasm of anus and anal canal, including Hilmo

143

1209

1.27

1.52

2.6

3.0

1337.42

1542.22

ng/l

0.23

131

1024

Malignant neoplasm of eye and adnexa, including Hilmo

181

1560

1.23

1.51

3.5

3.1

1321.04

1610.50

ng/l

0.84

161

1320

Juvenile osteochondrosis

214

1847

1.19

1.51

3.0

3.2

1199.13

1023.13

ng/l

0.24

177

1495

Chronic inflammatory disorders of orbit

211

1.68

1.50

2.4

2.9

2105.19

1044.07

ng/l

0.47

177

Congenital malformations of ovaries, fallopian tubes and broad ligaments

326

2894

1.15

1.50

2.2

2.6

417.74

666.99

ng/l

2.83

257

2361

Other abnormal auditory perceptions

765

1.31

1.49

3.0

3.1

570.02

938.71

ng/l

1.99

654

Shigellosis

209

1.64

1.49

3.2

3.1

1726.79

891.92

ng/l

0.58

181

Chlamydial lymphogranuloma (venereum)

0.00

1.48

0.0

4.6

—

685.26

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

229

2016

1.20

1.48

3.1

2022.07

1808.76

ng/l

0.30

200

1732

Neuroendocrine tumor and carcinoma of stomach

455

1.46

1.48

3.1

1583.69

1580.51

ng/l

0.00

382

Necrobiosis lipoidica, not elsewhere classified

343

1.47

1.48

2.7

1011.67

787.09

ng/l

0.30

285

Impacted maxillary canine

374

1.43

1.47

3.5

4.4

964.43

882.31

ng/l

0.07

313

Other/unspecified mastoiditis and related conditions

435

1.45

1.47

3.8

3.1

1506.08

1258.76

ng/l

0.22

372

Glaucoma secondary to drugs

272

1.59

1.47

3.6

2.9

986.50

971.29

ng/l

0.01

224

Granuloma faciale [eosinophilic granuloma of skin]

3.01

1.47

1.8

3.5

718.57

1509.22

ng/l

—

Antepartum haemorrhage, not elsewhere classified

400

3592

1.13

1.46

2.3

2.4

319.35

416.90

ng/l

0.60

324

2881

Villonodular synovitis (pigmented)

527

1.37

1.46

2.7

3.3

601.71

1126.86

ng/l

2.47

444

Patellar tendinitis

108

879

1.27

1.45

2.6

3.3

240.40

1135.98

ng/l

8.81

707

Whooping cough

257

1.52

1.45

3.1

2047.54

766.42

ng/l

0.58

197

Other congenital malformations of ear

390

1.40

1.45

3.9

3.3

511.30

548.17

ng/l

0.09

301

Subarachnoid haemorrhage

1213

11479

1.08

1.45

2.9

3.0

1752.88

1618.31

ng/l

0.45

1069

9847

Colitis, primary sclerosing, strict definition

614

1.33

1.45

2.2

3.2

1313.56

754.59

ng/l

0.59

501

Q fever

3.30

1.44

3.3

2.6

871.00

981.03

ng/l

—

Cervical root disorders

586

1.37

1.44

2.8

3.0

1198.58

882.94

ng/l

0.34

503

Sequelae of intentional self-harm, assault and events of undetermined intent

344

1.45

1.42

4.4

2.7

361.71

734.87

ng/l

2.05

284

Benign lipomatous neoplasm of of intra-abdominal organs

301

1.57

1.42

2.9

3.0

1683.50

1102.08

ng/l

0.41

241

Other congenital malformations of circulatory system

232

2037

1.18

1.42

2.9

786.95

1077.66

ng/l

1.43

201

1714

Seronegative juvenile rheumatoid arthritis

709

1.29

1.41

3.2

1877.41

554.23

ng/l

1.02

559

Dissection of cerebral arteries, nonruptured

567

1.36

1.41

3.5

3.0

1769.84

905.88

ng/l

0.75

470

Multiple delivery

497

5436

0.90

1.40

2.3

2.6

738.08

720.39

ng/l

0.05

387

4542

Benign neoplasm: Rectum/anal canal icd-9

117

981

1.29

1.40

3.4

3.3

2051.14

1988.42

ng/l

0.05

838

Contact with other specified venomous animals

506

1.38

1.40

2.3

3.1

560.29

1143.81

ng/l

2.04

417

Bus occupant injured in other and unspecified transport accidents

516

1.39

1.40

2.7

3.1

1634.01

1142.29

ng/l

0.37

424

Ulcerative ileocolitis

310

2767

1.15

1.39

2.7

3.0

1189.71

1080.18

ng/l

0.21

255

2300

LSIL lesion of the vagina

116

961

1.26

1.39

2.7

2.9

492.63

888.59

ng/l

2.13

100

810

Respiratory tuberculosis

650

6040

1.11

1.39

3.7

3.2

2160.07

1981.81

ng/l

0.38

574

5174

Respiratory tuberculosis, confirmed and not-confirmed

650

6040

1.11

1.39

3.7

3.2

2160.07

1991.25

ng/l

0.35

574

5174

Malignant neoplasm of parotid gland

735

1.33

1.39

2.5

3.0

1234.14

1432.35

ng/l

0.32

617

Benign neoplasm of brain and other parts of central nervous system

646

5994

1.10

1.39

2.9

3.0

1030.65

1351.96

ng/l

1.57

545

5124

Other lack of coordination

174

1505

1.22

1.38

3.2

3.3

925.10

1469.36

ng/l

1.97

148

1292

Benign neoplasm: Vulva

206

1803

1.20

1.38

2.4

2.8

1123.24

980.49

ng/l

0.19

166

1506

Benign neoplasm: Other/unspecified site

164

1413

1.22

1.37

3.1

999.87

1186.72

ng/l

0.33

135

1196

Papillary adenocarcinoma of thyroid gland

460

4205

1.12

1.37

3.2

2.9

1231.43

1169.71

ng/l

0.12

389

3527

Pneumoconiosis due to dust containing silica

374

1.50

1.37

3.8

3.5

1486.92

1793.87

ng/l

0.35

323

Right side

626

1.39

1.37

3.5

3.2

705.51

1386.64

ng/l

2.31

527

Benign neoplasm: Lip

233

2061

1.18

1.37

3.1

1404.39

1438.86

ng/l

0.06

192

1763

Other obstructed labour

513

4699

1.11

1.36

2.2

2.6

822.87

617.81

ng/l

0.79

413

3908

Mastocytosis

359

1.45

1.35

2.7

3.2

1220.11

923.82

ng/l

0.20

297

LeFortI or BSSO operation

242

2126

1.16

1.35

1.9

2.7

450.96

667.28

ng/l

1.00

193

1718

Congenital vesicoureteral reflux

137

1.67

1.35

2.7

3.5

845.32

359.97

ng/l

0.52

104

Staphylococcal scalded skin syndrome

2.36

1.34

2.1

6.6

836.00

757.63

ng/l

—

Frostbite

804

1.29

1.34

3.0

3.1

1999.66

1300.14

ng/l

0.60

670

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

176

1.72

1.34

2.4

3.4

1168.95

1964.01

ng/l

0.73

148

Toxic effect of alcohol

189

1643

1.20

1.34

3.1

1234.97

1220.02

ng/l

0.02

157

1397

Other effects of reduced temperature

167

1.70

1.33

4.2

3.1

1976.26

1488.29

ng/l

0.23

140

Scissor bite

119

975

1.23

1.33

4.1

4.2

568.98

659.40

ng/l

0.17

100

792

Toxic effect of organic solvents

240

1.54

1.32

3.3

3.6

1511.96

1067.96

ng/l

0.32

190

Obstructed labour due to malposition and malpresentation of fetus

1119

11070

0.94

1.32

2.1

2.3

411.57

467.96

ng/l

0.39

892

8909

Other infective (teno)synovitis

301

1.49

1.32

3.8

3.1

2343.59

1045.38

ng/l

0.71

253

Ankylosis of teeth

147

1.69

1.32

4.6

3.2

881.76

942.33

ng/l

0.06

123

Crushing injury of ankle and foot

321

1.50

1.31

3.1

2.8

2171.20

1552.69

ng/l

0.22

261

Melanoma in situ, other sites/unspecified

333

1.51

1.31

2.9

3.3

2128.12

1178.53

ng/l

0.48

284

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

236

2094

1.17

1.30

3.4

3.0

1185.10

1205.53

ng/l

0.04

192

1778

Benign neoplasm of thyroid gland

332

3004

1.14

1.29

2.8

2.9

943.21

1136.41

ng/l

0.51

282

2529

Malignant neoplasm of penis, including Hilmo

607

1.35

1.29

3.4

3.2

5547.88

1708.39

ng/l

1.05

521

Polyglandular dysfunction, other/unspecified

2.29

1.29

2.2

5.0

150.67

906.84

ng/l

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

381

1.42

1.28

3.8

3.0

1115.26

889.96

ng/l

0.25

326

Benign neoplasm: Orbit, unspecified

552

1.36

1.28

3.3

1136.76

1474.07

ng/l

0.44

463

False labour

1615

9578

1.06

1.28

2.1

2.3

235.89

465.67

ng/l

6.71

1237

7637

Non-small cell lung cancer, squamous, helper endpoint

510

5513

0.90

1.28

3.0

3.3

1423.47

2281.11

ng/l

8.92

468

4774

Benign neoplasm: Lower jaw bone

312

1.47

1.28

3.0

3.1

1371.43

1094.89

ng/l

0.18

262

Cellulitis of external ear

102

845

1.27

1.28

3.3

3.2

818.76

1039.72

ng/l

0.41

725

Endometriosis of fallopian tube

404

1.38

1.27

2.4

2.8

3490.57

1116.75

ng/l

0.45

343

Malignant neoplasm of vulva

114

967

1.27

1.26

3.3

3.0

1762.19

1442.29

ng/l

0.39

816

Hereditary spastic paraplegia

2.07

1.26

2.2

3.6

2064.50

675.41

ng/l

—

Other disorders affecting eyelid function

833

0.76

1.25

3.0

3.1

1479.70

1287.20

ng/l

0.16

706

Viral conjunctivitis

279

2494

1.15

1.25

2.7

2.8

1101.61

951.80

ng/l

0.24

241

2066

Other mosquito-borne viral fevers

469

1.36

1.25

2.4

3.1

774.73

758.12

ng/l

0.02

373

Other demyelinating diseases of the central nervous system

238

2104

1.16

1.25

2.3

3.0

638.16

796.09

ng/l

0.53

197

1726

Hypergammalglobulinemia, unspecified

2.10

1.24

1.6

3.2

1072.49

936.90

ng/l

0.08

Maternal care for known or suspected fetal abnormality and damage

621

5769

0.92

1.23

2.1

2.3

420.64

382.29

ng/l

0.07

487

4579

Amyloidosis of skin

2.22

1.23

5.4

4.0

1003.04

1648.86

ng/l

0.77

Labour and delivery complicated by fetal stress [distress]

953

6647

0.93

1.23

2.0

2.2

303.42

348.27

ng/l

0.39

726

5186

Other corneal oedema

101

850

1.29

1.23

3.4

3.1

2772.59

1363.86

ng/l

1.32

722

Inflammation of lacrimal passages (acute and unspecified)

171

1490

1.20

1.23

3.6

3.0

1466.16

1426.35

ng/l

0.05

151

1248

Habitual aborter

542

1.30

1.22

2.7

2.6

295.13

473.75

ng/l

0.49

418

Injury of blood vessels at forearm level

255

1.53

1.22

3.0

3.1

3336.73

1053.04

ng/l

0.63

211

Generalized epilepsy, strict definition

153

1314

1.20

1.22

2.6

3.3

784.01

985.34

ng/l

0.47

116

1096

Non-seminoma of testis, including Hilmo

259

1.46

1.21

2.4

2.8

590.50

1548.17

ng/l

0.80

195

Burn and corrosion confined to eye and adnexa

173

1504

1.19

1.21

2.4

3.0

1269.00

910.97

ng/l

0.41

131

1244

Malignant neoplasm of liver and intrahepatic bile ducts

328

2985

1.14

1.20

2.8

3.2

1392.27

1881.71

ng/l

0.91

282

2577

Benign neoplasm: Brain, supratentorial

142

1221

1.21

1.20

3.0

3.1

732.68

1121.61

ng/l

1.74

121

1041

Injury of blood vessels at hip and thigh level

339

1.48

1.19

3.3

3.1

916.08

1194.33

ng/l

0.51

283

Blepharospasm

106

896

1.26

1.19

3.2

3.0

1093.77

1231.90

ng/l

0.19

759

Vascular dementia (multiple infarctions)

126

1469

0.82

1.18

2.9

3.4

2304.84

2809.93

ng/l

0.57

108

1293

Respiratory and cardiovascular disorders specific to the perinatal period

574

1.27

1.18

7.7

7.3

1741.23

1084.44

ng/l

0.58

486

Meningococcal infection

454

1.34

1.18

4.1

3.3

1499.31

906.52

ng/l

0.51

379

Maternal care for cervical incompetence

309

2793

1.13

1.18

3.0

2.8

698.26

814.55

ng/l

0.57

257

2315

Choroidal haemorrhage and rupture

330

1.47

1.17

3.4

3.5

2305.62

1742.36

ng/l

0.50

271

Other acantholytic disorders

288

1.53

1.17

2.5

3.3

993.02

1606.09

ng/l

0.96

238

Polyneuropathy due to other toxic agents

2.21

1.17

3.2

4.5

3051.77

1154.99

ng/l

0.37

Other and unspecified disorders of binocular movement

359

1.40

1.17

2.8

3.7

2641.77

1043.79

ng/l

0.72

294

Other benign neoplasm of uterus: Corpus uteri

686

1.30

1.16

2.6

2.9

971.91

935.41

ng/l

0.03

584

Vertical strabismus

306

2772

1.14

1.16

2.7

2.9

1319.42

1248.45

ng/l

0.10

255

2339

Infliximab

775

1.25

1.16

2.1

3.1

301.08

783.34

ng/l

1.59

615

Acrodermatitis continua

148

1.69

1.16

2.1

3.0

3043.47

1525.74

ng/l

0.34

128

Other specified and unspecified disorders of eye and adnexa

365

3337

1.12

1.16

3.1

3.0

2195.11

1412.85

ng/l

0.83

310

2822

Intussusception

196

1731

1.17

1.15

2.2

2.8

743.85

1005.93

ng/l

1.22

171

1452

Gestational diabetes (for exclusion)

1979

13201

1.05

1.15

2.0

2.3

466.67

418.73

ng/l

0.22

1475

10548

Typhoid and paratyphoid fevers

531

1.33

1.15

2.2

3.0

492.46

1218.32

ng/l

3.49

453

Congenital malformations of uterus and cervix

820

1.23

1.15

4.0

2.7

715.59

779.61

ng/l

0.12

652

Malignant neoplasm of retroperitoneum and peritoneum

726

1.29

1.15

2.9

2006.63

1289.98

ng/l

0.72

606

Disorders of lacrimal system and orbit in diseases classified elsewhere

217

1929

1.16

1.14

2.4

2.9

964.71

991.27

ng/l

0.04

182

1601

Neuroendocrine tumor and carcinoma of rectum

312

1.46

1.14

4.0

2.7

813.10

1114.04

ng/l

0.46

262

Exposure to other specified electric current

116

1369

0.83

1.14

4.3

3.1

897.62

777.33

ng/l

0.15

1116

Hyperprolactinaemia, drug-induced

388

1.38

1.14

3.6

2.6

803.08

665.03

ng/l

0.17

319

Functional disorders of polymorphonuclear neutrophils

2.19

1.14

6.8

4.4

582.91

1165.99

ng/l

1.32

Striae atrophicae

654

1.28

1.13

3.1

3.0

843.66

904.76

ng/l

0.10

533

Other papulosquamous disorders

107

906

1.24

1.13

3.0

3.2

905.12

1372.35

ng/l

1.38

774

Vascular dementia (other)

834

1.28

1.13

3.8

3.4

2814.99

2368.50

ng/l

0.35

739

Traumatic spondylopathy

209

1.57

1.12

3.4

1131.55

1747.46

ng/l

0.91

179

Malignant neoplasm of bronchus and lung

2394

20529

0.96

1.12

3.0

3.2

1497.76

1781.17

ng/l

2.84

2175

17753

Moderate visual impairment, monocular

365

1.41

1.12

3.6

3.3

742.69

1270.74

ng/l

1.21

319

Injury of blood vessels at abdomen, lower back and pelvis level

366

1.41

1.12

3.5

866.03

1641.00

ng/l

1.86

307

Hyperfunction of pituitary gland, other and/or unspecified

134

1.75

1.12

3.9

3.1

954.84

1309.39

ng/l

0.33

112

Glaucoma-related operations

717

6764

1.09

1.12

3.0

3.2

1761.15

1711.98

ng/l

0.10

602

5857

Other melanin hyperpigmentation

249

2248

1.16

1.11

2.8

3.0

1185.69

1365.64

ng/l

0.44

204

1931

Radiodermatitis

228

1.56

1.11

5.0

2.6

943.51

1000.63

ng/l

0.09

190

Guttate psoriasis

118

1006

1.22

1.11

3.2

3.1

1810.52

1164.64

ng/l

0.33

101

854

Follicular adenocarcinoma of thyroid gland, including Hilmo

105

891

1.25

1.10

2.9

3.1

987.99

1361.32

ng/l

0.99

744

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

738

1.28

1.10

2.7

3.1

1019.94

1324.04

ng/l

0.69

610

Other fibroblastic disorders

277

1.45

1.09

2.0

3.3

3975.74

1278.02

ng/l

0.55

232

Noninfective disorders of pinna

158

1.63

1.09

1.7

3.6

633.86

956.77

ng/l

0.66

132

517

1.28

1.09

6.2

7.6

1813.73

1154.45

ng/l

0.55

429

Other specified/unspecified disorders of ear

226

1.52

1.09

2.4

3.1

986.06

1128.09

ng/l

0.18

194

Clubfoot

512

1.30

1.08

3.2

740.19

752.76

ng/l

0.02

419

Congenital malformations of ear causing impairment of hearing

190

1.53

1.08

2.8

3.9

3351.67

656.64

ng/l

0.50

157

Use of glatiramer acetate

727

1.24

1.08

2.2

2.8

571.69

543.53

ng/l

0.04

591

Rare circulating lymphoid malignancy

577

1.33

1.08

3.8

3.4

1814.56

1870.21

ng/l

0.05

483

Q fever

2.63

1.08

3.3

2.7

871.00

951.84

ng/l

—

Other abortion

441

1.32

1.08

2.5

3.1

573.38

697.18

ng/l

0.22

362

Toxic effect of contact with venomous animals

360

3300

1.12

1.07

2.7

3.0

1048.20

1174.15

ng/l

0.18

299

2775

Benign neoplasm: Bone and articular cartilage, unspecified

544

1.30

1.07

2.0

3.2

493.46

1143.64

ng/l

2.68

453

Other specified acquired deformities of limbs

294

1.42

1.07

2.3

3.6

1465.04

1167.44

ng/l

0.12

242

Open wounds involving multiple body regions

278

1.44

1.07

3.2

3.4

3381.22

1030.64

ng/l

0.57

229

Carcinoma in situ of skin of eyelid, including canthus

250

1.56

1.06

3.8

3.2

2708.21

1538.38

ng/l

0.93

208

Unspecified parasitic disease

693

1.28

1.06

3.3

3.1

1283.39

1223.28

ng/l

0.07

591

Other and unspecified disorders of pigmentation

508

1.31

1.06

3.8

3.2

965.59

1014.83

ng/l

0.06

427

Other disorders of binocular movement

156

1361

1.18

1.06

3.0

3.1

1424.25

1034.25

ng/l

0.44

125

1132

L02BA Anti-estrogens

1597

16612

0.95

1.06

2.4

2.8

1094.40

1092.59

ng/l

0.00

1368

14117

Short Achilles tendon (acquired)

217

1937

1.15

1.05

2.5

2.9

748.51

1084.12

ng/l

1.47

201

1592

Hirsutism, drug-induced

101

1.77

1.05

1.4

2.6

143.51

413.91

ng/l

1.21

Malignant neoplasm of rectosigmoid junction

180

1601

1.18

1.05

2.5

3.0

1224.49

1705.40

ng/l

1.61

157

1364

Spontaneous abortion

3883

26883

0.97

1.05

2.4

2.5

701.62

832.95

ng/l

1.62

3186

22432

Left hemicolectomy

272

2478

1.14

1.05

3.4

3.1

1410.43

1614.10

ng/l

0.48

232

2137

Internuclear ophthalmoplegia

271

1.45

1.04

3.3

2.6

1511.22

945.59

ng/l

0.42

228

Malignant neoplasm of anus and anal canal

479

1.35

1.04

2.4

3.1

1427.96

1418.68

ng/l

0.00

404

Alcohol induced polyneuropathy

113

974

1.23

1.04

2.7

3.1

2798.72

1290.54

ng/l

0.92

100

837

Communicating hydrocephalus

186

2085

0.86

1.04

2.5

3.1

1387.87

1608.90

ng/l

0.22

166

1793

Degenerative myopia

603

1.29

1.04

2.6

3.0

893.95

1083.85

ng/l

0.43

502

Bilateral sagittal split ramus osteotomy operation

198

1755

1.15

1.03

2.0

2.7

426.02

642.52

ng/l

0.88

160

1416

Disorder of mineral metabolism, other/unspecified

143

1.63

1.03

3.1

3933.88

1019.79

ng/l

0.57

118

Other and unspecified medical devices associated with adverse incidents

526

1.33

1.03

3.3

3.2

1201.38

1149.46

ng/l

0.06

436

Calcium deposit in bursa

161

1.61

1.03

3.0

2.5

3243.56

1094.02

ng/l

0.34

143

Cytomegaloviral pneumonitis

181

1.64

1.03

4.0

3.2

2359.15

1048.11

ng/l

0.96

145

Erysipeloid

382

1.39

1.02

3.6

3.4

1316.49

1429.51

ng/l

0.11

332

Laparoscopic left hemicolectomy

193

1731

1.17

1.01

2.6

3.0

1083.01

1214.80

ng/l

0.35

170

1489

Melanocytic naevi of upper limb, including shoulder

206

1844

1.15

1.01

3.2

3.0

1242.53

1191.68

ng/l

0.07

170

1564

Onycholysis

495

1.31

1.00

3.9

3.0

1619.72

953.70

ng/l

0.65

409

Mesial bite

427

1.31

1.00

2.6

3.0

317.73

600.22

ng/l

1.43

356

Pregnancy examination and test

740

4313

1.07

1.00

2.2

316.44

393.48

ng/l

0.42

578

3366

Cystic disease of liver

589

1.29

1.00

2.2

3.2

2016.94

1168.85

ng/l

0.62

504

Medicines for HER+ breast cancer

4337

40159

1.03

1.00

2.6

2.8

991.26

1166.23

ng/l

2.34

3685

34084

Mesothelioma

119

1037

1.22

1.00

3.2

1081.06

1828.99

ng/l

2.64

110

898

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

194

1740

1.17

1.00

3.0

3.1

1580.68

1695.62

ng/l

0.14

170

1497

Atypical virus infections of central nervous system

780

1.24

0.99

3.5

3.1

740.27

990.31

ng/l

0.69

654

Unspecified dementia

1622

14057

1.05

0.99

3.3

3.5

2531.36

2461.60

ng/l

0.18

1359

12248

Viral infections of central nervous system, not elsewhere classified/unspecified

796

1.23

0.99

2.3

3.0

773.22

936.42

ng/l

0.25

667

HSIL lesion of the cervix uteri

1024

9732

1.06

0.98

2.5

2.4

650.78

569.31

ng/l

0.53

838

7833

Glaucoma secondary to eye trauma

619

1.29

0.98

3.3

3.4

1680.87

1803.36

ng/l

0.11

537

Malignant neoplasm of stomach, including Hilmo

709

6704

1.08

0.98

3.0

3.2

1802.32

1870.99

ng/l

0.15

643

5774

Carcinoma in situ of breast, lobular

655

1.27

0.98

2.6

2.9

638.13

966.98

ng/l

0.98

549

Malignant neoplasm of uterus, part unspecified, including Hilmo

502

1.33

0.97

4.1

3.1

4300.77

1879.85

ng/l

0.39

428

Benign neoplasm: Hypopharynx

410

1.35

0.97

2.5

3.4

2214.26

1301.27

ng/l

0.50

342

Pregnancy, childbirth and the puerperium

3384

18150

0.97

3.0

3.1

1390.11

1577.93

ng/l

2.04

2854

15429

Pityriasis rubra pilaris

171

1.55

0.97

2.8

2.9

593.16

992.69

ng/l

1.12

147

Other haemoglobinopathies

155

1.61

0.97

11.0

3.0

1265.75

1172.24

ng/l

0.06

130

Other and unspecified hydrocephalus

192

1722

1.16

0.97

2.8

3.2

951.58

1488.08

ng/l

2.03

161

1479

Unspecified organic or symptomatic mental disorder

320

1.40

0.97

3.8

3.0

1042.53

1883.51

ng/l

1.43

255

Injury of nerves at ankle and foot level

478

1.30

0.96

3.0

2.9

950.37

1132.94

ng/l

0.27

394

Polypectomy (DHB20)

678

6402

1.08

0.96

2.6

3.0

1161.04

1448.39

ng/l

1.19

603

5481

Social disorders starting during childhood or adolescence

209

1.43

0.96

3.2

3.6

1239.87

411.00

ng/l

0.39

160

Degenerative macular diseases, drug-induced

340

1.40

0.96

2.9

3.4

1631.62

1800.18

ng/l

0.13

280

Felty syndrome

520

1.31

0.96

3.9

3.4

2000.80

1398.03

ng/l

0.59

445

Migraine, unspecified, drug-induced

479

1.30

0.96

2.4

3.1

729.38

782.54

ng/l

0.10

397

Hereditary motor and sensory neuropathy

681

1.25

0.96

3.1

3.2

1293.81

1097.12

ng/l

0.16

568

Nail dystrophy

518

1.30

0.95

2.5

3.1

729.03

1178.60

ng/l

1.26

434

Blindness or visual impairment, binocular

401

1.35

0.95

3.6

3.4

2469.83

1368.56

ng/l

0.68

331

Supervision of high-risk pregnancy

1125

6444

1.06

0.95

2.2

2.3

260.02

534.80

ng/l

5.55

892

5158

Traumatic subcutaneous emphysema

115

1.76

0.95

3.1

3.2

706.88

1044.70

ng/l

0.41

Disorders of endocrine glands in diseases classified elsewhere

113

1.68

0.94

8.4

3.1

1835.72

1670.00

ng/l

0.08

Adult-onset Still disease

266

1.41

0.94

5.7

2.7

568.30

796.05

ng/l

0.86

220

Malignant neoplasm of base of tongue

539

0.74

0.94

2.2

3.1

2449.88

1232.25

ng/l

0.31

451

Benign neoplasm: Spinal meninges

117

1022

1.21

0.93

3.1

3.0

1466.55

1149.98

ng/l

0.37

107

867

Noise effects on inner ear

403

3746

1.10

0.93

3.0

3.1

1151.64

1590.13

ng/l

1.60

331

3233

Transient acantholytic dermatosis [Grover]

221

1.55

0.93

2.0

3.5

1048.35

1679.49

ng/l

0.78

182

Idiopathic hypoparathyroidism

270

1.43

0.93

11.7

3.4

1754.67

1301.03

ng/l

0.37

224

Lumbosacral spina bifida and hydrocephalus

2.00

0.92

2.3

2.5

483.63

864.72

ng/l

—

Prophylactic surgery

380

1.31

0.92

2.1

2.3

518.54

570.79

ng/l

0.10

311

Livedoid vasculitis

379

1.37

0.91

3.4

3.3

1316.70

1166.09

ng/l

0.20

325

Alopecia universalis

164

1.52

0.91

3.8

3.4

1395.45

795.94

ng/l

0.30

137

Mandibular prognathia

837

1.20

0.90

3.8

3.4

966.36

751.74

ng/l

0.31

698

Malignant neoplasm of floor of mouth, including Hilmo

820

1.23

0.90

2.9

3.0

1872.55

1473.85

ng/l

0.40

696

Congenital malformations of gallbladder, bile ducts and liver

770

1.23

0.90

2.6

3.8

1762.58

1109.73

ng/l

0.60

659

Other and unspecified disorders of refraction

1.94

0.89

3.6

3.8

293.16

843.14

ng/l

—

Immunodeficiency with increased immunoglobulin M [IgM]

2.98

0.89

5.6

2.8

624.20

1865.45

ng/l

—

L02BG Aromatase inhibitors

3602

35147

1.03

0.89

2.6

2.8

1001.91

1160.13

ng/l

1.66

3073

29936

Melanocytic naevi of scalp and neck

197

1774

1.14

0.88

3.3

3.1

2579.36

1210.65

ng/l

1.01

177

1493

Malignant neoplasm of bronchus and lung, including Hilmo

2962

24172

1.04

0.88

3.1

1480.16

1728.33

ng/l

2.83

2694

20918

Other congenital malformations of intestine

622

1.25

0.88

2.9

3.5

1938.49

974.08

ng/l

0.52

521

Drowning to ice

109

0.48

0.88

2.5

3.2

2656.18

850.14

ng/l

—

Unspecified human immunodeficiency virus [HIV] disease

650

0.78

0.88

2.6

3.1

895.59

779.57

ng/l

0.17

525

Benign neoplasm: Scrotum

343

1.36

0.87

3.0

3.2

3206.06

1048.89

ng/l

1.27

285

Disorders of urea cycle metabolism

2.02

0.87

4.4

2.4

3372.29

1008.49

ng/l

—

Injury of nerves at hip and thigh level

344

1.36

0.87

2.4

2.7

631.23

1193.21

ng/l

1.28

279

Disorders of brain, other and unspecified

819

1.22

0.87

2.4

3.1

1286.54

1558.18

ng/l

0.29

706

Small plaque parapsoriasis

256

1.43

0.86

1.8

3.6

1526.85

1274.84

ng/l

0.20

213

All dysplastic lesions of the cervix uteri

1565

14948

1.04

0.86

2.5

2.4

619.39

614.14

ng/l

0.03

1276

12083

Environmental-pollution-related condition

1.83

0.86

4.8

3.7

172.75

1022.41

ng/l

3.39

Foreign body in ear

147

1303

1.16

0.86

3.3

3.2

1431.11

959.31

ng/l

0.79

125

1091

Postprocedural disorders of ear and mastoid process, not elsewhere classified

796

1.23

0.85

3.3

3.2

1681.02

1397.93

ng/l

0.26

682

Intermittent hydrarthrosis

176

1.51

0.85

3.1

517.85

955.91

ng/l

1.22

157

Idiopathic hypercalciuria

443

1.30

0.85

2.6

3.0

313.16

809.41

ng/l

5.00

373

Cerebral atherosclerosis

158

1414

1.17

0.85

3.3

3.2

2297.33

2144.88

ng/l

0.12

139

1230

Beau lines

2.69

0.85

2.2

2.6

1230.84

668.85

ng/l

—

579

1.22

0.84

5.9

7.4

1468.85

1132.41

ng/l

0.28

475

Haemophilus septicemia

169

1.53

0.84

3.6

3.1

2128.26

1142.79

ng/l

0.63

138

Other disorders originating in the perinatal period

312

1.32

0.84

3.9

8.6

1045.17

1165.55

ng/l

0.07

267

Torsion of testis

804

1.19

0.83

3.9

4.0

1795.04

938.75

ng/l

0.45

630

Type 1 diabetes, strict definition, subgroup 2

0.48

0.83

17.6

4.1

728.60

589.76

ng/l

—

Tick-borne viral encephalitis

390

1.31

0.83

2.4

3.0

714.13

995.04

ng/l

0.52

315

Family history of other specific disorders

696

1.21

0.83

2.5

2.4

748.13

780.15

ng/l

0.05

558

Other disorders of breast and lactation associated with childbirth

583

1.22

0.83

1.9

2.5

199.68

449.83

ng/l

3.86

452

Amoebiasis

398

1.30

0.82

3.3

3.2

1214.61

1137.03

ng/l

0.06

330

Other and unspecified cicatricial alopecia

231

1.44

0.82

2.5

3.1

1850.09

1013.03

ng/l

0.30

190

Genetic anomalies of leukocytes

1.99

0.82

3.5

3.4

339.71

1397.60

ng/l

—

Benign neoplasm: Bones of skull and face

757

1.21

0.82

2.9

868.69

1046.46

ng/l

0.31

633

Pedestrian injured in collision with car, pick-up truck or van

225

2053

1.13

0.82

2.9

3.0

1842.62

1297.02

ng/l

0.67

177

1726

Esophageal diverticulum (pouch)

360

1.36

0.81

3.1

3.2

902.71

1472.84

ng/l

1.87

303

Macrocephaly

0.00

0.80

0.0

7.6

—

790.40

—

UC patients in KELA-register (code 208), prior to 1994

423

3966

1.09

0.80

3.0

2.9

1709.09

1242.52

ng/l

1.01

364

3364

Alzheimer disease, including avohilmo

5928

41067

1.02

0.80

3.0

3.3

2164.80

1989.19

ng/l

1.64

5022

35897

Other menopausal disorders

2700

14809

1.03

0.80

2.3

2.7

569.28

1211.30

ng/l

33.53

2272

12610

Burns and corrosions of multiple body regions

647

1.22

0.80

3.4

3.2

2029.13

1060.78

ng/l

0.96

537

Congenital malformations of breast

660

1.21

0.80

2.4

2.7

496.72

623.89

ng/l

0.27

529

Interstitial emphysema and related conditions originating in the perinatal period

1.78

0.79

12.1

8.7

1096.56

1240.60

ng/l

—

Cicatricial alopecia [scarring hair loss]

669

1.23

0.78

2.7

3.1

904.39

884.40

ng/l

0.02

559

Other zoonotic bacterial diseases, not elsewhere classified

112

1.67

0.78

2.5

3.6

1644.00

1570.22

ng/l

0.03

Pedestrian injured in collision with heavy transport vehicle or bus

267

1.37

0.78

1.8

3.4

1930.96

1357.91

ng/l

0.31

219

Lipodystrophy, not elsewhere classified

111

1.62

0.77

3.9

2.3

265.09

915.09

ng/l

1.77

Alzheimer disease

4990

37133

0.98

0.77

3.0

3.3

2320.57

2066.10

ng/l

2.39

4190

32472

Other or unspecified paralytic strabismus

606

1.23

0.77

2.5

3.2

1165.19

1310.09

ng/l

0.15

531

Fetus and newborn affected by other complications of labour and delivery

1.71

0.76

6.9

7.1

4937.89

1307.70

ng/l

—

Abnormal findings on antenatal screening of mother

275

2524

1.10

0.76

2.0

2.4

387.41

317.83

ng/l

0.20

211

1956

Benign neoplasm: Vagina

121

1074

1.17

0.76

3.0

2.9

540.46

1049.01

ng/l

3.39

105

908

Other transepidermal elimination disorders

2.33

0.76

5.6

1.9

3260.80

329.95

ng/l

—

Physical medicine devices associated with adverse incidents

1.95

0.75

3.4

4.6

1037.60

799.32

ng/l

—

Edwards' syndrome and Patau's syndrome

1.86

0.75

3.4

3.1

3649.71

1076.98

ng/l

—

Congenital malposition of the kidney

1.79

0.75

2.5

2.4

278.71

429.13

ng/l

0.62

Maxillary hypoplasia

161

1.44

0.74

3.3

4.1

784.47

523.51

ng/l

0.24

135

Melanoma in situ of trunk

174

1586

1.14

0.74

3.3

3.2

1887.21

1513.22

ng/l

0.38

147

1382

Congenital ovarian cysts

228

2083

1.11

0.74

2.1

2.5

342.18

593.57

ng/l

2.64

178

1692

Disorders of glycine metabolism

2.04

0.74

3.0

3.4

1699.65

2006.62

ng/l

—

Pemphigus vegetans

2.01

0.74

2.4

3.3

419.25

1403.74

ng/l

—

Graves ophthalmopathy

213

1950

1.12

0.74

2.5

2.8

977.85

869.71

ng/l

0.17

179

1619

Burn and corrosion of wrist and hand

271

2502

1.10

0.74

3.2

1225.46

1152.95

ng/l

0.11

222

2083

Melanocytic naevi of lip

644

1.22

0.74

2.6

3.0

2921.96

1140.07

ng/l

0.40

544

Congenital absence of the vagina

2.05

0.73

4.0

1.6

1182.50

191.68

ng/l

—

APECED

2.05

0.73

5.2

2.3

226.04

694.58

ng/l

—

Ovarian hyperstimulation (induction)

509

1.22

0.72

1.6

2.3

96.59

463.42

ng/l

1.65

384

Other and unspecified disorders of psychological development

304

1.28

0.72

4.6

5.2

1108.13

1217.25

ng/l

0.05

234

Hypertensive encephalopathy

420

1.30

0.71

3.8

3.1

3860.55

1623.32

ng/l

0.99

354

Pterygium

330

3091

1.10

0.71

3.3

3.1

1383.81

1692.33

ng/l

1.16

286

2688

Other congenital malformations of skull and face bones

119

1.49

0.71

2.1

9.7

955.88

1025.58

ng/l

—

100

Exclusion endpoint for supernumerary teeth

549

1.21

0.71

4.8

3.7

1296.75

828.70

ng/l

0.40

433

Disorders of tyrosine metabolism

1.66

0.70

3.9

3.1

4924.07

1794.46

ng/l

0.67

Mandibular hypoplasia

341

1.28

0.70

2.9

472.98

554.45

ng/l

0.18

284

Induced delusional disorder

1.88

0.70

3.0

3.2

460.75

576.40

ng/l

—

Open wound of neck

544

1.22

0.70

3.5

3.1

1294.20

986.57

ng/l

0.32

452

Congenital dislocation of hip, unilateral

332

1.28

0.70

3.9

3.3

1033.37

1188.44

ng/l

0.16

283

Congenital malformations of breast

698

1.18

0.69

2.4

2.8

489.25

637.40

ng/l

0.34

559

Other acute disseminated demyelination

543

1.21

0.69

2.7

3.1

956.27

675.50

ng/l

0.22

445

Maternal care for known or suspected abnormality of pelvic organs

1347

9497

0.96

0.69

2.2

2.4

439.02

508.80

ng/l

0.56

1066

7630

Pathological resorption of teeth

295

2749

1.09

0.68

2.9

1282.82

1121.09

ng/l

0.23

259

2318

Malignant neoplasm of other and unspecified major salivary glands

311

1.33

0.68

2.7

2.9

1000.00

1181.28

ng/l

0.16

256

Abscess of spleen

1.83

0.68

2.7

3.5

6122.10

1899.32

ng/l

0.38

Other disorders of choroid

147

1333

1.14

0.67

3.9

3.1

1914.45

1452.17

ng/l

0.98

132

1136

Erythema in diseases classified elsewhere

185

1.43

0.67

4.1

3.0

845.42

865.22

ng/l

0.02

158

Acquired stenosis of external ear canal

106

946

1.17

0.66

3.1

1364.71

1315.92

ng/l

0.05

808

Other disorders following mastoidectomy

386

1.29

0.66

3.0

3.3

2066.69

1637.00

ng/l

0.21

329

Cerebral amyloid angiopathy

547

1.25

0.66

2.6

3.2

1763.97

1320.47

ng/l

0.36

470

Lymphocyte function antigen-1 [LFA-1] defect

100

1.68

0.66

4.1

3.5

3142.00

2572.91

ng/l

0.16

Cholinergic urticaria

318

1.29

0.66

2.5

3.0

743.36

881.23

ng/l

0.22

263

Other combined immunodeficiencies

116

1.56

0.65

2.8

4.1

2602.55

1602.48

ng/l

0.18

100

Osteomalacia

614

1.20

0.65

3.2

3.1

994.78

966.14

ng/l

0.04

512

Multiple congenital exostoses

1.57

0.65

3.1

3.6

1774.68

682.93

ng/l

0.33

Recurrent cholesteatoma of postmastoidectomy cavity

276

1.34

0.65

2.5

3.3

1083.03

1296.69

ng/l

0.25

229

Acne keloid

115

1.53

0.65

1.9

2.5

313.88

959.73

ng/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

386

3635

1.08

0.65

2.5

2.6

673.00

751.64

ng/l

0.23

338

3055

Acne varioliformis

185

1.40

0.65

3.1

6511.89

1274.92

ng/l

0.90

154

Other cestode infections

338

0.74

0.64

2.7

3.4

3251.96

1886.00

ng/l

0.44

283

Corneal degeneration

163

1491

1.13

0.64

2.9

3.1

1218.36

1113.41

ng/l

0.16

137

1269

Malignant neoplasm, without specification of site, including Hilmo

553

5272

1.07

0.64

3.3

3.2

2132.82

1896.40

ng/l

0.52

484

4547

Immunodeficiency associated with other specified major defects, or unspecified

1.72

0.63

2.2

3.6

2528.78

965.74

ng/l

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

688

1.18

0.63

3.3

2.9

671.56

679.06

ng/l

0.01

572

Localized hypertrichosis

1.94

0.63

3.7

2.9

306.18

409.27

ng/l

—

Pityriasis rosea

410

1.23

0.63

3.2

2.9

422.11

985.61

ng/l

2.54

336

Mental and behavioural disorders due to hallucinogens

192

1.34

0.63

2.0

2.7

409.59

516.15

ng/l

0.20

149

Idiopathic peripheral autonomic neuropathy

304

1.30

0.63

2.8

3.4

370.33

1691.95

ng/l

4.69

255

Congenital lens malformations

293

1.28

0.62

3.9

3.6

909.18

1116.75

ng/l

0.24

241

Acute necrotizing ulcerative gingivitis

1.60

0.62

1.5

2.7

2031.13

801.28

ng/l

—

Enterobiasis

767

0.85

0.62

2.3

3.3

424.45

577.53

ng/l

0.52

599

Keratoconus

182

1670

1.11

0.61

2.7

3.1

1438.55

942.08

ng/l

0.90

153

1381

Superficial injury of ankle and foot, unspecified

293

1.28

0.61

3.3

2.7

1004.46

1095.36

ng/l

0.10

230

Exposure to excessive heat of man-made origin

778

0.84

0.61

2.5

3.3

1661.55

1684.28

ng/l

0.01

655

Maxillary prognathism

211

1.32

0.61

6.2

3.1

688.64

621.24

ng/l

0.06

170

Dermatitis herpetiformis

172

1581

1.12

0.60

3.3

3.1

1174.76

1176.30

ng/l

0.00

154

1353

Alzheimer’s disease (Early onset), excluding more controls

397

3952

0.93

0.60

2.9

3.0

2216.59

2259.26

ng/l

0.05

317

3423

Bicornuate uterus

274

1.28

0.60

2.4

1006.84

646.78

ng/l

0.42

216

Motor neuron disease

176

1618

1.11

0.60

2.9

2.8

1032.63

1560.21

ng/l

1.34

146

1405

Other congenital malformations of face and neck

196

1805

1.10

0.60

3.0

3.1

1722.52

990.33

ng/l

0.47

161

1499

Malignant neoplasm of oesophagus, including Hilmo

398

3775

1.08

0.60

2.7

3.0

1539.00

1652.24

ng/l

0.21

356

3239

Victim of lightning

1.62

0.59

3.4

2.3

596.89

531.11

ng/l

—

Degenerative conditions of globe

501

1.22

0.59

3.3

2020.97

1775.31

ng/l

0.15

410

Acute alcohol intoxication ICD-9

345

3257

1.08

0.59

3.6

3.1

1720.65

1695.73

ng/l

0.03

307

2779

Disorders of visual cortex

1.75

0.59

4.3

5.1

756.83

1435.06

ng/l

—

Injury of muscle and tendon at ankle and foot level

191

1762

1.10

0.59

2.9

973.73

1016.38

ng/l

0.07

153

1468

Scarlet fever

348

1.24

0.58

3.3

3.4

1158.79

574.37

ng/l

0.50

279

Injury of blood vessels at neck level

297

1.28

0.58

2.5

3.2

1440.81

1013.31

ng/l

0.19

245

Certain zoonotic bacterial diseases

173

1594

1.11

0.58

3.1

3.0

1526.70

1262.64

ng/l

0.31

151

1354

Lichen planopilaris

261

1.31

0.58

1.7

2.9

237.70

884.45

ng/l

4.85

220

Other porphyria

136

1.46

0.58

2.7

2.8

1665.00

725.44

ng/l

0.33

110

Use of trihexyphenidyl

145

1.44

0.58

2.7

3.6

1762.29

1308.87

ng/l

0.32

124

Malignant neoplasm of renal pelvis

627

1.20

0.58

3.1

3.3

3850.56

2000.63

ng/l

1.48

546

Graves ophthalmopathy, strict

189

1747

1.11

0.58

2.4

2.8

1050.10

877.39

ng/l

0.26

157

1451

Medical treatment for female infertility

922

9508

0.96

0.57

2.1

2.2

279.42

389.52

ng/l

1.65

742

7533

Burns classified according to extent of body surface involved

716

1.17

0.57

2.7

3.2

3007.10

1164.12

ng/l

0.46

594

Ductal carcinoma of pancreas

750

1.18

0.57

2.2

3.1

805.82

1238.15

ng/l

1.10

643

Proteinuria and renal glomerular damage; focal glomerulonephritis

102

1.56

0.57

6.1

2.9

6550.64

874.03

ng/l

1.34

Acute thyroiditis

307

1.27

0.57

3.3

3.0

674.11

1126.58

ng/l

0.78

257

Other spirochaetal diseases

3392

33332

1.02

0.56

2.6

2.9

762.24

1211.21

ng/l

21.79

2734

28565

Pneumoconiosis due to other inorganic dusts

356

1.26

0.56

3.2

3.6

2884.89

2064.96

ng/l

0.41

297

LSIL lesion of the cervix uteri

634

6071

1.05

0.56

2.5

559.25

614.41

ng/l

0.28

518

4934

Benign neoplasm: Mediastinum

319

1.28

0.55

3.6

3.1

891.93

1056.15

ng/l

0.24

256

Crushing injury of wrist and hand

139

1272

1.12

0.55

2.9

3.0

1722.99

1260.22

ng/l

0.42

121

1096

Injury of blood vessels at wrist and hand level

550

1.19

0.55

2.9

3.2

2927.15

1149.13

ng/l

0.71

462

Renal agenesis and other reduction defects of kidney

391

1.23

0.55

3.2

3.3

6815.32

1274.19

ng/l

1.79

319

Mandibular retrognathia AND surgery (BSSO)

146

1333

1.11

0.55

2.0

2.7

486.00

675.15

ng/l

0.50

118

1076

Carcinoma in situ of breast

410

1.22

0.55

2.0

2.9

357.37

827.81

ng/l

2.35

352

Toxic myoneural disorders

1.70

0.54

2.7

4.3

1940.71

939.23

ng/l

—

Malignant neoplasm of oropharynx, including Hilmo

205

1912

1.10

0.53

3.3

3.0

1859.15

1409.98

ng/l

0.49

183

1620

Postprocedural disorders of eye and adnexa, not elsewhere classified

341

1.28

0.53

2.4

3.4

1519.65

1681.61

ng/l

0.12

274

Meckel's diverticulum

467

1.20

0.53

2.6

3.3

1075.21

1063.44

ng/l

0.01

387

Unspecified maternal hypertension

379

1.21

0.53

3.8

2.5

273.00

600.75

ng/l

0.84

303

Other degenerative diseases of the basal ganglia

210

1968

1.10

0.53

2.7

3.1

894.44

1600.67

ng/l

4.26

187

1725

Anisometropia and aniseikonia

276

2598

1.08

0.53

3.4

3.1

1519.56

1293.94

ng/l

0.34

231

2205

Congenital malformations of eyelid, lacrimal apparatus and orbit

362

1.21

0.52

3.9

4.9

594.36

1010.72

ng/l

0.59

303

Placenta praevia

191

1766

1.09

0.52

1.8

2.5

323.17

431.46

ng/l

0.50

154

1411

Tooth agenesis EXCLUDE clefts and syndromes

147

1343

1.10

0.52

3.6

3.4

885.57

745.05

ng/l

0.17

111

1038

Malignant neoplasm of accessory sinuses, including Hilmo

414

1.22

0.52

2.6

3.2

644.91

1680.25

ng/l

3.59

355

Intentional self-harm by crashing of motor vehicle

1.59

0.51

19.6

4.3

665.14

1174.67

ng/l

—

Crohn's disease (strict) with PSC

1.50

0.51

1.6

2.4

216.77

512.94

ng/l

1.37

Exposure to ignition of highly flammable material

311

1.25

0.51

2.4

2.9

460.72

762.89

ng/l

1.06

248

Wilms' tumor, including Hilmo

556

1.19

0.51

3.6

3.4

3424.07

1858.45

ng/l

1.34

473

Burn and corrosion of shoulder and upper limb, except wrist and hand

169

1565

1.10

0.50

2.6

3.2

1587.93

1169.80

ng/l

0.42

149

1308

Other diseases of appendix

114

1040

1.13

0.50

2.6

3.0

1211.92

1118.86

ng/l

0.09

871

Premature separation of placenta [abruptio placentae]

108

976

1.12

0.50

2.3

2.8

223.26

481.43

ng/l

3.86

819

Purulent endophthalmitis

682

1.17

0.50

3.4

3.3

3226.54

1630.87

ng/l

0.95

571

Spirochaetal infections, other/unspecified

3340

32868

1.02

0.50

2.6

2.9

749.93

1209.55

ng/l

23.05

2687

28176

Dysplastic lesion of the vagina of unknown severity

0.61

0.50

5.8

2.9

842.83

774.89

ng/l

—

Malaria

372

0.80

0.49

3.4

2.9

712.96

952.74

ng/l

0.50

302

Vibratory urticaria

1.64

0.49

3.5

3.1

582.30

810.18

ng/l

—

Other spirochaetal diseases

3346

32933

1.02

0.49

2.6

2.9

742.13

1206.52

ng/l

24.16

2694

28231

Pedestrian injured in collision with two- or three-wheeled motor vehicle

285

1.25

0.49

2.3

3.4

759.38

1371.04

ng/l

0.81

236

Benign neoplasm: Brain, unspecified

500

1.19

0.49

2.6

3.4

1093.34

1386.09

ng/l

0.42

422

Exposure to uncontrolled fire in building or structure

575

1.17

0.48

2.8

3.2

1660.06

1256.56

ng/l

0.34

487

Benign neoplasm: Connective and other soft tissue of head, face and neck

148

1368

1.11

0.48

2.7

3.1

1486.75

1221.71

ng/l

0.35

129

1164

Benign neoplasm: Uterine tubes and ligaments

597

1.17

0.48

2.9

3.1

989.12

1143.49

ng/l

0.19

514

Other infestations

145

1565

0.90

0.48

3.1

3.0

1660.11

1146.37

ng/l

0.42

131

1332

347

3287

1.06

0.48

1.9

2.3

397.63

328.51

ng/l

0.38

274

2571

Kela-code for behavioural disturbances in mental retardation

748

1.15

0.48

2.7

3.2

531.08

1292.53

ng/l

3.99

629

Lyme disease

3314

32627

1.02

0.48

2.6

2.9

740.06

1206.99

ng/l

24.13

2663

27978

Procedures for purposes other than remedying health state

192

1792

1.09

0.48

2.4

2.5

804.27

807.16

ng/l

0.00

163

1475

Type1 diabetes, definitions combined, early onset

248

2317

1.07

0.47

3.2

3.5

1951.91

548.54

ng/l

2.03

206

1769

Exposure to excessive natural cold

972

0.88

0.47

3.7

3.3

2194.22

1552.86

ng/l

0.55

817

Unattended death

948

0.88

0.47

4.0

3.3

2588.47

1874.37

ng/l

0.64

811

Benign neoplasm: Cranial nerves

260

2748

0.93

0.47

2.7

3.0

1364.18

1274.38

ng/l

0.11

226

2343

Other obstetric trauma

222

2077

1.08

0.47

2.3

2.5

367.67

415.59

ng/l

0.13

176

1683

Epiphyseal arrest

1.74

0.46

2.6

5.0

641.00

633.29

ng/l

—

Frostbite involving multiple body regions and unspecified frostbite

168

1.33

0.46

3.6

3.2

2277.57

1161.26

ng/l

0.38

143

Melanocytic naevi of ear and external auricular canal

436

1.19

0.46

4.6

3.2

844.22

1280.76

ng/l

0.89

361

Corneal pigmentations and deposits

372

1.22

0.46

3.9

3.2

1123.39

958.15

ng/l

0.22

307

Systemic atrophies primarily affecting the central nervous system

404

4219

0.94

0.46

2.8

3.1

1457.94

1622.76

ng/l

0.23

334

3604

Other and unspecified degenerative diseases of nervous system

276

2905

0.93

0.46

2.5

3.2

1173.45

1927.60

ng/l

5.53

236

2538

Malignant neoplasm of base of tongue, including Hilmo

821

0.87

0.45

3.3

3.0

1983.47

1355.78

ng/l

0.27

686

Contact with other and unspecified heat and hot substances

474

1.18

0.45

2.6

3.1

4234.86

1302.31

ng/l

0.51

392

Benign neoplasm: Skin of upper limb, including shoulder

182

1703

1.09

0.45

3.0

1654.46

1187.81

ng/l

0.54

156

1449

Use of cabergoline

930

0.88

0.45

3.0

3.1

836.07

1213.16

ng/l

0.95

769

Pedal cyclist injured in noncollision transport accidents

959

9318

1.04

0.45

3.2

3.0

961.83

1226.18

ng/l

2.20

804

7805

Helminthiases

148

1374

1.10

0.44

3.7

3.1

1461.73

1394.66

ng/l

0.07

128

1164

Chronic myringitis

388

0.82

0.44

2.4

3.4

574.78

1074.85

ng/l

1.55

324

Contact with other hot metals

129

1191

1.11

0.44

3.1

3.4

1654.69

1114.87

ng/l

0.65

110

995

Iliac crest spur

1.48

0.44

3.2

3.5

644.22

2079.00

ng/l

—

Retained (old) intraocular foreign body

1.53

0.44

3.6

861.71

843.42

ng/l

—

Malignant neoplasm of gallbladder, including Hilmo

716

1.15

0.44

2.1

2.9

871.82

1674.23

ng/l

2.67

593

Postdysenteric arthropathy

655

1.14

0.44

3.2

3.1

1962.67

1024.31

ng/l

0.54

537

Tularaemia

167

1560

1.09

0.43

3.2

3.0

1269.66

1205.54

ng/l

0.06

146

1320

Other/unspecified postprocedural disorders of ear and mastoid process

309

0.79

0.43

4.2

3.1

2698.73

1245.98

ng/l

0.59

267

Combined immunodeficiency, unspecified

1.50

0.43

3.9

3.1

4103.33

1034.78

ng/l

—

Memory loss

1128

11015

1.03

0.43

2.7

3.2

1713.54

1763.28

ng/l

0.13

955

9618

Amoebiasis

580

1.15

0.43

3.1

3.0

1150.27

991.88

ng/l

0.18

489

Melanocytic naevi of other and unspecified parts of face

497

4782

1.05

0.43

2.7

2.9

1109.81

1227.17

ng/l

0.28

401

4012

Pedal cyclist injured in collision with pedestrian or animal

556

0.85

0.42

3.2

669.93

897.53

ng/l

0.75

464

Inhalation and ingestion of food causing obstruction of respiratory tract

901

0.88

0.42

3.7

3.3

992.30

1598.72

ng/l

1.95

762

Malignant neoplasm of adrenal gland

328

1.21

0.42

2.6

3.1

1761.10

1296.90

ng/l

0.29

272

Benign neoplasm: Endocrine gland, other/unspecified

301

1.23

0.42

2.6

3.4

1178.54

1109.81

ng/l

0.07

255

Underdevelopment of the second kidney

1.44

0.42

4.6

4.2

14118.67

1286.20

ng/l

—

Cleft lip, lip and palate or palate

728

0.88

0.41

5.0

3.3

1229.87

723.85

ng/l

0.45

586

Dementia due to Parkinson's disease

282

2952

0.93

0.41

3.2

3.4

1534.22

2111.26

ng/l

1.49

235

2583

Other congenital malformations of peripheral vascular system

781

1.12

0.41

3.9

3.2

1291.35

897.28

ng/l

0.63

644

Relapsing fevers

116

1.36

0.41

4.3

3.3

391.99

756.71

ng/l

1.20

Vitreous prolapse

237

1.26

0.40

4.7

3.1

2894.91

1018.96

ng/l

0.65

204

Malignant neoplasm of penis

359

1.21

0.40

3.1

3.2

2254.12

1283.68

ng/l

0.78

307

Maternal care for known or suspected disproportion

187

1754

1.07

0.39

1.9

2.6

622.99

386.04

ng/l

0.32

148

1421

Benign neoplasm: Peripheral nerves and autonomic nervous system

151

1414

1.09

0.39

2.8

3.2

711.18

1121.31

ng/l

1.99

124

1192

Increased muscle tone

509

1.15

0.39

3.1

3.5

1590.34

1098.11

ng/l

0.27

421

Synovial hypertrophy, not elsewhere classified

526

1.14

0.39

2.4

3.2

896.25

897.88

ng/l

0.00

422

Other maternal disorders predominantly related to pregnancy

4812

29808

1.01

0.38

2.4

2.5

604.57

746.77

ng/l

2.41

3916

24655

Frontotemporal dementia, wide, incl. Pick's disease

726

0.87

0.38

2.6

3.1

782.29

1587.71

ng/l

2.72

621

Maternal care for known or suspected malpresentation of fetus

760

5678

0.97

0.38

2.0

2.3

420.78

367.49

ng/l

0.12

574

4440

Neonatal jaundice from other and unspecified causes

384

0.85

0.38

10.5

9.2

1499.59

1394.26

ng/l

0.06

333

Pervasive developmental disorders excl. Autism + Asperger

370

1.16

0.38

3.4

4.9

485.98

1194.38

ng/l

0.76

282

Malignant neoplasm of pancreas, including Hilmo

972

9950

0.97

0.37

2.8

3.2

1383.11

1726.12

ng/l

1.66

857

8560

Physiological and behavioural disorders associated with sexual development and orientation

1.39

0.37

2.8

3.1

533.83

768.85

ng/l

0.32

Liposarcoma

676

1.13

0.37

3.2

3.0

2008.16

1355.56

ng/l

0.64

571

Other disorders of kidney and ureter in diseases classified elsewhere

1.52

0.36

6.4

3.7

4254.86

1175.07

ng/l

—

Discontinuity and dislocation of ear ossicles

398

1.17

0.36

2.1

3.1

617.21

996.89

ng/l

1.22

335

Deep bite that required surgery

605

1.12

0.36

1.8

2.8

671.86

580.42

ng/l

0.10

500

Other perinatal haematological disorders

1.40

0.35

4.7

9.1

1239.00

1613.03

ng/l

—

Female infertility, cervical, vaginal, other or unspecified origin

1904

12159

1.02

0.35

2.3

2.5

531.01

919.67

ng/l

10.12

1548

10096

Degenerative diseases of the nervous system

5525

40943

0.99

0.35

3.0

3.3

2245.22

1975.86

ng/l

2.83

4651

35812

Traumatic amputation of forearm

1.44

0.35

2.9

2.8

1429.14

1451.48

ng/l

—

Cleft lip and cleft lip and palate

391

0.85

0.35

5.5

3.2

1493.90

725.33

ng/l

0.37

314

Pedal cyclist injured in collision with motor vehicle

240

2286

1.06

0.35

2.9

3.1

1216.17

1256.37

ng/l

0.05

184

1906

Iodine-deficiency-related thyroid disorders and allied conditions

103

1.41

0.34

1.6

2.8

227.53

1488.32

ng/l

2.10

Other specified transport accidents

323

1.17

0.34

2.1

3.4

4671.46

780.37

ng/l

0.47

259

Malignant neoplasm of cervix uteri

115

1071

1.09

0.34

2.2

2.7

3250.70

1185.23

ng/l

1.01

102

889

Carcinoma in situ, other and unspecified urinary organs

1.43

0.34

1.6

2.9

829.67

977.19

ng/l

—

562

1.13

0.34

2.4

2.9

591.56

724.04

ng/l

0.25

469

Arteriovenous malformation of cerebral vessels

900

1.10

0.34

3.3

2.9

929.89

1014.91

ng/l

0.14

753

Other and unspecified postprocedural disorders of eye and adnexa

243

1.24

0.33

2.5

3.3

1359.43

1652.15

ng/l

0.19

194

Effects of air pressure and water pressure

306

1.18

0.33

1.6

2.5

263.26

643.64

ng/l

3.39

250

Malignant neoplasm of tonsil, including Hilmo

165

1563

1.08

0.32

3.3

3.0

1463.82

1382.48

ng/l

0.06

146

1324

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

117

0.71

0.32

3.8

334.78

1905.71

ng/l

—

Transient synovitis

381

1.15

0.32

4.6

3.4

1985.63

936.14

ng/l

0.46

306

Malignant neoplasm of oesophagus

275

2641

1.06

0.32

2.7

3.1

1308.22

1712.39

ng/l

1.86

246

2262

Endometroid carcinoma of ovary, including Hilmo

846

1.11

0.32

3.3

2.7

1843.43

1235.09

ng/l

0.37

701

Scarlet fever

287

1.17

0.32

3.5

2.9

1465.41

570.84

ng/l

0.63

227

Congenital malformations of eyelid, lacrimal apparatus and orbit

430

1.13

0.31

3.6

4.8

625.60

985.28

ng/l

0.56

358

Moyamoya

1.38

0.30

20.3

1.8

1031.12

464.46

ng/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

635

1.12

0.30

2.6

3.1

1401.75

1185.47

ng/l

0.15

539

Cleft hard palate NOS

176

1.22

0.30

3.5

1080.53

664.71

ng/l

0.46

142

Other congenital malformations of male genital organs

279

1.17

0.30

5.6

6.2

1825.48

1071.67

ng/l

0.56

227

Other congenital malformations of female genitalia

307

1.16

0.30

3.5

2.7

1049.92

803.13

ng/l

0.29

240

Carcinoma in situ of breast, intraductal

819

8011

1.03

0.30

2.5

2.8

807.32

1023.57

ng/l

1.61

680

6833

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

656

1.11

0.29

2.9

3.1

1745.79

1601.49

ng/l

0.07

550

Cyst of spleen

132

1.28

0.29

5.4

2.8

738.75

1011.66

ng/l

0.33

108

Viral conjunctivitis

142

1342

1.07

0.29

2.6

3.0

1559.78

984.06

ng/l

0.60

124

1112

Twin gestation

420

4064

1.04

0.29

2.3

429.14

403.55

ng/l

0.09

327

3268

Thiamine deficiency

483

1.13

0.29

2.4

3.0

1131.19

1181.14

ng/l

0.07

411

Medullary carcinoma of thyroid gland

1.30

0.29

4.1

2.7

735.11

713.02

ng/l

—

Multiple gestation

436

4222

1.04

0.29

2.3

428.38

413.32

ng/l

0.06

339

3403

Congenital cataract

272

1.17

0.29

3.7

3.4

957.17

1040.04

ng/l

0.08

225

Accessory breast

300

1.15

0.28

2.0

2.5

669.01

870.12

ng/l

0.19

244

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

909

1.09

0.28

2.8

3.1

1411.72

1823.99

ng/l

0.32

772

Melanoma in situ of lower limb, including hip

600

1.11

0.28

3.8

3.0

1064.30

1145.72

ng/l

0.12

507

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

809

0.91

0.28

2.3

3.0

930.19

928.71

ng/l

0.00

680

Pediculosis and phthiriasis

339

1.14

0.27

2.6

2.7

840.16

870.40

ng/l

0.04

273

Dementia in other diseases classified elsewhere

534

5209

1.04

0.27

3.0

3.2

1356.63

1857.33

ng/l

2.31

434

4528

Haemorrhagic and haematological disorders of fetus and newborn

468

1.11

0.27

8.5

1186.23

1245.33

ng/l

0.05

400

Carcinoma in situ of prostate

642

1.11

0.27

2.7

3.2

1504.31

1333.72

ng/l

0.11

555

Mumps

207

1984

1.05

0.26

2.5

2.9

809.22

1053.10

ng/l

0.69

176

1644

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

390

0.87

0.26

3.3

2.9

5544.13

1213.80

ng/l

0.44

325

Personality and behavioural disorders due to brain disease, damage and dysfunction

141

1339

1.07

0.26

3.5

3.3

1814.19

1371.00

ng/l

0.33

114

1141

Polymorphous light eruption

475

1.12

0.26

2.2

2.9

593.02

841.77

ng/l

0.65

404

Qualitative platelet defects

295

1.16

0.25

3.3

1084.38

1043.87

ng/l

0.04

246

Degenerative and vascular disorders of ear

135

1.26

0.25

2.7

883.45

1170.05

ng/l

0.32

120

Melanocytic naevi of eyelid, including canthus

787

1.09

0.25

2.7

3.1

939.61

1094.79

ng/l

0.30

662

Acute myringitis

457

1.12

0.25

4.7

3.1

509.23

1202.77

ng/l

3.13

390

Use of anticholinesterases

5399

42856

0.99

0.25

2.7

3.3

1784.86

2015.34

ng/l

3.31

4530

37445

N06DA Anticholinesterases

5399

42856

0.99

0.25

2.7

3.3

1784.86

2015.34

ng/l

3.31

4530

37445

Psoriatic arthropathies, strict definition

1.35

0.25

1.4

4.6

92.00

1161.22

ng/l

—

Malignant neoplasm of vagina, including Hilmo

306

1.16

0.25

2.5

2.9

2172.00

1476.93

ng/l

0.28

262

Contact with blunt object, undetermined intent

400

1.12

0.24

2.9

564.51

872.92

ng/l

1.02

322

Occlusion and stenosis of arteries, not leading to stroke

156

1492

1.06

0.24

4.2

3.3

2552.27

2190.04

ng/l

0.28

140

1298

Other congenital malformations of integument

258

1.17

0.24

2.6

3.2

3413.03

1308.78

ng/l

0.69

214

Malignant neoplasm of other and unspecified female genital organs

160

1533

1.06

0.24

2.3

2.7

1156.69

1185.32

ng/l

0.04

149

1276

Other congenital malformations of integument

1.33

0.24

2.8

5.2

316.00

1167.80

ng/l

—

Human immunodeficiency virus [HIV] disease resulting in other specified diseases

1.29

0.24

2.2

3.6

1696.20

2172.98

ng/l

—

Obstructive hydrocephalus

134

1276

1.07

0.24

2.8

3.3

1053.93

1434.79

ng/l

1.05

115

1085

Obstructed labour due to maternal pelvic abnormality

1230

12491

0.98

0.24

2.5

2.6

904.68

789.03

ng/l

0.36

995

10545

Dysplastic lesion of unknown severity of the cervix uteri

496

1.10

0.24

2.4

2.7

669.86

642.02

ng/l

0.03

406

Melanoma in situ of upper limb, including shoulder

742

1.09

0.24

2.6

3.2

1910.14

1331.93

ng/l

0.44

623

Other inherited muscular atrophy

145

1.23

0.24

1.5

3.0

3048.33

1396.81

ng/l

0.30

119

Respiratory tuberculosis, clinically confirmed

123

1292

0.94

0.23

3.4

3.3

1371.22

2226.87

ng/l

1.97

107

1106

Gastric ulcer - Acute with haemorrhage, drug-induced

176

0.81

0.23

4.1

3.2

3055.61

1800.03

ng/l

0.35

139

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

462

0.90

0.23

2.0

3.5

404.14

634.23

ng/l

0.70

385

Occupant of pick-up truck or van injured in other and unspecified transport accidents

373

1.12

0.23

3.5

3.0

1437.08

840.82

ng/l

0.53

308

Disorders of other digestive organs in diseases classified elsewhere

1.41

0.23

1.8

3.8

432.65

877.13

ng/l

—

Other sexually transmitted chlamydial diseases

331

3416

0.97

0.23

2.4

2.8

354.10

537.75

ng/l

1.38

220

2559

Tularaemia

115

1094

1.07

0.22

3.1

3.0

1596.82

1265.72

ng/l

0.27

103

925

Dermatitis due to ingested food

114

1035

1.06

0.22

3.7

5.0

1566.43

943.44

ng/l

0.30

821

Use of levodopa decarbox-comt-inhibitor

371

3619

1.04

0.22

2.7

3.2

1099.41

1773.95

ng/l

5.39

317

3144

Other abnormal products of conception

1841

12036

1.01

0.21

2.1

2.3

383.13

479.64

ng/l

0.70

1436

9720

Malignant neoplasm of stomach

577

5656

1.03

0.21

2.9

3.1

1797.15

1863.24

ng/l

0.13

525

4862

Niacin deficiency [pellagra]

1.35

0.21

3.9

2.5

342.38

1934.32

ng/l

—

Lichen ruber moniliformis

0.67

0.21

2.2

3.7

635.80

1433.88

ng/l

—

Medullary cystic kidney disease, nephronophthisis

109

1.25

0.21

3.6

2.8

7965.15

869.26

ng/l

1.11

Use of interferon beta-1a

111

1055

1.06

0.20

2.1

2.8

594.02

633.32

ng/l

0.08

858

Hereditary erythropoietic porphyria

1.30

0.20

3.1

2.8

717.86

1999.17

ng/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

107

1018

1.06

0.20

3.4

3.0

1540.37

961.81

ng/l

0.47

832

Other specified/unspecified diseases of inner ear

455

1.10

0.20

3.2

3.0

1459.18

1505.67

ng/l

0.03

383

Carcinoma in situ of middle ear and respiratory system

485

1.10

0.20

3.5

3.3

770.33

1556.38

ng/l

1.68

405

Leprosy [Hansen's disease]

1.22

0.20

5.6

3.5

1187.43

1444.72

ng/l

—

Caries of enamel

10020

72590

0.99

0.20

2.9

866.62

1129.60

ng/l

10.29

8168

61403

Drug-induced tics and other tics of organic origin

0.72

0.19

2.4

3.0

923.40

759.41

ng/l

—

Fall involving playground equipment

319

1.11

0.19

3.8

5.3

416.54

1121.79

ng/l

3.23

265

Follicular adenocarcinoma of thyroid gland

573

1.09

0.19

3.4

3.1

906.07

1588.20

ng/l

2.09

481

Infections specific to the perinatal period

299

1.11

0.19

8.5

6.8

2426.16

715.45

ng/l

0.90

252

Sequelae of transport accidents

330

1.11

0.18

2.4

3.4

679.06

1095.42

ng/l

1.28

272

Epileptic seizures related to alcohol

525

0.91

0.18

2.5

3.0

2040.72

983.93

ng/l

0.98

440

Frostbite with tissue necrosis

246

0.87

0.18

1.9

3.0

1701.35

1277.05

ng/l

0.13

199

Microtia (small ears)

1.19

0.18

4.1

5.5

330.71

672.76

ng/l

—

Melanoma in situ of eyelid, including canthus

0.77

0.18

3.3

3.5

659.29

1187.51

ng/l

—

Accidental poisoning by and exposure to alcohol

110

1150

0.95

0.18

3.0

1589.44

1367.90

ng/l

0.14

938

Early syphilis

886

1.06

0.17

2.7

3.0

992.56

927.14

ng/l

0.11

744

Frontotemporal dementia

604

0.92

0.17

2.7

3.2

696.77

1584.81

ng/l

3.27

522

Malignant cancer of tonsil and base of tongue

179

1847

0.96

0.17

3.2

3.0

1423.65

1369.33

ng/l

0.04

156

1566

Postpartum hemorraghe, parous women as controls

1368

11508

1.01

0.17

2.0

2.3

427.63

462.88

ng/l

0.17

1059

9259

Malignant neoplasm of palate

246

1.14

0.17

2.8

3.0

1184.59

1168.84

ng/l

0.02

212

Malignant neoplasm of oropharynx

152

1469

1.05

0.17

3.4

3.1

1492.10

1322.22

ng/l

0.20

134

1246

Pediculosis and phthiriasis

197

1.14

0.17

2.3

2.9

951.24

703.72

ng/l

0.37

167

Fibrosarcoma

694

1.07

0.16

2.3

3.0

1375.35

1573.00

ng/l

0.16

594

Tonsillectomy and adenotomy

4283

29990

0.99

0.16

2.7

2.8

678.70

889.07

ng/l

2.55

3362

24599

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

1.16

0.16

2.6

3.2

1054.22

1013.98

ng/l

—

Benign neoplasm: Short bones of upper limb

117

1125

1.05

0.16

2.1

2.9

889.28

840.02

ng/l

0.06

951

Perioral dermatitis, drug-induced

0.81

0.16

6.4

3.1

799.70

1955.56

ng/l

—

Cleft palate

409

0.92

0.15

4.2

3.5

762.77

714.97

ng/l

0.07

319

Malignant neoplasm of eye and adnexa

796

1.06

0.14

3.5

3.3

1091.67

1495.57

ng/l

0.86

676

Benign neoplasm: Male genital organ, other/unspecified

1.24

0.14

2.8

3.1

1227.70

835.31

ng/l

—

Carcinoma in situ of cervix uteri

496

4879

1.02

0.14

2.8

2.6

996.09

738.59

ng/l

0.89

413

3938

Open bite that required surgery (Lefort1 or BSSO)

376

0.92

0.13

1.7

2.4

215.88

445.12

ng/l

1.81

295

Helminthiases

260

2543

1.03

0.13

3.1

1099.74

1168.67

ng/l

0.12

222

2120

Chondrosarcoma, including Hilmo

415

1.08

0.13

2.9

3.1

1359.62

1341.88

ng/l

0.01

351

Mucinous and mucinous cystic tumor, including Hilmo

542

1.07

0.13

3.3

2.8

1229.27

1069.71

ng/l

0.13

440

Prominent ears

277

1.09

0.13

2.4

3.3

372.10

447.57

ng/l

0.19

206

Malignant neoplasm of other and ill-defined digestive organs

857

1.05

0.13

2.7

3.2

1751.88

1812.07

ng/l

0.05

733

Sequelae of poliomyelitis

106

1026

1.05

0.13

2.3

3.1

1248.69

1801.45

ng/l

0.81

889

Congenital obstruction of the pelviureteric junction

598

0.94

0.12

3.2

2476.03

876.40

ng/l

0.67

494

Convergence insufficiency and excess

711

0.95

0.12

2.9

2.8

527.11

720.63

ng/l

0.55

568

Asymmetry of jaw

719

1.05

0.12

2.9

3.0

463.75

697.66

ng/l

0.60

579

Benign neoplasm: Tonsil

109

1056

1.04

0.12

2.9

3.1

1783.10

1044.08

ng/l

0.83

897

Malignant neoplasm of larynx

147

1509

0.97

0.12

2.3

3.2

2164.36

1872.68

ng/l

0.18

127

1299

Non-small cell lung cancer, squamous

510

5167

0.98

0.12

3.0

3.3

1423.47

2199.37

ng/l

7.18

468

4458

Febrile neutrophilic dermatosis [Sweet]

125

1.16

0.11

4.1

3.4

1984.16

1239.80

ng/l

0.43

108

Benign neoplasm: Female genital organ, unspecified

271

1.10

0.11

2.1

2.8

1052.51

1169.93

ng/l

0.07

231

Malignant neoplasm, without specification of site

351

3457

1.02

0.11

3.5

3.2

2398.27

2003.54

ng/l

0.76

306

2989

Benign neoplasm: Brain, infratentorial

437

1.07

0.11

2.1

3.5

436.74

1218.70

ng/l

2.60

370

Other specified and unspecified disorders of choroid

320

0.92

0.11

4.3

3.4

1552.74

1052.07

ng/l

0.51

260

Malignant cancer of tonsil and base of tongue, including Hilmo

232

2277

1.03

0.11

3.3

3.1

1363.69

1386.35

ng/l

0.02

205

1931

Melanoma of uvea

105

1020

1.04

0.10

3.5

3.3

1129.93

1477.79

ng/l

0.91

879

Pityriasis lichenoides chronica

340

1.08

0.10

2.0

3.3

1882.46

1675.87

ng/l

0.09

291

Neurological devices associated with adverse incidents

0.82

0.10

2.6

2.9

1287.20

1041.91

ng/l

—

Caries in Clefts patients

437

1.06

0.10

5.9

3.1

1560.81

597.39

ng/l

0.68

344

Malignant neoplasm of meninges

1.16

0.10

2.0

2.4

105.08

992.41

ng/l

—

Other congenital malformations of male genital organs

320

1.07

0.10

5.4

6.5

1705.03

1055.89

ng/l

0.50

259

Other drug-induced osteomalacia in adults

1.08

0.10

2.2

2.3

421.00

370.09

ng/l

—

Fibrosarcoma, including Hilmo

814

1.04

0.10

2.4

2.9

1387.98

1492.34

ng/l

0.09

691

Other disorders of binocular vision

714

1.04

0.09

2.3

3.0

339.29

917.52

ng/l

5.26

575

Irritant contact dermatitis due to drugs in contact with skin

1.10

0.09

1.2

3.5

216.70

1010.74

ng/l

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

163

1597

1.03

0.09

3.4

3.1

1589.50

1785.19

ng/l

0.23

148

1369

Schistosomiasis [bilharziasis]

214

1.09

0.09

2.7

3.1

400.81

1042.11

ng/l

1.96

175

Pinta [carate]

1.07

0.09

3.8

3.5

4698.00

608.32

ng/l

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.81

0.09

4.7

3.6

2172.33

1161.81

ng/l

—

Toxoplasmosis

440

0.94

0.09

3.3

3.0

1423.97

1010.98

ng/l

0.59

362

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

439

1.05

0.09

1.7

2.6

397.20

514.74

ng/l

0.27

349

Hookworm diseases

0.78

0.09

2.2

3.2

369.00

1214.25

ng/l

—

Sweet's syndrome

127

1.14

0.09

4.1

3.5

1984.16

1795.77

ng/l

0.07

108

Solar urticaria

1.17

0.09

3.3

3.5

734.10

1097.14

ng/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

2790

23304

0.99

0.08

3.0

3.2

1503.39

1727.32

ng/l

2.01

2535

20139

Postpartum haemorrhage

1368

11587

0.99

0.08

2.0

2.3

427.63

519.00

ng/l

0.54

1059

9329

Biliary cirrhosis, secondary

1.17

0.08

3.2

2.5

4042.89

1865.99

ng/l

—

Abnormalities of forces of labour

554

5485

1.01

0.08

2.0

2.4

546.36

454.16

ng/l

0.23

444

4518

Lichen striatus

0.81

0.08

1.3

3.6

240.93

1747.63

ng/l

—

Benign neoplasm: Lacrimal gland and duct

118

1.15

0.08

2.5

3.8

689.86

1210.58

ng/l

—

100

Post-traumatic hydrocephalus, unspecified

245

1.08

0.08

2.4

3.2

2019.14

1747.43

ng/l

0.13

200

Benign neoplasm: other/unspecified salivary gland

274

2704

1.02

0.08

3.8

3.0

1804.14

1572.14

ng/l

0.32

230

2326

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

679

0.96

0.07

2.9

3.4

844.50

1583.45

ng/l

2.19

588

Mandibular prognathia AND surgery (LeFortI or BSSO)

226

1.07

0.07

1.9

2.8

502.51

487.53

ng/l

0.02

191

Desensitization to allergens

234

2373

0.98

0.07

2.5

3.1

1072.71

609.21

ng/l

0.31

178

1899

Malignant neoplasm of meninges, including Hilmo

365

1.06

0.06

2.7

3.1

634.44

1445.76

ng/l

1.98

303

ILD medications: acetylcysteine

771

1.03

0.06

3.5

2.9

1595.89

2372.32

ng/l

1.17

645

Benign neoplasm: Parathyroid gland

111

1090

1.03

0.06

3.5

3.1

4599.61

1255.08

ng/l

1.21

921

Contraceptive management

3344

23379

1.00

0.06

2.5

2.6

469.48

754.41

ng/l

9.43

2691

19162

Precocious puberty

110

0.90

0.05

1.4

4.1

653.20

600.02

ng/l

—

Other and unspecified heterotropia

249

1.06

0.04

2.6

3.8

685.10

1222.42

ng/l

1.26

212

Sequelae of poliomyelitis

865

0.98

0.04

2.3

3.1

1258.69

1753.63

ng/l

0.54

749

Malignant neoplasm of larynx, including Hilmo

200

1980

1.01

0.04

2.8

3.1

2012.23

1799.76

ng/l

0.17

173

1699

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

533

0.97

0.04

3.2

3.1

1131.26

997.49

ng/l

0.19

445

Early syphilis

825

0.98

0.04

2.7

3.1

1068.75

966.63

ng/l

0.16

691

Mucinous and mucinous cystic tumor of rectum

488

1.04

0.04

2.8

3.0

1670.17

1428.35

ng/l

0.23

408

Respiratory tuberculosis, not confirmed

452

4496

1.01

0.03

3.5

3.2

1738.33

2007.81

ng/l

0.61

397

3874

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

632

0.98

0.03

4.1

3.0

945.33

1388.01

ng/l

1.04

537

Hereditary ataxia

116

1174

0.98

0.03

2.8

3.3

1752.68

1430.10

ng/l

0.15

1005

Foreign object accidentally left in body during surgical and medical care

249

0.95

0.03

4.5

3.2

2040.66

902.03

ng/l

0.59

208

Malignant neoplasm of tonsil

136

1347

1.01

0.03

3.5

3.0

1104.57

1367.00

ng/l

0.66

119

1138

Other sexually transmitted chlamydial diseases

227

2254

1.01

0.02

2.1

2.8

373.48

517.43

ng/l

0.66

148

1697

Sequelae of other accidents

140

1413

0.99

0.02

2.5

3.1

1573.66

1565.31

ng/l

0.01

119

1197

Endometroid carcinoma of ovary

570

0.98

0.02

3.4

2.6

2700.47

1127.15

ng/l

0.67

471

Other and unspecified spinal muscular atrophies

780

1.02

0.02

3.0

3.2

1734.69

1463.43

ng/l

0.19

667

Hydatidiform mole

740

0.98

0.02

2.4

2.7

910.04

693.80

ng/l

0.16

616

Hypotony of eye

137

0.93

0.02

4.2

2.7

2271.35

1020.81

ng/l

0.37

110

Mucinous and mucinous cystic tumor

368

0.97

0.02

3.1

2.9

458.74

1120.36

ng/l

2.13

298

Acute disseminated encephalitis/encephalomyelitis

133

1.07

0.02

2.4

2.9

845.32

895.41

ng/l

—

109

Rubella [German measles]

250

2511

0.99

0.01

2.9

2.8

565.76

803.36

ng/l

1.46

218

2101

Carcinoma in situ of cervix uteri, exocervix

353

1.02

0.01

2.3

2.9

1288.26

544.77

ng/l

0.51

294

Mechanical strabismus

174

1.04

0.00

1.7

3.1

261.15

1079.85

ng/l

4.49

152

Malignant neoplasm of nasopharynx, including Hilmo

476

0.98

0.00

3.3

3.0

937.01

1521.74

ng/l

1.04

406

Malignant neoplasm of gallbladder

484

1.02

0.00

2.0

2.7

958.17

1732.30

ng/l

1.52

396

Undefined dementia

1652

15231

1.00

0.00

3.3

3.4

2569.33

2503.63

ng/l

0.16

1383

13138

Benign neoplasm: Short bones of lower limb

744

1.01

0.00

2.8

3.1

1429.14

951.29

ng/l

0.45

615

Personal history of allergy to analgesic agent

374

0.99

0.00

1.9

2.7

382.85

715.98

ng/l

1.42

302

Vaginal lichen planus

436

1.01

0.00

2.2

3.0

585.79

892.19

ng/l

0.85

373

Benign neoplasm: Ill-defined sites within the digestive system

574

0.99

0.00

2.8

3.2

1609.75

1146.76

ng/l

0.26

489

Arteriovenous malformation of peripheral vessels

311

1.00

0.00

3.6

3.2

1433.43

832.00

ng/l

0.47

256

Otosclerosis

751

7507

1.00

0.00

2.9

3.0

1482.66

1406.56

ng/l

0.10

621

6455

Carcinoma in situ of cervix uteri, endocervix

541

1.00

0.00

2.2

2.7

638.97

798.01

ng/l

0.17

440

Other assisted single delivery

649

1.00

0.00

1.5

2.8

238.00

420.39

ng/l

0.68

532

Contact with venomous snakes and lizards

829

1.00

0.00

2.5

3.3

539.24

1118.95

ng/l

3.90

699

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

325

3248

1.00

0.00

3.6

3.1

1882.05

1990.22

ng/l

0.15

287

2810

Carcinoma in situ of breast, other/unspecified

132

1319

1.00

0.00

2.5

2.8

1018.99

1097.18

ng/l

0.15

107

1118

Disorders of acoustic nerve

247

2471

1.00

0.00

2.6

2.9

1065.36

1243.63

ng/l

0.45

215

2131

Placental disorders

317

1.01

0.00

1.7

2.9

132.02

450.18

ng/l

3.50

258

Other and unspecified syphilis

233

0.98

0.00

2.8

3.0

2068.56

1131.90

ng/l

0.31

178

Motorcycle rider injured in noncollision transport accidents

180

1795

1.00

0.00

2.6

3.1

629.64

981.13

ng/l

1.54

142

1468

Diving or jumping into water causing injury other than drowning or submersion

287

1.01

0.00

2.1

3.1

513.30

826.77

ng/l

0.82

237

Acute hepatitis A

353

0.99

0.00

2.3

3.0

1569.29

884.60

ng/l

0.43

288

Chondrosarcoma

265

1.03

0.00

2.2

3.1

1891.11

1423.56

ng/l

0.12

218

Other infiltrative disorders of skin and subcutaneous tissue

415

0.98

0.00

3.8

3.2

2291.46

1094.14

ng/l

0.75

359

Use of teriflunomide

416

1.01

0.00

2.0

3.0

471.06

630.46

ng/l

0.25

343

Congenital absence of the uterus

0.88

0.00

3.2

2.8

620.30

966.23

ng/l

—

Other hypertrophic osteoarthropathy

0.98

-0.00

1.0

4.2

565.67

2750.57

ng/l

—

Diphyllobothriasis and sparganosis

0.98

-0.00

2.0

2.3

321.67

1149.77

ng/l

—

Contact with other specified venomous plants

1.04

-0.00

2.0

2.5

343.33

1340.40

ng/l

—

Von Hippel-Lindau syndrome

1.05

-0.00

5.6

2.8

7590.40

685.86

ng/l

—

Injury of muscle and tendon at neck level

0.94

-0.00

3.6

3.5

602.33

763.30

ng/l

—

Congenital absence, atresia and stenosis of small intestine

1.02

-0.00

4.0

4.8

862.00

932.99

ng/l

—

Other benign neoplasm of uterus: Cervix uteri

480

1.00

-0.00

2.3

3.0

600.78

838.24

ng/l

0.82

404

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

0.86

-0.00

4.8

2.7

1731.20

1092.62

ng/l

—

Hookworm diseases

0.95

-0.00

2.2

3.2

369.00

1183.20

ng/l

—

Other degenerative disorders of globe

1.00

-0.00

3.8

3.5

1939.80

1549.19

ng/l

—